87049087 alli health personnel electr countershock emerg emerg medic technician human prognosi recurr support govt ph factor transport patient ventricular fibrillationth refibril manag emtd incid outcom param backup patient convert ventricular fibril organ rhythm defibrillationtrain ambul technician emtd refibril befor hospit arriv author analyz case ventricular fibril manag emtd work param backup patient initi convert organ rhythm refibril reconvert perfu rhythm includ spontan pul prior refibril patient initi convert organ rhythm hospit admi rate lower patient refibril patient versu ns discharg rate virtual ident respect scenetohospit transport predict associ frequenc refibril patient outcom defibrillationtrain emt effect manag refibril addition shock ar signif disadvantag param backup avail 
87049088 antidepress agent tricyclicpo arrhythmiapp california electrocardiographi emerg emerg servic hospit femal human length stai male prognosi retrospect studi tachycardia sinusdith tricycl antidepress overdo emerg depart predictor clinic cour controversi regard appropri util health care resourc manag tricycl antidepress overdosag antidepress overdo patient present emerg depart ed ar routin admit inten care unit onli propor develop cardiac arrhythmia complic requir environ author review patient present ed antidepress overdo thei major manifest toxic ed evalu alter mental statu seizur arrhythmia conduc defect commonli associ complic hospit cour patient isol sinu tachycardia qtc prolong complic patient experienc seriou toxic event major evid toxic ed evalu continu evid toxic dure hospit cour data support concept proper ed evalu identifi larg bodi patient trivial ing mai requir hospit observ 
87049089 adult aircraft altitud blood ga monitor transcutaneousmt conjunctivam femal human male monitor physiologicmt regr analysi transport patientsmt transconjunctiv oxygen monitor predictor hypoxemia dure helicopt transport helicopt air transport critic ill patient increa avail monitor devic physiolog paramet dure flight becom import ha arteri po2 pao2 decrea dure unsuppl nonpressur flight thi studi author examin transconjunctiv oxygen cjo2 monitor assess adequaci arteri oxygen dure helicopt flight healthi volunt arteri pao2 measur conven blood ga analysi wa compar cjo2 ground level feet feet altitud mean pao2 drop significantli mm hg respect analysi varianc repeat measur mean cjo2 decrea significantli mm hg respect analysi varianc repeat measur individu subject cjo2 wa accur predictor pao2 multipl regr analysi relationship cjo2 pao2 wa linear regr coeffici author conclud transconjunctiv o2 monitor mai monitor adequaci arteri oxygen dure helicopt flight hemodynam stabl patient result studi support supplem oxygen patient subject helicopt transport 
87049090 adolesc adult ag blood glucosem diabet mellitusbl emerg femal glucosead human hypoglycemiath male middl ag prospect studi solution serum gluco chang administr dextro solution pre inhospit calcul prospect clinic trial wa conduct estim rise serum gluco level venou bolu ml dextro solution d50 emerg depart fifti subject alter level consciou studi patient diabet diabet chang gluco level total studi group rang low mgdl high mgdl mean mgdl mean diabet nondiabet group mgdl mgdl result suggest serum gluco level quantit predict singl venou bolu d50 
87049092 ag ag case report femal human intub gastrointestinala pneumothoraxetrath suicid attempt nasogastr intub morbid asymptomat patient unusu case misdirect nasogastr tube describ elderli woman wa emerg depart follow inten drug overdo initi unrecogn errant placem largebor nasogastr tube result tension pneumothorax pneumonia subsequ death pertin medic literatur review clinic consid elderli patient ar discuss sugg proper nasogastr tube placem ar offer 
87049093 abdomin injurieset accid occup accid traffic adult amput blood transfusion case report femal fractureset human pelvic bonesin shock hemorrhagicetth wound nonpenetratingco massiv transfusion major complic trauma case massiv deglov injuri trunk open pelvic fractur evisc abdomin content blunt trauma present signif aspect thi case wa transfusion unit pack cell unit fresh frozen plasma thirti patient ultim recov return work 
87049094 adult carbon monoxid poisoningcoth femal human labor pregnanc pregnanc complicationsth pregnanc trimest respir artifici respiratori distress syndrom adultetth acut carbon monoxid poison dure pregnanc cour pregnant patient term wa acut expo carbon monoxid describ review fetalmatern carboxyhemoglobin relationship differ fetal oxyhemoglobin physiologi ar explain recommend pregnant women carbon monoxid poison receiv oxygen therapi otherw necessari role hyperbar oxygen therapi consid 
87049096 case report child preschool drug administr rout emerg human male phenytoinadbl statu epilepticusbldt tibia osseou infusion phenytoin critic ill child administr fluid medic osseou rout prove lifesav author describ case child statu epilepticu phenytoin wa administ osseou rout seizur resolu therapeut serum level achiev osseou drug administr reserv rare critic ill child vascular access prove imposs 
87049098 alcohol drink case report emerg esophag diseasescodisu human male middl ag ruptur spontan syndrom vomitinget boerhaav syndrom elu diagnosi boerhaav syndrom repr diagnost dilemma emerg physician prognosi thi truli lifethreaten emerg darken ani signif diagnost delai unfortun classic expect symptom sign ar frequent absent present circumst lead frequent misdiagnosi case boerhaav syndrom atyp clinic present ar review discuss clear boerhaav syndrom alwai suspect evalu ani sudden chest abdomin pain associ emesi howev emphasi thi entiti mai occur emesi chest radiograph help diagnost aid undoubtedli mainten high degr suspicion emerg physician boerhaav syndrom lead consist earlier diagnosi subsequ aggress interven result consid reduc rate morbid mortal 
87049099 adult case report electrocardiographi extrasystolepp femal human male middl ag tachycardia sinuspp tachycardia supraventricularpp case electrocardiographi 
87049100 bone marrow child child preschool drug administr routesismt human infant needl osseou infusion usabl techniqu osseou infusion wide pediatr patient dure report reintroduc thi concept confirm safeti readi access fluid drug administr howev report address difficulti encount dure inser osseou needl spinal needl standard metal venou iv needl bone marrow biopsi needl suggest osseou infusion needl test ea inser pediatr cadav leg site needl placem wa evalu dure studi wa 13gaug kormedjamshidi dispo bone marrowaspir needl wa easiest insert plug bone tissu dure inser area proxim medial malleolu wa provid stabl rel flat easili penetr locat needl placem thi method wa successfulli util pediatr adult patient osseou needl placem safe rapid method gain access venou circul util techniqu stabl usabl fluid line establish dehydr pediatr patient 
87049101 adult case report cellulitisci human injec venou male pulmonari edemaci suicid attempt turpentinead venou hydrocarbon abu case inject turpentin venou attempt kill report patient develop immedi pulmonari edema hypoxia follow cellul site injec onli death date ha attribut thi form chemic abu exten local reaction pulmonari involv central nervou depr febril reaction anticip patient admit hospit patient observ local reaction myonecrosi site injec especi occur 
87049102 abdomen administr inhal adolesc adult alopeciaci case report cocain drug contamin human hypertensionci male painci substanc abu thalliumpo thallium poison cocain abu user illicit drug endang unpredict concentr drug unexpect adult mai present cocain ha adult admix numer substanc local anesthet amphetamin phencyclidin strychnin report case thallium poison follow nasal insuffl substanc wa believ cocain 
87049103 adult case report ethchlorvynol femal human injec venou male pulmonari edemaci substanc abu pulmonari edema induc venou ethchlorvynol venou injec ethchlorvynol uncommon cau noncardiac pulmonari edema case venou ethchlorvynolinduc pulmonari edema ar present patient asleep inject liquid content placydil capsul ethchlorvynol awok sever sever dyspnea arteri blood gase demonstr mark hypoxia chest radiograph reveal bilat diffu alveolar densiti patient symptom radiograph resolv sever dai support care chang lung cau ethchlorvynol mai result direct effect drug lung 
87049104 adolesc atropinetu baclofenpo bradycardiacidt case report human hypotensioncidt male atropin treatment baclofen overdo patient suffer baclofen overdo successfulli treat atropin report admi ing mg baclofen singl dose patient becam comato subsequ bradycard hypoten hypotherm prompt increa heart rate blood pressur follow administr mg atropin sulfat atropin appear treat case baclofen overdo complic bradycardia hypoten 
87049105 administr oral adolesc burn chemicalet case report colloid epiglottisin human male pharynxin salicyl acidsad suicid attempt tonguein ing compound unusu caustic case unusu caustic ing involv compound counter wart remov present chemic burn tongu pharynx larynx develop activ ingredi thi prepar salicyl acid flexibl collodion vehicl produc caustic injuri keratolyt action mai enhanc presenc collodion 
87049106 alli health personnel electr countershock emerg medic technician human lidocainetu recurr ventricular fibrillationmoth emtd fibril shock futur editori 
87049107 adolesc child child preschool emerg femal suitsut human male massachusett retrospect studi transport patient estim prehospit demand pediatr antishock garment 
87049108 emerg servic hospit human thorac injuriessu transport patientsmt wound penetratingmo emerg depart thoracotomi letter 
87049109 adult career choic emerg medicin femal goal human internship resid male academ aspir resid 
87049271 adult antithrombin iiibl blood proteinsan case report femal fibrinogenan heparintu human hypercholesterolemiablth lipoprotein hdl cholesterolbl lipoprotein ldlblip lipoprotein ldl cholesterolbl male middl ag plasma volum plasminogenan precipit select continu elimin low densiti lipoprotein ldl heparin precipit clinic applic 
87049272 anaphylaxi celluloseaaan ethylen oxideaean hemodialysisa human kinet membran artifici steril extract ethylen oxid cuprammonium cellulo plate dialyz import pot compound result suggest ethylen oxid reten steril increa cuprammonium cellulo plate dialyz contain pot compound contrast cuprammonium cellulo plate dialyz pot compound charact rapid disappear retain ethylen oxid steril explain low incid sard cuprammonium cellulo plate dialyz contain pot materi continu studi experi 
87049273 adult ag case report compar studi creatininem femal human kidnei failur chronicth male middl ag periton dialysi periton dialysi continu ambulatori filtrat uream periton dialysi 
87049275 anim carotid arteriestrul collagenan complianc delayedac prepar dog heparinadantu scopi electron scan develop calib vascular graft new crosslink method incorpor slow heparin relea collagen natur tissu complianc 
87049276 adolesc adult ag aluminumtu antacidsantu hemodialysi human middl ag strontiumanbl uremiablth strontium overload urem patient regular dialyt treatment 
87049277 celluloseaa human kidnei failur acuteth kidnei failur chronicth kidnei artifici membran artifici prosthesi design uremiath bagfilt model new pret porter artifici kidnei 
87049278 calciumbl calcium carbonatetu femal hemodialysismt human kidnei failur chronicblth male phosphatesm phosphorusbl calcium carbon phosphat binder hemodialysi patient calcium carbon appear effect aluminum hydroxid bind dietari phosphoru hemodialysi patient longterm safeti thi medic appear accept view todai therapeut option 
87049279 anim artifici organ capsul endocrin glandstr periton cavitysu rat rat inbr strain periton receptacl macroencapsul endocrin tissu 
87049280 anim artifici organ hypocalcemiath scopi electron parathyroid glandscytrul periton caviti rat rat inbr strain bioartifici parathyroid 
87049281 adult bilirubinbl femal fluoresc human hyperbilirubinemiaetth liver diseasesth male middl ag phototherapi plasmar innov blood purif hepat failur direct photoirradi plasma 
87049282 human membran artifici middl ear ventilationi oxygen permeabl permeat rate oxygen membran tympanostomi tube 
87049284 anim blood glucosean dog electrod insulin infusion prosthesi design rabbit support govt ph shortterm vivo oper gluco sensor 
87049285 adh anim dog elast human rubber stress mechan surgeri tissu adh novel elastom surgic adh design properti vivo perform 
87049286 acryl resin electrochemistri implant artifici kinet muscl contrac musclesph povidon contractil behavior electr activ mechanochem polym actuat 
87049287 anim aortapa blood pressur cholesterolbl heart rate hypercholesterolemiapappth male plasmapheresi rabbit region blood flow longterm repetit plasmapheresi hypercholesterolem rabbit 
87049289 adolesc adult bicarbonatestu child evalu studi followup studi hemodialysisaemt hospit human middl ag morbid risk factor uremiappth rapid higheffici bicarbon hemodialysi 
87049290 ag aluminumblpo case report diabet nephropathiesth encephalitisci femal hemodialysisa human kidnei failur chronicetth male middl ag nephrot syndromecoth uremiath acut fatal hyperaluminem encephalopathi undialyz dialyz urem patient 
87049292 anim arteriesmesu collagenbi dog hydroxyprolinebi laser surgeri support govt ph tensil strength veinsmesu laser weld larg diamet arteri vein base preliminari studi result thi studi conclud argon laser weld mm intern diamet vein arteri arterioven fistula mai sever potenti advantag compar conven sutur techniqu benefit laser repair mai includ improv mechan properti absenc foreign bodi respon relat sutur laser weld steril nontactil possibli conserv wound heal rapidli aneurysm excess tissu prolif 
87049293 aspirinpd blood plateletsd cell divisiond cell cultur dipyridamolepd endotheliumcyd human ibuprofenpd kinet umbil vein effect antiplatelet drug human endoth cell growth tissu cultur 
87049294 anim blood plateletsph blood vessel prosthesi dog femor arterysu femor veindetr fibrinogenph indiumdu iodin radioisotopesdu polytetrafluoroethylen radioisotopesdu support govt ph thrombosispp tropoloneaadu vitamin eblpd quantit platelet fibrinogen deposi ptfe vein graft dog effect vitamin graft thrombosi acut phase 
87049295 anim biocompat materi blood vessel prosthesi dog scopi electron scan polyurethan silicon siloxan surfac properti thrombosispc evalu new antithrombogen polyurethanepolysiloxan complex biomateri 
87049296 adult aluminuma case report deferoxaminetu fracturesdtet hemodialysisa human humer fracturesdtet humerusra kidnei failur chronicth male osteomalaciacico support nonu govt support govt ph wound healingd fractur heal deferoxamin therapi patient aluminumassoci osteomalacia 
87049297 anim assist circul dog electrocardiographi heartassist devic myocardi infarctionppth nuclear magnet resonanceduismt therapeut effect left ventricular assist devic acut myocardi infarc evalu magnet reson imag 
87049298 anim cattl cerebrovascular disorderset compar studi heart artificiala human prosthesi design sheep support nonu govt support govt ph comparison clinic anim recipi pneumat artifici heart 
87049299 angioplasti transluminalaeismt anim dog heart failur congestiveetppth heartassist devic hemodynam experi evalu extrapulmonari arteri balloon pump epabp right heart failur diver etiologi 
87049300 anim aortasu assist circul cardiac output coronari circul dog heartpp heart atriumsu heartassist devic myocardi infarctionppth effect left ventricular assist area infarct myocardium 
87049301 cardiac output emerg heart artificiala human hyperten pulmonaryetth monitor physiolog drive manag emerg condition perman total artifici heart patient 
87049304 allylamin anim chronic disea disea model anim echocardiographi heartd heart failur congestivecipapp scopi electron myocardiumpaul sheep support govt ph largeanim model chronic congest heart failur induc coronari allylamin 
87049306 anim assist circul blood chemic analysi bodi temperatur cattl evalu studi heartassist devic human implant artifici prosthesi design respir support govt ph vivo evalu perman implant thermal ventricular assist pumpactuatorengin combin ha demonstr biolog compat physiolog effect respon tva vivo studi 75dai implant support feasibl extend reliabl compon postop mainten wa necessari onli becau nonhermet design howev abil pump lmin beatsmin synchron beat rate beatsmin pump mean arteri pressur mmhg maintain hematolog biochem valu physiolog rang veri optimist stage hardwar concept shown figur hardwar includ thermal salt packag capabl provid complet unteth circulatori support nomin 8h period recharg accomplish transcutan transform thermal manag problem becom minim averag energi input peak human preclin test 
87049307 anim chronic disea disea model anim dog heartpp heart failur congestivepapp heart ventriclepp myocardiumpa support govt ph experi chronic left ventricular failur dog 
87049309 compar studi evalu studi heartphpp heart artifici human comput prosthesi design support nonu govt sonic instrum deriv pneumat tah control signal drivelin pressur flow 
87049310 anim arteriolespa assist circul cattl heartpp heart ventriclepp heartassist devic hemodynam prosthesi design pul region blood flow renal circul support nonu govt idioperiph pulsat dure nonpulsatil biventricular bypass experi 
87049311 assist circulationa betathromboglobulinan blood coagul blood plateletsph heartassist devicesa human lactat dehydrogenasebl prosthesi design stress mechan investig flow centrifug blood pump 
87049312 analysi varianc azur stain extracorpor circul heparinbl human regr analysi stain stain rapid assai heparin dure extracorpor circul 
87049313 anim blood pressur heart surgeri heart ventriclesu myocardi contrac support govt ph swine systol right ventricular endsystol pressuredimen relationship dure left ventricular bypass anesthet pig 
87049314 bioprosthesisst heart valv prosthesisst human prosthesi design qualiti control stress mechan mechan factor influenc durabl heart valv pericardi bioprosth 
87049317 anim arterioven shunt surgicala dog hemodialysisaemt kidnei artifici perfusion polytetrafluoroethylen prosthesi design silicon support nonu govt thrombosiset ptfesilicon selfseal dialysi prosthesi 
87049318 alloi anim anticoagulantstu blood pressur blood vessel prosthesi dog monitor physiolog prosthesi design support nonu govt nonsurg implant vascular ring prosthesi thermal shape memori tini alloi nitinol wire 
87049319 femal followup studi hematocrit hemodialysismt human kidnei artifici kinet male middl ag uream longterm experi routin singleneedl dialysi review 
87049320 anemiaet femal hemodialysisa human kidnei failur chronicblth male manganesebl middl ag nickelbl trace elementsbl zincbl trace metal anemia chronic hemodialysi patient 
87049321 anim blood vessel prosthesi compar studi dog endotheliumcyul evalu studi femal male scopi electron scanningmt polyest evalu new vascular graft prosthesi fabric fine polyest fiber 
87049323 blood coagulationd blood coagul test fibrinolysisd human kinet scopi electron scan polymethacryl acidspd effect hydrogel polyethyleneoxid chain blood coagul fibrinolysi 
87049324 adsorp blood coagulationd blood coagul factorsm blood proteinsm human igg platelet adhesivenessd polyurethanespd serum albumin support govt ph reduc platelet adhesion activ coagul factor polyurethan treat albuminigg complex 
87049325 anim aortareul coronari vesselsreul doserespon relationship radiat heat human laser scopi electron rabbit violet rai thermal effect violet excim laser radiat biolog tissu 
87049326 anim cattl erythrocytesul hemoglobinsan hemolysi mathemat membran artifici scopi electron scan model theoret plasmapheresi pressur model hemolysi membran plasmapheresi 
87049327 adult anim blood vessel prosthesi cell surviv cell cultur compar studi crosslink reagent cultur media dog endotheliumci femal fibronectin human polyest polytetrafluoroethylen pregnanc speci specif umbil vein vein fluid shear disrup cultur endothelium effect cell speci fibronectin crosslink support polym 
87049329 anim biocompat materi capsul chromatographi gel collagen drug screen implant artifici lactatesm polymersm factor tissu develop bioresorb implant loadbear versu histologi 
87049335 anim biocompat materi cathet indwel compar studi diabet mellitu experimentaldt dog insulin infusion polyethylen silicon elastom polyethylenelin silicon rubber cannula longterm insulin infusion dog 
87049336 adult aluminumblip case report chromatographi gelmt deferoxamineadblip femal hemodialysi human infusion venou male middl ag molecular weight uremiablth chromatograph studi aluminumdesferrioxamin complex urem patient 
87049337 adult ag aluminumtu blood femal followup studi hematocrit hemodialysi human kidnei failur chronicblth male middl ag phosphatesbl support nonu govt filtrat reduc aluminum load hemodiafiltr 
87049338 adult ag blood chemic analysi femal followup studi hemodialysismt human kidnei failur chronicblth male middl ag support nonu govt factor hemodialysis10year followup 
87049339 adult ag hemodialysismt human kidnei failur chronicppth middl ag nutrition statu parathyroid hormonesbl serum albuminan factor uremiappth rapid blood flow dialysi doe adver affect clinic biochem nutrition statu patient 
87049341 blood dextran human kidnei artifici molecular weight structureact relationship support govt nonph filtrat macromolecular charg affect hemofilt solut siev 
87049342 human hypercholesterolemia familialblth lipoprotein ldlblip scopi electron scan plasmapheresisismt temperatur filtrationismt comparison plasmafrac filter filtrat techniqu clinic practic ldlapheresi 
87049345 anim blood cattl electrolytesbl membran artifici scopi electron scan permeabl polytetrafluoroethylen water extrac solutefr water blood membran distil 
87049346 adult ag blood burnsppth cathet indwel edemaetth femal heparintu human kidnei failur acuteetth male middl ag filtrat continu arterioven hemofiltr treatment anasarca acut renal failur sever burn patient 
87049347 blood compon removalismt dispo equip erythrocyt count hematocrit human leukocyt count membran artifici plasma platelet count polyethylen autom plasma collector innov membran cassettelik dispo 
87049348 anim blood compon removalismt cattl ceram filtrat hematocrit membran artifici plasma support nonu govt design plasma separ ceram membran 
87049349 assist circul blood cardiopulmonari bypass creatininem femal heart surgeri heartassist devic human aortic balloon pump kidnei failur acuteetth male middl ag postop complicationsth filtrat continu renal replac therapi patient acut renal dysfunc undergo aortic balloon pump andor left ventricular devic support 
87049350 filtrat human mathemat membran artifici plasmapheresismt relationship staverman reflec siev coeffici plasma fraction 
87049351 evalu studi foreign bodiespa heart artificiala human skinpa support govt ph factor scopic evalu skin button longterm human total artifici heart recipi 
87049353 adsorp biocompat materi blood proteinsip charcoal hemodialysi hemoperfu human kidnei failur chronicth molecular weight polyurethan elimin low molecular weight protein dure hemoperfu dialysi patient urethanesheet emb powder charcoal 
87049354 anim biocompat materi blood compon removalismt dextran dog filtrationmt human hypercholesterolemiablth membran artifici molecular weight plasma support nonu govt effect plasma solutemembran interac mean pore diamet 
87049357 anim ceram compar studi heart valv prosthesi materi test sheep support nonu govt vena cavaeph develop fine ceram heart valv cardiac prosthesi 
87049360 anim assist circulationi cattl heart rate heartassist devicesismt hemoglobinsan male postop care support nonu govt factor roller screw electr motor ventricular assist devic roller screw electr vad easier manufactur lighter previou describ drum cam model thi devic requir pump lmin minim hemolysi motor drive ha function period dai vivo measur wear complianc chamber volum vari cc dure vad function doe maintain pressur variat mmhg complianc chamber volum loss ccdai explain ga transport spu subcutan sampl port provid readi access seal 
87049361 adult ag assist circul case report child preschool echocardiographi femal heartpp heart surgeri heartassist devic hemodynam human male middl ag monitor physiolog postop complicationsth natur heart recoveri left ventricular assist devic pump studi echocardiographi 
87049363 anim axonsul collagenph extracellular matrixph femal glycoproteinsph heparitin sulfateph implant artifici lamininph membran artifici mice scopi electron myelin sheathul nerv regen sciatic nervecyphul regen transect sciatic nerv semiperm nerv guidanc channel effect extracellular matrix protein addit 
87049365 anim antibodi format drug hypersensit ethylen oxideto femal hemodialysi human igean male mice mice inbr strain passiv cutan anaphylaxi rat rat inbr strain anim model ethylen oxid eto associ hypersensit reaction 
87049366 adolesc ag blood proteinsan case report chronic disea complementan demyelin diseasesth femal followup studi human immunoglobulinsan inflamm male plasma polyradiculoneuritisth filtrationismt treatment chronic inflammatori demyelin polyradiculoneuropathi plasma filtrat 
87049367 ag blood heparintu human middl ag suction support nonu govt filtrationmt ureabl vacuum clinic trial predilu vacuum suction enhanc effici cavh treatment 
87049368 alanin aminotransferasebl anim aspart aminotransferasebl blood coagul test creatininebl dog electrolytesbl erythrocyt count erythrocytesan exchang transfusion blood hematocrit hemoglobinsan platelet count polyethylen glycol solution support nonu govt ureabl physiolog effect pyridoxalatedhemoglobinpolyethylen glycol conjug solution exchang transfusion 
87049369 ag blood blood proteinsan case report cryoglobulinsipm femal human immunoglobulinsan sjogren syndromeblth filtrationismt clinic evalu multilai cryofilt highli select cryoglobulin remov 
87049371 blood pressur cathet indwellingst hemodialysisst human kidnei failur acuteppth kidnei failur chronicppth polyurethan qualiti control support nonu govt minimum perform standard doublelumen subclavian cannula hemodialysi 
87049374 cathet indwel diabet mellitu insulindependentdt equip failur followup studi human insulin infusion implant continu venou insulin infusion devic restor flow slowdown 
87049375 anim dog fibrinogenan implant artificiala scopi electron scan oxidationreduc platelet aggreg polyethylenesa region blood flow support govt ph thrombosiset blood flow surfaceinduc thrombosi 
87049376 aluminumblip blood proteinsan deferoxaminetu hemodialysismt human kinet permeabl factor remov aluminum chronic dialysi patient administr desferrioxamin dialysi order perform quantit vitro clinic studi remov al combin therapi dfo administr hd hplc measur dfo wa establish leaki membran enhanc permeabl middl molecular substanc wa develop dfo infusion cau rise plasma al level regard indic elution accumul al patient undergo hd plasma level increa longterm patient bone pain examin al clearanc demonstr thi increa plasma al content pass hd membran level gramsl leaki membran wa effect remov al dfo conven complex dfo al aqueou solution wa confirm format alrich complex vivo wa suggest conclud aldfo complex form vivo effect remov leaki membran 
87049377 anim artifici organ cardiopulmonari bypassi dog extracorpor circulationi hemodynam lungph membran artifici portabl pumpless av bypass ecco2r hollow fiber membran lung 
87049380 extracorpor circulationa femal human infant newborn infant newborn diseasesblth male oxygenbl partial pressur respiratori distress syndromeblth thrombocytopeniaet thrombocytopenia neonat extracorpor membran oxygen 
87049381 acut disea anim assist circul blood pressur cardiac output compar studi dog extracorpor circul heartpp heart diseasesth heart ventriclepp heartassist devic vent cardiac assist ecmo versu left heart bypass acut left ventricular failur 
87049383 adolesc adult ag femal human male middl ag morbid ontario periton dialysi continu ambulatorya peritonitisepetpc staphylococc infectionsepetpc staphylococcu aureu staphylococcu epidermidi support nonu govt capd periton rate improv 
87049384 anim gluco milk protein osmolar concentr peptid periton dialysismt protein hydroli rabbit peptid substitut osmot agent gluco periton diali 
87049385 adult heartpp heart ventriclepp human infusion parent kidnei failur chronicppth myocardi contrac periton dialysi continu ambulatorymt postur systol effect periton infusion volum postur left ventricular systol function patient continu ambulatori periton dialysi 
87049386 adult diabet nephropathiesth femal glomerulonephritisco human kidnei failur chronicetth male patient educ periton dialysi continu ambulatoryaei peritonitispc qualiti control support nonu govt unit state multic trial evalu capd 
87049387 california demographi followup studi human kidnei failur chronicth nevada periton dialysi continu ambulatorya peritonitiset longterm outcom continu ambulatori periton dialysi southern californiasouthern nevada experi 
87049388 anim diltiazempd glucosem male periton dialysi proteinsm rat rat inbr strain support nonu govt uream verapamilpd effect calcium channel blocker verapamil diltiazem periton transport 
87049389 blood human kidnei failur chronicth kidnei artifici membran artifici model biolog nephronsph filtrationismt continu arterioven hemofiltr wearabl devic treat endstag renal disea 
87049390 adolesc adult ag dispo equip evalu studi femal human kidnei failur chronicth male middl ag periton dialysi continu ambulatoryi support nonu govt multic evalu bagless capd 
87049391 adult ag ag compar studi creatininem femal glucosem human kidnei failur chronicmeth kinet male middl ag periton dialysi periton dialysi continu ambulatori phosphatesm potassiumm sodiumm support nonu govt uream daili clearanc continu ambulatori periton dialysi nightli periton dialysi 
87049392 blood substitutesad halflif hemoglobinsadmetu human kinet liposomesad oxygenbl phosphatidylcholin support govt nonph liposomeencapsul hemoglobin red cell surrog prepar scaleup 
87049393 air diaphragmra human periton dialysi continu ambulatorya postur air diaphragm signif capd patient incid air diaphragm capd patient veri low cau directli attribut standard capd techniqu ar lower bowel perfor gener cau larger volum air collec diaphragm 
87049394 antigen neoplasmip breast neoplasmsim extracorpor circulationismt femal human immunosuppr male neoplasmsim plasmapheresi support nonu govt support govt ph extracorpor remov tumor antigen 
87049395 anim calcinosispapc cattl delayedac prepar diphosphonatestu heart valv prosthesi male scopi electron scan rat silicon elastom support nonu govt support govt ph inhibi bioprosthet heart valv calcif sustain local deliveri ca na diphosphon control relea matric 
87049396 anim blood plateletsci cattl fibrinan fibrinogenan heart valv prosthesisa indiumdu iodin radioisotopesdu radioisotopesdu support govt ph thrombosiset factor tropoloneaadu quantit platelet fibrinogenfibrin deposi compon tissu valv ionescushilei calv 111inlabel platelet 125ilabel bovin fibrinogen region map platelet fibrinogen deposi leaflet sew ring wa obtain holstein calv receiv 25mm mitral valv islm kill dai implant twentyfour befor calv kill ci 111inlabel platelet ci 125ilabel bovin fibrinogen administ venou compon tissu valv leaflet sew ring separ leaflet wa cut free edg central zone flexion zone attach zone radioact blood leaflet zone sew ring area leaflet zone platelet count fibrinogen level blood mean region densiti adher platelet fibrinogenfibrin fibrinogenplatelet calcul densiti platelet fibrinogen deposit compon valv decrea postimpl number fibrinogen molecul platelet fivefold 20fold higher receptor concentr platelet leaflet zone suggest heterogen fibrinogenfibrin thrombu compon valv 
87049397 adult human vitro lipid apd lipopolysaccharidespd luminesc neutrophilscydeph salmonellaim support nonu govt neutrophil stimul lipid lipopolysaccharid salmonella minnesota 
87049398 anim arteriessu blood vessel prosthesi dog femor arterysu scopi electron scan silicon elastom support govt ph vascular patenc mainten complianc diamet arteri prosthesi thi studi demonstr porou replamineform silicon rubber prosth remain isocompli adjac arteri segment follow implant thi contrast result current avail prosth includ autolog vein rapidli becom minim compliant conclud thi vascular construc stabl longterm follow implant mai improv success intern diamet arteri reconstruc elimin failur cau intim hyperplasia 
87049399 anim elast implant artifici scopi electron scan polyvinyl alcohol prosthesi prosthesi design rabbit tensil strength new hydrogel medic applic 
87049400 anim biopsi factor xiii gelatin hemostasi heparin liverci male rat rat inbr strain support nonu govt thrombin wound heal new hemostat materi gtxiii 
87049401 adult ag catheterizationmt cathet indwel compar studi femal followup studi human male middl ag periton dialysi support nonu govt preliminari experi swan neck periton dialysi cathet 
87049402 adult bilirubinblip case report femal human infant newborn infant prematur jaundic neonatalblth resin support nonu govt filtrationmt bilirubin remov jaundic prematur infant resin hemoperfu summar result bilirubin remov hemoperfu wa successfulli perform prematur infant hemoperfu cau adver effect clinic state infant bilirubin remov min13 mgindic exist larg extravascular pool hemoperfu suggest bilirubin remov newborn babi reduc blood exchang bank blood 
87049404 cellulo complem activ hemodialysismt human leukocyt count membran artifici platelet count surfac properti develop regen cellulo noncompl activ membran hemodialysi develop new cellulo membran activ hydroxyl carboxyl group origin cellulo fiber ar mask cation synthet polym membran wa shown vitro clinic test affect activ complem veri littl retain high dialysi effici toler steam autoclav steril econom produc cost characterist origin cellulo membran thu appear new cellulo provid optimum combin qualiti hemodialysi membran 
87049405 antibodi monoclonaltu antigenantibodi complex autoimmun diseasesth human kinet membran artifici membraneimmobil monoclon antibodi immunoadsorp 
87049408 ag ascit fluidth case report diabet nephropathiesth femal hemodialysi human kidnei failur chronicetth male middl ag peritoneoven shuntismt extern peritoneoven shunt ctabl ascit 
87049453 anim disea model anim human respiratori distress syndrom adultdietth sheep acuteadultanim respiratori distress syndrom editori 
87049454 anesthesia inhal atracuriumm child child preschool human infant isofluran isoquinolinesbl kinet liverpp liver diseasesblmepp nitrou oxid support nonu govt pharmacokinet atracurium anaesthet infant children pharmacokinet atracurium studi infant children anaesthet isofluran nitrou oxid oxygen signif differ volum distribu area ml kg1 clearanc ml kg1 min1 t12 alpha min t12 beta min children normal hepat renal function moder impair hepat function present hepat transplant signif differ volum distribu area ml kg1 clearanc atracurium ml kg1 min1 infant children normal excretori function infant clearanc atracurium ml m2 min1 tend greater t12 alpha t12 beta tend shorter children normal excretori function howev trend reach statist signif plasma laudanosin concentr wa ng ml1 greater patient liver disea normal children min follow bolu atracurium mg kg1 
87049455 anesthesia tracheal atracuriumadpd biliari atresiappsu drug administr schedul femal human infant infant newborn oper care liverpp male neuromuscular block agent atracurium dure major abdomin surgeri infant hepat dysfunc biliari atresia atracurium dure major abdomin surgeri wa assess infant hepat dysfunc cau biliari atresia initi dose mg kg1 provid excel intub condition patient subsequ neuromuscular blockad wa monitor periph nerv stimul increm dose atracurium reappear singl twitch neuromuscular conduc wa allow return end surgeri care increm wa necessari antagon neuromuscular blockad onli patient 
87049457 adolesc anesthesia inhalationa child child preschool femal halothaneada hepat toxicetpp human infant liverdepp male postop period prospect studi support nonu govt factor prospect studi liver function children follow multipl halothan anaesthet interv januari decemb children receiv halothan anaesthet twentyf patient anaesthet halothan patient develop postop jaundic sixtynin children expo halothan anaesthet dai occasion serial estim serum liver enzym concentr obtain minor increa concentr serum ast alt record patient entri respect postop ggt sap concentr increa patient entri patient enzym valu increa befor anaesthet subject develop chang 
87049458 atracuriumpd child child preschool femal histaminebl histamin liberationd human infant male neuromuscular junctiond factor vecuroniumpd histamin relea dure administr atracurium vecuronium children histamin relea potenti equiv bolu dose atracurium mg kg1 vecuronium mg kg1 wa evalu children anaesthet halothan blood sampl obtain befor min administr neuromuscular blocker twitch respon hz wa evalu patient receiv vecuronium signif increa plasma histamin concentr children receiv atracurium plasma histamin concentr increa markedli ani appar clinic manifest recoveri neuromuscular function twitch height vecuronium mg kg1 wa faster atracurium mg kg1 
87049459 adrenocorticotrop hormonebl anesthesia inhal catecholaminesbl child child preschool halothan hormonesbl human hydrocortisonebl infant midazolampd postop period preme pulmonari ga exchang respirationd support nonu govt surgeri oper ventil ventilatori carbon dioxid hormon respon dure halothan anaesthesia surgeri children midazolam preme intub spontan breath children bodi weight bw rang kg influenc midazolam mg kg1 im group m01 mg kg1 im group m02 preme sedat ventil ventilatori respon carbon dioxid hormon stress respon wa studi connec minor surgic procedur dure halothan anaesthesia concentr catecholamin acth cortisol measur immedi induc dure undisturb anaesthesia dure surgeri min end surgic procedur sedat wa plasma catecholamin concentr dure undisturb anaesthesia children receiv larger dose midazolam dure surgeri recoveri differ hormon concentr recoveri concentr hormon significantli greater compar dure undisturb anaesthesia dure surgeri ve respiratori rate somewhat lower group m02 co2 wa similar dose depend depr respon carbon dioxid wa howev clinic ventilatori respon carbon dioxid surgeri wa consid adequ group 
87049466 adult alcuroniumaipd atracuriumaipd compar studi electromyographi evok potentialsd human muscl contractiond musclesd neostigminepd neuromuscular block agent toxiferineaa evok electromyograph mechan respon adductor pollici compar dure onset neuromuscular blockad atracurium alcuronium dure antagon neostigmin effect atracurium alcuronium evok mechan electromyograph respon adductor pollici investig adult patient ulnar nerv wa stimul train supramaxim pul ms durat frequenc hz interv mechan respon wa measur strain gaug forc transduc evok compound action potenti ecap wa record simultan medelec ms91 electromyographi depr electromyograph mechan respon cau atracurium wa similar dure onset antagon blockad dure onset blockad alcuronium mechan respon wa depress significantli greater extent compar ecap thi differ wa observ dure antagon neostigmin rate onset atracurium alcuronium gener similar rate onset mechan fade wa greater alcuronium group wa signif quantit differ rate antagon alcuronium atracurium assess mechan respon ratio electromyograph respon electromyograph mechan trainoffour ratio recov rapidli atracurium group suggest differ mechan electromyograph measur neuromuscular blockad ar drugspecif ar pronounc dure onset blockad dure antagon neostigmin 
87049467 adult atracuriumai compar studi edrophoniumpd human middl ag muscl contractiond neostigminepd neuromuscular block agentsai factor vecuroniumai antagon profound neuromuscular blockad induc vecuronium atracurium comparison neostigmin edrophonium effect neostigmin mg kg1 edrophonium mg kg1 antagonist profound neuromuscular blockad induc vecuronium mg kg1 atracurium mg kg1 wa studi healthi patient antagonist administ min total ablat twitch respon endpoint recoveri wa trainoffour ratio patient vecuronium mean reach thi durat tof70 wa min control group antagonist min group neostigmin min group edrophonium durat tof70 wa shorter neostigmin group control edrophonium group durat tof70 differ control edrophonium group patient atracurium durat tof70 min control neostigmin edrophonium group respect durat tof70 neostigmin edrophonium group shorter control durat tof70 neostigmin group wa shorter edrophonium group result profound neuromuscular blockad rapidli antagon agent rever requir circumst neostigmin effect drug 
87049468 atracuriumaipd compar studi edrophoniumpd human muscl contractiond neostigminepd neuromuscular block agentsai factor antagon atracuriuminduc neuromuscular blockad neostigmin edrophonium antagon atracuriuminduc neuromuscular blockad neostigmin edrophonium ha studi tetan hz trainoffour hz singl twitch respon adductor pollici muscl anaesthet patient patient anticholinestera act control group group patient anticholinestera antagon wa attempt blockad tetan respon recoveri tetan respon dose edrophonium mg kg1 iv wa statist differ control group recoveri dose neostigmin mg iv wa significantli faster recoveri singl twitch respon antagon edrophonium neostigmin wa significantli shorter control group edrophonium commenc recoveri initi rapid antagon tetan block sustain wherea antagon neostigmin persist recoveri phase significantli shorten group patient atracurium mg kg1 iv antagon wa attempt peak height tetan contrac reach approxim control valueabstract truncat 
87049469 adult atracuriumpd evok potentialsd femal human male middl ag muscl contractiond neuromuscular block agent factor tubocurarinepd vecuroniumpd reappear trainoffour neuromuscular blockad induc tubocurarin vecuronium atracurium characterist trainoffour recoveri atracurium vecuronium studi enfluran anaesthesia compar associ tubocurarineinduc blockad patient receiv vecuronium mg kg1 atracurium mg kg1 tubocurarin mg kg1 neuromuscular blockad wa calcul percent depr twitch wa determin reappear fourth twitch trainoffour pattern dure recoveri blockad induc neuromuscular block agent wa similar t2 t3 t4 reappear approxim residu blockad respect result ar differ previou report lee indic enfluran anaesthesia trainoffour count mai incorrect estim degr neuromuscular blockad 
87049470 anesthesia generalmt anesthesia inhal compar studi enfluran femal human male muscl contractiond neuromuscular block agent nitrou oxid thiopent transduc vecuroniumpd visual percep comparison visual measur trainoffour recoveri vecuroniuminduc neuromuscular blockad anaesthet techniqu thi studi evalu trainoffour recoveri administr vecuronium compar measur visual observ respon respon supramaxim stimuli ulnar nerv measur forc transduc compar visual observ movem contralat thumb patient anaesthet nitrou oxid enfluran fourth twitch visual reappear measur blockad respect patient anaesthet narcoticbarbitur techniqu fourth twitch reappear result differ anaesthet techniqu 
87049471 adult ag anesthesia gener cholinestera inhibitorsm femal galanthamineblmeur human kinet middl ag pharmacokinet galanthamin longact anticholinestera drug anaesthet patient pharmacokinet longact anticholinestera drug galanthamin investig patient iv injec mg kg1 decrea serum concentr galanthamin follow biexponenti curv serum concentr decrea rapidli ng ml1 ng ml1 min t12 alpha min declin slowli t12 beta min total serum clearanc galanthamin ml min1 kg1 renal clearanc wa ml min1 kg1 cumul urinari excretion galanthamin injec administ dose biliari excretion galanthamin dure dose wa evid glucuronid sulphat conjug galanthamin 
87049472 anesthesia gener anesthesia spinal anim cardiac outputd chlormethiazolemepd hemodynamicsd intestinesb iodohippur acidm liver circulationd region blood flowd renal circulationd sheep subarachnoid space sheep prepar studi interac blood flow drug disposi vi effect gener subarachnoid anaesthesia blood flow chlormethiazol disposi blood flow chlormethiazol extrac ratio lung liver kidnei gut measur awak unrestrain sheep control anim anaesthet halothan whilst undergo high thorac subarachnoid blockad amethocain controldrug studi chlormethiazol infu subs blood concentr produc signif chang haemodynam kinet iodohippur renal hepat blood flow chlormethiazol wa elimin predominantli liver mean extrac ratio clearanc respect litr min1 lung litr min1 renal clearanc wa absent neglig greater litr min1 becau pulmonari clearanc mean total bodi clearanc wa deriv analysi pulmonari arteri concentr gener anaesthesia signif reduc mean cardiac output hepat renal blood flow control chlormethiazol mean hepat extrac ratio clearanc reduc respect control pulmonari renal clearanc abolish subarachnoid anaesthesia signif chang haemodynam chlormethiazol extrac ratio clearanc 
87049473 adult ag bronchi bronchoscopi human intubationaemt male middl ag placem doublelumen endobronchi tube correl clinic impr bronchoscop doublelumen endobronchi tube blindli patient undergo thoracotomi clinic criteria suggest satisfactori position case howev subsequ fibreopt bronchoscopi reveal malposi bronchoscop includ inabl view bronchial cuff narrow bronchial lumen tube level cuff herniat cuff carina potenti hazard associ ar discuss 
87049474 anesthesia anesthet anim human proce anaesthet research societi leed meet april abstract 
87049475 anim dog human respir artifici respiratori dead space tidal volum deadspac dure high frequenc ventil letter 
87049476 atracuriuma histamin liberationd human histamin liber atracurium letter 
87049477 analgesiamt human injec spinal morphinead thorac injuriesth thecal morphin multipl fractur rib letter 
87049478 anim atracuriuma femal human preeclampsiam pregnanc rabbit seizuresci atracurium preeclampt patient letter 
87049507 adolesc adult ag calcitoninbl cholecalciferolstu dihydroxycholecalciferolsbltu femal human hydroxycholecalciferolsbltu male middl ag parathyroid hormonesbl psoriasisbldt support nonu govt open studi vitamin d3 treatment psoriasi vulgari activ form vitamin d3 alphahydroxyvitamin d3 alpha25dihydroxyvitamin d3 administ opendesign studi patient psoriasi vulgari wai patient alphahydroxyvitamin d3 wa oral dose gramsdai patient alpha25dihydroxyvitamin d3 wa oral dose gramdai patient alpha25dihydroxyvitamin d3 appli topic concentr gramg base improv wa observ end individu studi period patient group mean period treatment sd patient group treatment patient group chemic wa appli sideeffect observ ani trial data suggest psoriasi mai respond activ metabolit vitamin d3 abnorm vitamin metabol respon skin cell activ metabolit vitamin mai involv pathogenesi thi skin disea 
87049508 adolesc adult ag dihydroxycholecalciferolstu femal human male middl ag ointment psoriasisdt success treatment psoriasi topic applic activ vitamin d3 analogu alpha24dihydroxycholecalciferol treat psoriat patient topic alpha24dihydroxycholecalciferol new synthet analogu activ vitamin d3 test lesion clear complet relap occur shortli cessat treatment sideeffect suggest alpha 24oh2d3 merit investig potenti topic therapi psoriasi 
87049509 antibodi fungalan antigen fungalim counterimmunoelectrophoresi cross reaction dermatomycosesim deuteromycetesim human hyphomycetesim immunoelectrophoresi twodimen circul antibodi antigen crossreact hendersonula toruloidea scytalidium hyalinum infec twelv thirtyf patient activ infec palm sole cau hendersonula toruloidea scytalidium hyalinum circul antibodi organ counter immunoelectrophoresi immunodiffu compar uninfect control everi instanc wa crossreact posit patient sera heterolog nondermatophyt antigen cross intermedi gel immunoelectrophoresi wa cytoplasm extract toruloidea hyalinum precipitin peak respect share organ crossreac observ nondermatophyt cytoplasm extract hyperimmun anim antisera rai trichophyton rubrum trichophyton interdigit aspergillu fumigatu candida albican exoantigen prepar nondermatophyt similar crossreact speci appear toruloidea hyalinum ar veri similar antigen structur lend support view thei mai close relat thei ar antigen distinct pathogen fungi commonli infect skin mai cultur identif recogni tissu specimen 
87049511 administr topic doserespon relationship radiat erythemadtet human indomethacinadtu model biolog skinr violet raysa quantit studi effect topic indomethacin cutan erythema induc uvb uvc radiat effect indomethacin gel uvb uvc erythema wa assess object reflect instrum indomethacin wa appli immedi irradi uvr violet radiat dosedepend suppr erythema wa demonstr wavelength irradi indomethacin control gel basetr site equal erythemat suppr erythema occur applic indomethacin wa delai irradi wavelength prostaglandin synthesi remain increa thi period degr suppr ani howev wa greater achiev singl applic immedi irradi indic eventu equal erythema indomethacin gel basetr site wa tachyphylaxi inadequ dosag construc doserespon curv indomethacinrespon indomethacinunrespon compon erythema human skin differ erythem respon uvb uvc radiat format differ mediat wavelength 
87049512 adolesc adult behavior therapi combin modal therapi dermat atopicdtth human hydrocortisonetu middl ag ointment pruritusdtth support nonu govt behaviour treatment scratch patient atop dermat behaviour method habit rever combin hydrocortison cream wa compar cream alon treatment patient atop dermat patient assign randomli group receiv combin treatment regular ointment treatment patient skin statu wa assess befor treatment patient record scratch dure studi group improv group receiv habitrev therapi improv significantli strong correl wa reduc scratch improv skin statu 
87049513 adolesc adren cortex function test case report child child preschool cosyntropindu cush syndromeci dermat atopicblm femal human hydrocortisoneblm infant male seborrheablm skin absorp support nonu govt effect percutan absorp hydrocortison adrenocort respon infant sever skin disea percutan absorp hydrocortison wa studi children ag atop seborrho dermat measur serum cortisol befor applic hydrocortison cream endogen secretion cortisol wa suppress dexamethason absorp test wa perform children percutan absorp wa detect highest serum cortisol level wa reach absorp test wa develop basi test thi absorp test wa perform children absorp hydrocortison wa detect rise serum cortisol rang nmoll acth test wa perform evalu effect previou treatment topic glucocorticoid suppress adrenocort function wa children wa associ significantli high postappl serum cortisol level thi occur infant sever skin disord older children mild moder skin disea 
87049514 adult allergensim dermat atopicim human immunolog test male mitesim pruritusim skin test challeng reaction atop dermat percutan entri mite antigen succe reproduc eczemat lesion appar normal skin patient atop dermat scratch continu applic ointment contain ferritinlabel mite antigen percutan entri mite antigen wa demonstr skin biopsi festain scratch skin urticari reaction typic type allergi chang eczemat reaction typic type iv allergi thi chang wa shown histolog 
87049515 adult case report diagnosi differenti femal human neutrophil skin diseasesdi syndrom syphilisdi secondari syphili mimick sweet syndrom describ patient secondari syphili facial skin lesion resembl sweet syndrom clinic histolog suggest serolog test syphili patient sweet syndrom 
87049516 case report child ecthyma contagiousco granulomaetpa human male skin diseasesetpa giant orf normal individu 
87049517 blisteretpa burnscopa case report cicatrixpa human infant male scopi electron blister burn scar child present case 11monthold babi burn heal normal subsequ develop success crop blister scar chang hi gener condition clinic immunolog histolog structur studi provid diagnosi mechan dermat produc trauma electron scopi studi reveal subepiderm natur blister presenc underli fibrin deposit 
87049519 ag case report femal human killer cell naturalim lymphomatoid granulomatosisim skin diseasesim natur killer cell lymphomatoid granulomatosi letter 
87049520 antiinflammatori agent nonsteroid human photosensit disorderset propionatesa propion acidsa persist phototox benoxaprofen letter 
87049559 femal human pregnanc propranololtu puerper disordersdi thyroiditisdidt thyroxinetu postpartum thyroiditisan underdiagno disea 
87049560 adolesc adult coliti ulcerativeblco compar studi crohn diseaseblco femal hemoglobinsan human infant low birth weight infant newborn labor induc labor prematureet pregnanc pregnanc complicationset retrospect studi effect inflammatori bowel disea pregnanc casecontrol retrospect analysi retrospect analysi pregnanc women ulcer coliti crohn disea suggest gener disea major effect pregnanc outcom birthweight babi born women inflammatori bowel disea margin lower born women control group match ag pariti differ wa statist signif onli women crohn disea disea group wa higher frequenc low haemoglobin level pregnanc match control group statist signif effect ulcer coliti crohn disea durat pregnanc mode deliveri rai blood pressur andor proteinuria absenc relap diagnosi inflammatori bowel disea influenc obstetr manag 
87049561 compar studi extrac obstetricalaemt femal human infant newborn infant newborn diseaseset labor complicationsth labor stage obstetr forcep pregnanc puerper disorderset retrospect studi vacuum extrac obstetricala fetal matern effect forcep vacuum extrac 
87049563 amniot fluidan compar studi femal fetal bloodan fetal membranesan human interferon type ian placentaan pregnancyblm support nonu govt alpha interferon human pregnanc concentr interferonalpha wa measur specif twosit immunoradiometr assai varieti fluid tissu collect dure human pregnanc matern blood blood tissu nonpregn adult contain littl interferonalpha fetal blood fetal organ placenta membran amniot fluid decidua contain signif roughli equiv rang uml tissu demonstr fetu immedi surround ar permeat interferon suggest thi mai plai role regul maternalfet graft relat 
87049564 adult centrifugationmt compar studi femal human macrophagesmi phagocytesph phagocytosi pregnancyblph staphylococcu epidermidi enhanc phagocytosi mononuclear phagocyt pregnanc phagocyt activ periph blood mononuclear phagocyt staphylococcu epidermi healthi nonpregn pregnant women pregnanc wa examin relat gestat ag studi includ healthi nonpregn women healthi pregnant women equal distribut trimest variabl investig number mononuclear cell phagocytosi averag number bacteria monocyt phagocytosi pregnanc progress gradual signif increa wa number monocyt phagocytosi significantli higher propor macrophag bacteria phagocyt 
87049566 adult femal heparintu human pregnanc pregnanc complic cardiovasculardidt pulmonari embolismdidt warfarintu unusu present pulmonari thromboembol late pregnanc case report 
87049568 case report endometri hyperplasiacopa femal hemangiomacopa human middl ag ovarian neoplasmscopa haemangioma ovari associ endometri hyperplasia case report 
87049569 adult carcinoma squamou cellpasc case report cervix neoplasmspa femal human ovarian neoplasmspasc ovarian metastasi stage 1b squamou carcinoma cervix case report 
87049570 ag femal human menopau ovarian neoplasmsblpa sertoli cell tumorblpa steroidsbl femin sertolileydig cell tumour postmenopau woman case report 
87049571 adult arteritispa case report cervix diseasespa femal human middl ag necrosi isol arter uterin cervix case report 
87049572 adult case report femal human hydatidiform molegepa karyotyp mosaic pregnanc uterin neoplasmsgepa diploid complet hydatidiform mole mosaic normal fertil cell androgenet homozyg cell case report 
87049573 carcinoma mucinouspasc case report cervix neoplasmspasc femal gallbladd neoplasmspa human middl ag carcinoma gall bladder metastat cervix case report 
87049575 converg ocular electrooculographi ey movem form perceptionph human pattern recogni visualph support nonu govt support govt ph vergenc amplitud randomdot stereogram randomdot stereogram capabl produc fusion vergenc amplitud absenc monocular contour vergenc amplitud ar artefact monocular contour provid target border test instrum ar compar rang vergenc amplitud measur clinic degr fusion target amblyoscop conclud diplopia monocularli recogni contour necessari produc fusion vergenc amplitud 
87049576 cataract extractionmt human len capsul crystallinesu len ocular surgic instrum posterior chamber ocular len implantationa new forcep simplifi capsular bag fixat case capsular bag fixat sinskykratz type posterior chamber ocular implant len present variou method position implant len ar outlin new forcep ar describ ration adop illustr stepbystep fashion addition anterior chamber ocular len implant mention brief summari author experi thi instrum 
87049579 ag cataract extrac corneapa corneal diseasesetpa femal human male middl ag violet raysa visual acuiti regr labrador keratopathi follow cataract extrac labrador keratopathi lk acquir corneal degen cau chronic exposur solar irradi report suggest progress stationari condition ar report recommend therapi prospect clinic studi wa conduct regr lk follow extracapsular cataract extrac seventeen black patient ey lk matur cataract underw extracapsular cataract extrac sever lk wa record photograph pre postop followup rang twentyfour ey regr lk reduc exposur violet light result aphak photophobia factor regr lk 
87049581 adolesc adult athlet injuriesep england ey injuriesep ey protect devic femal human male soccer tenni sussex ey hospit sport injuri assess preval sport ey injuri area regist wa kept octob march squash associ footbal badminton tenni main offend severest injuri wa golf ball involv fractur zygoma wa retin dialysi len disloc requir extrac spectacl broken case contact len glass fragment oper remov case penetr injuri valu ey protec worn ani patient emphasi 
87049584 capillariespa case report choroid neoplasmsbspa fluorescein angiographi human male melanomabspa middl ag neovascularizationpa retin vesselspa support nonu govt infer bead retin vein drain choroid melanoma bead retin vein drain choroid melanoma report endoth prolif produc bead respon blood born factor traver vein retin capillari nonperfu adjac bead vein necessari process 
87049585 fundu oculi human light photographi retinapa retin vesselspa photograph record slitlamp appear ocular fundu method illumin slitlamp biomicroscopi anterior segment describ vogt ar equal posterior ey examin ocular fundu difficult particular photographi central periph fundu demand addition technic arrang appear biomicroscopi ar record 
87049586 doserespon relationship radiat eyeglass human len crystallin pupil retinar sunlighta violet raysa sunglassesan ocular hazard sugg protect ey gear pose threat crystallin len retina examin epidemiolog view conclud mai accentu preexist highrisk hazard ha littl signif lowrisk hazard 
87049587 adult aneurysmpa blood coagul test case report diabet retinopathyblpa femal fluorescein angiographi hemoglobin glycosylatedan human male middl ag retin vesselspa retin cottonwool spot earli diabet retinopathi insulin depend diabet patient ar report retin cottonwool spot soft exud total isol associ fewer aneurysm observ suggest cottonwool spot mai earli diabet retinopathi signif biolog abnorm patient high level glycosyl haemoglobin mild increa thrombin gener indic slight activ coagul possibl signif clinic biolog discuss 
87049588 adult case report human male optic atrophyet plant poison vision disorderset presum neurotox effect catha edulisan exot plant avail unit kingdom bilat optic atrophi report patient thei longstand user leav catha eduli chew larger quantiti usual sinc leav thi plant ar wide nativ area sourc mildli stimul narcot effect case mai idiosyncrat reaction unusu larg dose 
87049589 case report child child preschool femal human laurencemoonbiedl syndromepa male scopi electron mitochondriaul pedigr pigment epithelium eyeul retinaul retin degenerationgepa rod conesul support nonu govt histopathologi mitochondri cytopathi laurencemoonbiedl syndrom clinic histopatholog studi patient distinctli differ inherit juvenil retin dystrophi indic ocular defect mitochondri cytopathi involv underli pigment epithelium wherea laurencemoonbiedl syndrom photoreceptor cell ar primarili affect 
87050029 antibodi monoclonalim antibodydepend cell cytotox bone marrowimph endotheliumim fibroblastsim hematopoiesi human stem cellsim support nonu govt support govt ph lysi human fibroblast colonyform cell endoth cell monoclon antibodi complem murin igg2a monoclon antibodi bind wide varieti nonhematopoiet cell includ human marrowderiv stromal cell doe bind marrow periph blood cell studi effect thi antibodi rabbit complem marrow cell fibroblast coloni elimin light densiti marrow cell singl incub monoclon antibodi complem growth composi granulocyt erythroid coloni unaffect specif complem mediat cytotox antibodi wa confirm passag human fibroblast deriv marrow fibroblast ar kill singl treatment similar result obtain human umbil cord endoth cell addition treatment abolish initi dexter cultur stroma incub bone marrow cell suspen thi antibodi complem allow studi stromafr marrow cell longterm liquid cultur 
87050030 anemia macrocyticpapp anim bone marrowcyph cell differenti cell division colonyform unit assai growth inhibitorsr growth substancespd hematopoiesi mice mice mutant strainsph radiat ioniz slsld mou bone marrow stroma vitro contain activ radiationsensit inhibitor normal hemopoiesi slsld mice defect hemopoiet environ ha assum base previou studi primari abnorm mice simpli necessari support induct materi hemopoiet stroma vitro longterm bone marrow cultur charact natur hemopoiet environ defect slsld mice slsld mou bone marrow cell consist produc total hemopoiet cell multipot unipot hemopoiet progenitor cell produc cultur marrow normal congen mice fresh slsld marrow cell mix prior establish longterm marrow cultur wa direct correl number slsld cell ad degr inhibi hemopoiesi preestablish confluent slsld adher stromal layer inhibit hemopoiesi fresh marrow cell nearli compar dish irradi stroma thi inhibitori effect wa abrog irradi slsld stroma prior addition fresh marrow cell similarli unirradi gy irradi slsld stroma inhibit prolif factordepend fdcp1 hemopoiet progenitor cell line thu slsld hemopoiet environ activ inhibit hemopoiesi vitro thi inhibi partial elimin irradi slsld stroma 
87050034 antibodi monoclonaldu blood plateletsdem calciumph epinephrinepd fibrinogenm human magnesiumm platelet aggregationd platelet membran glycoproteinsdem support nonu govt support govt ph factor expr fibrinogen receptor dure activ subsequ desensit human platelet epinephrin epinephrin cau platelet aggreg secretion interact alpha 2adrenerg receptor platelet surfac platelet aggreg requir bind fibrinogen specif receptor membran glycoprotein iibiiia complex iibiiia complex identifi surfac rest platelet fibrinogen receptor express onli platelet activ current studi design examin effect occup platelet alpha 2adrenerg receptor epinephrin expr fibrinogen receptor aggreg platelet abil epinephrin induc expr fibrinogen receptor wa studi differ condition acut stimul min prolong stimul min associ reduc desensit platelet aggreg respon expr fibrinogen receptor wa monitor 125ifibrinogen 125ipac1 pac1 monoclon antibodi bind glycoprotein iibiiia complex onli platelet ar activ epinephrin cau immedi increa pac1 fibrinogen bind wa depend occup alpha 2receptor epinephrin presenc extracellular free ca kca mumol mmoll mg wa unabl support induc fibrinogen receptor epinephrin howev decrea ca requir order magnitud prolong stimul unstir platelet epinephrin decrea aggreg respon platelet subsequ stir despit decrea aggreg respon desensit platelet bound pac1 fibrinogen normal indic loss aggreg wa simpli decrea fibrinogen receptor expr desensit wa affect pretreat platelet aspirin wa partial prevent extracellular ca wa chelat edta dure incub epinephrin studi demonstr onc platelet alpha 2adrenerg receptor ar occupi epinephrin extracellular ca involv initi aggreg respon support induc fibrinogen receptor bind fibrinogen furthermor cadepend reaction subsequ fibrinogen bind mai necessari maxim platelet aggreg ar impair platelet becom desensit epinephrin 
87050049 cell membraneul fetal bloodpa human infant newborn lymphocytespa scopi electron scan villiul support nonu govt support govt ph wiskottaldrich syndromedipa morpholog abnorm lymphocyt patient wiskottaldrich syndrom lymphocyt patient wiskottaldrich syndrom wa examin scan electron scopi sem periph blood lymphocyt normal individu ar cover slender villu projec larg propor lymphocyt wa patient rel devoid villi lymphocyt morphologi score wa develop quantifi densiti villi grade classifi lymphocyt greater surfac cover villi progress decrem grade villi mean lymphocyt morphologi score normal individu wa mean lymphocyt score wa patient wa substanti lower addition wa lymphocyt qualit abnorm blunt villi morpholog criteria diagno wa cord blood lymphocyt atrisk patient thu wa primari immunodefici morpholog abnorm identifi aid diagnosi 
87050056 erythrocyt deform erythrocyt membranephul erythrocytesd heinz bodiesul human membran proteinsbl scopi electron molecular weight oxidationreduc phenylhydrazinespd support nonu govt support govt ph quantit relationship heinz bodi format red blood cell deform ultim cau destruc red blood cell rbc oxid damag heinz bodi format understood correl chang rbc morphologi membran protein composi oxid treatment alter deform cell cell membran incub rbc phenylhydrazin concentr mgdl degr dosedepend format heinz bodi rang isol heinz bodi mgdl confluent coat inner membran surfac mgdl phenylhydrazin sodium dodecyl sulfatepolyacrylamid gel electrophoresi reveal presenc larg quantiti hemoglobin bound ghost membran treat rbc electrophoresi dithiothreitol indic disulfid bridg ar abund hemoglobin molecul ar present membran protein ar major bond hemoglobin membran chang spectrin ankyrin band band appear 260000dalton complex observ phenylhydrazin concentr mgdl presenc multipl heinz bodi rbc deform measur filtrat 68micron pore membran deform determin filter aspir techniqu alter mgdl phenylhydrazin entir membran wa coat heinz bodi rbc filter membran deform drastic reduc result indic oxid damag rbc discret heinz bodi format cau focal membran rigidif doe affect global cellular deform heinz bodi nearli cover entir cell endofac 
87050059 consanguin fetal hemoglob gene amplif globe haplotyp homozygot human pedigr support nonu govt support govt ph thalassemiag beta zerothalassemia associ gammaglobin gene quadrupl studi hematologi hemoglobin composi globin gene arrang young turkish boi beta zerothalassemia homozygo hi rel evid present chromosom beta zerothalassemia determin carri gammaglobin gene quadrupl perhap gammag gammag gammaa gammagen arrang gammaglobin gene thi patient produc gamma gamma chain ratio nearli patient hemoglobin wa fetal type clinic condition resembl thalassemia intermedia hbf level betathalassemia heterozygot vari percentag gamma thi hbf averag thi level extent relat haplotyp normal chromosom subject carri alphaglobin gene new bglii polymorph wa observ psi alphaglobin gene 
87050061 cell differentiationd cell divisiond cell line dimethyl sulfoxidepd drug resist granulocytesci human neuraminidasem sialic acidsph sialoglycoproteinsph support govt ph thioguaninepd tretinoinpd hyposialyl differentiationinducerresist hl60 cell total sialic acid concent retino acid raresist 6thioguanin 6tgresist hl60 cell wa tenfold lower dimethylsulfoxid dmsoresist hl60 cell wa approxim twofold lower parent wildtyp wt hl60 cell neuraminidaseinaccess residu cellassoci sialic acid neuraminida treatment wa twelvefold lower differentiationinducerresist sublin parent line neuraminida treatment 125ilabel surfac membran glycoprotein smg wt hl60 cell convert twodimen gel electrophoret pattern featur common ra 6tgresist cell howev neuraminida treatment alter sensit wt hl60 cell differenti induc ra hypoxanthin purin base dmso result indic differ periph neuraminidaseaccess sialic acid ar import determin gel electrophoret mobil smg hl60 line sublin ar relat differentiationresist mechan studi ar requir determin hyposialyl cryptic neuraminidaseinaccess site ha function signif 
87050062 anim blood proteinsto cytotox immunolog drug synerg human hydrogen peroxideto kinet mice neoplasm experimentalim neutrophilsph rabbit speci specif support govt nonph support govt ph vitro tumor cell cytolysi mediat peptid defensin human rabbit granulocyt examin activ defensin cysteinerich cation peptid ar abund cytoplasm granul human rabbit granulocyt variou tumor target human defensin hnp1 hnp2 hnp3 lyse human murin target chromium relea dye exclusion assai defensinmedi tumor cell lysi wa concentrationdepend inhibit serum depend temperaturesensit event lysi wa detect incub reach plateau vitro exposur murin teratocarcinoma cell hnp abrog oncogen vivo nonmalign target cell suscept defensinmedi lysi rabbit granulocyt defensin exert mark np1 np2 moder np3a np3b cytotox activ wherea defensin np5 wa cytotox tumor cell incub human defensin combin hydrogen peroxid synergist cytotox wa detect defensin ar relea granulocyt variou stimuli relea contribut extracellular cytotox independ reactiv oxygen intermedi 
87050064 glycoproteinsdf human thrombosisg mode inherit type ii protein defici letter 
87050065 anemia sickl cellbl erythrocyt abnormalph hemoglobin sickl hemoglobin human polym deoxyhemoglobin polym format sickl cell letter 
87050482 arthriti rheumatoidepet great britain human factor unit state trend rheumatoid arthriti 
87050485 ag antiinflammatori agentsaetu arthriti rheumatoidcodt femal human male middl ag osteoarthritiscodt peptic ulcerciet peptic ulcer rheumatoid arthritisintrin relat drug therapi report incid peptic ulcer disea pud patient rheumatoid arthriti ra higher gener popul unusu suscept pud ra independ therapi ha suggest compar ra patient similar drug exposur predisposi pud patient hospit treatment sever arthriti ra osteoarthr assess questionnair pud histori drug histori relev variabl relationship pud sex distribu smoke alcohol consump antiinflammatori therapi follow expect pattern high similar pud rate ra osteoarthr oa patient ra oa thi suggest common factor probabl drug respon feel docum high incid pud ra probabl relat drug therapi avail method determin pud occur primari manifest ra 
87050490 adren cortex hormonestu adult ag arthriti rheumatoidbldt femal human vitro leukocyt countd male middl ag monocytesdem prednisolonepd superoxidebl effect corticosteroid therapi blood monocyt superoxid gener rheumatoid arthriti studi vitro ex vivo rate superoxid sa gener blood monocyt stimul ex vivo studi befor dure corticosteroid treatment rheumatoid arthriti ra patient control patient healthi control direct effect stimul sa produc preincub cell prednisolon vitro wa studi signif inhibi monocyt sa output stimul iggtreat zymosan itz fluorid ion serumtr zymosan stz wa demonstr follow steroid therapi ra inhibitori effect prednisolon demonstr vitro itz stz stimuli data blood monocyt yield size cytochemistri suggest vivo effect shift blood monocyt traffic 
87050491 actuari analysi adult ag ag arthriti rheumatoiddt azathioprineadaetu compar studi femal human male methotrexateadaetu middl ag support nonu govt 6mercaptopurineadaetu comparison methotrex azathioprin 6mercaptopurin refractori rheumatoid arthriti lifet analysi methotrex mtx appear patient rheumatoid arthriti ra refractori drug longterm toxic efficaci ar uncertain retrospect studi mtx patient comparison purin analogu azathioprin 6mercaptopurin wa lifet analysi eightyfour patient mtx median dose mgweek whilst receiv purin analogu mgdai median patient cea mtx toxic compar purin analogu toxic sever warrant stop therapi wa uncommon drug mtx patient achiev defin criteria improv compar purin analogu number patient improv purin analogu increa substanti wherea number improv mtx continu mtx lowdo regimen refractori ra superior lowdo purin analogu 
87050492 azathioprineaetu chlorambucilaetu connect tissu diseasesdtg cyclophosphamideaetu drug resist human hypoxanthin phosphoribosyltransferaseg immunosuppress agentsaetu lymphocytesdeen mutat thioguanineresist mutat induc cytotox drug lymphocyt patient connect tissu disea cell mutat hypoxanthineguanin phosphoribosyl transfera hprt locu mai detect vitro resist toxic effect thioguanin assess hprt mutant periph blood lymphocyt patient connect tissu disea treat period cytotox drug result patient treat cyclophosphamid abnorm suggest presenc druginduc mutat result patient treat chlorambucil azathioprin differ controlseith drug induc mutat techniqu suffici sensit detect possibl ar discuss specif mutat induc cytotox drug patient connect tissu disea previou record 
87050493 antilymphocyt serumtu arthriti rheumatoidblimth combin modal therapi hemoglobinsan human immunosuppress agentstu leukocyt count inten immunosuppr ctabl rheumatoid arthriti twelv patient ctabl rheumatoid arthriti treat antilymphocyt globulin alg prednisolon cytotox agent usual azathioprin follow wa signif improv mean score earlymorn stiff grip strength sever nodul vascul compar initi visit howev patient thi benefit wa sustain despit continu cytotox steroid therapi rise haemoglobin fall esr wa maintain studi period 
87050495 carpal tunnel syndromedi electrodiagnosi human median nervepp neural conduc clinic test carpal tunnel syndrom evalu clinic test common diagnosi carpal tunnel syndrom shown littl diagnost valu individu variou combin physic sign diagnosi thi condition suspect basi present symptom confirm electrodiagnosi standard median nerv conduc test 
87050496 ag case report femal hodgkin diseasecopa human joint diseasesetpa knee jointpa synovi membranepa synovi involv hodgkin disea report case monoarthropathi patient hodgkin disea invasion synovium appar normal juxtaarticular bone 
87050497 adult arthritiset case report cystic fibrosisco human male vasculitiset episod arthriti cystic fibrosi case report episod arthriti uncommon manifest cystic fibrosi describ case 21yearold cystic fibrosi suffer episod arthriti associ vasculit skin lesion aetiologi discuss refer possibl role immun complex disea 
87050498 case report celiac diseaseco fingersra human male middl ag scleroderma systemiccora sclerodactyli complic coeliac disea 
87050501 carpal tunnel syndromeetpp diabet mellituscodi gluco toler test human assess gluco toler patient idiopath carpal tunnel syndrom letter 
87050502 antiinflammatori agent nonsteroidalaetu arthriti rheumatoiddt gastroscopi human stomach ulcerci gastric ulcer nsaid ra letter 
87050503 adult arthriti infectiouset case report coagulasean human male middl ag staphylococc infectionsdi staphylococcu epidermidisen coagulaseneg staphylococcu cau joint infec letter 
87050505 arthriti rheumatoidpp human pain measurementmt agreem horizont vertic visual analogu scale letter 
87050506 adult ag arthriti rheumatoidth brace equip design femal human knee joint male middl ag osteoarthritisth tv brace patient rheumatoid arthriti osteoarthr knee letter 
87050507 adenocarcinomart case report human male middl ag prostat neoplasmsrt radiat injuri reiter diseaseet reiter syndrom radiotherapi prostat carcinoma letter 
87050508 arthriti rheumatoidet coliti ulcerativeco crohn diseaseco human intestin diseasesco lipodystrophi intestinalco preliminari evid gut involv pathogenesi rheumatoid arthriti letter 
87050509 arthriti rheumatoidmi clostridium perfringensip fecesmi femal human male support nonu govt clostridium perfringen rheumatoid arthriti letter 
87050594 adult ag citratesur femal glycosaminoglycansur human hydrogenion concentr magnesiumur male middl ag recurr support nonu govt urinari calculiur zincur inhibitor urinari stone format recurr stone excretion inhibitor urinari stone format zinc magnesium citrat glycosaminoglycan gag wa studi normal control recurr calcium stone fix diet restrict calcium oxal purin unabl ani abnorm excretion zn mg gag patient low level urinari citrat wa signif featur wa associ case urinari ph valu abov citrat concentr litr output lower control respect determin over ratio averag urinari citrat concentr patient control wa figur agreem previou data 
87050596 adult case report child preschool colonpa colon diseasescopa femal human intestin fistulacopa kidneypa kidnei diseasescopa male middl ag pyelonephr xanthogranulomatouscopa urinari fistulacopa fistula sinu format xanthogranulomat pyelonephr clinicopatholog review report case fistula deep sinu format complic xanthogranulomat pyelonephr xpn ha describ previou british literatur present clinicopatholog featur case nephrodiaphragmat sinu complic xpn case nephrocol fistula includ record case fistula childhood xpn clinic radiolog patholog featur xpn complic ar review total nephrectomi togeth primari excision sinu fistula treatment choic 
87050597 ag carcinoma squamou cellpasc case report femal human kidnei neoplasmsparasc lung neoplasmspa male middl ag tomographi xrai comput renal metasta carcinoma lung case clinic manifest solitari bilat renal lesion metastat lung ar present case ar unusu renal metasta ar usual silent lesion discov autopsi review autopsi data thi hospit identifi renal metasta patient di carcinoma lung thi incid parallel seri solid renal lesion identifi patient histori pulmonari carcinoma rai suspicion renal metasta especi comput tomographi mass demonstr rel homogen minim enhanc frequent abdomin ct scan stage patient lung cancer render metastat carcinoma lung kidnei frequent ant mortem diagnosi 
87050598 adult ag endoscopi femal human male middl ag uret uret calculirath rigid ureteroscopi treatment uret calculi experi case 1year period rigid ureteroscopi ha retriev uret calculi patient technic cau failur complic ar describ initi success rate wa obtain wa conclud ureteroscopi replac blind procedur extrac uret stone 
87050599 adolesc bladder neurogenicco child child preschool endoscopi femal human infant male polytetrafluoroethylenead vesicouret refluxetrath endoscop correc vesicouret reflux secondari neuropath bladder patient vesicouret reflux secondari neuropath bladder treat endoscop injec pyroli polytetrafluoroethylen polytef thirteen uret treat disappear reflux injec polytef inject vari ml mean ml complic uret disten collect wa slightli increa compar preoper urogram 
87050600 anim bladderd cyproheptadinepd doserespon relationship drug femal human vitro ketanserinpd methysergidepd muscl contractiond muscl smoothd serotoninpd serotonin antagonistspd support nonu govt swine urethrad influenc serotonin lower urinari tract smooth muscl vitro influenc serotonin 5hydroxytryptamin human detrusor pig detrusor trigon bladder neck urethr smooth muscl wa explor seri vitro experi serotonin evok dosedepend rever contrac detrusor rever respon wa trigger trigon bladder neck urethr smooth musclea dosedepend rever relax maximum amplitud thi relax wa relax produc electr nerv stimul effect serotonin wa unalt blockad ganglia alpha betaadrenerg receptor cholinerg receptor prostaglandin synthesi serotonin antagonist ketanserin methysergid cyproheptadin partli inhibit effect serotonin antagon differ potenc strip differ origin antagonist ineffect minim effect block respon nerv stimul effect serotonin wa probabl mediat specif serotonin receptor differ serotonins2receptor predomin vascular smooth muscl serotonin potenti neurotransmitt lower urinari tract smooth muscl import micturi physiologi pathophysiologi unknown 
87050601 adult bladderpp femal human middl ag pressur urethrapp urinari incontinencedtppsu urin urodynam pressurevolum plot predic treatment outcom femal incontin graphic repres micturi cycl pressurevolum plot ha obtain women incontin patient normal control pattern contrac dure void allow predic outcom treatment patient urethr sphincter incompet sustain detrusor contrac result colposuspen detrusor instabl wa dure urethr sphincter wa compet patient urg incontin detrusor instabl dure cystometri respon drug provid sustain detrusor contrac wa present dure void urethr sphincter incompet wa characteri low detrusor void pressur 
87050604 adolesc adult ag ag femal followup studi hematuriaet human male middl ag factor 5year followup undiagno haematuria eightyfour patient haematuria seen dure thi symptom wa investig definit cau thei follow patient experienc urolog symptom wa develop malign genitourinari tract possibl cau bleed ar discuss 
87050605 cardiovascular diseasesmo compar studi estradiolaaaetu estrogen synthetictu ethinyl estradioltu followup studi human male neoplasm metastasi orchiectomi prognosi prostat neoplasmsdtmosu comparison primari orchiectomi oestrogen therapi advanc prostat cancer 2year followup report nation prospect prostat cancer studi hundr seventyseven patient advanc prostat cancer treat orchiectomi oestrogen dure 2year followup period respon treatment wa consid favour oestrogen group thi respon wa particularli emphasi patient poorli differenti tumour metasta diagnosi evalu includ cardiovascular effect oestrogen therapi 
87050610 adolesc adult followup studi human male middl ag penil erec penisinsu fractur peni longterm result surgic treatment twentyf patient fractur peni treat surgic longterm followup wa obtain case ani earli postop complic patient state thei achiev normal painless erec patient develop slight penil curvatur thi affect sexual activ strongli recommend earli surgic interven becau encourag result urethr injuri associ fractur occur thi seri 
87050612 ag case report human male neoplasm recurr localsu penil neoplasmssu sarcoma kaposissu kaposi sarcoma peni 
87050613 ag case report fistulaet human male polycythemia veraco postop complic prostatectomi prostat diseaseset skin diseaseset thigh urinari fistulaet prostatocutan urinari fistula thigh retropub prostatectomi patient polycythaemia rubra vera 
87050614 adult case report human hydronephrosiscora kidneyab male giant hydronephrosi pelvic kidnei 
87050615 adenocarcinomadi case report endometriosisdi human male middl ag prostat neoplasmsdi endometrioid carcinoma prostat utricl 
87050616 adolesc case report cystssu epididymissu human male spermat cord torsionsu torsion larg epididym mass 
87050617 adren gland neoplasmsbsrasc case report femal human kidnei neoplasmssu middl ag nephrectomi postop complicationsra renal arteryra bilat adren metasta renal carcinoma treat surgic prolong surviv 
87050618 ag bladdersu case report femal human reoper factor urinari diver rehabilit bladder suprapub cystostomi 
87050619 adult case report human male ureterabra invert uret male 
87050620 case report genit neoplasm malepa human lymphomapa male middl ag spermat cordpa primari lymphoma spermat cord 
87050621 actinomycosisco adult case report human kidneyab kidnei diseasesco male primari renal actinomycosi presenc horsesho kidnei 
87050622 case report femal human intervertebr disk displacementsu oper complic laminectomya middl ag ureterin unusu uret injuri 
87050623 human urinari catheterizationmt new method chang suprapub cathet 
87050681 acquir immunodefici syndromeep commun diseasesep great britain human lyme diseaseep mene meningococcaleppc rabieseppc salmonella infectionseppc report phl commun disea surveil centr public health laboratori servic publish erratum appear br med clin ed nov 
87050700 adult child electromyographi femal human male middl ag movem muscl spasticitypp musclespp reflex abnormalpp reflex stretch support govt nonph support govt ph movem deficit cau hyperexcit stretch reflex spastic human spastic patient instruct accur rapid ankl dorsiflexion plantarflexion movem differ distanc target ankl position surfac electromyogram emg tibiali anterior ta soleu sol muscl record spastic patient test dorsiflexion evok velocitydepend activ antagonist sol muscl imp movem extent limb uninten rever movem direc propo thi activ reflex origin sinc tightli synchron ha larg peak amplitud occur ms initi movem veloc depend patient reflexinduc antagonist activ dorsiflexion demonstr sustain clonu dure plantarflexion thi usual occur onli target overshot return limb stretch soleu muscl trigger clonu conclud patient hyperact stretch reflex cau movem deficit 
87050701 anim corpu striatumph dopamineph femal forelimbph methamphetaminepd motor cortexph psychomotor performanceph rat rat inbr strain stereotyp behaviord substantia nigraph support nonu govt contribu motor cortex nigrostriat dopamin caudateputamen skill forelimb rat skill forelimb wa studi rat unilat lesion sensorimotor cortex caudateputamen dopaminerg nigrostriat bundl task involv reach food limb prefer effici evalu relationship limb spontan methamphetamineinduc rotat bia preoper postop induc nonpref limb bracelet prevent reach movem wa attach forearm prefer forelimb wherea cortic lesion forepaw area sensorimotor cortex mildli influenc limb prefer larger lesion chang prefer furthermor medium sensorimotor cortex lesion impair contralat limb surpri recoveri occur forc test bracelet larg cortic lesion abolish effect reach forc test impair similar follow sensorimotor cortex lesion obtain follow larg caudateputamen lesion contrast unilat dopamin depletion onli block limb contralat depletion impair ipsilat limb wa recoveri ipsilat forelimb contralat forelimb correl analysi weak relat methamphetamineinduc rotat limb prefer preoper signif relat variabl postop similar deficit follow sensorimotor cortex lesion basal ganglia lesion suggest skill forelimb depend share neural organ 
87050702 adult ag ag cognitionph corpu striatumph femal frontal lobepp human lateralityph male memoryph mental processesph middl ag neuropsycholog test parkinson diseasepp psychomotor perform support nonu govt frontal lobe dysfunc parkinson disea cortic focu neostriat outflow thi studi investig hypothesi consequ parkinson disea disturb caudat outflow lead deficit cognit function depend integr prefront cortex cortic focu caudatofug signal sinc parkinson disea involv lesion extrastriat midbrain cell reduc extrin suppli dopamin thi cortic region function ar doubl risk forti nondem parkinsonian patient drawn pool consecut patient match normal control subject accord ag educ iq sex patient quantit rate neurolog indic disea neuropsycholog assess patient normal group includ test gener intellig psychomotor skill memori visuospati execut function global cognit declin wa observ parkinsonian group moreov memori visuospati abil gener intact cluster deficit emerg interpret reflect impair abil spontan gener effici strategi reli selfdirect taskspecif plan addition sever test sensit frontal lobe function distinguish patient symptom strongli right versu left bodi deficit strateg plan investig relat sever disea patient attribut includ iq ag relev perform specif task result compar previou investig parkinsonian patient discuss perspect anim human studi involv damag cerebr cortex basal ganglia prefront cortex plai crucial role selfdirect behaviour plan valid outflow model predict consequ caudat nucleu dysfunc wa support 
87050703 anim axoplasm flowd doxorubicinpd fucosem male methioninem neuron afferentd periph nervesd rat rat inbr strain sciatic nerv support nonu govt effect doxorubicin slow fast compon axon transport rat studi wa design investig chang axon transport result disturb protein synthesi doxorubicin antineoplast drug interf function dna ha select effect periph sensori nerv becau high vascular permeabl dorsal root ganglia venou administr moder dose mgkg male wistar rat transport slow compon sca wa retard transport veloc decrea mmdai vs mmdai control transport kinet fast anterograd retrograd compon afc rfc unchang administr dose mgkg rel afc wa decrea vs control suggest neuronopathi induc doxorubicin mediat chang axon transport 
87050705 adolesc adult ag case report central nervou diseaseset creatin kinasebl ey diseaseset femal human lactatesbl male middl ag mitochondria musclem muscular diseasesclcog neurolog examin succin dehydrogenasem support nonu govt tomographi xrai comput clinic featur mitochondri myopathi clinic featur patient histolog defin mitochondri myopathi ar describ ag onset symptom rang birth wa befor nineteen patient similarli affect rel group case identifi clinic combin progress extern ophthalmoplegia weak limb induc increa exer limb weak alon clinic featur ataxia dementia deaf involuntari movem seizur predominantli exclu ari cn wa consid overlap group pigmentari retinopathi present patient occur mean disea durat twenti patient group sever disabl abl work vitro studi mitochondri metabol perform case commonli defici mitochondri respiratori chain local complex patient complex iii typic clinic pictur emerg ani identifi biochem defect 
87050706 ag ag amyotroph sclerosispa anterior horn cellspa cell count femal human imag process computerassistedmt male middl ag motor neuronspa spinal cordpa support nonu govt focal loss anterior horn cell cervic cord motor neuron disea threedimen studi distribu anterior horn cell c8 segment human spinal cord recogn medial zone motor neuron group abl recogn subgroup neuron group resembl anatom column describ earlier investig thi observ doe invalid concept function group anterior horn cell pool studi segment cord obtain autopsi patient motor neuron disea zone focal loss motor neuron identifi consist sever distribu differ level impli vari resist disea differ pool motor neuron 
87050707 adolesc brainpp case report child corpu callosumppsu femal human male motor skillsph neural pathwayspp neurolog examin neuropsycholog test seizuressu stereognosisph support nonu govt touchph effect earli late transec corpu callosum children studi tactil tactuomotor transfer integr children ag test unilat discrimin interhemisph transfer tactil inform tactuomotor learn variou interv befor therapeut callosotomi comparison preoper postop capac reveal younger children ar consid affect interrup callo transmi older children bilat organ speech particip anterior commissur larg exclud possibl compensatori mechan plausibl explan excel preserv interhemisph integr tactil function younger patient appear continu relianc ipsilat pathwai rel greater deficit observ older children hand suggest sensorimotor function depend exten contralat pathwai corpu callosum reach function matur 
87050708 adult antibodi viralan environ femal human leukocyt count longitudin studi male middl ag multipl sclerosisgeim suppressor cell suppressor cell famili member patient multipl sclerosi previou serial measur lymphocyt subpopul individu multipl sclerosi ms demonstr period reduc number okt8 posit t8 cell thi longitudin studi involv twice monthli sampl particip carri phase respect confirm fluctuat t8 cell occur patient ms signif reduc thi lymphocyt subpopul patient spou sibl compar unrel control chang observ spou relat occur patient occasion famili tempor relationship occur remaind low t8 valu signif patient spou sibl control chi abnorm stage result provid indirect evid role environ factor determin certain immunolog abnorm present patient ms illustr role famili studi determin specif chang disea 
87050709 femal human male middl ag parkinson diseasepp psychomotor perform reaction space perceptionph support nonu govt visuospati function parkinson disea previou research visuospati function parkinson disea review present experi wa design test fundam aspect spatial abil rightleft discrimin manipul concept differ spatial perspect measur accuraci reaction perform patient parkinson disea differ normal subject spatial compon task review literatur result present studi support gener visuospati deficit parkinson disea 
87050917 anim burn inhalationm dextransdu dtpadu extracellular spacem lungm rabbit technetiumdu earli detec extravascular lung water inhal injuri anim model publish erratum appear burn incl therm inj feb13182 rabbit inhal injuri model dual tracer radioact isotop techniqu rowland et al ha util medium molecular weight tracer oedema format smoke inhal fluid resuscit especi combin inhal injuri fluid resuscit correct thi oedema appear decrea postinjuri doe appear ani differ medium tracer transit tracer lung vascular compart increa extravascular water volum confirm gravimetr anali lung thu pulmonari oedema rabbit anim model detect postinjuri return normal valu fluid challeng period fluid resuscit exacerb oedema develop onset pulmonari oedema mai therefor earlier previou seen clinic fluid resuscit modif mai benefit smoke inhal injuri 
87050918 anim burnspp cytochromesm male mitochondria liverenph oxid phosphoryl rat rat inbr strain succin dehydrogenasem function chang ratliv mitochondria dure earli phase burn injuri succin substrat respiratori control ratio liver mitochondria burn male spraguedawlei rat skin burn cover bodi surfac area increa min burn peak min postburn sham group act control comparison sham group specif activ succin dehydrogena wa slightli decrea activ cytochrom decrea significantli min burn result suggest increa metabol activ dure earli phase burn injuri 
87050919 axilla burnsco contracturecletsu human neck surgic flap burn contractur neckaxillari region 
87050920 adult burnssu case report cicatrix femal human male surgic flap scar flap secondari flap reconstruct surgeri exten burn report scar flap secondari flap surgic repair exten burn patient burn scar contractur repair scar axial pattern flap scar musculocutan flap scar fasciocutan flap ar describ howev conten applic strictli limit exampl scar secondari axial pattern musculocutan flap reconstruc burn ear shown 
87050921 bacteri infectionsim burnsim femal human male rosett format evalu eac rosetteform cell patient thermal injuri thermal injuri lead chang cellmedi humor respon patient thi studi wa undertaken assess respon postburn period bacteri infec alter respon ha conclud alter cellmedi humor immun respon follow thermal injuri ar alter infec consequ ar import heal process 
87050922 adult burnspx child counselingmt femal human male parentspx multidisciplinari group approach counsel parent burn children thi studi ha shown multidisciplinari group approach counsel parent burn children decrea parent anxieti medic psycholog social problem featur primarili group discu 
87050923 accid occup adult australia burnsep burn chemicalep ey burnsep femal human male epidemiologi industri burn brisban retrospect epidemiolog studi industri burn admit royal brisban hospit wa conduct period total patient includ thi survey173 male femal propor industri burn ha decrea total admi burn unit fifti burn occur male old averag ag wa twothird burn cover bodi cover scald commonest cau industri burn studi flame burn cloth ignit cau exten burn hand common site involv burn region mainli cau flame electr burn ey burn compri sampl chemic ga explosion electr flash twentysix patient suffer respiratori injuri onli patient seri di progress ha industri safeti careless human error toll 
87050924 accid home burnsep denmark femal human male epidemiologi sever burn injuri epidemiologi sever burn anali septemb august patient femal male admit burn unit copenhagen major burn domest wa predomin cau vulner area arm leg children highest incid thermal injuri predispo factor signif sever accid import preven stress 
87050925 anim electr injuriesetmo human lightn mice rat rat inbr strain support nonu govt lightn injuri cau discharg accompani flashoversa clinic experi studi death surviv dure prece march patient sustain lightn injuri cau thunderbolt fifti patient evid current flow bodi victim classifi group consist victim ruptur cloth linear superfici dermal burn bodi head feet indic occurr surfac flashov remain patient evid thi flash effect noteworthi group surviv wherea group onli surviv result indic flashov occur bodi probabl surviv higher condition determin death surviv investig experi impo artifici lightn voltag impul rat develop flashov rat surviv voltag drop cau flashov occur immedi peak current waveform exhibit sharp peak contrast rat kill voltag drop cau flashov wa delai current waveform blunt cone shape ha conclud fast flashov appreci diminish energi dissip bodi consequ result surviv 
87050926 adult burnsco calcinosiset case report human male skin diseaseset factor calcinosi cutisa rare late complic burn pillar calcif ar rare skin case describ row new bone develop skin graft previou cover partial skin burn shin problem heterotrop ossif ar discuss 
87050927 adult bladder fistulaet case report electr injuriesco human intestin fistulaet intestin male abdomin viscer perfor secondari electr injuri case report review literatur patient vesicoent fistula wa successfulli treat resec intestin dome bladder drainag interven abscess search literatur reveal thi veri unusu complic highvoltag electr injuri 
87050930 burnsrh hand injuriesrh human occup therapi plai playth game occup therapi hand burn activ rang motion hand burn obviou adapt game patient arou provid incent activ particip hisher therapeut programm game ar individu player differ intellectu level provid differ activ rang motion finger wrist elbow shoulder game patient retir copi game collec occup therapist game ar isra manufactur game ga autoclav therefor patient patient game provid outlet intellectu stimuli distrac burn unit signifi 
87051060 anterior ey segmentr choroidr eyer human lighta pigment epithelium eyer retinar vitreou bodyr potenti damag effect light ey electromagnet spectrum consist radiant energi classifi accord specif wavelength constantli expo portion electromagnet spectrum particularli radiat violet visibl infrar region tissu ey skin ar particularli sensit nonion wavelength radiant energi tissu possess endogen protect mechan minim effect exposur problem occur absorp radiat cornea len retina shown suscept damag light violet visibl infrar rang thi twopart articl examin structur ey ar suscept light damag ii publish issu journal focu ey protec 
87051061 equip design human irrigationi suctioni support nonu govt vitrectomyi new variabl suction fingertip control develop variabl suction irrig aspir vitrectomi regul oper fingertip 
87051062 abducen nerv adolesc adult ag case report child cranial nerv diseasessu evalu studi human middl ag oculomotor musclessu oculomotor nerv paralysissu supramaxim horizont rectu surgeri manag sixth nerv palsi supramaxim medial rectu surgeri wa perform correct horizont deviat case sixth nerv palsi case nerv palsi satisfactori result case advantag disadvantag procedur ar discuss 
87051063 adult brain neoplasmscoppra case report femal human male middl ag nerv fiberspp tomographi xrai comput vision disorderset visual acuiti visual field nerv fibr bundl visual field defect cranial mass lesion nerv fibr bundl visual field defect ar hallmark pathologi optic nerv head retina present seri ey patient larg cranial mass lesion demonstr field defect visual acuiti spare involv ey case visual function opposit ey offer clue local lesion 
87051064 carbamazepinetu case report fasciculationdtppsu femal followup studi human middl ag oculomotor muscl superior obliqu myokymia treatment necessari 56yearold woman present 10year histori torsion diplopia right monocular oscillopsia symptom intermitt continu practic uninterrupt dure wa diagno superior obliqu myokymia right ey adequ trial oral carbamazepin baclofen phenytoin unsuccess suppress symptom initi present underw right superior obliqu tenectomi right inferior obliqu rece eventu requir oper ey cure annoi diplopia downgaz 
87051065 case report cellular inclusionsul cytoplasmul femal human lymphomaparaul scopi electron middl ag orbit neoplasmsparaul signetr cell lymphoma orbit case report review author report case signetr cell lymphoma involv orbit thi variant nonhodgkin lymphoma contain vacuol eosinophil cytoplasm inclusion squeez nucleu cell thi case inclusion eosinophil stain posit pa immunoglobulin igm heavi chain kappa light chain electron scopi granular electronden materi trap distend loop rough endoplasm reticulum twentytwo case signetr cell lymphoma previou report elsewh bodi ar review clinic signif discuss 
87051142 accid trafficpc automobil drive canada human light daytim vehicl light letter 
87051143 human nicotin acid nomenclatur vitamin b3 letter 
87051144 adult ag burnset child child preschool heat human legionnair diseasepc risk water suppli balanc risk legionella pneumophila pneumonia tap water scald home editori 
87051145 aerospac medicin canada human legisl medic physicianpati relat aeronaut act doctorpati relationship 
87051146 canada femal genet screen human human right infant newborn legisl medic pregnanc quebec truth disclosur genet inform law constraint liabil right 
87051150 acut disea adult ag ag allopurinola antiinflammatori agent nonsteroidala antibioticsa cephaloridinea cimetidinea femal fenoprofena human indomethacina kidneypa male middl ag nephriti interstitialcidipa penicillinsa druginduc acut interst nephriti report case januari june patient acut allerg interst nephriti seen clinic nephrologi servic larg region hospit onset renal failur wa tempor relat drug nonsteroid antiinflammatori agent nsaid patient cimetidin antibiot allopurinol onset renal failur wa acut patient insidi patient exhibit mark proteinuria clinic featur fever rash hematuria pyuria eosinophiluria mild mark proteinuria suspicion disea diagnosi wa confirm renal biopsi inflammatori cell predominantli lymphocyt plasma cell eosinophil patient requir hemodialysi receiv steroid steroid therapi wa patient nsaidinduc proteinuria renal function improv patient dai patient continu slow progress deterior renal function acut interst nephriti distinguish form acut renal failur heavi renal uptak gallium maxim injec improv renal function discontinu implic drug characterist histopatholog allerg interst nephriti presenc eosinophil sometim ig blood suggest hypersensit reaction 
87051152 british columbia cacaopo child preschool disea outbreaksep femal human plant edibl salmonellaip salmonella food poisoningepet salmonella nima british columbia 
87051153 adult canada child human influenzapc influenza vaccinead orthomyxoviru type humanim vaccin supplementari statem influenza vaccin 
87051154 canada human physicianssd school medic medic school cutback unfair young canadian confer 
87051155 human physician prison tortur doctor tortur tortuou issu 
87051156 philosophi medic philosophi medicin letter 
87051157 amniocentesi chorion villian ethic medic femal human pregnanc pregnanc trimest prenat diagnosi firsttrimest fetal diagnosi prudenti ethic letter 
87051158 ag ag angina pectorisdi electrocardiographi exerc test human silent angina elderli letter 
87051159 canada femal human jurisprud premenstru syndromepx violenc legal implic premenstru syndrom canadian perspect letter 
87051160 acut disea anesthesia inhalationa hepat toxicet human isofluranea acut hepat isofluran anesthesia letter 
87051161 accid traffic adolesc adult athlet injurieset canada child human transport danger offroad vehicl young driver editori 
87051162 academ medic centersec canada fund rai nation health program research support univ 
87051163 aerosol child human infant paramyxoviru infectionsdt respiratori syncyti viru respiratori tract infectionsdt ribavirinadaetu ribonucleosidestu ribavirin indic pediatr infecti disea immun committ canadian paediatr societi 
87051165 adolesc adult ag femal followup studi human interview psycholog male middl ag motiv ontario paraquatpo suicideep suicid attemptedpx factor chang motiv sever suicid patient ambigu suicid patient state motiv ha studi atten ha changeabl motiv twentysix patient overdo paraquat highli lethal herbicid motiv admi dai patient claim thei wish die admi surviv patient wish live discharg hospit patient di state thei wish die interview befor death dure follow surviv patient kill themselv empha import thoroughli assess aspect suicid patient situat determin risk patient state inten factor consid 
87051166 accid traffic adolesc athlet injurieset child child preschool fractureset human male season transport injuri associ offroad vehicl children offroad vehicl attain grow popular expand market increa rate associ injuri especi young peopl patient treat children hospit eastern ontario ottawa injuri suffer offroad vehicl accid averag ag patient wa softtissu injuri occur patient sever injuri fractur patient patient di result hi injuri common mechan injuri wa lose control tumbl machin seventeen patient struck vehicl collid object car tree peopl health care cost accid ar seriou concern appropri legisl protect consum particularli young 
87051167 acut disea adult anim bite stingsco case report cat emerg femal fetal deathet human pasteurella infectionstm pregnanc pregnanc complic infectiouset septicemiaet zoonosestm pasteurella multocida septicemia dure pregnanc 
87051168 adult blood coagul test case report drug interac femal human partial thromboplastin prothrombin trazodonea warfarinm reduc prothrombin partial thromboplastin trazodon 
87051169 case report femal human infant ovarian diseasesmo sudden infant deathet torsion ovarian torsion relat sudden infant death 
87051170 acquir immunodefici syndromeep adult ag factor canada femal herpesviridaeip herpesviru infectionsep human infant male middl ag sex factor laboratori report herpesviru infec canada 
87051171 abnorm multipl child advocaci ethic medic human infant newborn infanticid parentspx qualiti life ethic issu infanticid sever defect infant 
87051239 ag bone marrowul chromosom aberr femal human male middl ag myeloprolif disordersg preleukemiag prognosi support govt ph chromosom studi preleukem state prognost signif singl versu multipl abnorm prognost valu marrow chromosom wa examin patient preleukem myelodysplast syndrom md myeloprolif disord mpd emphasi signif singl versu multipl karyotyp chang group result patient multipl chromosom abnorm marrow clone veri high probabl earli death progr leukemia complic hematopoiet dysfunc conver patient hemic clone onli karyotyp alter involv singl chromosom singl transloc surviv wa onli slightli reduc compar chromosom abnorm onli singl karyotyp alter perhap associ markedli shorten surviv wa monosomi suggest conclusion previou studi concern grave consequ chromosom alter preleukemia larg reflect clinic signif clone multipl cytogenet chang prior knowledg karyotyp statu preleukem patient help evalu current attempt effect treatment difficult disord 
87051240 adult case report drug evalu femal human interferon type itu male melanomath middl ag neoplasm metastasi recombin proteinstu skin neoplasmsth recombin leukocyt interferon rifnalpha treatment dissemin malign melanoma analysi complet longterm respond patient ninetysix patient dissemin malign melanoma receiv thrice weekli muscular injec leukocyt recombin interferon rifnalpha roferona hoffmann la roch dose um2 um2 cimetidin immunorestor agent patient prior chemotherapi demonstr complet respon soft tissu metastasi excep durabl respon durat soft tissu lung lesion soft tissu soft tissu liver lesion patient particularli characterist clinic paramet previou chemotherapi propor patient advanc malign melanoma despit prior therapi mai achiev prolong object regr rifnalpha 
87051241 adolesc child child preschool femal human infant infant newborn male mesonephromamopa neoplasm embryon mixedmopa ovarian neoplasmsmopa support govt ph teratomamopa testicular neoplasmsmopa nongerminomat malign germ cell tumor children review case pediatr oncologi group  clinic morpholog featur case childhood yolk sac tumor ys embryon carcinoma ec associ teratoma submit rare tumor registri southwest oncologi group pediatr oncologi group review submit statist analysi thi review improv surviv 5year period regardless tumor site statist signif differ pure tumor mix teratomat compon statist signif differ ys ec children report prognosi sacrococcyg tumor occur neonat period particularli poor prognosi neonat benign sacrococcyg teratoma resect coccygectomi thei recur ys excel surviv testicular tumor regardless ag presenc ec occurr mediastin tumor femal 
87051242 ag anim cat diarrheaci drug evalu femal head neck neoplasmsdt human male middl ag mitoguazonetotu nauseaci support govt ph vomitingci phase ii trial methylglyox bi guanylhydrazon mgbg advanc head neck cancer methylglyox bi guanylhydrazon mgbg inhibitor polyamin synthesi vitro studi demonstr accumul tumor cell g2 phase cell cycl nineteen patient advanc head neck cancer enter phase ii trial mgbg mgbg mgm2 wa administ brief venou infusion weekli everi dose modif base cumul toxic weekli treatment patient prior exposur chemotherapi disea recurr patient evalu respon toxic brief partial respon wa observ common toxic mild moder nausea vomit diarrhea stomat myelosuppr occur patient dose modif requir patient maximum dose mgm2 wa toler result phase ii singl combin chemotherapi trial mgbg head neck cancer ar review singl agent respon rate patient wa rang poor respon rate observ thi trial wa similar trial heavili pretreat group patient wa evalu conclud singl agent mgbg drug heavili pretreat recurr disea patient howev becau biochem effect test combin cycl specif agent larger number patient minim prior treatment mai warrant 
87051243 adult ag antineoplast agent combinedtu bone neoplasmssc breast neoplasmsdt femal fractureset human middl ag spine factor clinic cour breast cancer patient osseou metastasi treat combin chemotherapi juli decemb patient metastat breast cancer treat doxorubicincontain chemotherapi patient osseou metasta onli initi diagnosi osteolyt metasta osteoblast metasta mix metasta diffu osteoporosi ani obviou bone destruc common site involv dorsal spine lumbosacr spine pelvi object respon chemotherapi wa observ patient complet respon partial respon median surviv wa rang median lap chemotherapi disea progr wa rang patient respond treatment chemotherapi wa discontinu median durat continu remi completion therapi incid patholog fractur wa common site spine sustain compr fractur rib incid hypercalcemia spinal cord compr metasta respect 
87051244 adolesc adult antineoplast agent combinedtu bleomycinsad case report cisplatinad dysgerminomadt etoposidead femal human lymphat metastasi neoplasm recurr localdtsu ovarian neoplasmsdt chemotherapeut complet remi patient metastat ovarian dysgerminoma potenti cure preserv reproduct capac patient metastat dysgerminoma ovari treat combin etoposid bleomycin cisplatin univ texa md anderson hospit tumor institut houston patient achiev complet remi patient develop massiv recurr paraaort lymph node diagnosi treatment right salpingooophorectomi alon receiv cycl chemotherapi free disea chemotherapi patient stage iii dysgerminoma lymphangiogram posit tumor paraaort lymph node surgeri receiv cycl chemotherapi free disea chemotherapi complet remi docum secondlook laparotomi chemotherapi mai altern radiotherapi treatment metastat dysgerminoma consid select patient stage disea literatur review support conclusion addition clinic trial expand indic chemotherapi patient thi disea 
87051245 antineoplast agent combinedaetu case report cisplatinad followup studi gastrointestin diseasesci human male neoplasm embryon mixeddtmo raynaud diseaseet support nonu govt testicular neoplasmsdtmo longterm surviv morbid patient metastat malign germ cell tumor treat cisplatinba combin chemotherapi fortythr patient treat clinic metastat germ cell cancer surviv median rang patient previou chemotherapi 5year surviv rate wa wherea onli patient prior chemotherapi surviv limit disea complet clinic respon histopatholog proven postchemotherapi tumor necrosi complet resect posttreat matur teratoma indic favor prognosi patient prior chemotherapi onli patient clinic complet respon posttreat residu malign tumor salvag line therapi posttreat matur teratoma resect complet whenev possibl thi condition mai lead reactiv malign sever raynaudlik phenomena andor gastrointestin problem ar main longterm sequel modern multimod treatment advanc germ cell cancer fertilityrel problem ar consid major surviv patient lifestyl unaffect previou inten treatment evalu discontinu therapi 
87051246 antineoplast agentsada combin modal therapi femal human infant infant newborn male rhabdomyosarcomacneppa support govt ph infant younger ag rhabdomyosarcoma total patient regist intergroup rhabdomyosarcoma studi ir mai patient younger ag infant differ older children ag malefem ratio clinic group surviv rate infant younger ag significantli greater frequenc undifferenti sarcoma versu older children infant significantli greater propor cancer botryoid pathologi versu older children review newli propo ir cytopatholog classif wa differ patholog type ag group infant younger ag higher rate bladderprostatevagina primari tumor site older children versu addition infant tend receiv prescrib dose chemotherapi radiat therapi older children develop toxic treatment older children despit differ over surviv curv ag group appear similar contrast wilm tumor neuroblastoma ag favor prognost factor ag doe appear import prognost factor rhabdomyosarcoma 
87051247 adult ag antineoplast agent combinedaetu bleomycinsad doxorubicinad femal human liver diseasesci lymphat metastasi male mechlorethaminead methotrexatead middl ag mycosi fungoidesdtsu neutropeniaci skin diseasesci skin neoplasmsdt splenectomi treatment advanc stage mycosi fungoid bleomycin doxorubicin methotrex topic nitrogen mustard bamm patient advanc stage tnm iibivb mycosi fungoid treat combin chemotherapi program consist bleomycin methotrex weekli doxorubicin everi topic nitrogen mustard daili bamm patient obtain histolog docum complet remi rang durat median surviv patient splenomegali wa detect dure stage evalu underw splenectomi patient unmaintain diseasefr surviv thi studi indic bamm effect therapi advanc stage mycosi fungoid suggest therapeut role splenectomi evalu 
87051249 evalu studi gallium radioisotopesdu human lymphographi lymphoma nonhodgkinsrari retrospect studi support nonu govt tonsillar neoplasmsrari valu gallium scan lymphangiographi nonhodgkin lymphoma waldei ring patient seemingli local nonhodgkin lymphoma waldei ring wrnhl lymphangiographi lag andor gallium67 scan ga67 scan befor procedur patient diagno stage stage ii lag wa ga67 scan patient upstag stage iii iv ga67 scan onli abnorm lag ga67 scan abnorm accumul paraaort region becau thi low posit rate lag recommend stage wrnhl 
87051251 adult antibodi format antibodyproduc cellsim compar studi femal human immun cellular immunoglobulinsan leukoplakiaim male middl ag mouth diseasesim mouth neoplasmsim oral submuc fibrosisim rosett format support nonu govt cell mediat humor immun respon oral submuc fibrosi cellmedi humor immun respon assess patient oral submuc fibrosi osmf result compar patient oralleukoplakia oral cancer patient normal healthi adult control number highaffin rosetteform cell harfc wa significantli decrea osmf oral cancer wherea number total rosetteform cell trfc remain unalt level serum iga igd ig elev osmf oral cancer immunolog derang pronounc oral cancer osmf enum harfc estim serum level iga igd ig indic osmf intermediari stage malign transform normal cell paramet mai serv marker earli detec oral cancer 
87051253 ag bone marrowpa case report endometriumpa femal histiocytosi malignantcopa human lymph nodespa male middl ag phagocytosi tuberculosisco tuberculosisassoci hemophagocyt syndrom process virusassoci hemophagocyt syndrom ha identifi benign reactiv histiocyt prolif distinct rappaport malign hystiocytosi etiolog agent includ differ bacteria identifi autopsi case hemophagocyt syndrom associ acut tubercul sepsi ar present benign histiocyt prolif strike hemophagocytosi wa present dissemin multisystem pattern case relationship histiocyt prolif anerg statu patient suggest 
87051254 adolesc adult ag bone neoplasmsclimpa child child preschool femal human infant lymphomaclimpa male middl ag neoplasm recurr local prognosi factor malign lymphoma bone total patient malign lymphoma bone seen mayo clinic major group base stage disea wa group primari lymphoma bone group multifoc osseou lymphoma group lymphoma bone nodal soft tissu disea lastmen group separ basi onset osseou lymphoma relat nonoss disea stage disea wa singl import prognost indic over surviv malign lymphoma bone 10year surviv rate respect patient primari bone lymphoma patient bone nodal soft tissu disea patient multifoc osseou disea featur signif prognost valu sex patient histolog grade lymphoma accord work formul kiel presenc tcell featur cleav cell thi studi abl adequ address efficaci treatment treatment mai veri import outcom 
87051255 adult ag carcinomacfsc case report femal head neck neoplasmscfpa human male mene neoplasmscfrasc tomographi xrai comput mene carcinomatosi head neck cancer report case review literatur head neck cancer ha rare report cau mene carcinomatosi tumor ar local inva distant metastasi thi appear preclud mene involv close proxim multipl cranial nerv mai provid access mene case head neck cancer mene invasion ar present case malign cell cerebrospin fluid case malign cell recov ventricular specimen lumbar punctur neg common clinic present wa cranial nerv involv optic nerv wa involv nerv vi frequent headach wa present patient seizur occur patient meningismu current treatment plan involv inser ommaya reservoir ventricular methotrex onli patient primari head neck tumor respon therapi undergo ommaya placem mene carcinomatosi head neck cancer mai preval previou mechan direct exten hematogen spread 
87051258 carcinomablsu femal followup studi gastrectomi human male stomach neoplasmsblsu testosteronebl serum testosteron level patient gastric carcinoma befor gastrectomi serum testosteron level stl wa determin male femal patient gastric carcinoma male femal patient benign disea control group stl male patient carcinoma wa lower ngdl male control group ngdl male patient earli carcinoma lower stl ngdl normal group femal patient wa lower ngdl control group ngdl postop stl case surviv gastrectomi wa higher preoper data male patient femal patient greater greater wherea obviou decrea patient di recurr therefor appear gastric carcinoma decrea stl mechan 
87051259 adolesc adult ag blood protein femal human lipidsbl liver neoplasmssc lymphat metastasi male middl ag neoplasm metastasi neoplasmsbl sialic acidsbl support nonu govt support govt ph total lipidassoci serum sialic acid level cancer patient differ primari site differ degr metastat involv serum total sialic acid tsa lipidassoci sialic acid lasa level drawn consid becau carbohydr aberr malign cell current investig determin tsa lasa total protein tp tsatp valu cancer patient variou primari site differ degr metastat disea patient nonmalign disea patholog control normal individu data analysi indic signif increa mean sd tsa tsatp valu cancer patient mgdl mgg respect patholog control mgdl mgg compar normal control mgdl mgg signif decrea mean tp valu cancer patient gdl patholog control gdl compar normal control gdl signif differ wa observ group lasa valu analysi data patient subgroup base tissu involv specif disea sever malign indic specif marker wa primarili restrict subgroup sensit tsa tsatp increa malign becam sever result tsatp wa marker test detect malign thi marker prove monitor malign disea recurr andor progr evalu effect variou therapeut approach 
87051261 adolesc adult ag case report chondrosarcomadipart femal human male middl ag protonstu skull neoplasmsdipart tempor bone tomographi xrai comput chondrosarcoma tempor bone diagnosi treatment case review literatur chondrosarcoma tempor bone rare lesion clinic ha confu multipl sclerosi glomu jugular tumor meningioma chordoma cranial nerv palsi frequent observ tumor ar relat anatom locat tumor thirteen patient thi entiti ar present case literatur ar review histolog tumor ar low grade exhibit myxoid featur myxoid featur differenti chordoma chondroid chordoma tumor locat preclud surgic excision conven radiat therapi cau unaccept neurolog sequela proton beam therapi ha effect shortterm result appear capabl avoid seriou neurolog effect 
87051265 carcinomapara carcinoma oat cellpara case report cerebr ventricl neoplasmsrasc femal human lung neoplasmspa male middl ag tomographi xrai comput diffu subependym periventricular metasta report case clinicopatholog case remark pattern exten diffu subependym periventricular spread cerebr metasta solid cancer ar report patient cell carcinoma lung case histolog featur brain metasta consist neuronspecif enolaseposit cell anaplast carcinoma involv choroid plexu leptomen wa moder absent parenchymat nodular metasta case rare nodular superfici cortic metasta present clinic data nonspecif orthostat hypoten patient wa probabl infiltr floor fourth ventricl result cerebrospin fluid examin avail case normal onli diagnost investig wa contrastenhanc comput tomographi scan 
87051266 ag factor child child preschool denmark femal human male neuroblastomamoth prognosi regr analysi sex factor prognost factor neuroblastoma treat denmark statist estim prognosi base case multivari analysi unselect patient popul consist children treat neuroblastoma denmark dure stage ag treatment ar independ prognost variabl calendar diagnosi sex patient site primari tumor signif prognost factor analysi multimod treatment surgeri irradi chemotherapi especi patient older ag stage ii disea ha influenc surviv significantli ag diagnosi administr chemotherapi independ prognost signif explain theori neuroblastoma ar virtual congenit therefor differ ag diagnosi larg reflect differ growth rate tumor thu accord thi theori ag mai measur probabl metasta addition clinic extent stage disea repr durat disea addition chemotherapi mai thu erad metasta older children sinc ag influenc stage ii disea disappear multimod treatment wa thi studi implic treatment polici ar discuss view thi theori 
87051267 adult breast neoplasmsg case report human male pedigr support nonu govt famili breast cancer male case report review literatur occurr breast cancer relat male uncl nephew report review previou report case male breast cancer occur famili associ cancer famili member includ previou report breast cancer male famili hereditari factor gener recogn major contribut factor famili report includ suffici inform famili femal breast cancer appear ar famili male femal increa risk develop breast cancer 
87051268 cathet human male neoplasmsco peritoneum pleural effusionsu pleuroperiton shunt malign pleural effusion tradition therapi malign pleural effusion includ thoracentesi tube drainag instil irrit achiev pleurodesi thi requir lengthi hospit cau pain discomfort ha appreci failur rate becau drawback author shunt devic transfer fluid periton caviti patient malign pleural effusion patient undergon previou therapeut thoracent chest tube placem fail sclerosi shunt wa subcutan valv pump chamber attach pleural periton cathet manual compr transfer fluid normal abdominalpleur pressur gradient oper placem local gener anesthesia wa perform complic patient achiev minim benefit becau moribund statu inabl compress pump effect patient wa radiograph evid diminish stabil pleural effusion respiratori symptom effect palliat treatment effusion wa requir periton dissemin malign cell ha clinic detect feel pleuroperiton shunt valid new method treatment malign pleural effusion effect palliat respiratori symptom low morbid advantag includ absenc extern tube possibl onli hospit outpati placem shunt applic patient ar abl perform requisit pump particularli suitabl trap lung fail attempt pleural sclerosi 
87051269 adult ag autopsi echocardiographi electrocardiographi femal heartpp heart neoplasmssc human male mesotheliomapp middl ag pleural neoplasmspp support govt ph cardiac abnorm patient diffu malign pleural mesothelioma mani patient diffu malign pleural mesothelioma dyspnea chest pain cardiac symptomatologi frequent difficult differenti symptom pleuropulmonari disea defin clinic characterist cardiac involv patient mesothelioma electrocardiograph ekg echocardiograph patient biopsyproven malign pleural mesothelioma review total patient autopsi studi avail review ekg wa abnorm patient half arrhythmia includ sinu tachycardia prematur atrial ventricular contrac atrial fibril atrial flutter conduc abnorm includ bundl branch block hemiblock incomplet right bundl branch block echocardiographi reveal total patient pericardi effusion pericardi thicken anterior sonoluc space autopsi cardiac invasion wa half pericardium quarter myocardium conclud clinic cardiac abnorm occur great major patient malign pleural mesothelioma patholog cardiac invasion occur great major patient pleural mesothelioma ekg echocardiogram ar help differenti cardiac involv progress pulmonari disea patient pleural mesothelioma 
87051270 ag bladder neoplasmsdipath bcg vaccinetu carcinomadipath case report fal neg reaction femal flow cytometri human male middl ag support govt ph monitor vesic bacillu calmetteguerin treatment superfici bladder carcinoma serial flow cytometri simultan urinari flow cytometri cytolog cystoscop examin perform 3month interv minimum patient receiv vesic bacillu calmetteguerin bcg treatment superfici bladder carcinoma flow cytometri fcm cytologi concord examin fcm cytologi posit instanc carcinoma wa confirm biopsi instanc fcm cytologi neg carcinoma wa present biopsi examin suspici techniqu determin discord fcm cytologi subdivid patholog confirm recurr instanc evid patholog andor cystoscop disea instanc instanc recurr fcm wa posit suspici neg cytologi wa posit suspici neg patient sever bcginduc inflammatori respon cau elev hyperdiploid popul believ secondari epith regen prolif instanc detect recurr hyperploidi rel high propor posit suspici result fcm onli distinct aneuploid popul possibl thi group harbor occult carcinoma conven cytologi nonrecurr group wa posit suspici neg instanc tumor wa confirm biopsi falseneg rate fcm wa falseneg rate cytologi wa thu fcm appear sensit specif conven cytologi lower falseneg higher falseposit rate serial fcm provid object quantit measur aneuploid stemlin hyperdiploid popul bladder irrig specimen help follow vesic bcg therapi superfici bladder carcinoma conven cytologi greatest difficulti fcm present conven cytologi case mark inflamm result report obtain stringent condition repr minimum level accuraci potenti improv techniqu addition immunolog marker hold hope increa accuraci fcm 
87051271 ag biopsi bladder neoplasmspartsu carcinoma transition cellpartsu human male middl ag preoper care support govt ph transition cell carcinoma urinari bladder effect preoper irradi morphologi effect preoper irradi morphologi transition cell carcinoma tcc evalu studi pretreat biopsi radic cystectomi specimen patient twentysix patient receiv rad prece surgeri patient receiv preoper treatment frequenc bladder residu tcc wa irradi nonirradi case tcc classifi papillari biopsi specimen irradi papillari compon cystectomi case wa inva compon elimin regr muscl invasion superfici tcc notic flat carcinoma situ ci respond irradi cystectomi nuclear pleomorph wa greater biopsi irradi tcc wherea nonirradi case retain grade biopsi addition irradi induc squamou differenti neoplast cell onli affect nonneoplast urothelium 
87051547 heart diseasespp heart ventriclepp human right heart 
87051550 adult ag chronic disea femal heart failur congestivepp heart ventriclepp hemodynam human hypertensionpp male middl ag postur support nonu govt support govt ph vascular resist assess right left heart interac applic resist ratio chronic congest heart failur 
87051551 coronari diseasepp heart failur congestivepp heart valv diseasespp heart ventriclephpp human hypertensionpp effect left ventricl right ventricl import onceobscur right ventricl becom evid disord primarili affect left ventricl onceconsideredpass conduit ha prove essenti mainten normal cardiac output coronari arteri disea function right ventricl affect circul afterload dysfunc left ventricl congest heart failur right ventricular function relat function capac wherea left ventricular function doe right ventricular ejec fraction prognost guid patient mitral aortic valvular disea role right ventricl onli becom evid preci interplai factor ha explain hyperten pulmonari circul affect humor factor elev pressur 
87051552 anim chronic disea coronari diseaseco heart enlargementetpa heart failur congestiveetpa heart valv diseasesco heart valvespa heart ventriclepa human hypertensionco lung disea obstructiveco pathologi right heart chronic hypertrophi failur 
87051558 case report coronari diseasecosu femal heart failur congestiveetppsu heart ventriclepp human oper complicationspp oper period male middl ag mitral valv stenosissu postop complic preoper care support nonu govt support govt ph periop right heart failur etiologi pathophysiologi consid literatur ha devot comprom right ventricl spontan myocardi infarc littl inform avail regard dispropor dysfunc right ventricl associ cardiac oper recoveri period therefrom recogni problem paramount import support measur ar implem great deal ha learn regard appropri support acut fail right ventricl remain accomplish regard assess right ventricl reserv defin role risk factor quantit valu measur optim protect right ventricl injuri dure periop period recogn integr right ventricl alter numer preoper periop postop factor provid enlighten disposi surgic team awar consid plan conduct surgic procedur reduc morbid mortal periop right ventricular failur imposi new unexpect morbid dure oper rel unrel problem repr surgic imperfec appropri effort minim insult right ventricl result significantli decrea incid sever periop right ventricular failur befor impetu continu clinic problem dictat improv techniqu appropri treat thi frequent prevent problem 
87051559 cardiopulmonari bypass heart failur congestiveth heart ventricl heartassist devic human oper complicationsth lungb pulsatil flow periop right heart failur treatment right ventricular failur prohibit separ cardiopulmonari bypass standard method increa pulmonari blood flow emploi includ correc hypoxia acidosi volum load inotrop support right ventricl infusion pulmonari vasodilatorsparticularli lowdo nitroprussideshould pulmonari vascular resist elev pulmonari blood flow remain unsatisfactori aortic balloon counterpul emploi refractori case rightatrialtopulmonaryarteri bypass biomedicu centrifug pump recommend therapi center piercedonachi pneumat ventricular assistpump avail refractori right ventricular failur follow surgic repair congenit cardiac defect placem right atrial pulmonari arteri cannula technic feasibl highfrequ highvolum ventil appear quit promi util pulmonari arteri counterpul creation atrial septal defect mai lifesav recommend therapi choic 
87051560 heart failur congestivedtetppsuth heart ventriclepp human oper complicationsdtppsuth support nonu govt vascular resist right ventricular failur associ left ventricular failur rv lv failur frequent coexist experi evid suggest rv failur result primari insult right ventricl increa pulmonari vascular resist lv failur result elev left atrial pressur therebi reduc transpulmonari hydrostat gradient becau rv function depend contrac left ventricl thi contribu reduc dure lv failur treatment aim restor lv function rv failur persist simpl mechan problem treatment rv failur commenc volum load inotrop ph adjust result adequ rv output mechan assist devic consid rhbp power devic capabl restor perfusion residu rv function clinic result thi devic encouragingmost patient demonstr improv rv function decrea pulmonari vascular resist sever dai treatment allow wean assist howev thi techniqu veri inva requir constant close atten pabc simpl power assist devic experi studi suggest rv function extrem depressedcardiac output greater percent normalpabc mai effect restor perfusion normal level current result suggest rhbp remain gold standard sever rv failur clinic experi pabc mai clearli defin role manag rv failur 
87051563 heart defect congenitalpa heart valv diseasescn heart ventricleab human pulmonari valveab tricuspid valveab pathologi congenit malform right heart 
87052045 administr cutan administr oral drug toler human infusion venou nitratesadm ointment factor toler organ nitrat 
87052046 anim coronari diseasedtpp dog drug evalu drug screen fibrinolyt agentstu heartdepp heart ventriclepp human myocardi contractiond support govt ph systol assess ischem region myocardi dysfunc rever 
87052050 blood flow veloc compar studi echocardiographymt fetal heartph gestat ag heart ventricleph human prospect studi refer valu stroke volum support govt ph chang cardiac blood flow veloc right left ventricular stroke volum gestat ag normal human fetu prospect doppler echocardiograph studi doppler echocardiographi quantit chang cardiac blood flow veloc right left ventricular stroke volum normal human fetu gestat blood flow veloc spectra aortic pulmonari tricuspid mitral valv digit obtain peak veloc msec flow veloc integr aortic pulmonari diamet measur valv level twodimen echocardiograph imag crosssec area wa calcul assum circular orif ventricular stroke volum wa calcul product crosssec area great vessel flow veloc integr vessel pulmonari arteri aortic diamet increa linearli gestat ag pulmonari arteri diamet consist exce aortic diamet wa posit relationship stroke volum gestat ag stroke volum increa exponenti ml ml right ventricl ml ml left ventricl similar result obtain right left ventricular combin cardiac output fetu wa possibl quantit right left ventricular stroke volum wa close correl right left ventricular stroke volum fetu right ventricular stroke volum exce left ventricular stroke volum 28abstract truncat 
87052052 adolesc androstenedionebl apolipoproteinsbl caucasoid race child dehydroepiandrosteroneaabl estradiolbl human lipidsbl lipoproteinsbl louisiana male negroid race progesteronebl sex hormonesbl sex matur support govt ph testosteronebl racial blackwhit comparison relationship level endogen sex hormon serum lipoprotein dure male adolesc bogalusa heart studi crosssec relationship endogen androgen testosteron androstenedion dehydroepiandrosteron sulfat dhea estrogen estradiol progestin progesteron serum level lipoprotein cholesterol veri lowden vldl lowden ldl highden lipoprotein hdl apolipoprotein apo ai apo studi white black adolesc boi ag bogalusa heart studi black boi significantli higher level estradiol hdl cholesterol apo ai lower level androstenedion vldl cholesterol white boi independ ag adipo ag wa correl strongli testosteron androstenedion moder dhea estradiol level race howev onli white boi wa ag consist relat vldl cholesterol posit hdl cholesterol neg apo ai neg over testosteron wa associ inver hdl cholesterol apo ai white boi progesteron wa relat posit apo ai race adjust ag adipo howev relationship differ ag partial correl level sex hormon lipoprotein adjust ag adipo associ ag group boi race signif posit relat testosteron vldl cholesterol inver relat testosteron hdl cholesterol apo ai dhea hdl cholesterol appar onli white boi ag groupabstract truncat 
87052053 cineradiographi compar studi coronari diseaserath coronari vesselsra evalu studi followup studi heart cathet human imag process computerassist method random alloc retrospect studi risk support nonu govt support govt ph factor optim detec progr coronari arteri disea comparison method suitabl risk factor interven trial assess method quantit progr coronari disea studi measur coronari segment medic treat patient angiogram obtain apart onli steno visual nearli ident projec angiogram evalu vessel edg measur cathet calibr autom comput algorithm yield absolut dimen mean minimum diamet measur percent stenosi atheroma area requir normal refer diamet coeffici variat repeat segment measur wa mean minimum diamet percent stenosi area atheroma measur progr coronari disea determin test comparison differ method wa chang mean diamet decrea calcul coronari segment patient basi base thi measur standard deviat progr coronari disea thi patient subset rel benign disea estim patient group requir interven studi demonstr reduc disea progr patient reduc confid level power 
87052055 angina pectorispp angina unstablepp cardiac pace artifici circadian rhythm coronari diseasepp coronari vesselsra electrocardiographi heart atriumpp heart cathet hemodynam human male middl ag rest rest angina fix coronari arteri stenosi nocturn declin ischem threshold atrial pace wa perform patient angina rest signif coronari arteri stenosi greater consecut dai morn pm afternoon pm midnight assess possibl circadian variat ischem threshold over incid rest angina wa highest pace result posit greater equal mm st segment shift tend reproduc patient wherea neg posit result ischem threshold significantli lower morn afternoon vs beatsmin mean sem patient pace test produc st segment elev perform conclud patient rest angina sever coronari stenosi exhibit nocturn declin ischem threshold facilit develop transmur ischemia dure atrial pace 
87052056 adult ag angina pectori variantetpp colddu coronari vasospasmetpp coronari vesselsdepp ergonovinedu exer femal histaminedu human hyperventilationpp male middl ag support nonu govt vasoconstrictiond local coronari supersensit diver vasoconstrict stimuli patient variant angina ha shown differ group patient variant angina coronari spasm reproduc physiolog maneuv pharmacolog agent howev extent differ stimuli induc spasm patient investig coronari arteri spasm result specif abnorm agonistreceptor interac local nonspecif coronari supersensit differ stimuli patient vasospast angina submit seri diver vasoconstrict stimuli provok coronari spasm ergonovin hyperventil handgrip cold pressor exercisetest carri patient patient histamin wa administ spasm wa provok ergonovin patient hyperventil histamin exerc cold pressor handgrip test respect signif differ respon provoc test patient normal coronari arteri nonsignif steno signif lesion individu spasm wa induc vasoconstrict stimuli differ mechan action patient spasm wa induc stimuli test repeat patient shortterm reproduc parallel sensit result suggest patient variant angina local nonspecif supersensit abnorm specif agonistreceptor interac plai major role genesi coronari arteri spasm 
87052058 compar studi death sudden electrocardiographymt followup studi heart ventricleppri human membran potenti monitor physiologicmt myocardi infarctioncodipp prognosi prospect studi risk stroke volum support nonu govt tachycardiadipp factor ventricular fibrillationdipp late potenti detect myocardi infarc natur histori prognost signif risk develop spontan ventricular tachycardia vt andor sudden death arrhythm event wa prospect assess patient surviv acut myocardi infarc signalaverag electrocardiogram ecg perform befor hospit discharg serial regular interv follow addition hr holter monitor wa perform left ventricular ejec fraction wa determin sixtyf patient group abnorm signalaverag ecg voltag msec filter qr filter qr durat greater msec normal signalaverag ecg group bundl branch block exclud analysi group spontan normal voltag msec qr complex occur patient total filter qr durat chang over dure followup median patient di suddenli present spontan symptomat vt group patient arrhythm event compar patient group sensit signalaverag ecg predictor arrhythm event wa specif patient subsequ arrhythm event consid lower voltag msec qr vs event filter qr complex vs msec multivari logist regr determin signalaverag ecg provid independ prognost inform presenc complex ventricular ectopi degr left ventricular dysfunc assess hospit discharg signalaverag ecg provid import prognost inform identifi patient risk arrhythm event myocardi infarc dynam chang termin qr voltag ar observ dure myocardi infarc 
87052059 adult biopsi calcium gluconatepd compar studi dobutaminepd endocardiumandepa heartdepp heart cathet heart failur congestivemepp hemodynamicsd human male middl ag myocardiumanpa radioligand assai receptor adrenerg betaand support nonu govt support govt ph assess betaadrenerg receptor pathwai intact fail human heart progress receptor downregul subsensit agonist respon develop method identifi betaadrenerg receptor human right ventricular endomyocardi biopsi tissu radioligand 125iiodocyanopindolol icyp specif icyp bind crude highyield membran prepar deriv endomyocardi biopsi tissu wa high specif greater high affin kd pm satur stereospecif vs isom isoproterenol subject mildmod sever biventricular dysfunc respect decrea betaadrenerg receptor densiti normal method averag signif differ icyp dissoci constant subgroup subject wa subdivid left ventricular ejec fraction lvef mild cardiac dysfunc lvef greater sever heart failur lvef grade sequenti infusion dobutamin calcium glucon sever cardiac dysfunc mark impair dobutamin dpdt stroke work index respon wherea respon calcium differ group data indic intact human heart endomyocardi biopsi mai direct analysi betaadrenerg receptor heart failureassoci myocardi betaadrenerg downregul begin mildmod ventricular dysfunc reduc myocardi betareceptor densiti relat degr heart failur betareceptor downregul associ pharmacolog specif impair betaagonistmedi contractil respon 
87052060 cardiac outputd cardiomyopathi congestivedtpp coronari diseasedtpp diureticstu heart cathet heart ventricledepp hemodynamicsd human prospect studi rheumat heart diseasedtpp vasodil agentstu mainten cardiac output normal pressur patient dilat heart failur therapi elev ventricular pressur patient dilat heart failur mai limit concern cardiac output compromi twentyf patient sever symptom ejec fraction studi determin lowest ventricular pressur achiev vasodil diuret therapi maintain cardiac output patient normal pulmonari capillari wedg pressur pcw achiev mean mm hg compar mm hg baselin stroke volum wa vs ml baselin stroke work index wa vs gmm2 patient rang pcw stroke volum stroke work index maintain maxim lowest pcw achiev upright position wa toler patient normal supin pcw normal pressur achiev patient congest heart failur comprom cardiac output congest symptom improv feasibl benefit maintain normal pressur term establish 
87052061 aortic valv aortic valv insufficiencyppsu aortic valv stenosisppsu heart cathet heart valv prosthesi hemodynam human mitral valv mitral valv insufficiencyppsu mitral valv stenosisppsu postop period prognosi stroke volum systol hemodynam predictor outcom patient undergo valv replac publish erratum appear circul mar753650 afterloadcorrect endsystol volum index ratio endsystol stress endsystol volum index essesvi wa previou predict outcom patient mitral regurgit undergo valv replac therefor test essesvi togeth standard hemodynam variabl possibl predictor outcom patient variou valvular lesion underw valv replac thirteen patient preoper mitral regurgit aortic stenosi aortic regurgit mitral stenosi twentyseven patient group satisfactori outcom defin return nyha class ii togeth normal postop ejec fraction twelv patient di remain class iii iv subnorm postop ejec fraction deem unsatisfactori result group mean right atrial pressur pulmonari arteri pressur pulmonari capillari wedg pressur enddiastol volum index endsystol volum index esvi endsystol wall stress greater group wherea essesvi ejec fraction lower group factor submit stepwi discrimin multivari analysi essesvi esvi onli independ predictor outcom howev patient mitral regurgit bia studi exclud discrimin analysi esvi onli independ predict variabl conclud endsystol indic ventricular function ar superior standard hemodynam variabl predict outcom valv replac 
87052062 adolesc adult child child preschool color compar studi echocardiographyismt evalu studi heart septal defect ventriculardipa heart septumpara heart ventriclepara human infant support govt ph color doppler detec multipl ventricular septal defect combin twodimen doppler echocardiographi ha high sensit specif detec isol perimembran ventricular septal defect howev muscular multipl ventricular septal defect mai difficult diagno noninva method particularli older children necessit angiographi accur diagnosi detec singl multipl ventricular septal defect twodimen color flow map wa compar detec standard twodimen imag doppler techniqu compar fourchamb left ventricular angiographi fiftyon patient ag mean studi eighteen solitari ventricular septal defect multipl ventricular septal defect patient intact ventricular septum serv control group ventricular septal defect wa detect color doppler twodimensionaldoppl method patient ventricular septal defect prove angiographi fal posit detec multipl ventricular septal defect sensit color doppler wa twodimensionaldoppl wa specif color doppler fail identifi multipl ventricular septal defect patient weigh kg reduc pulmonari blood flow howev larg addition muscular defect miss imag color doppler color doppler detec ventricular septal defect ha higher sensit twodimensionaldoppl multipl ventricular septal defect contribu color doppler appear detec addition muscular ventricular septal defect 
87052063 adult ag compar studi electrocardiographyismt electrod femal human male membran potenti comput middl ag minicomput support nonu govt tachycardiadidtsu factor vectorcardiographyismt charact spatial distribu late ventricular potenti bodi surfac map patient ventricular tachycardia lowlevel activ end qr complex wa analyz thorac lead normal subject patient ventricular tachycardia vt old myocardi infarc conduc disturb receiv antiarrhythm drug normal subject patient vt isopotenti map timeaverag filter hz highpass electrocardiogram dure termin portion qr dipolar thei singl posit neg region patient vt extrema distant precordi area close togeth precordi region patient map record administr antiarrhythm drug remain qr durat wa prolong patient map record befor antiarrhythm surgeri distant extrema septal posteroba vt site origin close extrema anterior posteroap site gener qr durat wa reduc map modifi surgeri late potenti detect onli orthogon lead becau distribu ar dipolar map provid addition inform distribu mai relat conduc delai site possibli vt site origin sourc torso surfac produc close extrema wherea deeper sourc produc distant extrema 
87052064 adolesc adult arrhythmiadi child compar studi comput electrocardiographyismt electrod femal heart ventriclepp human qt syndromedi male middl ag vectorcardiographymt map bodi surfac potenti patient idiopath qt syndrom bodi surfac potenti map record chest lead patient affect idiopath qt syndrom lqt healthi control subject match ag sex potenti integr qrst stt interv calcul lead displai isointegr isoi map main abnorm qrst stt isoi map area neg valu larger normal right anterior inferior thorax complex multipeak distribu integr valu abnorm wa present patient lqt control subject isoi map wa repr weight sum fundam compon eigenvector detect quantit nondipolar content percent contribu nondipolar eigenvector eigenvector wa significantli higher lqt group control group specif abnorm high nondipolar content qrst isoi map wa observ frequent patient lqt control subject vs thi wa true stt isoi map vs correl wa major abnorm bodi surfac map syncop episod howev high preval alter patient lqt infrequ occurr control popul strongli suggest thei mai marker diagnosi atyp case promin electroneg area anterior thorax relat delai repolar portion anterior wall heart thi agreem hypothesi lower normal right cardiac sympathet activ main pathogenet mechan lqt multipeak distribu high nondipolar content suggest region electr dispar ventricular recoveri process thi mai account high suscept patient lqt malign arrhythmia 
87052065 cardiac pace artifici cardiopulmonari bypass cineradiographi compar studi comput electrocardiographyismt electrod evalu studi heart catheterizationismt heart ventriclepprasu human oper caremt support nonu govt tachycardiadisu endocardi cathet map wire skeleton techniqu repres comput arrhythmogen site compar oper map guid surgic therapi ventricular tachycardia preoper endocardi cathet map necessit improv accuraci local arrhythmogen site therefor new mathemat cineradiograph method dure cathet map comput position left ventricular arrhythmogen site rel anatom refer center aortic mitral valv ostia left ventricular apex enabl surgeon identifi position comput site wire skeleton patient repr singl multipl arrhythmogen site rel anatom refer wa construct thi wire skeleton wa insert left ventricular caviti dure surgeri branch devic indic preoper local arrhythmogen site result consecut patient compar oper simultan map endocardi site sixteen morpholog distinct monomorph ventricular tachycardia map cathet oper map ventricular tachycardia ident morphologi wa record dure techniqu distanc arrhythmogen site local method wa cm ventricular tachycardia cm ventricular tachycardia result indic endocardi cathet map combin wire skeleton repres comput position arrhythmogen site reliabl guid surgic therapi ventricular tachycardia sinc ventricular tachycardia induc onli dure preoper oper map techniqu addit valu addition wire skeleton prove conveni dure surgeri identifi arrhythmogen site 
87052066 acetylprocainamidebl ag cardiac pace artifici doserespon relationship drug drug evalu electrocardiographi femal heart cathet heart conduc systemd heart ventricl human infusion venou male middl ag procainamideadbl prospect studi tachycardiabldtet effect increm dose procainamid ventricular refractori ventricular conduc induc ventricular tachycardia shortterm effect increm dose procainamid mgkg right ventricular effect refractori period ventricular conduc induc ventricular tachycardia determin patient histori sustain unimorph ventricular tachycardia qr durat dure increm ventricular pace wa index ratedepend chang ventricular conduc mean plasma procainamid concentr correspond increm dose sd mgliter increm dose procainamid dose mgkg result signif increm right ventricular effect refractori period dose mgkg potenti ratedepend prolong qr durat mgkg dose procainamid induc ventricular tachycardia wa suppress patient higher dose procainamid induc ventricular tachycardia wa suppress addition patient patient induc ventricular tachycardia wa suppress mgkg procainamid sustain unimorph ventricular tachycardia wa induc higher dose procainamid patient onli nonsustain ventricular tachycardia wa induc mgkg dose procainamid howev patient sustain ventricular tachycardia wa induc administr higher dose procainamid conclusion dure electropharmacolog test procainamid worthwhil test dose mgkg becau thi dose effect patient respond thi drug howev result thi studi indic procainamid mai effect suppress induc sustain ventricular tachycardia rel low plasma concentr higher plasma concentr therefor dure longterm therapi procainamid mai import avoid plasma procainamid concentr onli lower higher concentr result suppr induc tachycardia 
87052067 angina pectoristh angina unstabledietth angioplasti transluminalmt coronari vesselsra electrocardiographi followup studi human myocardi infarctioncodi recurr factor coronari angioplasti earli postinfarc unstabl angina coronari angioplasti wa perform patient unstabl angina reoccur hr dai sustain myocardi infarc singlevessel disea wa present patient multivessel disea prece myocardi infarc moder size major patient left ventricular ejec fraction wa patient fortyf patient refractori pharmacolog treatment initi stabil onc becam symptomat light exer angioplasti wa perform patient dai patient dai infarc averag dai infarc initi success rate wa success rate patient treat dai wa lower patient treat dai reach statist signif death relat procedur failur emerg bypass surgeri wa perform patient sustain myocardi infarc furthermor myocardi infarc complic angioplasti procedur patient thu over procedurerel myocardi infarc rate wa followup patient underw angioplasti recurr angina wa successfulli treat repeat angioplasti bypass surgeri medic therapi late death late myocardi infarc occur patient thu total myocardi infarc rate angioplasti wa patientsabstract truncat 
87052068 angioplasti transluminalaemt compar studi coronari diseasecorasu coronari vesselsinrasu emerg human prognosi factor coronari dissec total coronari occlusion associ percutan translumin coronari angioplasti signif initi angiograph morphologi coronari steno coronari dissec total coronari occlusion lead emerg coronari surgeri ar frequent complic percutan translumin coronari angioplasti ptca occurr usual unpredict identifi angiograph characterist coronari steno mai affect incid complic diagnost preptca coronari angiogram consecut patient group undergo emerg coronari surgeri dissec occlusion review compar angiogram random sampl patient stratifi left anterior descend right coronari arteri group emerg coronari surgeri group ii stenosi morphologi befor angioplasti wa consid complic follow criteria wa present irregular border lumin lucenc local stenosi curv bifurc baselin characterist maximum inflat pressur type balloon cathet routin regist angiograph stenosi properti sever length eccentr calcif similar group irregular border befor ptca present patient group vs group ii lumin lucenc vs local curv pt vs local bifurc vs ns complic angiograph morphologi coronari stenosi mai repr risk factor dissec occlusion therefor predict valu low evalu angiograph morphologi coronari steno mai improv patient selec reduc complic rate ptca 
87052069 compar studi coronari vesselsra drug evalu electrocardiographi heart cathet heart ventriclederi hemodynamicsd human hydroxybutyr dehydrogenasebl myocardi infarctiondtenmo myocardiumen streptokinasead factor patient benefit earli thrombolyt therapi coronari streptokina publish erratum appear circul feb752394 effect thrombolysi acut myocardi infarc enzymat infarct size left ventricular function earli mortal wa studi subset patient random trial earli thrombolyt therapi coronari streptokina patient coronari streptokina prece venou streptokina patient wa compar conven treatment patient patient admit coronari care unit hr onset symptom indic acut myocardi infarc hundr eightyeight patient elig thi analysi alloc thrombolyt therapi conven treatment earli angiograph examin perform patient alloc thrombolyt therapi patenc infarctrel arteri wa achiev patient enzymat infarct size measur cumul alphahydroxybutyr dehydrogena relea wa smaller patient alloc thrombolyt therapi median vs ulit control patient left ventricular ejec fraction measur radionuclid angiographi befor discharg hospit wa higher thrombolyt therapi median vs control patient mortal wa lower patient alloc thrombolyt therapi vs control group multivari regr analysi infarct size limit improv left ventricular ejec fraction mortal predict sum st segment elev onset symptom admi killip class admi thrombolysi wa effect patient admit hr onset symptom patient sum st segment elev mv hand benefici effect streptokina enzymat infarct size left ventricular function mortal observ subset patient sum st segment elev mv admit hr onset symptom 
87052072 anim cerebrovascular circul compar studi coronari circul dog epinephrinetu heart arrestmoppth pressur respir artifici resuscitationismt support govt ph factor ventricular fibrillationppth vest inflat simultan ventil dure cardiac arrest dog improv surviv prolong cardiopulmonari resuscit myocardi cerebr blood flow gener dure cardiac arrest techniqu manipul thorac pressur augment thorac pressur highpressur ventil simultan compr chest dog ha shown produc higher flow heart brain ha limit becau requir endotrach intub complex devic wa develop produc high thorac pressur simultan ventil pneumat cycl vest thorax vest cardiopulmonari resuscit cpr wa test shortterm studi maximum achiev flow dure arrest peak vest pressur mm hg kg dog induc ventricular fibril administr epinephrin spheredetermin myocardi blood flow wa mlmin100 prearrest flow cerebr flow wa mlmin100 prearrest sever lung liver trauma wa dog peak vest pressur wa limit mm hg howev sever trauma wa observ studi hemodynam dure surviv prolong resuscit wa perform group dog vest cpr wa compar manual cpr conven newton high newton sternal forc induc ventricular fibril techniqu wa perform min defibril wa performedabstract truncat 
87052073 analysi varianc anim blood flow velocityd coronari circulationd dog doserespon relationship drug flowmet heartdeph hemodynamicsd iohexoldupd support nonu govt support govt nonph factor immedi effect iohexol coronari blood flow myocardi function vivo radiograph techniqu quantifi coronari blood flow requir bolu injec contrast materi markedli alter flow measur newer nonion contrast agent shown fewer adver hemodynam inotrop rheolog effect compar ionic media ha suggest thei substanti affect coronari blood flow dog instrum electromagnet flow probe subendocardi sonic crystal coronari injec iohexol mgml iodin administ establish relationship dose rate contrast injec effect flow region myocardi function ml volum iohexol inject mlsec ml volum administ mlsec ml volum decrea coronari flow mean ml injec mlsec magnitud fall flow wa directli relat dose rate flow nadir wa attain wa directli relat rate injec decrem fraction shorten tempor delai sever beat compar flow chang mean decrem effect region myocardi function independ contrast volum howev degr dysfunc wa profound slower infusion rate suggest prolong contrastinduc ischemia wa major modul factorabstract truncat 
87052074 anim compar studi coronari circul coronari diseasedtppri dog drug screen femal human male sphere myocardi infarctiondtppri myocardiumpa necrosi recombin proteinstu superoxid dismutasetu support govt ph reduc experi infarct size recombin human superoxid dismuta insight pathophysiologi reperfu injuri determin import reperfu injuri abil freerad scaveng recombin human superoxid dismuta hsod prevent openchest dog underw min proxim circumflex coronari arteri occlusion onli reperfu receiv hsod iu bolu left atrium follow iu iv infusion hr salin hr surviv anim kill measur risk region postmortem angiographi infarct size gross pathologi measur investig blind treatment code wa broken onli end studi hemodynam variabl collat flow dure ischemia similar group infarct size control anim averag left ventricl risk region compar left ventricl risk region hsodtreat dog infarct treat anim onli smaller exhibit distinct patchi suggest protec vascular distribu furthermor analysi relationship infarct size collat flow measur dure ischemia group indic protec hsod wa greatest anim lowest collat flow thi studi support concept reperfu ischem myocardium result separ compon cell damag presum link gener oxygen free radic reflow sinc hsod prevent reperfu compon injuri wa pronounc heart sever ischemia scaveng oxygen radic reflow mai offer novel particularli promi therapeut approach protec ischem myocardium 
87052075 anim compar studi coronari circul dog drug screen dtpadu gadoliniumdu vitro myocardi infarctiondi myocardiumpa nuclear magnet resonancedui support nonu govt support govt ph tetrazolium saltsdu magnet reson imag acut myocardi infarc gadolinium diethylenetriamin pentaacet acid marker reperfu examin effect paramagnet contrast agent gadolinium diethylenetriamin pentaacet acid gddtpa magnet reson imag acut myocardi infarc reperfu twentytwo dog underw occlusion left anterior descend coronari arteri lad dog group lad remain occlud hr group ii hr follow hr reperfu gddtpa mmkg wa administ dog group hr min occlusion dog group ii min reperfu hr ligat heart exci imag spin echo inver recoveri pul sequenc tesla magnet reson imag reperfu heart gddtpa demonstr signif increa contrast normal reperfu myocardium compar nonreperfu heart reperfu heart gddtpa thi enhanc wa particularli promin inver recoveri imag studi perform vivo addition dog demonstr similar enhanc reperfu gddtpa gate spin echo imag contrastenhanc magnet reson imag allow detec reperfu earli cour acut infarc 
87052076 american heart associ calor intak cardiovascular diseasespc dietst human nutrition requir unit state dietari guidelin healthi american adult statem physician health profes nutrition committ american heart associ thi statem physician replac american heart associ diet coronari heart disea publish current guidelin propo optim prevent diet coronari heart disea emphasi reduc satur fat total fat complex carbohydr ar recommend major replac calori fat polyunsatur monounsatur fat partial replac calori fat sourc cholesterol sodium guidelin ar express rel calor intak upper limit alcohol possibl mean prevent cardiovascular disea advi mainten ideal bodi weight calori control adequ level activ empha 
87052078 critic carest emerg heart diseasesth human resuscitationst support nonu govt proce nation confer standard guidelin cardiopulmonari resuscit emerg cardiac care juli dalla texa 
87052086 adolesc child child preschool emerg medic servic health servic demand health servic research human infant life support care pediatr unit state assess advanc life support emerg medic servic pediatr patient state art outcom cardiopulmonari arrest children prehospit hospit gener poor event comprom cardiac statu respiratori embarrass present rhythm ar bradyarrhythmia asystol emerg medic servic em primarili adult focu mai organ manag optim critic ill injur child data survei train program demonstr param emt educ pediatr emerg mai inadequ fortyon percent program survei hr pediatr train data suggest em provid mai equip manag children effect lo angel em children describ ar level receiv facil emerg depart approv pediatr pediatr critic care center voluntari ha hospit complianc guidelin earli recogni prearrest state improv train equip prehospit care personnel develop em servic children dissemin advanc pediatr life support cour research pediatr cpr mai improv outcom resuscit pediatr popul 
87052087 alli health personnel commun health servic electr countershock emerg medic technician human support govt ph unit state special consid defibril perform emerg medic technician commun defibril minim train ambul technician significantli improv surviv outofhospit cardiac arrest commun size howev special consid develop servic commun chiefli becau problem associ low volum true emerg commun consid implem program defibril perform emerg medic technician emtd evalu ambul respon inadequ alter ambul respon implem program perman formal skill mainten program establish defibril protocol allow mani patient refibril success conver advanc care defibril gener avail final everi commun institut emtd program maintain monitor emt perform patient outcom docum accept survivaltodischarg rate safeti program smaller commun region statewid evalu mai prefer individu commun program 
87052090 educ measurementmt human life support care resuscit support nonu govt educ evalu emerg cardiac care program cpr advanc cardiac life support state art increa surviv rate outofhospit cardiac arrest improv train lai rescuer ar motiv abil involv overcom fear involv educ strategi ar adult learn didact inform understand skill repeti reinforc limit adult commit learn cpr method simplif techniqu suffici repeti reinforc teach tworescu cpr lai rescuer routin adult particularli highrisk individu learn onerescu cpr infant resuscit taught predominantli children method reinforc mass media attempt routin basi whenev possibl cour spread period allow repeti reinforc therebi maxim learn advanc cardiac life support acl wide taught health profes acl instruc spread whenev logist possibl enhanc learn reten valid examin ar routin rotat method evalu ar benefit type program improv costbenefit ratio 
87052092 drowningth human method drown sever condition contribut drown drown consid treatment neardrown victim regardless cau mechan ventil begin possibl closedchest cardiac massag administ ani adequaci cardiac output aspir fresh seawat larg pulmonari physiolog shunt occur requir aggress mechan ventilatori support ensur adequ oxygen return pulmonari function normal drown multisystem disea abnorm lung brain empha definit therapi tailor patient address patient 
87052096 electr countershock emerg medic servic human life support care resuscit support nonu govt unit state emerg medic servic acut cardiac care state art decad emerg medic servic unit state greatli improv organ prehospit provid health care ha improv outcom mani patient particularli trauma patient acut cardiac patient seattl mani outsidethehospit cardiac arrest victim ventricular fibril save rapid deliveri basic life support respond follow advanc life support param ar grow improv health care mani adequ medic control physician involv emerg medic servic physician involv manag meet capabl ha becom appar factor ar critic determin abil resuscit individu onc cardiac arrest ha occur ani rescu procedur electr defibril indic epinephrin adequaci techniqu basic life support particularli ventil compon provid defibril earliest possibl defibril respond emerg medic technician appear benefit advent automat semiautomat defibril respond famili member mai abl defibril victim defibril peopl train param howev approach caution ensur adequ medic control individu devic ar properli train 
87052097 anim cough dog human resuscitationmt support nonu govt support govt ph modif cardiopulmonari resuscit base cough abil cardiopulmonari resuscit cpr provid adequ vital organ blood flow dure prolong resuscit ha ha mechan blood flow dure cpr becau cough dure cardiac arrest ha shown produc adequ anterograd flow maintain consciou compress heart cough cpr ha model pure thorac pump mechan base modif cpr thorac pump mechan left heart passiv conduit blood express pulmonari vasculatur aorta select flow brachioceph vascular bed becau low pressur vein ar protect closur thorac inlet venou valv right heart flow vein lung occur applic pressur altern modal exploit thorac pump concept studi dog dure ventricular fibril angiograph pressur record cough cpr simultan chest compr lung inflat abdomin compr lung inflat inflat vest binder techniqu wa associ success defibril recoveri min circulatori support dure ventricular fibril preliminari studi primat prepar indic thi techniqu prolong circulatori support defibril initi avail success 
87052098 anim dog heart arrestth heart massagemt hemodynam human support govt ph influenc manual chest compr rate hemodynam support dure cardiac arrest highimpul cardiopulmonari resuscit consid effort ha expend number laboratori improv method cardiopulmonari resuscit thi articl briefli summar investig group hemodynam support dure extern cardiac massag studi longterm canin prepar implant transduc allow preci hemodynam measur cardiac output wa depress cpr method manual chest compr high veloc moder forc brief durat rate 120min optim coronari blood flow thi method wa term highimpul cpr highimpul techniqu appli exten clinic preliminari observ support efficaci base thi experi suggest american heart associ guidelin chang recommend manual chest compr rate 120min dure closedchest cardiac massag 
87052099 airwai obstructionth foreign bodiesth human method foreign bodi airwai obstruc consid manag foreign bodi airwai obstruc continu major controversi emerg medic care disagr doubt base uniformli accept model acut airwai obstruc repr clinic event varieti model assess differ aspect airwai obstruc foreign bodi model analyz variabl kinet energi inerti aerodynam forc attempt focu specif aspect thi controversi human volunt anesthet paralyz patient cadav sever studi wa conclud subdiaphragmat pressur treatment choic addition studi firm blow appli patient head hang downward recommend treatment reliev airwai obstruc appar conflict view reconcil consensu recommend treatment thi emerg effect 
87052100 heart arrestth human respir artificialmtst respiratori insufficiencyth altern method ventil dure respiratori cardiac arrest artifici ventil cornerston basic life supportcardiopulmonari resuscit blscpr data corrobor clinic studi perform suggest chang present american heart associ standard artifici ventil studi gastric insuffl follow regurgit pulmonari aspir ar major hazard artifici ventil unprotect airwai present blscpr standard requir ventil perform rapidli extern chest compr increm breath method ventil predispo victim gastric insuffl altern method ventil inspiratori thu lower flow rate peak inspiratori pressur ar suggest addition rescu personnel particularli emt param taught appli cricoid pressur prevent gastric insuffl victim unprotect airwai 
87052103 anim bicarbonatestu dog resuscitationmt sodiumtu support govt ph ventricular fibrillationth failur sodium bicarbon improv resuscit ventricular fibril dog determin valu sodium bicarbon resuscit ventricular fibril preven spontan refibril sodium bicarbon meqkg placebo wa administ random basi pentobarbitalanesthet dog min induc ventricular fibril cardiopulmonari resuscit defibril wa attempt min administr bicarbon placebo anim successfulli defibril bicarbonatetr control anim di electromechan dissoci ns spontan refibril occur anim group ns success resuscit wa depend treatment arteri mix venou pco2 arteri mix venou ph correl strongli coronari perfusion pressur spontan refibril occur relat ani identifi variabl gradient diastol aortic right atrial pressur wa mm hg control mm hg treat anim entir min cardiopulmonari resuscit ns howev anim successfulli resuscit mean diastol coronari perfusion pressur averag mm hg compar mm hg dy electromechan dissoci final min resuscit drug administr gradient mm hg respect sphere determin myocardi perfusion correl diastol aorticright atrial perfusion pressur gradient wa mlming survivor mlming nonsurvivor 01abstract truncat 
87052106 alli health personnel electr countershock emerg medic technician human support govt ph unit state defibril perform emerg medic technician mean provid defibril possibl suffer outofhospit ventricular fibril numer commun train author emerg medic technician emt provid defibrillatori shock emtd control studi experi variou commun answer import emtd program shown effect urban suburban rural commun param backup emtd program appear safe error commi extrem rare error omi accept low incid issu resolv includ degr train manual automat defibril medic supervi qualiti control import aspect emtd program core success emtd program confirm principl earli defibril wider dissemin earli defibril improv surviv sudden cardiac death 
87052264 conver disorderet esophagogastr junctionpp esophaguspp gastroesophag refluxco gastrointestin diseasescodi human manometri pressur globu sensat 
87052265 carcinomaparasu case report human laryng neoplasmsparasu laryngectomi male neoplasm stage tomographi xrai comput comput tomographi mandatori investig procedur tstage advanc laryng cancer eighteen patient underw comput tomographi ct prior total laryngectomi order assess accuraci ct scan evalu carcinoma larynx ct scan prospect interpret extent tumour wa record tumour extent wa evalu wholemount histolog laryng specimen prepar horizont plane similar ct scan result compar assess abil ct identifi tumour infiltr horizont plane accur base clear ct ha influenc tstage choic treatment laryng cancer radiotherapi versu surgeri 
87052266 adolesc child child preschool human infant parent pharyngitiset regr analysi smoke tobacco smoke pollutiona tonsillectomi children sore throat relat parent smoke ha concern smoke tobacco adver affect health nonsmok thi cogent children ar subject smoke home aim thi studi relat children sore throat smoke habit parent parent children ask ag sex birthweight method postnat feed ag school dai nurseri child frequenc sore throat smoke habit histori tonsillectomi member household size famili dwell size occup father analysi multipl regr signif associ children sore throat matern smoke reduc domest cigarett smoke exposur benefit child reduc number sore throat suffer 
87052267 adolesc bacteri infectionset child child preschool human middl ear ventilationa otiti media effusionetmi prospect studi risk swim bacteriolog aspect swim grommet prospect bacteriolog symptomat studi wa carri swimmer nonswimm grommet insert secretori otiti media risk develop otorrhoea posit bacteri pathogen wa similar swimmer nonswimm subdivid nonswimm wetter strictli dry wa similar risk ear symptom pathogen children swim befor inser grommet continu postop ad risk ear infec 
87052268 adult femal human male noseph respiratori airflow support nonu govt thermographyismt noninva method demonstr nasal cycl flexibl liquid crystal thermographi relationship air flow degr area colour chang flexibl liquid crystal film wa virtual linear valu min1 cm2 thi valu flow unit area correspond valu expect level nostril dure quiet breath seri subject ask breath flexibl liquid crystal film regularli dure dai area colour chang produc flow nostril wa examin subject regular chang rel flow nostril whilst subject constant flow nostril thi simpl noninva techniqu provid method examin nasal cycl adult children health disea 
87052269 carcinomapapp cell movem human laryng neoplasmspapp lymphocytesph scopymt mitosi photographi videotap record video timelap scopi human laryng carcinoma vitro twelv human laryng carcinoma normal vocal cord epithelia studi vitro method tissu cultur incorpor video timelap scopi differ event photograph televi monitor dure playback outgrowth tumour normal explant form onli monolai mito mainli local approxim midwai explant edg outgrowth cell seen becom suddenli activ produc oscil bleb sometim thei detach themselv monolai cultur chang appear thi wa preval tumour cultur tumour normal cell cultur lymphocyt observ normal chemokinet movem wa chang rapid chemotact attrac presenc mitot epith cell lymphocyt appear repr tsuppressor cell present studi ha shown primari tissu cultur valuabl tool studi laryng carcinoma interac mitot tumour cell lymphocyt mai repr transform tlymphocyt lak cell 
87052270 carcinomagepa cell division epitheliumpa human hyperplasia laryng neoplasmsgepa polyploidi precanc conditionsgepa support nonu govt vocal cordspa hypertetraploid cell vocal cord epithelia dna measur yield inform natur cell mai provid diagnost prognost inform static cytofluorometri wa perform smear remov laryngoscopi vocal cord lesion patient stem cell line diploid carcinoma sever dysplasia polyploid mean prolif activ percentag nuclei greater diploid peak wa group epithelia hyperplasia mild dysplasia moder dysplasia sever dysplasia carcinoma hypertetraploid cell nuclei ht cell epithelia hyperplasia mild dysplasia patient epithelia moder dysplasia ht cell patient develop carcinoma ht cell develop sever dysplasia patient sever dysplasia ht cell recurr develop carcinoma patient ht cell recurr develop carcinoma ht cell patient t1 t2 carcinoma residu carcinoma wa present radiotherapi recurr fourteen patient t1 t2 carcinoma ani ht cell residu carcinoma radiotherapi recurr dna measur especi demonstr epithelia ht cell prove prognost importanceabstract truncat 
87052272 ethmoid bonesu human orbitsu patterson oper decompr orbit modif patterson extern antroethmoidectomi oper describ provid direct simpler approach transantr oper decompr orbit 
87052273 adult epistaxiset femal followup studi human male nasal mucosab recurr support nonu govt varico veinscosu transec varico vessel nasal mucosa patient recurr epistaxi 2year followup twentytwo patient recurr nose bleed varico vessel nasal septum subject transec vessel followedup oper wa possibl identifi origin vessel locat new varico vessel appear end followup period observ oper transec result immedi decrea frequenc nose bleed end control period patient bleed dure previou spite observ rapid format new vessel muco atrophi symptom increa nasal crust occur patient transec varico vessel patient nose bleed lead decrea number bleed 
87052274 anim cat denerv ganglia autonomicul human nasal mucosadeir neostigminepd rhiniti vasomotoretsu autonom ganglia nasal mucosa relat vasomotor rhiniti classic concept autonom innerv nasal mucosa state postganglion sympathet neuron lie superior cervic ganglion postganglion parasympathet neuron ar pterygopalatin ganglion carri studi fine structur respiratori nasal mucosa cat techniqu describ jabonero champi maillet koellefriedenwald strike wa presenc ganglia deep mucosa inferior turbin close gland ganglia cholinerg natur sinc thei demonstr posit reaction anticholinestera thi deduc nasal parasympathet pathwai ha postganglion neuron onli pterygopalatin ganglion ganglia inferior turbin group cat submit differ techniqu includ administr neostigmin inferior turbinectomi vidian neurectomi resec ganglia mean turbinectomi reduc hypersecr cau neostigmin thi wa notic vidian neurectomi wa carri addition 
87052276 anim human otorhinolaryngolog disea otorhinolaryngolog research societi london octob abstract 
87052382 adult anim antiinflammatori agent nonsteroidalad crystal drug interac femal human hydrogenion concentr kidneyd male middl ag rat triamtereneadaeur urin triamtereneinduc crystalluria cylinduria clinic experi studi examin occurr crystal cast urin healthi subject administr triamteren site crystal format experi anim twenti twenti healthi subject abund triamteren crystal cast acid urin receiv singl mg dose cast present urin administr diuret cast format occur acid urin wa prevent alkalin urin potassium citrat anim studi crystal cast format occur medullari papillari collect duct rat kidnei provid possibl explan report nephrotox triamteren particularli patient ar receiv nonsteroid antiinflammatori agent 
87052386 ag factor biopsya hematuriaet human infant infant newborn kidneypa kidnei diseasespa percutan renal biopsi infant young children record percutan renal biopsi perform children ag dai review radiograph sound imag techniqu util dure biopsi procedur fortynin biopsi attempt yield suffici tissu histolog evalu transient gross hematuria requir interven wa sole complic wa biopsi attempt percutan renal biopsi perform safe veri young children success procedur compar older children 
87052389 antithrombin iiian blood proteinsan compar studi femal fibrin fibrinogenan fibrinopeptid aanbl heparinadan human male periton caviti periton dialysi continu ambulatorya periton fibrinform inhibi capd periton fibrin format inhibi periton heparin wa investig patient capd periton heparin concentr decrea linearili uml uml dure 4hour dwell antithrombin iiiconcentr increa mgdl reach normal plasma valu antithrombin iiipor total protein wa plasma diali fibrinopeptid aconcentr specif product thrombin action fibrinogen wa ngml plasma normal rang ngml ngml diali dure regular capd addition heparin fibrinopeptid aconcentr diali decrea ngml dure 4hour dwell vitro experi remark inhibi fibrin format heparin antithrombin iii diali suggest fibrinopeptid produc periton antithrombin iiiconcentr diali suffici inhibit fibrin format accel heparin 
87052390 ag ag case report femal glomerulonephritiscidi human ketoprofena nephrot syndromecidi osteoarthritisdt phenylpropionatesa rever membran glomerulonephr associ ketoprofen 87yearold woman present nephrot syndrom administr ketoprofen mg daili osteoarthr clinic cour laboratori data consist druginduc nephropathi kidnei biopsi membran glomerulonephr evolu wa favor resolu proteinuria drug withdraw steroid administr review literatur nephrot syndrom associ nsaid reveal membran glomerulonephr unusu complic 
87052415 adolesc case report cervic vertebraesu femal followup studi human osteoma osteoiddisu spinal neoplasmsdisu osteoid osteoma cervic pedicl resec transpillar approach lesion pedicl cervic spine ar diagnost technic challeng osteoid osteoma pedicl fourth cervic vertebra occur 17yearold girl resec tumor adjac dura medial vertebr arteri anterolat wa accomplish transpillar approach transosseu approach preserv facet joint posterior elem obviat interbodi fusion 
87052416 adolesc adult elbow jointir human movem musclesir propriocep scoliosisetpp upper extrem propriocep idiopath scoliosi twentythr patient idiopath scoliosi test upper extrem propriocept function subject docum progr deform averag curvatur degr averag ag scoliot control subject respect control spinal deform underw ident test procedur test result scoliot subject signif asymmetri right left limb threshold detec joint motion equal abil reproduc angl elbow joint previou position equal slight asymmetri wa observ reproduc test control group equal howev wa signif asymmetri seen thi group threshold test perform bilat limb wa design group limb perform propriocept function wa design limb analysi data scoliot limb perform inferiorli threshold angl reproduc test compar normal control result thi studi impli local neurolog deficit scoliot patient 
87052417 adult ankl jointinra bone nail followup studi fractur fixat medullaryismt fracturessu human new approach treatment ankl fractur inyo nail inyo nail new medullari devic treatment fractur distal fibula taper vshape nail malleabl stainless steel provid rigid fractur fixat torsion stress resist becau triflang shape mai introduc close imag intensifi group patient evalu group wa treat inyo nail group ii wa treat associ studi intern fixat asif techniqu eightyf percent patient group rate compar group ii wa significantli morbid complic group sever factor observ treatment ankl fractur stress radiograph obtain oper surgeri mai indic unstabl supin rotat type ii injuri occur patient high physic demand anatom reduc malleolu obtain earli weightbear motion produc result late reconstruc malunion accomplish inyo nail 
87052419 adolesc athlet injuriesrhth brace footbal human immobil knee injuriesrhth ligamentsin prospect studi factor nonop manag isol grade iii collat ligam injuri high school footbal player prospect studi high school footbal player isol grade iii injuri medial collat ligam mcl knee treat conserv manag thi includ activ rehabilit program progress immobil control motion orthot rehabilit knee brace muscl strengthen agil exerc stabl knee wa achiev case averag recoveri wa dai athlet return competit sport mean dai result confirm previou report success nonop manag isol grade iii mcl injuri 
87052420 ag femal followup studi human knee jointra knee prosthesi male photogrammetrymt statist tibiara tibial compon fixat knee arthroplasti roentgen stereophotogrammetr analysi rsa integr bond tibial compon tibia wa studi knee implant cement kinemat total knee prosthesi gonarthrosi migrat rang mm twoyear period occur case displac induc extern forc rang mm wa observ case measur migrat induc displac mai rule excep total knee arthroplasti tka accordingli absolut rigid fixat necessari success function tka 
87052421 adult ag cast surgic evalu studi femal femurpp human knee injuriesppth knee jointppra male middl ag patellapp ruptur tendonspp ruptur extensor mechan knee joint clinic result patellofemor articul function result case ruptur quadricep patellar tendon ar report excel result quadricep patellar tendon radiograph comparison opposit knee disclo incongru patella femor groov tangenti view andor cranialcaud position patella view quadricep tendon ruptur patellar tendon ruptur patient residu pain patellofemor incongru sinc twothird patient incongru asymptomat incongru alon mai cau symptom wa posit correl muscular strength rang movem exact adapt patellar tendon periarticular tissu necessari obtain correct patellofemor articul reinforc tendon wire cerclag recommend decrea tension sutur line consequ risk secondari ruptur acut ruptur quadricep tendon endtoend sutur ar suffici 
87052422 adult child human implant artifici knee ligamentssu orthop equip orthopedicsmt polyethylen terephth prosthesi modifi techniqu anterior cruciat ligam acl surgeri new drill guid isometr position acl reconstruct anterior cruciat ligam acl import inner end drill channel correctli acl isometr position anatom studi demonstr valu modifi surgic techniqu special drill guid standard position anterior cruciat substitut drill guid consist metal frame adjust fix guid tube drill anteromedi aspect tibia upward joint space femur straight line channel drill singl procedur precision guid drill wa superior freehand drill position ligam correct anatom 
87052423 adolesc bone disea developmentalco dislocationsetra femal femurgd human knee jointra male mathemat patellagdra retrospect studi patella alta adolesc growth spurt presenc patella alta ha link recurr disloc patella patellofemor stress syndrom patella alta inherit acquir trait investig relationship patella dure adolesc growth spurt serial orthoroentgenogram growth studi film retrospect analyz patient proxim patella migrat correl femor growth rate thi wa signif level girl higher correl patella height growth rate boi certain case patella alta acquir inherit condition thi support theori overgrowth dure growth spurt lead patella alta individu 
87052424 fal neg reaction human knee injuriesdi knee jointpp ligamentsin movem physic examinationmt support nonu govt tibiapp accur interpret lachman test consecut seri patient knee complaint tibial rotat consist affect interpret lachman test passiv anterior tibial translat slight knee flexion perform lachman test correctli anterior tibial forc appli posteromedi proxim tibia thi achiev leg examin bed examin slight extern tibial rotat reach bed examin leg creat fal posit fal neg lachman result inadvert tibial rotat intern tibial rotat decrea translat inaccur comparison injur normal leg import tibial rotat recogn lachman test reliabl maximum sensit 
87052425 exer fractureseprith human male militari personnel painetri physic educ train prospect studi technetium tc 99m medronatedu tibiainri medial tibial pain prospect studi cau militari recruit prospect studi infantri recruit dure basic train medial tibial pain routin scintigraph evalu case medial tibial bone pain abnorm stress fractur wa onli patient periost ischem medial compart syndrom physic examin differenti case medial tibial bone pain secondari stress fractur scintigraph normal tibia pain swell local middl onethird tibia lesion prove stress fractur 
87052426 doubleblind method exud transudatesd followup studi human injec articular knee jointppsu methylprednisoloneaatu movementd painpc support govt nonph articular methylprednisolon acet knee arthrotomi ninetyeight arthrotomi patient undergo meniscectomi oper articular methylprednisolon mg placebo doubleblind techniqu evalu clinic dai twelv oper patient receiv methylprednisolon statist signif accel rehabilit respect subject evalu pain rang motion oper wa advantag placebo rehabilit 
87052427 adult ag femal femurra human knee jointra male middl ag osteoarthritispara tibiara tomographi xrai comput torsion tibial torsion patient medialtyp osteoarthrit knee comput tomographi measur tibial torsion evalu patient medialtyp osteoarthrit knee normal adult differ degr femor torsion knee joint rotat extern tibial torsion wa observ mean valu degr significantli smaller degr observ normal adult advanc osteoarthrit stage greater wa reduc extern tibial torsion reduc extern torsion tibia wa sever proxim tibial metaphysi 
87052428 adult bone screw case report femor fracturessu femor neck fracturessu fluoroscopi fractur fixat intern fractur fixat medullari hip fracturessu human male ipsilat femor neck shaft fractur report case altern techniqu techniqu ipsilat femor neck shaft fractur slide compr hip screw plate combin trochant antegrad ender nail femur wa appli case ender nail pass difficulti compr hip screw bicort plate screw hip femur fix intern singl approach singl position slide compr hip screw devic provid excel preliminari stabl femor neck fixat blood suppli femor head disturb femor medullari fixat perform antegrad ender nail avoid common knee complic associ retrograd techniqu decrea oper blood loss technic difficulti earli mobil ar import factor multipleinjur patient femor medullari fixat mai requir open reduc circlerag ensur stabil mainten align case signif comminu allow earli crutch ambul thi mode fixat mai advantag select case 
87052429 bone cementsa bone resorptionpara case report followup studi hip jointpara hip prosthesisa human male middl ag osteoarthritisra reoper 14year followup studi patient massiv calcar resorp case report author present indepth clinic radiograph patholog analysi 62yearold massiv bone reabsorp proxim femur total hip arthroplasti tha tha wa revi implant thirti meter calcar resorp wa radiograph evid stem bend wa present examin femor implant mark wear acetabular cup wa patholog evalu remov calcar bone cement reveal histiocyt mass invad bone cellular extracellular polymethylen debri wa inva mass evid fragment methylmethacryl cement wa present bonec interfac exci calcar region contain segment activ bone remodel cement interpo membran possibl thi case calcar resorp histiocyt activ recruit polyethylen wear debri follow activ bone lysi process mai perpetu fragment cement motion occur calcar bonec interfac mai repr extrem exampl process occur case calcar resorp gener 
87052430 adolesc adult case report followup studi human male osteochondritissu osteochondr dissecansrasu osteotomymt talussu close percutan drill osteochondr dissecan talu report case case osteochondr dissecan talar dome treat close percutan drill ar present illustr procedur highrisk patient oper perform aid imag intensifi ostoechondr fragment percutan drill avoid open oper osteotom medial malleolu 
87052431 acetabulumra adolesc adult bone disea developmentalcora case report epiphi slippedra femal femur headra femur neckra followup studi hip jointgdra human leggperth diseasera male middl ag osteoarthritisetrasu etiologi osteoarthr hip patient socal primari idiopath osteoarthr hip suffici data avail assess normal hip joint cessat growth clearli demonstr abnorm hip joint common ar mild acetabular dysplasia andor pistol grip deform thi deform associ mild slip capit femor epiphysi recogn unrecogn leggperth disea recogn unrecogn multipl epiphi dysplasia spondyloepiphi dysplasia andor presenc acetabular labrum certain instanc acetabular dysplasia abnorm ar conjunc detec metabol abnorm lead osteoarthr hip mai recogn readili hemochromatosi ochronosi calcium pyrophosph disea monarticular rheumatoid arthriti clear osteoarthr hip doe exist primari disea entiti doe extraordinarili rare 
87052432 ag bone wire calcaneussu case report dislocationsetsu femal fracturessu human male middl ag fractur disloc calcaneu report case typic case calcan fractur disloc primari fractur run forward medial sustentaculum tali associ inver hindfoot calcaneu split anteromedi larger posterolat fragment ruptur collat ligam allow posterolat calcan fragment lie immedi subjac distal fibula close reduc imposs open reduc thi rare fractur disloc essenti approach calcaneu gener suffici medial incision mai requir 
87052433 adult case report followup studi human immobil male synostosisrari ulna fracturesrath radioulnar synostosi follow isol fractur ulnar shaft case report case 19yearold overu hi nondomin forearm result radioulnar synostosi despit persist synostosi patient adapt loss forearm rotat treatment wa necessari isol fractur ulnar shaft ar slow heal sever author observ earli function mai benefici howev excess activ cau motion fractur site mai cau subperiost hemorrhag soft tissu trauma mai stimul exub callu format fractur ulnar shaft undisplac immobil prevent overu 
87052435 adult ag backachedtet femal followup studi human injec articular lidocainetu male metrizamidead middl ag spinal diseasesdtpara facet joint degen cau low pain recogn patient low pain lumbar disc disea author inject facet joint june experi patient inject fluoroscop control mixtur local anesthet steroid technic problem occur larg osteophyt block access facet joint otherw complic minim morbid patient initi respon smaller number follow respon repeat injec alwai temporari improv rare relief factor charact patient neg screen examin cau pain sciatica pain tender local facet joint radiolog chang degen joint disea facet joint facet joint disea mai signif cau low pain abov criteria ar clinic identif patient thi problem facet joint injec plai import role diagnosi treatment low pain 
87052436 ag case report chymopapaina femal followup studi human intervertebr diskdepaul intervertebr disk chemolysi intervertebr disk displacementrasu prolap support govt ph tomographi xrai comput effect chymopapain prolap human intervertebr disc clinic correl histochem studi light electron scopi demonstr exten matrix degrad fail chymopapaintr disc compar untreat degen control disc specimen contain viabl cell patch degen cell wa loss disc height chymopapaintr disc improv symptom result illustr wellcircumscrib case docum disc protrusion spinal canal disc space narrow follow injec mai aggrav symptom nerv root entrap especi lowgrad recess stenosi associ disc protrusion persist aggrav symptom probabl relat anatom consid low level enzym activ inject area mai mai correl clinic respon treatment 
87052437 adult case report femal followup studi fracturesrath human immobil osteopetrosiscora spinal injuriesetra stress fractur vertebr arch osteopetrosi stress fractur fourth vertebr arch occur 21yearold woman benign osteopetrosi fractur heal applic bodi cast osteopetrot bone resist forc parallel cortic layer fragil forc right angl plane cortic layer 
87052438 accid traffic adolesc adult femal followup studi fractur fixat internala human male middl ag spinal cord injuriesco tibial fracturescosuth manag tibial fractur acut spinal cord injuri patient tibia fractur acut spinal cord injuri patient complet incomplet neurolog lesion tibia fractur divid group group nonop treatment group ii earli open reduc intern fixat group iii type iii open injuri group includ fractur delai union malunion nonunion averag union wa patient pressur sore pulmonari emboli fractur group ii delai union superfici wound infec heal uneventfulli deep vein thrombosi averag union wa group iii tibia delai nonunion regardless treatment nonop fractur heal prolong rate open reduc intern fixat enhanc rate union fractur treat earli open reduc intern fixat exclud group iii patient orthop medic complic open reduc intern fixat justifi altern nonop treatment uncompl tibia fractur regardless neurolog lesion improv medic fractur care 
87052439 adolesc adult compar studi femal followup studi human knee jointsu male middl ag orthopedicsaemt osteoarthritissu patellasu postop complicationssu reoper maquet procedureanterior displac tibial tubercl indic contraind precaution maquet recommend cm anterior tibial tubercl elev patient symptomat osteoarthrosi patellofemor joint fiftythr patient osteoarthrosi divid group patient treat classic maquet procedur total reliev patellofemor pain wa failur complic group patient patella wa realign groov alter track patella proxim femor condyl necessari fishmouth techniqu inser drain surgeri twoyear followup examin failur complic group patient wa treat ferguson modif maquet oper 125cm tibial tubercl elev transver incision complic subsequ treat successfulli convert ferguson oper maquet oper modifi group ii modifi maquet procedur effect reliabl treatment patellofemor arthrosi rel low incid complic 
87052440 achil tendoninsu adult case report femal followup studi human rheumat feverdt ruptur steroidsa tendon injuriespc bilat simultan achil tendon ruptur case report review literatur bilat simultan achil tendon ruptur ar rare onli case report english literatur case 44yearold woman review literatur affect person usual ar chronic steroid treatment fifth seventh decad life patient mai concomit disea injuri occur rel mild trauma goal treatment ar mainli prevent cessat steroid possibl protect brace remain intact achil tendon 
87052441 anim bone marrowmepaul cell differenti cell cultur collagenbi electron probe analysi hematopoiet stem cellsm hydroxyapatitesbi male scopi fluoresc mineralsm osteogenesi rabbit miner vitro cultur rabbit marrow stromal cell local region miner confluent cultur rabbit marrow fibroblast cell miner tissu develop cluster giant fat cell space cell investig light electron scopi demonstr site wa differenti fibroblast cell osteogen direc shown chang polygon shape synthesi wellband collagen similar bone tissu differenti mai increa cell densiti confin space growth miner tissu wa observ live cultur fluoresc scope electron probe analysi confirm miner form wa hydroxyapatit initi site miner includ membran vesicular bodi lipid product cellular degen onc initi miner appear spread rapidli adjac collagen structur suggest appear mixtur skeletaltyp dystroph miner 
87052442 biomechan bone regen bone resorp human iliumpapp model biolog osteoporosisdtpapp probabl stochast process stochast analysi iliac trabecular bone dynam publish normal histomorphometr data deriv distribu trabecular plate complet bone remodel unit basic multicellular unit carri bone remodel bmu complet term structur unit bsu stochast model wa investig predic current bmu theori trabecular wa drawn appropri normal distribu random number gener dai surfac quiescent wa assum chanc initi remodel cycl resorp activ dai rever phase dai wa follow format dai result bmu balanc resorp depth wa fenestr wa assum lead perman loss trabecula origin model unrealist increa mean trabecular trabecula lost thi wa correct assum trabecula greater osteoblast stimul consequ tendenc thicken perhap higher mechan load trabecula lost bmu balanc wa exact distribu trabecular wa unchang onehalf fenestr deeperthanaverag resorp caviti develop trabecula remaind coincid remodel surfac fall osteoblast lifespan result addition loss trabecular bone volum mean trabecular compat courpron data simul rapid mechan bone loss approxim trabecula lost arrest bone format doubl resorp depth unchang bone format doubl rate initi new bmu unchang bone format rate follow complet recoveri bmu balanc onli case mean trabecular onli transient trabecula continu lost recoveri prolong osteoblast life span wa explan increa mean trabecular trabecular bone volum seen patient osteoporosi treat sodium fluorid plu calcium supplem daili injec parathyroid peptid hpth 
87052443 adolesc bone neoplasmsscsu carcinomascsu case report combin modal therapi femal followup studi human neoplasm recurr localsu radiussu sella turcicasu skull neoplasmsrtsu tibiasu evolu case multicentr giant cell tumor 23year period 17yearold girl multicentr giant cell tumor origin sphenoid sella turcica wa observ dure lesion appear right proxim tibia left distal radiu curettag tibial lesion pack process bovin bone follow chronic osteomyel continu intermitt wound drainag curettag radial lesion pack initi autogen iliac bone graft subsequ methylmethacryl bone cement follow local recurr radial lesion eventu wa erad segment resec distal radiu result boni defect wa bridg bicort autogen iliac graft stabil bone plate produc painless solid wrist fusion tumor recurr ha 
87052444 anim bone bonespp cartilag articularmepp disea model anim human osteoarthritisetpp proteoglycansm rabbit stress mechan support govt ph role subchondr bone initi progr cartilag damag osteoarthrosi physiolog imbal joint failur similar heart failur mechan factor plai role initi progr cartilag damag ar distinct phenomena mechan initi mai steep stiff gradient underli subchondr bone progr cartilag lesion probabl requir stiffen subchondr bone situat transver stress base articular cartilag cau deep horizont split tissu cau subchondr stiffen otherw congruent joint repeat failur musculoskelet peak dynam forc attenu mechan health integr overli articular cartilag depend mechan properti boni bed certain model osteoarthrosi alter boni bed occur befor cartilag chang suggest thi occur clinic condition stiffen subchondr bone effect joint conform involv deform articular cartilag bone creat maximum contact area load 
87052446 cartilag articularim case report complem 3an femal hip jointsu histocytochemistri human igaan iggan igman inflammationim knee jointsu male middl ag osteoarthritisimpasu support nonu govt synovi membraneim immun pathologi polyarticular osteoarthr osteoarthr oa gener consid disord mechan origin common occurr chronic mononuclear cell infiltr synovium conjunc immunofluoresc evid immunereact product cartilag surgic case specimen knee hip periph joint ha suggest local involv immun process arthriti polyarthropathi major case indic propen disord wide variat synovi cartilag immun chang quit differ rheumatoid arthriti frequent asymptomatologi mani joint involv featur cau factor suggest immun reaction local andor origin occur popul risk joint degrad 
87052450 anim cartilag articulardemepa disea model anim estradiolpd femal human male organ cultur osteoarthrit ovariectomi prostaglandinsbi proteoglycansbi rabbit stain stain support govt ph tamoxifenpd estrogen osteoarthr clinic laboratori observ suggest relationship exist sex hormon develop osteoarthr mechan wherebi hormon influenc pathophysiologi osteoarthr explor tamoxifen estrogen antagonist reduc ero chang meniscectomyinduc osteoarthr rabbit contrast estradiol worsen wa effect agent incid osteophyt thi model estradiol tamoxifen affect proteoglycan prostaglandin proteoglycana produc cartilag compon observ suggest cartilag sex hormonesensit tissu thi mai therapeut implic futur 
87052451 anim antiinflammatori agent nonsteroidalaetu atrophym cartilag articulardemepa dog extracellular matrixm hindlimb human immobil vitro inflammationdt osteoarthritisdtmepa paindt proteoglycansm support nonu govt support govt ph synovi fluidm nonsteroid antiinflammatori drug treatment osteoarthr clear synovi inflamm occur joint affect osteoarthr oa recogn mani patient oa experi decrea pain joint stiff follow administr salicyl nonsteroid antiinflammatori drug nsaid howev extent synov contribut cartilag breakdown oa effect chronic administr nsaid natur histori oa human studi indic sever nsaid includ salicyl suppress proteoglycan synthesi articular cartilag vitro effect oa cartilag mark normal cartilag studi salicyl feed mai suppress proteoglycan metabol degen cartilag vivo aggrav decrea proteoglycan content cau disea howev effect salicyl normal articular cartilag ha observ vivo damag cartilag magnitud nsaidinduc suppr proteoglycan metabol appear relat inver proteoglycan content tissu addition nsaid treatment arthriti todai mai differ respect vivo effect articular cartilag metabol differ molar concentr drug synovi fluid 
87052473 atten atten deficit disord hyperactivitydipx child femal followup studi human languag develop disorderspx male psychiatr statu rate scale social behavior pediatr manag nonperva hyperact children sixtyf children view teacher hyperact evalu thei benefit stimul medic underw exten neurodevelop educ test addition inform wa obtain school parent questionnair interview children medic unless thei demonstr characterist impul inatt andor overact behavior environ home school clinic fiftytwo children medic followup wa complet percent percent children nonpharmacolog interven initi comparison children medic reveal ag race se resourc help reten distinguish group children medic difficulti earlier school chi werent delai academ chi neurodevelop disord chi care psychosoci histori doe reveal impul inatt andor hyperact behavior outsid school child evalu rule neurodevelop educ problem 
87052476 adolesc anxieti chest paindietpx child depr femal followup studi headacheet human male recurr stress psychologicalco natur histori idiopath chest pain children followup studi repetit chest pain obscur origin commonli encount older children adolesc questionnair studi wa conduct determin longterm outcom patient diagno idiopath recurr chest pain averag 41year followup period percent report persist symptom chest pain disappear percent follow equal reassur case occult disea subsequ appear account initi symptom thi studi support current clinic approach limit diagnost evalu reassur manag patient 
87052477 adolesc alcohol intoxicationblep blood glucosean canada child child preschool electrolytesbl femal human hypoglycemiaet infant male retrospect studi ethyl alcohol ing children 15year review inform ethyl alcohol intox children scarc retrospect studi wa conduct chart review patient docum ethanol ing admit alberta children hospit foothil provinci hospit calgari gener hospit holi cross hospit patient hypoglycemia experienc convul rate alcohol elimin wa greater mmlhr mgdlhr approxim twice rate seen adult patient hypokalemia sever metabol acidosi 
87052478 adolesc ambul child child preschool emerg medic servic femal heart arrestepth human infant inten care unit male mobil health unit pediatr prospect studi resuscit seizuresepth sudden infant deathepth mobil inten care unit respond pediatr emerg octob octob mobil inten care unit micu jerusalem respond pediatr emerg repr total micu case load common medic problem wa seizur diagno case frequent group relat trauma case case cardiac arrest resuscit wa attempt longterm survivor cardiac arrest patient asystol antec seriou medic problem compar adult popul children requir benefit advanc level prehospit care resourc advanc care ar limit prioriti adult emerg 
87052479 bronchoscopi case report child diagnosi differenti femal foreign bodiesdira human infant male respiratori tract infectionsdi thorac radiographi trachea normal radiograph foreign bodi aspir histori count foreign bodi aspir children frequent associ unilat emphysema atelectasi chest xrai case ar report tracheal bilat foreign bodi origin chest xrai read normal histori wa suggest foreign bodi aspir earli bronchoscopi prevent longterm morbid result unrecogn tracheobronchi foreign bodi 
87052480 case report human infant newborn infant prematur diseasesth intub trachealmt male pulmonari emphysemath endotrach tube modif therapi rightsid pulmonari interst emphysema 
87052481 hemangioma cavernouspa human klippeltrenaunai diseasepa puberti skin neoplasmspa growth cavern hemangioma puberti letter 
87052482 adolesc anorexia nervosadh bodi weight calor intak diet human food exchang treatment anorexia nervosa letter 
87052485 paminohippur acidm adult blood pressur compar studi dopaminemepd femal heart rate human hypertensionm infusion venou inulinm kidneyd male middl ag enhanc dopamin renal respon patient hyperten purpo studi wa compar renal effect low dose exogen dopamin assess respon renal dopaminerg receptor normoten hyperten subject hyperten patient normoten volunt subject studi inulin paraaminohippur pah clearanc natriuresi fraction excretion sodium increa significantli venou dose dopamin gramsminkg group increa significantli higher hyperten normoten subject vs inulin clearanc vs pah clearanc vs natriuresi suggest hyperrespon dopamin dure hyperten thi enhanc respon exogen dopamin consid argum favor exist deficit dopaminerg activ dure hyperten dopamin induc signif reduc blood pressur increa heart rate hyperten subject signif chang blood pressur heart rate occur normoten subject 
87052486 acetyl adult amrinoneaablmeur human infusion venou kinet male phenotyp effect acetyl phenotyp amrinon pharmacokinet healthi male subject phenotyp isoniazid acetyl statu receiv venou amrinon dose mg dure period minut blood sampl drawn specifi dure 24hour period dose plasma concentr amrinon determin specif hplc method plasma concentr data fit biexponenti model nonlinear regr mean appar firstord elimin t12 amrinon slow acetyl wa wherea wa fast acetyl wa littl differ volum distribu steadi state clearanc wa lower slow acetyl lhr fast acetyl lhr auc wa higher slow acetyl gram hr ml1 fast acetyl gram hr ml1 concentr amrinon nacetyl metabolit urin volunt determin ratio nacetylamrinon amrinon wa calcul expect fast acetyl higher ratio slow acetyl 
87052487 adult diazepammepd doubleblind method drug evalu drug interac human kinet psychomotor performanc pyrimidinesmepd random alloc combin effect buspiron diazepam object subject test perform healthi volunt combin effect perform anxiolyt differ mechan action evalu doubleblind crossov healthi student object track divid atten maddox wing subject visual analogu scale questionnair test befor twice singl oral dose diazepam mgkg impair perform dose relatedli render subject drowsi calm mental slow clumsi buspiron mg prove inact object test match diazepam mgkg subject combin buspiron ad effect diazepam maddox wing letter cancel tend counteract diazepam effect divid atten learn acquisi subject buspiron prolong diazepaminduc sedat increa calm cau diazepam wa affect concomit buspiron suggest combin dose buspiron diazepam doe cau ani addition decrem psychomotor perform possibl advantag diazepambuspiron combin therapeut ar discuss 
87052489 adolesc adult chromatographi ga drug interac human kinet male platelet aggregationd prostaglandin endoperoxid syntheticpd random alloc thromboxan a2aaaiblpd quantit drug level platelet receptor blockad cau thromboxan antagonist sq structur analog thromboxan a2 inhibit effect thromboxan vitro fiftysix healthi male subject placebo equal daili dose sq rang mg plasma drug concentr increa dosedepend manner shape plasma drug concentrationtim curv wa consist enterohepat recircul effect sq ex vivo platelet aggreg suggest sq specif competit antagonist thromboxan a2 platelet receptor dissoci constant estim schild analysi nmoll approxim occup thromboxan receptor sq wa requir produc measur increa templat bleed doserang studi antithrombot drug ar difficult expen thi reason method wa develop allow estim dose thromboxan receptor antagonist expect therapeut equiv dose aspirin 
87052491 adult blood pressur debrisoquinmepd drug interac guanidinesblm human isoquinolinesm kinet liverdem liver cirrhos male metabol clearanc rate middl ag phenotyp puls support nonu govt support govt ph effect cirrhosi debrisoquin phenotyp disposi effect pinacidil pinacidil investig vasodil current undergo clinic trial antihyperten agent metabol human pinacidil noxid determin pinacidil metabol effect influenc liver disea subject debrisoquin phenotyp patient chronic stabl cirrhosi healthi subject studi healthi volunt exten metabol debrisoquin wherea poor metabol phenotyp clearanc pinacidil produc noxid wa alter subject debrisoquin phenotyp cirrhosi produc reduc pinacidil clearanc vs lhr prolong elimin t12 pinacidil wa metabol noxid metabolit patient cirrhosi normal individu thu pinacidil metabol clearanc ar reduc patient cirrhosi ar independ debrisoquin phenotyp 
87052492 blood proteinsm chromatographi high pressur liquid femal fetal bloodan fetusm human infant newborn kinet maternalfet exchang pregnanc ritodrineblm support nonu govt support govt ph ritodrin pharmacokinet purpo thi studi wa limit inform avail regard pharmacologi ritodrin peripartum period treatment fail labor inhibit plasma urin sampl parturi infant studi addition plasma sampl deliveri obtain total mother infant mother receiv ritodrin befor deliveri plasma urin ritodrin free conjug determin hplc electrochem detec matern plasma appar rapid distribu phase t12 minut wa follow prolong equilibrium phase t12 seventysix percent ritodrin excret mother wa form conjug nineti percent ritodrin excret neonat wa excret form conjug 
87052493 adolesc adult ag ag cimetidinepd compar studi drug evalu gastric acid gastric mucosad human hydrogenion concentr infusion venou male middl ag random alloc ranitidinepd effect singl venou dose cimetidin ranitidin gastric secretion venou cimetidin mg mg ranitidin mg wa administ singl dose volunt random crossov fashion aspir gastric juic obtain dose ph titrat acid gastric fluid volum gastric acid output determin baselin subject interven significantli increa ph suppress hydrogen ion concentr gastric fluid volum gastric acid output magnitud chang compar baselin mean maximum effect similar drug regimen effect interven gastric fluid volum gastric acid output diminish sharpli data indic gastric secretori respon interven differ substanti 
87052494 absorp adult aerosol blood gluco compar studi doubleblind method epinephrineadblm heart rate human injec subcutan male potassiumbl random alloc tremorci absorp inhal epinephrin determin absorp epinephrin inhal normal volunt puff follow puff epinephrin pressur aerosol gram epinephrinepuff peak mean se plasma epinephrin level nmoll minut dose respect effect physiolog finger tremor correl plasma epinephrin level return baselin minut higher dose wa fall mean plasma potassium level mmoll rise plasma gluco level mmoll separ occasion injec ml gram epinephrin wa subcutan individu thi cau peak plasma epinephrin level nmoll minut thi wa rai nmoll minut maximum fall mean plasma potassium level wa mmoll injec 
87052495 adult blood pressur drug therapi combin echocardiographi femal heart rate heart ventricl human hydrochlorothiazidetu hypertensiondt male middl ag nitrendipinetu propranololtu support nonu govt effect calcium channel blocker nitrendipin left ventricular mass patient hyperten reduc left ventricular lv mass report antihyperten therapi certain sympatholyt agent convert enzym inhibitor littl improv ha vasodil therapi thi studi evalu effect calcium channel blocker nitrendipin echocardiograph lv mass dure 12month period nitrendipin wa monotherapi patient combin propranolol diuret addition patient nitrendipin monotherapi lower supin blood pressur mm hg lv mass chang significantli supin blood pressur decrea mm hg patient receiv combin therapi chang lv mass signif data suggest nitrendipin effect lower blood pressur thi associ signif decrea lv mass patient mild hyperten 
87052588 ag factor ag analepticstu antidepress agent tricyclicadaebl depressionblcodidtth depress disorderbldtth electroconvul therapi femal human kinet male memori disordersdi middl ag monoamin oxida inhibitorstu nutrition disorderset prognosi psychotherapi suicid treatment depr elderli 
87052589 anticoagulantstu arteri occlu diseasesdtet basilar arterypp cerebellumb cerebr infarctionpp embolismpp fibrinolyt agent human migraineet subclavian arterypp vertebr arterypp vertebrobasilar insufficiencydtet treatment patient vertebrobasilar occlu disea 
87052590 ag benzodiazepin tranquilizerstu circadian rhythm diagnosi differenti femal human insomniadidtetppth male myoclonuscodt prognosi psychophysiolog disordersdt restless legscodt sleep apnea syndromescoth clinic aspect insomnia 
87052591 arteriosclerosissu human lasersmttu laser angioplasti 
87052592 electroconvul therapi femal human patient care team pregnanc pregnanc complicationsdtpxth psychotherapi psychot disorderscodtth psychotrop drugstu recurr psychosi pregnanc close continu collabor obstetrician psychiatrist nur disciplin requir improv mental health patient psychosi associ pregnanc complex case requir eitheror manag combin atten specialist disciplin 
87052593 dopamineai drug interac human intestin absorp kinet schizophreniadidt tranquil agent majoraemetu schizophrenia antipsychot drug varieti effect drug ar avail treatment schizophrenia knowledg sideeffect spectrum variou class antipsychot drug necessari clinician arriv ration choic medic gener prefer drug highpot neurolept follow basic principl clinic psychopharmacologi follow consid risk benefit clinic experi prerequisit establish diagnosi select appropri class psychotrop drug primari diagnosi drug class drug ar usual equal effect patient diagnosi dose high effect choo target symptom monitor indic stop increa drug avoid multipl drug possibl drug ar onli elem comprehen treatment strategi modal equal care consid psychotherapi group therapi famili treatment vocat rehabilit consult subspecialist sought readili indic 
87052594 ag anxietycodidt depressionco diagnosi differenti femal human male propranololtu tranquil agent minorclmetu manag anxieti elderli clinician awar cardin manifest clinic anxieti geriatr patient varieti psychotherapeut behavior chemic interven effect safe treat anxieti geriatr patient therebi greatli diminish morbid mortal 
87052595 acut disea dyskinesia druginducedet dystoniaci femal human male movem disordersci neurolept malign syndromeet parkinson disea symptomaticci psychomotor agitationci tranquil agent majora clinic neurobiolog implic antipsychoticinduc movem disord 
87052596 depress disorderth electroconvul therapya evalu studi human risk seizureset support govt ph electr induc seizur ect 
87052597 alprazolamtu anxietydidtet behavior therapi brainm fear femal human lactatesm male monoamin oxida inhibitorstu oxidationreduc panic phobic disordersdith pyruvatesm panic anxieti diagnosi etiologi treatment 
87052707 adult case report dermat contactet facial dermatoseset femal food handl human hypersensit immediateet occup dermatitiset shellfisha shrimp urticariaet region variat elicit contact urticaria syndrom immedi hypersensit syndrom shrimp 
87052708 adult case report dermat contactet femal food handl food hypersensitivityet human vegetablesa contact allergi cau bamboo shoot 
87052709 allergen anim azo compoundsa dermat contactet dyesa guinea pig textil disper blue strong sensit 
87052710 dermat contactet hair dyesa hair preparationsa human phenylenediaminesa paraphenylenediaminefr hair color mouss 
87052711 ag case report dermat medicamentosadiet dermat contactdiet human ibuprofena male patch test contact dermat ibuprofen 
87052712 adult case report catguta dermat contactet femal human suturesa catgut dermat 
87052713 benzydaminea case report dermat medicamentosaet dermat contactet human male middl ag patch test pyrazolesa contact dermat benzydamin hydrochlorid 
87052714 adult azo compoundsa case report dermat contact dyesa femal human patch test textil contact dermat basic red 
87052715 acroleinaaa ag ag aldehydesa case report cheilitisci dermat contactdiet femal human patch test sunscreen agentsa toothpastea cheiliti occult allergi cinnam aldehyd 
87052716 ag case report dermat medicamentosaet dermat contactdiet eyelid diseasesci human male patch test phenylephrinea allerg contact dermat phenylephrin 
87052717 adult case report dermat contactet hand dermatosesci human male music resinsa allerg contact dermat colophoni violoncellist 
87052718 adult ag dermat medicamentosaet dermat contactet femal human leg ulcerdt male middl ag triterpenesa contact allergi centela 
87052719 antiinflammatori agent topicala case report child dermat medicamentosaet dermat contactet human male patch test triamcinoloneaaa contact allergi amcinonid 
87052720 agricultur worker diseasesci anim anim feed case report dermat contactdiet human male middl ag occup dermatitiset patch test photosensit disordersdi quinoxalinesa swine occup photocontact dermat olaquindox 
87052721 adolesc adult ag amantadineaaa antivir agentsa dermat medicamentosaet dermat contactet femal herp labialisdt herp zosterdt human idoxuridinea male middl ag contact allergi antivir agent 
87052722 dermat contactdiet femal human male perfumea allergi perfum mixtur 
87052723 adult agricultur worker diseasesdiet anim case report cattl dermat contactdiet human male occup dermatitisdiet patch test radioallergosorb test saliva contact eczema cow saliva 
87052724 agricultur worker diseaseset dermat contactet human hydroxybenzo acidsa lichen male photosensit disorderset photosensit oak moss letter 
87052726 adult case report dental alloysa dermat contactdipa femal human middl ag mouth diseasesdietpa mouth mucosapa nickela patch testsismt skin testsmt new method oral patch test oral patch test wa perform subject contact sensit nickel maxillari acryl plate carri test piec contain nickel appli read perform remov ani clinic sign detect biopsi muco contact site lichenoid reaction biopsi control site slight nonspecif inflammatori reaction 
87052727 dermat contactdiet femal human male occup dermatitisdiet patch test quinazolinesa dermat quinazolin oxid dermat 2chloromethyl4phenyl6chloroquinazoline3oxid intermedi product prepar chlorodiazepoxid describ worker pharmaceut plant patch test posit quinazolin oxid patient wa earlier sever involv hand sensit thei contact work wash cloth worker work distanc produc line build 
87052728 adult case report cyclohexanecarboxyl acidsa dermat contactdiet epoxi compoundsa ether cyclica human industri oilsa male middl ag occup dermatitisdiet patch test allerg contact sensit glycidyl ester hexahydrophth acid cut oil allerg contact dermat report machin oper work cut oil contain epoxi compound stabil posit patch test reaction thi compound obtain neg control 
87052730 color dermat contactdi hemoglobinsan human patch test skinanpp skin test spectrophotometri support nonu govt skin reflect measur patch test respon skin reflect valu object measur skin haemoglobin content patch test site facilit quantif erythemat respon contact allergen patient allerg contact dermat reflect measur patch test respon correl clinic score provid numer measur reaction sever experi contact allergen formul evalu thi method 
87052731 adult dermat contactdiet femal glove surgic human igean latexaeim male middl ag patch test powder radioallergosorb test rubberaeim sorbic acida support nonu govt sweat urticariadiet discomfort rubber glove indic contact urticaria rubber glove intol common dermatolog problem hypersensit delai immedi type occur order studi immedi skin reaction induc rubber glove patient discomfort itch produc rubber glove examin patient provok wear rubber glove scratch test glove rubber chemic powder rasttest perform extract rubber tree hevea brasiliensi patient contact urticaria wa confirm ig antibodi latex demonstr 
87052732 adult chlorohydrinsa dermat contactetpc epichlorohydrina epoxi resinsa human male middl ag occup dermatitisetpc patch test phenolsa sensit epichlorohydrin epoxi compon epoxi resin manufactur plant worker workrel erup patch test test seri consist chemic manufactur process standard batteri sensit preval sensit epichlorohydrin andor epoxi resin group wa rel high preval epichlorohydrin sensit wa case sensit liquid epoxi resin mw observ case combin allergi solid epoxi resin mw sensit bisphenol wa seen 
87052733 administr topic case report cephalexinada dermat medicamentosaet dermat contactdiet femal human leg ulcerdt middl ag patch test contact dermat cephalexin 
87052734 acryl resinsa adult case report chloramphenicola dermat contactet femal human middl ag neomycina occup dermatitiset ophthalmologi polyurethanesa tetracainea occup contact sensit oculist 
87052735 acrylatesa adult case report dermat contactet human male occup dermatitiset allerg contact dermat uvcur acryl manufactur optic fibr 
87052736 benzoatesa case report dermat contactdiet femal human middl ag patch test sunscreen agentsa allerg contact dermat isopropyl dibenzoylmethan 
87052737 adult antifung agentsa case report dermat medicamentosaet dermat contactet femal human pyridonesa contact dermat cyclopyroxolamin 
87052738 adult case report dermat contactdiet femal human hypersensit delayeddiet hypersensit immediatediet nickela patch test immedi hypersensit nickel 
87052739 adult case report dermat contactdiet ethambutola hand dermatoseset human male occup dermatitisdiet patch test contact dermat ethambutol 
87052740 acetamidesa case report cosmeticsa dermat contactet facial dermatosesci femal human middl ag contact allergi chloroacetamid antiwrinkl serum 
87052741 adult case report dermat contactdiet human male patch test plant contact dermat pastinaca sativa 
87052742 adolesc adult ag factor ag ag automat data process child dermatitisep dermat atopicep dermat contactep femal foot dermatosesep hand dermatosesep human male middl ag occup dermatitisep patch test sex factor analysi consecut contact clinic consult simpl comput program wa anali result test consecut patient attend patch test clinic male femal posit test male femal occup dermat male femal irrit contact dermat male femal histori atop eczema 
87052743 adult australia case report dermat contactet femal human male patch test plant toxic rhu contact dermat grevillea robyn gordon grevillea robyn gordon australian hybrid plant mai cau allerg contact dermat ha plant exten australia export unit state western countri explosion incid contact dermat thi plant ha seen patient suspect sensit patch test fresh plant extract confirm sensit cross sensit toxicodendron wa demonstr clinic patch test allergen toxicodendron pentadecylcatechol close link chemic structur 5pentadecylresorcinol present grevillea banksii tridecylresorcinol grevillea robusta patch test patient sensit grevillea robyn gordon tridecylresorcinol produc posit reaction thu implic sensit role chain alkyl resorcinol grevillea robyn gordon allergi likelihood thi sensit potenti extend plant grevillea genu grevillea robusta spread grevillea robyn gordon market thi problem becom increasingli common 
87052744 dermat atopicco dermat contactco femal food servic hospit hand dermatosesep human mainten engin hospit male occup dermatitisep patch test personnel hospit psoriasisco occup skin disea hospit clean kitchen worker skin disord report cater staff women cleaner return questionnair emploi larg hospit hand dermat occur cater cleaner major dermat wa irrit origin relat wet work occup cleaner high preval jewelleri dermat limit patch test reveal major posit nickel neg indic jewelleri reaction invari predict nickel sensit subject atop psoriat patient hand problem encount worker abl carri occup despit hand dermat 
87052745 adolesc adult ag factor ag child chromatesa dermat contactep femal human male middl ag nickela patch test retrospect studi sex factor ag sex incid allerg contact dermat retrospect studi patient patch test wa undertaken case record patient unequivoc posit patch test studi ag sex distribu wa over femal prepond peak incid ag group femal onli peak incid ag group male wa steadi declin sensit 6th decad life sex nickel sensit wa common femal wherea dichrom sensit predomin male patient onli atop femal 
87052746 adult case report dermat contactet femal hand dermatosesci household productsa human sodium hypochloritea sensit sodium hypochlorit cau hand dermat patient ar report chronic hand dermat relat sensit sodium hypochlorit activ compon bleach product avoid irrit reaction patch test sodium hypochlorit concentr appear conclud regard frequent bleach agent allergi sodium hypochlorit consid certain case unidentifi chronic allerg hand dermat 
87052747 anim dermat contactetpa epidermispa femal guinea pig irrit solventsto support nonu govt anim model assess skin irrit irrit skin reaction repeat open applic low concentr sodium lauryl sulphat sl studi macroscop scopic guinea pig applic daili dai sl aqueou solution nake ey assess increa epiderm total dermal inflammatori cell respon wa greater sl solution dermal inflammatori cell respon wa mainli mononuclear lymphocyt natur sl reaction control variou organ solvent studi rank sl reaction intern trichlorethylen wa irrit solvent rank high sl chlorin hydrocarbon aromat hydrocarbon test cau irrit reaction alcohol aceton reaction white spirit wa irrit trichlorethylen thinner irrit level sl control reaction 4dai experi design conveni suitabl anim model screen irrit potenti provid inform relev pathogenesi irrit contact reaction 
87052748 adult ag femal glycineaato herbicidesto human irrit male middl ag patch testsmt photosensit disordersci irrit sensit photoirrit photosensit assai glypho herbicid glypho wide util herbicid wa evalu acut irrit cumul irrit photoirrit allerg photoallerg contact potenti volunt herbicid wa irrit standard liquid dishwash deterg gener purpo cleaner wa evid induc photoirrit allerg photoallerg contact dermat glypho water propo diagnost patch test concentr 
87052749 anim coumarinsto dermat contactet femal freund adjuvantad guinea pig irrit skin testsmt support nonu govt sensit capac coumarin coumarin perfumeri cosmet ointment investig differ method determin sensit capac onli compound 4methylesculetin serv sunscreen agent wa weak sensit coumarin neg assum thi dihydroxycoumarin becom sensit enzym oxid correspond orthoquinon skin 
87052750 acnecipa adult case report chlorophenolsa human male occup dermatitisetpa pentachlorophenolaean tetrachlorodibenzodioxinaaan wood chloracn pentachlorophenolpreserv wood patient present develop chloracn exposur lumber wa pressuretr pentachlorophenol pcp wa presum hi disea aro percutan absorp polychlorin aromat compound dioxin furan ar contamin technic grade pcp patient condition improv treatment oral isotretinoin 
87052751 asia cobaltaean construc materi human nickelaean occup dermatitisep solubl spectrophotometri atom absorp support nonu govt cobalt nickel content asian cement total cobalt nickel concentr brand asian cement rang gramsg gramsg respect metal exist mainli insolubl salt watersolubl concentr cobalt nickel cement rang gramsg gramsg respect construc worker prefabr construc factori cobalt sensit allerg contact dermat chromat cement worker isol cobalt sensit cement dermat appear sensit cobalt cement occur onli secondarili exist cement dermat worker nickel sensit allerg contact dermat nickel watch asymptomat allerg contact dermat chromat cobalt cement low preval cobalt nickel sensit cement wa probabl relat low concentr solubl cobalt nickel salt cement howev insolubl salt form solubl complex bodi fluid eczemat skin sensit skin 
87052752 femal human vitro ion nickelm permeabl skin absorp permeat nickel salt human skin vitro impact occlusion role counter ion permeat nickel ion skin examin exci human skin highli sensit electrochem method wa quantifi nickel permeat skin investig nickel ion ar capabl permeat skin barrier appli occlusion process slow lag approxim permeat rate thu physic bioavail consid increa aqueou nickel chlorid comparison aqueou nickel sulphat respect nickel permeat skin conclud choic salt import consid patch test 
87052753 adult ag ag dermat atopicdi dermat contactdi eyelid diseaseset femal hand dermatosesco human male middl ag patch test eyelid dermat role atopi contact allergi patient eyelid dermat studi patch test clinic method diagnosi atop skin disea patient contact allergi wa dermat wa expr atop dermat patient 
87052755 asthmaci case report dermat contactet dyesa human male middl ag occup dermatitiset occup diseasesci contact dermat asthma reactiv dye 
87052756 adult case report dermat contactet fungicid industriala human male nitrilesa occup dermatitiset painta contact dermat tetrachloroisophthalonitril paint 
87052757 adolesc adult ag case report dermat medicamentosaet ethylmercuri compoundsa femal human pharmaceut aidsa preserv pharmaceuticala thimerosala reaction thiomer 
87052759 administr oral adult case report cimetidinea dermat medicamentosaet human hypersensit delayedci male delai hypersensit oral cimetidin 
87052760 adult case report human male medicin orient tradition purpuraet suctiona vacuum puhanginduc purpura 
87052761 acnedt adult allergen case report decano acidsaetu dermat contactet drug combinationstu erythromycintu human male vehiclesa zinctu allerg contact dermat diisopropyl sebac 
87052762 femal human male patch testsmt resinsada skin testsmt vehicl patch test colophoni concentr 
87052763 dermat medicamentosaet human hypersensit delayedci patch test rash oral codein letter 
87052833 blood transfusiona complem activ complem 3an human prospect studi respiratori distress syndrom adultet risk septicemiaco support nonu govt support govt ph c3a adult respiratori distress syndrom massiv transfusion compar degr complem activ patient receiv massiv blood transfusion patient septic syndrom examin associ risk factor adult respiratori distress syndrom ard patient massiv transfusion onli risk factor ard lower c3a level ngml lower incid ard patient massiv transfusion plu risk factor c3a ngml ard patient septic syndrom c3a ngml ard patient degr complem activ appear reflect presenc complic clinic condition 
87052834 anim conjunctivam dog hemodynam hemorrhageppth oxygen consump resuscit cardiorespiratori conjunctiv oxygen tension monitor dure resuscit hemorrhag placem unheat miniatur oxygen electrod palpebr conjunctiva permit noninva measur tissu oxygen tension thi studi relationship conjunctiv oxygen tension pcjo2 standard cardiorespiratori variabl wa examin dure sequenti resuscit protocol acut hemorrhag anesthet dog rapidli bled mean arteri pressur mm hg retransfu shed blood stepwi fashion pcjo2 control valu hemorrhag return prehemorrhag valu shed blood reinfu pcjo2 wa cardiorespiratori variabl return control valu dure resuscit wa noninva variabl normal ratio pcjo2 arteri oxygen tension decrea prehemorrhag valu sem hemorrhag increa valu greater resuscit wa complet conjunctiv oxygen monitor mai plai import role assess adequaci resuscit acut hemorrhag 
87052837 adult ag cerebrovascular disordersm epinephrineur femal human male middl ag norepinephrineur oxygen consump metabol acut cerebrovascular disea oxygen consump vo2 co2 produc respiratori quotient rest metabol expenditur rme urin catecholamin level measur patient acut cerebrovascular disea rme correl posit urinari norepinephrin epinephrin excretion maximum valu wa higher expect uninjur rest person equiv ag sex size vo2 correl posit urinari catecholamin excretion impli sympathet nervou directli influenc vo2 rme moreov hypermetabol state consid care patient cerebrovascular disea malnutri cau weight loss decrea immun 
87052838 acquir immunodefici syndromecomo adult critic care femal human inten care unit male medic record opportunist infectionsco prognosi respiratori insufficiencycomo sarcoma kaposisco icu surviv patient acquir immunodefici syndrom icu record patient acquir immunodefici syndrom review patient admit respiratori failur requir intub mechan ventil patient pneumocysti carinii andor cytomegaloviru pneumonia patient admit respiratori failur monitor brain biopsi respiratori failur patient remain icu dai compar dai respiratori failur over mortal wa patient respiratori failur patient di compar respiratori failur icu survivor live hospit discharg 
87052839 equip design human intubationi tidal volum work breath work breath differ size endotrach tube abil breath spontan endotrach tube usual prerequisit befor intub patient remov research measur air flow resist endotrach tube thi studi evalu work breath joul min tensiontim index normal volunt breath differ size endotrach tube 275cm endotrach tube subject breath constant tidal volum ml increa respiratori frequenc minut ventil wa increa lmin tube diamet decrea work tensiontim index increa chang magnifi higher minut ventil 7mm endotrach tube tensiontim index critic fatigu level wa approach exce 
87052840 adolesc adult ag critic care dobutaminetu femal hemodynamicsd human male middl ag oxygen consumptiond postop period hemodynam oxygen transport effect dobutamin critic ill gener surgic patient effect dobutamin hemodynam oxygen transport evalu studi critic ill gener noncardiac surgic patient dobutamin begin low dose gramskg min significantli increa cardiac index ci oxygen deliveri do2 oxygen consump vo2 decrea mean arteri pressur pulmonari arteri wedg pressur pulmonari vascular resist blood gase ph pulmonari shunt significantli chang effect seen postop septic patient patient normal low high control ci respon poor termin ill hypovolem patient howev addition fluid respon markedli improv hemodynam effect dobutamin ar do2 vo2 effect suggest improv tissu perfusion appreci 
87052841 adult ag cardiac output cardiographi imp compar studi critic care electrod femal human inten care unit male middl ag plethysmographi imp pulmonari wedg pressur thermodilu comparison transthorac electr imp thermodilu method measur cardiac output cardiac output wa measur critic ill patient thermodilu transthorac electr imp method minimum mean valu distanc inner electrod varieti valu resist blood rho substitut kubicek empir formula calcul cardiac output transthorac electr imp mean distanc inner electrod rhovalu ohm cm agreem method mean differ lmin ventil alon posit endexpiratori pressur significantli affect bia estim affect precision compar measur spontan breath patient sd mean differ lmin respect vs lmin pulmonari arteri wedg pressur wa significantli higher patient abnorm diastol imp waveform zerowav wa relationship wedg pressur base imp unit length measur electrod 
87052842 birth weight blood pressur dopaminetu femal heart rate human infant newborn infant newborn diseasesdt male prospect studi retrospect studi support govt ph urinationd effect highdo dopamin urin output newborn infant achiev adequ arteri bp adequ capillari adequ periph pul hypoten newborn infant requir higher dose dopamin reportedli reduc urin output adult larger dose dopamin reduc urin output newborn therefor determin effect administ highdo dopamin gramskg min urin output newborn infant infant studi prospect retrospect prospect studi urin output wa determin dose dopamin wa increa retrospect studi urin output wa determin infant wean high dose dopamin data demonstr administ highdosag dopamin doe reduc urin output sick newborn infant therefor conclud dose dopamin previou report decrea urin output adult sick newborn infant consequ necessari high dose dopamin mai sick newborn infant achiev cardiovascular stabil reduc urin output 
87052843 blood ga analysi blood ga monitor transcutan compar studi human infant newborn monitor physiolog patient transfer respir artifici respiratori distress syndromeblth transcutan carbon dioxid monitor dure neonat transport studi valu transcutan carbon dioxid ptcco2 monitor dure neonat transport thirtytwo neonat respiratori distress altern enrol experi group result ptco2 ptcco2 avail clinic manag control group result onli ptco2 avail differ signif infant experi group chang intermitt mandatori ventil imv dure transport infant arriv receiv hospit accept ph pco2 valu arriv receiv hospit patient control group acidosi hypercarbia imv immedi arriv patient encount experi group patient imv dure transport percentag studi spent ptcco2 measur normal rang torr wa greater experi group continu ptcco2 monitor dure transport offer opportun decrea risk transport critic ill neonat 
87052844 child child preschool fibronectinsbldf human infant prognosi purpurablco shockblco plasma fibronectin sever infecti purpura children plasma fibronectin level determin children admit sever infecti purpura fibronectin concentr wa decrea sever infecti purpura sepsi wa signif differ shock nonshock patient fibronectin level lower children ecchymot necrot purpura admi petechi purpura thei lower develop cutan sequela correc fibronectin defici mai limit extent purpura prevent cutan sequela 
87052846 anuriath blood case report child preschool critic care equip design femal hemodialysi human infant infant newborn kidnei failur acuteth male periton dialysi filtrat earli experi continu arterioven hemofiltr critic ill pediatr patient applic continu arterioven hemofiltr cavh renal replac therapi wa evalu infant young children catastroph medic surgic ill patient cavh wa conjunc periton hemodialysi fifth patient cavh wa sole renal replac therapi emploi thi critic ill anur infant abl evalu abil cavh continu control fluid electrolyt acidba balanc allow administr adequ parent nutrition difficulti encount relat anticoagul establish adequ vascular access selec appropri hemofilt perform techniqu despit applic suctionassist unabl effect emploi prototyp pediatr hemofilt attain level plasma filtrat consist object therapi howev abl effect safe emploi adult hemofilt purpo modif adult hemofilt befor applic smallest pediatr patient experi suggest critic ill infant cavh successfulli appli effect renal replac therapi howev experi requir befor potenti impact patient surviv assess 
87052847 adult cardiac output case report equip failur femal heart cathet human spuriou high cardiac output inject thermal indic ensheath port 
87052848 critic care euthanasia euthanasia passiv hospit teach human resuscit patient care categori approach donotresuscit decision public teach hospit 
87052850 case report comacith critic care femal human ibuprofenpo middl ag suicid attempt coma cau ibuprofen overdo 
87052852 adult bacteroid melaninogenicu bacteroid infectionsdidt case report clindamycintu diagnost error epiglottitisdimith human laryngitismi male tracheotomi acut epiglott adult acut epiglott adult uncommon thi case report young acut epiglott secondari bacteroid melanogenicu supraglott abscess thi pathogen ha previou describ causit epiglott 
87052853 anesthesiaa human oper period monitor physiologicmt respir artificiala anesthet ventil mishap preven detec editori 
87052937 adult ag ag amput angiographi arteri occlu diseasesrasu arthropathi neurogenicdietth diabet mellituscopp diabet neuropathiesdietsuth foot diseasesdietpcpprasuth gangreneetsu human intermitt claudicationetsu ischemiadietppsuth middl ag tibiab diabet foot 
87052938 ascit fluidpa axillasu breast neoplasmssu femal gastrointestin neoplasmssu groinsu head neck neoplasmssu human intestin perforationsu male neoplasmssu omentumsutr ovarian neoplasmssc pelvic neoplasmssu periton neoplasmsscsu postop complic support nonu govt surgic flap thorac surgeri greater omentum applic cancer surgeri cancer therapi 
87053002 dyspneadtet human lung disea obstructiveco psychotrop drugsaetu treatment dyspnea psychotrop agent editori 
87053003 amyloidosispath human lung diseasespath prognosi clinic aspect pulmonari amyloidosi editori 
87053004 bronchipa exud transudatespa human irrig lung diseasesimmipa pulmonari alveolipa bronchoalveolar lavag clinic editori 
87053007 airwai obstructionco anesthesia inhalationa case report human intub tracheala male middl ag obesityco pulmonari edemaetpp risk postextub pulmonari edema follow anesthesia induc upper airwai obstruc ar certain patient increa risk pulmonari edema upper airwai obstruc observ varieti clinic situat predomin mechan increa neg thorac pressur hypoxia cardiac neurolog factor mai contribut laryngospasm associ intub gener anesthesia common cau pulmonari edema children howev onli case pulmonari edema presum laryngospasm report adolesc adult risk factor upper airwai obstruc diagnosi laryngospasm explain factor patient underli risk factor upper airwai obstruc form frust sleep apnea nasopharyng abnorm appear increa risk develop pulmonari edema intub anesthesia thi form pulmonari edema usual resolv rapidli aggress therapi inva monitor 
87053008 catheterizationaemt extrava diagnost therapeut materialset hemothoraxet human inten care unit phlebitiset pneumothoraxet prospect studi central vs periph venou cathet critic ill patient prospect studi venou cathet wa perform multidisciplinari inten care unit determin cathet remov site inser associ morbid techniqu inser vigor supervi central periph cathet care ident protocol overt phlebiti inflamm site wa common periph cathet central insert central cathet periph cathet remov averag dai central insert central cathet dai pneumothorax occur patient central insert central cathet hemothorax pneumothorac requir thoracostomi tube treat successfulli simpl cathet aspir patient periph periph insert central cathet requir phlebectomi suppur thrombophleb conclud over morbid critic ill patient lower central insert central cathet periph venou cathet periph insert central cathet intermedi position supervi techniqu inser ha kept high level complic central cathet accept level periph cathet site maintain frequent replac cathet 
87053010 adult anthropometri human male medroxyprogesteroneaatu middl ag sleep apnea syndromesdt sleep rem support govt nonph tidal volum transduc pressur vital capac effect medroxyprogesteron acet obstruct sleep apnea studi effect medroxyprogesteron acet respiratori stimul incid durat episod apnea disord breath nonhypercapn obstruct sleep apnea nocturn polysomnographi wa befor treatment medroxyprogesteron acet mgdai cessat treatment signif differ mean frequenc apneic episod sleep befor se dure treatment mean number disord breath episod sleep befor dure period treatment medroxyprogesteron alter significantli total apnea total disord breath express percentag total sleep arteri oxygen desatur dure apnea disord breath chang treatment medroxyprogesteron increa minut ventil occlusion pressur respon hypercapnia measur awak state howev result thi studi demonstr medroxyprogesteron doe improv breath disord dure sleep nonhypercapn patient obstruct sleep apnea 
87053012 adult ag amyloidm amyloidosispasu birefr bronchial diseasespa femal human lung diseasespasu lung neoplasmspa male scopi polar middl ag tissu distribu tracheal diseasespa amyloidosi lower respiratori tract clinic patholog featur seri patient twenti case amyloidosi lower respiratori tract seen singl center patient multifoc bronchial amyloid plaqu stenosi atelectasi tumor mass incid bronchoscop patient nodular parenchym amyloidosi lesion progress static patient diffu parenchym amyloidosi sever interst involv di respiratori failur congest cardiac failur parenchym amyloidosi wa postmortem senil cardiorespiratori amyloidosi autopsi amyloidosi wa associ malign degr respiratori embarrass relat amyloid ga diffusion zone irrespect etiologi amyloidosi 
87053013 ag alprazolamaetu doubleblind method drug evalu dyspneadtpa exer femal human lung disea obstructivedtpp male middl ag random alloc respiratori function test statist support nonu govt effect alprazolam exerc dyspnea patient chronic obstruct pulmonari disea evalu efficaci mild anxiolyt alprazolam reliev dyspnea conduct random placebocontrol doubleblind studi patient chronic obstruct lung disea twentyfour patient alprazolam mg bid placebo administ follow placebo placebo alprazolam assess test perform outset end final end paramet measur pulmonari function exerc test bicycl ergomet distanc cover minut walk subject sensat dyspnea rest dure guard exerc subject feel calm anxieti record wa differ mechan lung function po2 tend decrea pco2 increa alprazolam administr maximum exerc level attain distanc cover minut walk wa unchang subject percep dyspnea wa befor alprazolam rest dure exerc conclud alprazolam effect reliev exerc dyspnea patient obstruct lung disea 
87053014 adult ag cardiac output femal halflif human kinet lidocainem liverm male middl ag region blood flow respir respir artifici support nonu govt effect mechan ventil hepat drug pharmacokinet mechan ventil wa abl induc decrea cardiac output region blood flow especi hepat flow thu hepat elimin drug high hepaticextrac ratio wa link alter hepat blood flow reduc dure mechan ventil aim thi work wa determin effect mechan ventil pharmacokinet paramet lidocain wellknown nonrestrict elimin drug hepat level patient mean ag normal hepat function quit similar gasometr paramet befor wean mechan ventil studi washout period mechan ventil spontan ventil patient wa submit follow protocol lidocain bolu mgkg venou follow infusion mgmin minut result peak plasma concentr bolu dure mechan ventil wa mgl mean se vs mgl dure spontan ventil steadyst plasma concentr dure mechan ventil wa mgl vs mgl dure spontan ventil total clearanc wa mlmin dure mechan ventil vs mlmin dure spontan ventil elimin halflif wa minut dure mechan ventil vs minut dure spontan ventil distribu volum wa dure mechan ventil dure spontan ventil signif preliminari data clearli demonstr decrea lidocain elimin patient submit mechan ventil magnitud dosag adjust highli hepaticextract drug patient submit mechan ventil remain investig 
87053016 adult angiographi angioplasti translumin case report graft occlusion vascularrath human intern mammari arteri implant male middl ag myocardi revascular percutan translumin angioplasti right left intern mammari arteri graft patient recurr sever angina evid myocardi ischemia surgic coronari revascular submit percutan translumin angioplasti distal inser intern mammari arteri graft recipi vessel distal case illustr feasibl safeti translumin angioplasti right left intern mammari arteri graft mammari arteri wai access 
87053018 adult femal forc expiratori flow rate human male maxim midexpiratori flow rate pressur refer valu smoke statist support nonu govt vital capac maximum flow ratio midvit capac young healthi adult upper airwai obstruc usual diagno visual examin maximum expiratori inspiratori flowvolum curv calcul ratio expiratori inspiratori flow percent vital capac midvit capac flow ratio howev refer valu thi ratio establish consid variabl exist purpo thi studi wa examin rang midvit capac flow ratio group healthi subject determin variabl account differ maximum inspiratori pressur measur maximum expiratori inspiratori flow percent vital capac flowvolum curv maximum inspiratori pressur group healthi nonsmok women ag rang midvit capac flow ratio mean sd wa women coeffici variat midvit capac flow ratio wa percent percent women percent confid limit midvit capac flow ratio women maximum inspiratori pressur mean sd cm h2o cm h2o women significantli differ previou studi normal maximum inspiratori flow maximum inspiratori pressur reduc coeffici variat becam percent percent women conclud rang midvit capac flow ratio wide reduc standard maximum inspiratori pressur 
87053019 adult case report child compar studi death suddenpa femal followup studi heart conduc systempa heart defect congenitalsu human infant male postop complicationspa support govt ph conduc case sudden death congenit heart disea mani surgic correc conduc entir heart examin histolog patient congenit heart disea surgeri mani befor thei di suddenli asymptomat sinu rhythm live normal sudden death mai relat alter conduc previou present introduc previou surgeri relat inflammatori phenomena outgrowth previou surgeri 
87053020 colorimetrymt heat human kinina iiaibl qualiti control sarcoidosisen statist support govt nonph filtrat angiotensinconvert enzym ac inhibitor human serum increa sensit serum ac assai detect activ sarcoidosi measur serum angiotensinconvert enzym ac extrem aid diagnosi longitudin evalu patient sarcoidosi detect human serum aceinhibitor affect ac level obtain activ measur effect inhibitor elimin mere eightfold dilution serum sampl physiolog salin recommend serum ac perform dilution serum elimin effect ac inhibitor inhibitor ha mw abov dalton rever inhibi dilution appear ion depend dialysi inhibitorcontain serum sampl salin cau inhibi becom irrev allow distinc alinear assai vs inhibitor effect serum ha ac activ greater unitsml sourc serum aceinhibitor remain determin 
87053021 actuari analysi adult ag angioplasti transluminalaeec coronari diseasepasuth coronari vesselsah emerg followup studi human middl ag myocardi infarctionsu myocardi revascularizationmo vascular patenc coronari angioplasti treatment choic multivessel coronari arteri disea 
87053022 case report clinic trialsmt dihydromorphinonetu doubleblind method dyspneadtet femal human lung disea obstructiveco middl ag narcoticstu random alloc research design singlepati random clinic trial opiat ctabl dyspnea 
87053023 ag case report heart catheterizationmt human male vena cava superiorabra abnorm position flowdirect right heart cathet 
87053024 anim capillari permeabl human infectionco myocardi infarctionco pulmonari edemaetth shockco shock septicco pulmonari edema induc sepsi 
87053028 angiographi case report coronari vessel anomaliesra electrocardiographi exer human male middl ag sinu valsalvaabra dual left coronari dual left coronari origin normal anom right sinu valsalva describ 53yearold patient atyp chest pain exerciseinduc stdepr anterosept area v24 clinic consequ thi hitherto undescrib anomali ar discuss 
87053029 ag case report femal human male middl ag pulmonari embolismra thromboembolismrath vena cava inferiorabrasu duplic inferior vena cava thromboembol disea recurr pulmonari embol lower extrem pelvi despit anticoagul requir interrup inferior vena cava ivc report patient interrup ivc fail amelior symptom patient demonstr previou unrecogn duplic ivc stress import exclud abdomin venou anomali prior interrupt ivc surgic percutan method 
87053030 case report femal human leiomyosarcomacosc lung neoplasmscosc middl ag pleura pneumothoraxdtet tetracyclinead pleurodesi metastat pneumothorax 57yearold woman bilat pneumothorac secondari pulmonari metasta leiomyosarcoma uteru wa treat successfulli pleural instil tetracyclin 
87053034 carcinoma bronchiolarco case report femal human lung neoplasmsco middl ag pneumothoraxetsu spontan pneumothorax complic lung cancer letter 
87053035 human lung neoplasmsra lymphat metastasi lymphographymt mediastinoscopi neoplasm stagingmt tomographi xrai comput stage ct letter 
87053036 followup studi heart valv prosthesi human polyethylen terephth silicon tricuspid valvesu tricuspid valv insufficiencysu tricuspid annuloplasti letter 
87053037 atrial fibrillationth case report electr countershockmt male pul run new method cardiov letter 
87053304 case report femal human middl ag obesitym theophyllinebl subject variabl theophyllin clearanc morbidli ob patient appreci theophyllin pharmacokinet exhibit wide intersubject variat withinsubject chang clearanc gener report patient acut exacerb disea state cor pulmon heart failur appar random chang theophyllin clearanc patient report thi report describ case suspect chang clearanc theophyllin morbidli ob patient kg twomonth period frequent dosag adjust requir maintain theophyllin concentr rang gramsml possibl explan chang includ hypoxia medic induc starvat daili theophyllin dose rang mgd conclud individu withinsubject chang theophyllin clearanc substanti thu requir frequent monitor theophyllin concentr 
87053305 adult case report human kidnei failur acutecipp male phenylpropionatesa suprofena suprofeninduc acut renal failur case report acut flank pain rever renal failur young adult dose suprofen present blood urea nitrogen serum creatinin valu return normal significantli elev level admi 
87053307 adipo tissuem adolesc adult ag cefamandolemetuur chromatographi high pressur liquid drainag femal human kinet male middl ag obesitymeth stomachsu support nonu govt support govt ph surgic wound infectionmepc cefamandol distribu serum adipo tissu wound drainag morbidli ob patient distribu elimin cefamandol iv studi morbidli ob patient dure gastric bypass oper postop dai serum subcutan adipo tissu wound drainag urin analyz high perform liquid chromatographi cefamandol pharmacokinet paramet oper period compar obtain postop total bodi clearanc wa significantli greater postop mlmin oper mlmin volum chang unpredict elimin rate constant tend increa postop renal clearanc percentag urinari recoveri significantli increa postop patient mean sd volum central compart volum steadi state elimin rate constant h1 tissu concentr cefamandol highest dure drug administr gramg mean wound drainag concentr rang gramsml dure dose interv drop gramsml dose oper dose cefamandol requir maintain subcutan adipo tissu concentr greater gramg dure procedur morbidli ob patient postop dose cefamandol iv q6h provid sustain therapeut concentr wound drainag morbidli ob patient 
87053308 adult ag bodi weightd hospit human indolesa male middl ag molindoneaetu schizophreniacodt effect molindon weight chang hospit schizophren patient retrospect review wa conduct assess effect molindon weight monthli weight neurolept dosag dure psychiatr hospit compar match group patient receiv molindon combin molindon neurolept neurolept drug signif differ weight gain group result challeng common opinion molindon associ weight gain compar antipsychot 
87053309 dermatologi drug compound florida interprofes relat pharmacist physician prescrip drug survei profes interrel dermatologist pharmacist nation survei dermatologist pharmacist wa conduct charact involv commun pharmacist area skin disea elicit sugg improv profes interrel result dermatologist major complaint pharmacist inabl unwil compound prescrip studi clearli indic increa commun profe inventori control prescrip refil procedur substitu guidelin pharmacist gener admit defici educ prepar recogn common skin disord thu limit abil assess sever patient complaint 
87053310 drug therapi drugsad pharmacist drug dont dosespeopl dose clinic educ philosophi editori 
87053311 pharmacytd unit state control metamorphosi pharmaci editori 
87053312 pharmacytd pharmaci servic hospitaltd special unit state clinic pharmacyspecialti gener direc editori 
87053313 educ pharmacytd pharmacytd unit state basic scientist fiddl clinic faculti burn editori 
87053314 aminoglycosidesan antibioticsan drug incompat drug stabil heparinan heparin aminoglycosid instabl letter 
87053315 human imipramineadsttu therapeut equiv imipramin treatment failur defect gener product inadequ dose letter 
87053316 adult case report epidermolysi bullosadt human male phenytointu phenytoin treatment rdeb vegetan letter 
87053317 case report diltiazemmepo human kinet male middl ag suicid massiv diltiazem overdosag clinic pharmacokinet observ letter 
87053318 adult case report danazola femal hepat toxicet human pregnadienesa hepat associ danazol letter 
87053320 human kinet phenytoinbl comment predict phenytoin level letter 
87053321 great britain pharmacyma comment pharmaci manpow contrastuk letter 
87053529 critic care human inten care unit emerg depart manag critic ill 
87053543 anim cimetidinepd corpu luteumdeph diphenhydraminepd femal graafian follicleci lhbl ovaryd ovulationd progesteronebl sheepph ovarian function ew treat antihistamin ew treat dure periovulatori period antihistamin diphenhydramin h1receptor antagonist andor cimetidin h2receptor antagonist treatment prevent ovul howev combin drug inhibit subsequ function corpu luteum cl assess serum measur progesteron administr antihistamin alter pituitari secretion lh injec quantiti diphenhydramin cimetidin antrum preovulatori follicl cau aberr luteal activ blockad ovul follicular injec histamin rever inhibitori influenc antihistamin cl antihistamin suppress preovulatori thecal edema antral influx plasma transud contain lh thu effect antihistamin appear exert follicular level function matur cl wa compromi periph administr antihistamin action histamin preovulatori ovin follicl appear prerequisit ovul appar impact ensu luteal function propo hyperem reaction histamin preovulatori follicl enhanc vascular filtrat lh consequ maxim permeat avascular granulo layer follicl lh lead normal lutein respon 
87053545 anim deciduaim estradiolpd femal immunoglobulin fragmentsm immunoglobulinsm oil organ weightd ovariectomi ovum implant progesteronepd rat secretori componentm stress mechan support govt ph uterusahim immunoglobulin secretori compon regul rat uteru decidu determin effect decidu uterin immunoglobulin ig measur level igg iga secretori compon sc induc artifici decidu cell reaction dcr hormon prime ovariectom rat progesteronetr mgdai dai rat receiv lumin instil oil needl scratch stimul uterin horn stimul horn increa wet weight cytoplasm protein rel contralat horn condition igg level increa 10fold lumen stimul horn thi respon wa select igg becau induc dcr effect accumul iga sc stimul horn progesteroneinduc accumul igg dcr wa enhanc estradiol addition estradiol gram dai 4dai progesteron pretreat result increa wet weight stimul horn concentr igg lumen igg lumen stimul horn wa 5fold greater stimul horn progesteron alon level iga sc howev remain unchang thi treatment result indic movem igg uterin lumen occur dcr appropri endocrin balanc physic stimul ar essenti maxim igg accumul thei suggest igg mai plai central role earli pregnanc result success implant blastocyst 
87053547 anim antigenantibodi reaction chloridesm human male mice mice nude pilocarpinepd prolactinph support nonu govt sweatph sweat glandsph waterelectrolyt balanc modul chlorid concentr human sweat prolactin purpo thi studi wa determin avail prl modul chlorid concentr human sweat human skin graft immunoincompet nude congenit athym mice heal surviv life mice mice sweat gland thi provid model studi physiologi pathologi human sweat gland graft induc sweat sweat collect analyt studi presum normal skin obtain individu undergo reconstruct surgeri wa graft successfulli mice occasion sweat wa induc pilocarpin iontophoresi collect min chlorid concentr wa meqlit valu typic normal human sweat mice bear graft inject rabbit antihuman prl hprl chlorid concentr sweat obtain dai wa significantli elev concentr gener increa sometim injec antiprl averag maximum sweat chlorid obtain wa meqlit serum rabbit expo hprl wa prepar dilut wai antihprl chlorid concentr sweat mice receiv prepar sever dai remain unchang low normal level conclud depletion prl increa concentr chlorid human sweat 
87053549 anim chromosom map gene reiter prolact ratsg somatotrop support nonu govt support govt ph relat gene encod growth hormon prolactin disper chromosom rat assign rat gh gene chromosom rat prl gene chromosom dna seri mou bwtg3 rat hepatocyt somat cell hybrid ha retain uniqu complem rat chromosom wa analyz presenc rat gh prl genom fragment southern blot radiolabel complementari dna cdna encod rat gh rat prl molecular probe base assign conclud evolutionarili relat gh prl gene disper differ chromosom rat 
87053552 anim cell nucleusm cytoplasmm endometriumcym estradiolph femal follicular phase luteal phase macaca fasciculari menstruat mitot index myometriumm ovariectomi progesteroneph receptor estrogenm support govt ph immunocytochem local estrogen receptor macaqu endometrium dure lutealfollicular transition examin chang estrogen receptor er endometri stromal epith cell cynomolgu macaqu dure artifici induc menstruat repair silast implant estradiol e2 progesteron treat spai anim dai e2 follow dai e2 plu withdrew e2 implant remov uteri dai uterin tissu assai biochem er content fix histologi frozen immunocytochemistri er monoclon antiestrophilin dai er level endometrium low fmolmg dna increa total receptor wa evid dai withdraw fmolmg dna total receptor concentr increa linearli dai withdraw dai stain nuclear er glandular epithelium stroma zone ii iii endometrium wa neg begin continu dai withdraw nuclear stain becam detect increa inten onli endometri stromal fibroblast myometri smooth muscl cell glandular epithelium endometrium develop nuclear stain dai withdraw coincid 10fold increa mitot index epithelium upper zone thu increa endometri er level occur dure dai induc lutealfollicular transition exclu stromal fibroblast 
87053553 amanitinspd anim calcitriolpd calciumbind proteinsg cycloheximidepd dactinomycinpd duodenumph gene expr regulationd male rat rna messengerg support nonu govt transcrip geneticd translat geneticd vivo effect transcrip translat inhibitor duoden vitamin ddepend calciumbind protein messeng ribonucl acid stimul 125dihydroxycholecalciferol vivo stimul vitamin ddepend calciumbind protein cabp synthesi 125dihydroxycholecalciferol 125oh2d3 rat duodenum ha analyz specif 32pcomplementari dna probe rat cabp inhibitor rna transcrip actinomycin alphaamanitin protein synthesi cycloheximid rel cabp messeng rna mrna assai dotblot hybrid rel cabp ria inhibitor inject dose significantli inhibit 35smethionin 3huridin incorpor protein rna respect vitamin ddefici rat singl 125oh2d3 injec pmol100 bw result rapid produc cabp mrna wa significantli detect earli wa follow increa cabp level injec actinomycin grams100 bw befor 125oh2d3 treatment repeat everi prevent hormoneinduc elev duoden cabp mrna actinomycin dose wa doubl befor hormon treatment alphaamanitin grams100 bw fail block hormon stimul protein synthesi inhibitor cycloheximid grams100 bw cau ani chang 125oh2d3induc cabp mrna block cabp increa hormon injec thu transcrip inhibitor prevent vivo hormoneinduc elev cabp mrna suggest 125oh2d3 increa cabp synthesi increa cabp gene expr posttranscrip step preci data obtain measur rate cabp gene transcrip isol nuclei rat duodenum 
87053554 anim dopamineph estradiolpd femal vitro kinet ovariectomi pituitari gland anteriordeph prolactin rat receptor dopaminedem secretori rate spiperonem steroidspd direct effect estradiol number dopamin receptor anterior pituitari ovariectom rat effect betaestradiol beta e2 anterior pituitari dopaminerg receptor d2 content wa studi vitro relat prl secretion anterior pituitari ovariectom rat incub period medium steroid dopamin da receptor partial purifi pituitari membran quantifi equilibrium bind 3hspiperon prl relea incub medium wa analyz ria addition beta e2 incub medium anterior pituitari rapidli reversibli decrea number da receptor increa prl relea doserel fashion maxim effect receptor number prl secretion wa obtain beta e2 thi effect involv chang receptor affin kd nm presenc absenc beta e2 thi estrogeninduc decrea dabind capac wa appar result occup spiperon bind site steroid sinc 30min incub 3h17 beta e2 radioact wa detect partial purifi membran moreov presenc beta e2 label d2 ligand modifi kinet associ dissoci spiperon pituitari membran thi decrea anterior pituitari da receptor content increa prl relea alreadi signif 7min incub presenc beta e2 final effect beta e2 mimick alphastereoisom progesteron testosteron result suggest stimulatori effect beta e2 prl secretion mai desensit anterior pituitari cell da steroid mai produc thi desensit directli decrea number d2 latenc thi effect discard possibl genom action beta e2 
87053555 anim cell differentiationd cryptorchismpa dibutyryl cyclic amppd doserespon relationship drug germ cellsci vitro male mice spermatogenesisd spermatogoniaci spermatozoaci support nonu govt vitamin apd dibutyryl adenosin cyclic monophosph regul differenti type spermatogonia vitamin adult mou cryptorchid testi vitro surgic prepar cryptorchid mou test contain onli type spermatogonia cultur bu2camp combin vitamin retinol treatment bu2camp retinol basal medium addition dai stimul mitot activ type spermatogonia induc differenti germ cell howev bu2camp alon induc differenti type spermatogonia moreov cryptorchid test treat bu2camp dai presenc absenc retinol differenti type spermatogonia disintegr seminif tubul occur cryptorchid test cultur medium contain fix concentr retinol vari concentr bu2camp mm wa dosedepend increa number differenti mitot germ cell type spermatogonia likew fix dose bu2camp increa concentr retinol dosedepend increa number differenti mitot germ cell occur howev number type spermatogonia wa decrea addition puromycin cycloheximid actinomycin medium complet block retinolbu2campinduc differenti germ cell present result suggest camp retinol trigger biochem event promot synthesi specif macromolecul involv prolif differenti type spermatogonia 
87053556 anim exon femal gene expr regul hypothalamusph lactat peptid phige pregnanc rat rna messengerg support nonu govt support govt nonph support govt ph vasoact intestin peptideg hypothalam vasoact intestin peptid messeng ribonucl acid increa lactat rat vasoact intestin peptid vip ha propo induc prl relea moreov immunocytochem studi suggest increa vip content hypothalamu lactat rat investig thi increa regul level gene transcrip sensit rna detec assai vitro transcrib rna probe correspond specif exon vip gene wa devi studi vip gene expr thi method approxim 2000base rna contain code sequenc vip wa detect rat hypothalamu thi rna contain code sequenc viprel peptid phmi peptid histidin methionin amid isoleucin amid ident vipencod rna wa previou identifi rat cerebr cortex 2fold increa wa observ hypothalam vip mrna dure lactat addition level thi mrna increa hypothalamu sexual matur togeth result suggest physiolog regul vip gene expr associ potenti role neuroendocrin hormon 
87053562 adenosin cyclic monophosphatem anim biolog transport femal homeostasi iodidesm iodoproteinsm pregnanc rabbit support govt ph thyroid glandemm thyrotropinpd autoregul iodid transport rabbit absenc autoregul fetal tissu comparison matern fetal thyroid iodin product matern fetal rabbit thyroid gland compar abil respond excess iodid vitro reduc subsequ iodid transport activ preincub matern thyroid tissu slice excess iodid result reduc subsequ measur thyroidmedium radioiodid concentr ratio contrast similar iodid pretreat signif effect fetal iodid transport respect fetal iodid transport wa higher differ significantli matern transport activ combin radiolabel matern 125i fetal 131i rabbit thyroid tissu wa elut sephadex g25 column fraction analyz 125i 131i activ matern fetal ratio 125i131i determin fraction major iodoprotein elut void volum 125i131i ratio wa constant fraction thereaft peak elev 125i131i activ observ peak elut lysozym mr abov insulin mr appar mol wt peak peak elut column site similar mit protein mr ascend paper chromatographi thi peak 125i131i activ mit wa carri solvent peak comigr mit suggest failur fetal thyroid tissu exhibit autoregul mai associ reduc iodin compound approxim mr role thi substanc iodid transport remain identifi reason appar increa label mit observ matern vs fetal tissu unknown 
87053563 anim biolog transportd cat cattl cycloheximidepd emetinepd homeostasisd vitro iodidesm iodoproteinsph molecular weight proteinsbi puromycinpd sheep thyroid glandm autoregul thyroid iodid transport evid mediat protein synthesi iodideinduc suppr iodid transport role protein synthesi iodideinduc suppr subsequ iodid transport iodid autoregul wa studi cat thyroid slice thyroid slice pretreat min presenc absenc excess sodium iodid inhibitor protein synthesi tissu wa wash presenc mm methimazol prevent subsequ iodin reaction remov excess iodid iodid transport activ wa final evalu measur ratio tissu medium iodid concentr 90min incub addition mm cycloheximid dure preexposur thyroid tissu excess iodid effect control level iodid transport iodideinduc autoregul howev thyroid tissu wa treat cycloheximid alon befor preexposur excess iodid wa signif reduc degr iodideinduc induc autoregul similar result obtain pretreat tissu mm puromycin gramml emetin suggest protein synthesi involv mechan thyroid autoregul iodid transport cycloheximid effect abil excess iodid reduc tshstimul camp format twodimen gel electrophoresisisoelectr focu sephadex g25 column chromatographi emploi dualisotop comparison iodoprotein label control cycloheximidetr tissu suggest abil cycloheximid suppress iodideinduc autoregul associ reduc iodin 10kilodalton solubl compon thyroid gland 
87053565 adenyl cyclasem anim calcitriolpd calmodulinaiph chicken duodenumcyen enzym activationd forskolinpd guanylyl imidodiphosphatepd intestin mucosacyen male sodium fluoridepd support nonu govt support govt ph stimul 125dihydroxyvitamin d3 adenyl cycla villu chick duodenum administr pmol 125dihydroxyvitamin d3 125oh2d3 vitamin ddefici chick increa adenyl cycla activ basolat membran duoden epith cell thi increa enzymat activ wa accompani increa calmodulin content basolat membran exogen ad calmodulin gramsml calcium stimul enzym activ calmodulin antagonist trifluoperazin w7 w13 inhibit calmodulin content adenyl cycla activ alkalin phosphata activ measur cell sequenti elut tip base villu cell midregion base highest calmodulin content adenyl cycla activ wherea alkalin phosphata activ brush border membran enzym wa highest cell elut tip adenyl cycla activ wa increa 125oh2d3 particularli cell midvillu result indic respon adenyl cycla activ 125oh2d3 vari villu suggest calmodulin mai involv 
87053567 anim calcif physiologicd calcitriolad calciumm collagenm doserespon relationship drug male osteogenesisd prolinem rat support govt nonph chronic administr 125dihydroxyvitamin d3 increa bone impair miner male spraguedawlei rat infu continu dai vehicl pmol ngdai 125dihydroxyvitamin d3 125oh2d3 mean alzet osmot minipump implant sc anim infu 125oh2d3 exhibit mild hypercalcemia vs mgdl control increa serum concentr 125oh2d3 vs pgml decrea serum 25hydroxyvitamin vs ngml proxim tibial metaphysi anim wa charact increa trabecular bone volum vs osteoid accumul vs increa osteoblast surfac number 19mm vs 14mm respect decrea osteoclast surfac number 2mm vs 6mm respect similar strike chang seen lumbar vertebra increa fatfr weight calcium content tibia lumbar vertebra consist increa trabecular bone volum 125oh2d3 infusion howev tetracyclin label incorpor 45ca bone reduc 125oh2d3 infusion addition miner lag wa prolong lumbar vertebra 125oh2d3infu rat indic chronic 125oh2d3 administr increa bone mass cost impair bone miner 
87053570 anim cellfr cycloheximidepd dexamethasonepd gene expr regulationd isoelectr male molecular weight rat rna messengerg thymu glandph factor translat geneticd glucocorticoidinduc messeng ribonucl acid rat thymic lymphocyt rapid primari effect specif glucocorticoid examin mechan underli rapid min glucocorticoidmedi increa synthesi protein envision mediat initi steroid effect thymic lymphocyt analysi vitro translat product giant twodimen gel reveal rapid hormon influenc onli mrna translat product mol wt pi ident protein synthesi ha increa addition glucocorticoid thymu cell addition mrna code glucocortin induc thymu target cell ha report mrna induc protein 1n ar detect min addition dexamethason isol thymu cell continu increa wherea mrna protein ar increa mrna protein elev attempt quantit chang earlier fail becau thi protein focu poorli parallel vitro translat result increa synthesi individu protein seen cell demonstr increa mrna level underli cellular chang hormon estradiol testosteron t3 deoxycorticosteron induc messag partial induc 1n ar seen deoxycorticosteron consist classif partial glucocorticoid agonist cycloheximid doe block rise mrna rapid induc 1n result indic dexamethason rapidli specif induc thymu cell mrna addition code glucocortin cycloheximid result suggest repr primari steroid hormon respon 
87053571 anim femal gene expr regul gonadotropin chorionicpd molecular weight ovaryph peptid phige rat rna messengergem support nonu govt support govt nonph support govt ph vasoact intestin peptideg detec vasoact intestin peptideencod messeng ribonucl acid rat ovari vasoact intestin peptid vip ha detect rat ovari ha shown stimul steroidogenesi cultur rat granulosa cell thi studi investig vipmesseng rna mrna detect ovari thu suggest local synthesi peptid studi vipgen expr sensit rna detec assai vitro transcrib rna probe correspond specif exon vip gene wa develop thi method approxim 2000base rna band contain code sequenc vip wa detect rat ovari thi rna contain code sequenc viprel peptid peptidehistidinemethionin ident vipencod rna wa previou identifi rat cerebr cortex howev vipmrna quantiti cortex wa 12foldhigh compar ovari result mai reflect differ vip concentr organ vipencod mrna rat ovari suggest local synthesi vip ovari 
87053572 anim cell compart cell membraneen enzym activationd estradiolpd femal hydrogenion concentr hypothalamohypophi systemph kinet magnesiumm methyl methyltransferasesm ovariectomi phosphatidylcholinesbi phosphatidylethanolaminesm pituitari glandenir rat sadenosylmethioninem tissu distribu estradiol activ methyl enzym involv conver phosphatidylethanolamin phosphatidylcholin rat pituitari membran betaestradiol e2 affect sensit pituitari cell sever neurohormon lhrh trh dopamin presum modul receptor coupl mechan attempt pinpoint membran process underli thi modul studi effect e2 pituitari membran phospholipid methyl anterior pituitari membran prepar ovariectom ovx ovx plu e2treat rat assai phospholipid methyl methyl phospholipid separ tlc incorpor 3hmethyl group phospholipid increa membran concentr incub sadenosyllmethyl 3hmethionin wa mg2 depend wa inhibit dosedepend manner sadenosyllhomocystein methyltransfera inhibitor ph wa critic format phosphatidylmonoethanolamin phosphatidyldimethylethanolamin phosphatidylcholin wa markedli stimul treatment e2 effect increa progress anim kill dai e2 implant respon involv shift maximum veloc vmax wa chang avail substrat methyl enzym thi chang vmax probabl reflect chang methyl enzym administr alphaestradiol inact stereoisom e2 wa ineffect stereospecif interac differenti centrifug pituitari membran highest specif methyltransfera activ wa light mitochondri somal fraction lowest nuclei heavi mitochondri fraction sucro densiti gradient centrifug methyl phospholipid preferenti recov fraction correspond endoplasm reticulum andor secretori granul e2 treatment dai modifi subcellular distribu methyltransfera activ stimul fraction contrast modifi activ enzym measur fraction marker experi condition phospholipid methyl membran prepar cortex anterior medioba hypothalam structur wa affect steroid excep slight increm 3hmethyl incorpor medioba hypothalam membran phospholipid dai e2 treatment result indic e2induc chang pituitari respon concomit select effect steroid specif membran enzymat activ involv coupl mechan 
87053573 anim antibodi monoclonalim antibodi specif antigenantibodi reaction antigen determin bind competit cell membranem vitro liverm mammaem placent lactogenimm radioligand assai receptor prolactinm receptor somatotropinm sheep support nonu govt inhibi bind ovin placent lactogen growth hormon prolactin receptor monoclon antibodi singl cell fusion stabl hybridoma secret antiovin placent lactogen opl antibodi obtain secret immunoglobulin igg subclass secret igm class antibodi ascit fluid rai mice clone antibodi compon develop solid phase ria solidpha ria successfulli establish individu igg subclass monoclon antibodi igm class antibodi ineffect individu solidpha ria bind 125iiodoopl immobil antibodi wa inhibit unlabel opl ovin pituitari prl oprl ovin gh ogh ovin pituitari extract igg subclass antibodi abl inhibit bind 125i iodoopl prl receptorss gh receptor rabbit mammari gland liver respect igg subclass antibodi wa effect inhibit bind opl prl receptor rabbit mammari gland wherea effect inhibit bind opl gh receptor rabbit liver antibodi howev onli weakli inhibit bind 125iiodooprl rabbit mammari gland ineffect inhibit bind 125iiodoogh rabbit liver addition monoclon antibodi radioreceptor assai rra prl rraprl gh rragh affect parallel displac curv opl standard result suggest opl contain distinct bind sequenc respon bind opl prl receptor respon bind opl gh receptor bind sequenc overlap locat adjac anoth interac monoclon antibodi bind sequenc opl mai block bind opl prl gh receptor altern studi suggest monoclon antibodi bind hormon receptorsbind sequenc opl interac opl monoclon antibodi alter conform structur opl consequ lead lower bind opl prl gh receptor 
87053574 adenyl cyclasem anim calmodulinaiimph cell membraneen enzym activationd vitro rat support govt ph thymu glanden trifluoperazinepd triiodothyroninepd calmodulin mediat stimulatori effect 353triiodothyronin adenyl cycla activ rat thymocyt plasma membran previou demonstr t3 increa adenyl cycla activ rat thymocyt plasma membran mechan calcium depend present studi examin calmodulin particip thi respon t3 initi experi provid evid calmodulin involv regul activ guanyl nucleotidedepend adenyl cycla thi tissu thu compar freshli prepar membran dialysi thymocyt plasma membran prepar decrea calmodulin concentr initi valu approxim ng100 gram protein decrea adenyl cycla activ approxim storag prepar compar condition result chang calmodulin content cau approxim decrea adenyl cycla activ addition calmodulin effect adenyl cycla activ fresh store membran prepar produc dosedepend increa enzym activ prepar dialyz ad freshli isol membran calmodulin antagonist trifluoperazin calmidazolium calmodulin antibodi produc concentrationdepend inhibi adenyl cycla activ thi wa complet rever case addition high concentr exogen calmodulin stimul guanyl nucleotidedepend adenyl cycla activ t3 induc fresh membran prepar wa present membran store wa absent dialyz addition respon t3 fresh membran wa inhibit abolish calmodulin antagonist dialyz membran presenc antagonist respon t3 wa restor addition exogen calmodulin conclud calmodulin influenc activ guanyl nucleotidedepend adenyl cycla rat thymocyt ultim mediat stimul enzym activ t3 produc mediat veri explain calciumdepend natur stimulatori effect t3 thymocyt adenyl cycla activ 
87053577 amenorrheapp anim bone disea metabolicpapp bone resorp dog femal hysterectomi menopau osteoblastspp osteogenesi ovariectomi ovaryph support nonu govt osteoblast insuffici respon mainten osteopenia loss ovarian function experi beagl dog bone loss develop cessat ovarian function human repr major health problem establish valu ovariohysterectomi femal beagl dog model bone loss studi static dynam paramet bone associ neg bone balanc occur cessat ovarian function perform iliac crest bone biopsi befor ovariohysterectomi beagl dog shamop control cessat ovarian function wa docum increa serum level lh ovariohysterectomi wa chang serum calcium phosphoru creatinin dure studi cancel bone mass trabecular mean wall decrea significantli ovariohysterectomi addition number osteoblast wa increa bone format rate osteoblast activ boneform cell wa decrea paramet bone resorp significantli alter anim ovariohysterectomi chang histomorphometr paramet bone structur format resorp observ shamop control data indic ovariohysterectomi beagl dog mai serv model bone loss associ cessat ovarian function osteoblast insuffici appear plai major role mainten bone loss occur ovariohysterectomi beagl dog 
87053578 ag factor anim bodi weight femal male rat rat mutant strain receptor androgenph sex factor somatotropin support govt ph testicular feminizationpp growth hormonesecretori pattern androgenresist testicular femin rat investig role androgen receptor expr male ghsecretori pattern adult rat ghsecretori pattern androgenresist testicular femin rat compar normal male femal litterm anim prepar atrial silast cathet bled everi min normal male litterm displai characterist low frequenc high amplitud pattern gh secretion burst gh occur everi separ prolong trough period gh valu remain low undetect ngml min normal femal litterm characterist high frequenc low amplitud pattern gh secretion pul gh occur everi compar normal male litterm femal lower individu gh peak amplitud shorten ghtrough period contain higher gh level ghsecretori profil displai testicularfemin anim qualit quantit resembl normal femal litterm data suggest androgen receptor ar necessari expr masculin ghsecretori pattern 
87053579 ag factor anim bromocriptinepd dopamineph doserespon relationship drug estradiolpd estrogen antagonistspd estrogensph femal hypothalamu middl pituitari gland anteriord prolactinph rat receptor estrogend support govt ph antiestrogen action medial basal hypothalamu pituitari immatur femal rat insight concern relationship estrogen dopamin prolactin examin effect nonsteroid antiestrogen ae estradiol dopamin da level turnov rate medial basal hypothalamu mbh serum pituitari prl gain insight daprlea interrelationship 21dayold femal rat wa increa mbh da level turnov serum prl concentr concentrationdepend manner chang observ dai dai treatment gramdai mbh da level increa 2fold pgmg tissu da turnov rate increa 5fold pgmg tissu ae tamoxifen monohydroxytamoxifen ci628 ly117018 gramsdai dai weakli stimul uterin weight gain significantli suppress uterotrop action ae ly117018 monohydroxytamoxifen ci628 tamoxifen compet bind mbh estrogen receptor displai rel bind affin affin ar similar uterin estrogen receptor ae increa da turnov rate onli 2fold thei antagon einduc 5fold increa da turnov rate veri successfulli anim treat bromocriptin ae fail increa low serum prl level thei evok signif approxim 2fold increa da turnov rate nearli 2fold increa mbh da content henc action ae mbh da appear exert independ chang circul prl mai occur direct action compound estrogen receptor present mbh addition studi reveal ae behav partial estrogen agonistsantagonist term effect mbh da turnov 
87053586 anim glycoproteinsm hypothyroidismm kidneym liverm male metabol clearanc rate pituitari glandm rat structureact relationship thyroid glandm thyrotropinblm tissu distribu differ metabol clearanc pituitari serum thyrotropin tsh deriv euthyroid hypothyroid rat effect chemic deglycosyl pituitari tsh compar mcr volum distribu rapid phase rt12 slow phase halfliv purifi pituitari rat tsh tsh crude pituitari extract normal hypothyroid rat tsh hypothyroid rat sera tsh secret hypothyroid rat pituitari incub vitro iv bolu injec euthyroid rat 125ilabel rtsh wa determin acid precipit serum variou organ unlabel tsh wa measur ria mcr tsh normal pituitari extract mlmin wa similar unlabel purifi rtsh hypothyroid pituitari extract hypothyroid sera decrea reduc mcr tsh hypothyroid pituitari wa decrea distribu volum ml compar normal pituitari hypothyroid sera decrea mcr circul tsh hypothyroid sera reflect increa rt12 min vs normal hypothyroid pituitari rt12 secret tsh incub hypothyroid rat pituitari wa intermedi circul pituitari form hypothyroid rtsh clearanc intact bovin tsh btsh deglycosyl btsh dgbtsh compar dgbtsh mcr wa increa mlmin compar btsh primarili decrea rt12 dgbtsh min vs btsh uptak purifi 125irtsh wa highest kidnei vari inject dose min min conclud euthyroid rat metabol clearanc tsh differ pituitari serum form appear depend specif molecular featur vari physiolog state anim tsh deriv sinc chemic deglycosyl increa clearanc tsh specul chemic basi chang tsh clearanc mai relat alter carbohydr structur normal pituitari tsh kidnei major organ clearanc 
87053589 anim braind brain map diencephalonph estradiolpd femal hamster hypothalamu middleph mesencephalonph ovariectomi progesteronepd sex behavior animald support nonu govt support govt ph cranial site regul bipha action progesteron estrogenprim golden hamster dienceph mesenceph neural site regul bipha effect progesteron investig hormon implant techniqu ovariectom femal golden hamster prime estrogen doubl barrel cannula implant unilat bilat medial preoptic area anterior hypothalamu ventromedi hypothalamu vmh central grai interpeduncular nucleu test wa conduct sequenti paradigm facilit test commenc estrogen prime pfill cannula vmh region facilit lordosi behavior unilat bilat implant femal respect anterior hypothalamu onli implant adjac vmh area effect promot recept lordosi behavior wa observ femal implant medial preoptic area implant central grai interpeduncular nucleu region signif facilit effect sexual behavior test inhibi occur facilit test consist pretest follow administr behavior test dure pretest inhibi femal recept facilit test attack male rapidli previou nonrecept anim decrem lordosi score deliveri thi bipha effect complet inhibit recept sever anim vmh group addition experi howev investig bipha effect implant vmh suggest occurr copul facilit test mai involv mediat subsequ increa aggress behavior suppr sexual respon inhibi test final experi wa implant sequenti vmh facilit importantli reduc lordosi behavior score occur copul wa elimin facilit test implant mesenceph region exert signif inhibitori effect recept demonstr bipha action femal hamster regul nerv cell locat diencephalon especi vmh region 
87053590 anim antimycin aaapd bacitracinpd biolog transport activ cadaverineaapd endocytosisd vitro male musclesm oligomycinspd rat temperatur triiodothyroninem energydepend uptak 353triiodolthyronin rat skelet muscl uptak 125it3 rat skelet muscl wa investig incub intact soleu muscl tracer 125it3 125it3 uptak increa asymptot min muscl contain total 125it3 mg wet tissu 125it3 uptak wa specif 125it3 uptak determin subtract uptak presenc unlabel t3 total 125it3 uptak attain plateau min washout experi incub muscl min 125it3 unlabel t3 radioact respect wa relea indic cellular locat hormon incub addition increa concentr lt3 dt3 lt4 cau progress inhibi 125it3 uptak inhibitori concentr nm respect preincub soleu muscl metabol inhibitor complet inhibit 125it3 specif uptak oligomycin antimycin cau reduc respect monodansylcadaverin bacitracin inhibitor receptormedi endocytosi reduc specif 125it3 uptak dosedepend manner respect result indic presenc satur stereospecif energydepend process respon t3 uptak rat skelet muscl thi specif t3 uptak mai receptormedi endocytosi process 
87053592 anim cell cultur estradiolpd femal pituitari gland anteriord prolactin rat receptor angiotensind effect betaestradiol angiotensin ii receptor prolactin relea cultur pituitari cell angiotensin ii aii bind specif receptor lactotroph stimul prl secretion isol rat pituitari cell sinc estrogen exert major regulatori action prl secretion effect estradiol e2 pituitari aii receptor prl respon studi vivo cultur rat anterior pituitari cell femal rat treatment e2contain silast capsul dai cau signif increa pra ngml min decrea bind 125iaii anterior pituitari membranerich fraction vitro studi treatment cultur anterior pituitari cell nm e2 dai cau decrea aii receptor concentr chang bind affin reduc aii receptor e2 4dai cultur wa dose depend wa demonstr e2 concentr occur plasma dure estrou cycl nm decrea aii receptor cell incub nm e2 wa maximum cultur result similar receptor concentr calcul unit protein cell despit substanti decrea aii receptor e2 treatment specif decrea respon pituitari cell aii stimul thu prl respon aii nm trh nm unchang dai e2 treatment increa dai treatment demonstr e2 ha direct inhibitori action expr pituitari aii receptor accompani decrea aiistimul prl secretion rat pituitari estrogen modul postreceptor event predomin determin lactotroph respon dure stimul prl relea aii 
87053593 ammonium chloridepd antibodi monoclonaldu breast neoplasmspp cell compart estradiolpd estrogen antagonistspd femal gene expr regulationd glycosyl human leupeptinspd molecular weight monensinpd neoplasm proteinsph protein process posttranslationald support nonu govt process estrogen regul 52kilodalton protein insid mcf7 breast cancer cell 52k glycoprotein secret human breast cancer cell cultur estrogen stimul monoclon antibodi quantit charact correspond protein cell compart pulsecha experi shown 52k protein secret major success process 48k 34k protein thi protein veri stabl process inhibit lysosomotrop agent leupeptin suggest occur acid vesicl lysosom endosom estradiol increa cellular level immunoreact 52k relat protein 4fold effect howev obviou medium sinc constitut level cell stimulatori effect estradiol 3hmanno 35smethionin incorpor protein similar endoglycosyda sensit protein wa alter suggest estradiol modul glycosyl step antiestrogen stimul synthesi glycosyl 52k relat protein estradiol increa stabil 52k precursor total protein conclud secret 52k protein precursor cellular protein 48k 34k estradiol stimul cellular accumul protein secretion precursor 
87053596 adenosin triphosphata calciumm anim cell membraneen enzym activationd femal male rabbit reticulocytesen steroidspd structureact relationship support govt nonph support govt ph thyroxinepd structureact relationship sex steroid analog determin vitro thyroid hormonerespon membran ca2atpa model physiolog concentr lt4 previou stimul ca2atpa activ vitro reticulocyt membran femal rabbit inhibit thi enzym reticulocyt membran male previou studi preincub intact cell ghost testosteron convert femalesourc reticulocyt membran maletyp respon thyroid hormon inhibi ca2atpa activ preincub reticulocyt membran betaestradiol convert malesourc membran femaletyp respon stimul lt4 membran ca2atpa activ thi sex steroidsensit thyroid hormonedepend membran enzym investig structureact relationship analog sex steroid unrel steroid betaandrostan activ compar testosteron assai femalesourc membran alphaandrostan activ betaandrostan activ wa depend hydroxyl group c3 c17position nongonad steroid test activ establish specif sex steroid effect assai femalesourc membran assai malesourc membran estron 3hydroxy135107estratraen17on equilin activ compar estrogen effect betaestradiol estriol wa activ activ hydrocortison aldosteron respect thi structureact relationship ar distinct describ gonad steroidcytoplasm bind protein nuclear interac repr novel sex steroidthyroid hormon effect activ membran enzym 
87053600 adenosin cyclic monophosphateph anim calciumph cell cultur endorphinsm gene expr regul immunoassai male pituitari glandph pituitari gland anteriorph proopiomelanocort rat rna messengerg support nonu govt factor calcium ion cyclic adenosin 35monophosph regul proopiomelanocortin messeng ribonucl acid level rat intermedi anterior pituitari lobe role messeng camp ca control proopiomelanocortin pomc gene expr wa investig hybrid clone complementari dna probe effect camprel drug pomc messeng rna mrna level assess primari cultur intermedi il anterior rat pituitari cell maintain serumfr medium 8bromocamp mm 8bromocgmp mm induc 2fold increa il anterior lobe cell dai treatment similar increa wa obtain adenyl cyclaseactiv drug forskolin cholera toxin ngml phosphodiestera inhibitor ro treatment increa betaendorphin accumul medium transient decrea cellular betaendorphin content il cell suggest parallel effect camprel drug secretion biosynthesi incub cell ca channel antagonist d600 verapamil dihydropyridin nifedipin decrea basal pomc mrna level wherea dihydropyridin bayk activ ca channel increa pomc mrna level dai addition nifedipin decrea stimulatori effect forskolin wherea bayk stimul forskolinincrea pomc mrna level il cell conclud ca camp mai regul gene expr pomc 
87053601 anim calciumph cobaltpd fishesph gallopamilpd ion channelsph osmolar concentr pituitari gland potassiumpd prolactin secretori rate support govt nonph role calcium prolactin relea pituitari teleost fish vitro relea prl pituitari teleost fish tilapia oreochromi mossambicu ha previou shown depend calcium howev sourc specif action calcium secretori process identifi undefin ar mechan regul prl cell function mai alter calcium distribu present investig elev medium concentr dure static incub depolar concentr mm produc chang cumul prl relea control level dure incub dure perifu incub exposur high concentr briefli stimul equal min depress prl relea contrast reduc medium osmot pressur elicit rapid elev prl relea wa sustain d600 calcium entri blocker diminish kinduc pul prl relea concentr howev alter relea prl evok reduc osmot pressur contrast cocl2 block rang calciummedi process addition calcium influx suppress prl relea dure perifu static incub hyposmot medium suggest prl secretion tilapia pituitari calcium depend calcium entri voltageregul plasmalemma channel mai prerequisit action reduc osmot pressur 
87053603 anim femal hamstersph light maternalfet exchang melatoninph period pineal bodyph pregnanc reproduc support nonu govt support govt ph matern melatonin commun daylength fetu djungarian hamster daylength photoperiod influenc rate reproduct develop juvenil photoperiod speci studi daylength dure prenat period perceiv fetu thi percep profoundli influenc postnat reproduct somat develop photoperiod djungarian hamster assess role matern pineal gland hormon melatonin thi prenat percep daylength matern pinealectomi elimin influenc prenat photoperiod testicular bodi weight male pup suggest product matern pineal gland commun daylength fetu infusion pineal hormon melatonin pinealectom dam variou durat dure gestat mimick effect vari prenat photoperiod testicular bodi weight result indic pineal melatonin involv thi novel form commun mother fetu 
87053604 anim calcitriolpd cattl gene expr regulationd vitro parathyroid glandsph parathyroid hormonesg protein precursorsg rna messengerm support govt ph transcrip geneticd suppr 125oh2d3 transcrip preproparathyroid hormon gene bovin parathyroid cell cultur ar expo activ vitamin metabolit 125oh2d3 signif decrea steadyst level preproparathyroid hormon prepropth mrna occur possibl fall specif mrna decrea rate transcrip pth gene wa examin thi studi presenc 125oh2d3 wa rapid steadi declin pth gene transcrip rate minimum control effect wa observ physiolog level 1011m wa fulli rever 
87053605 anim biolog assai caseinsbi cell cultur immunoassai pituitari gland anteriorci prolactinanim rat structureact relationship novel bioassai lactogen activ demonstr prolactin cell differ anoth bio immunopot secret hormon rever hemolyt plaqu assai detect casein relea individu mammari cell cultur wa develop bioassai prl treatment rat prl cau doserel increa percentag mammari cell relea casein averag size casein plaqu form assai exhibit exquisit sensit fg rat prl assai slide evalu biopot prl relea individu cell combin thi plaqu bioassai standard plaqu assai measur secretion immunoreact prl wa possibl compar bio immunopot hormon relea pituitari cell result separ studi reveal major differ prl secretor potenc estim exist prl variant differ biolog immunolog efficaci suggest prl cell differ anoth molecular form hormon relea 
87053606 anim cell membranean cross reaction liverph molecular weight rat receptor insulinimip speci specif tissu distribu purif immunolog charact rat liver insulinlik growth factorii receptor rat liver somal insulinlik growth factorii igfii receptor ha purifi homogen singl step affin chromatograph procedur agaroseigfii elution ph determin igfii bind direct ria receptor purif 2000fold wa obtain mean recoveri wa prepar sodium dodecyl sulfateelectrophoresi autoradiographi purifi receptor radioiodin receptor affinitylabel receptor indic molecular mass approxim 250k scatchard analysi igfii bind purifi receptor solubil somal membran plasma membran singl class bind site affin constant litermol case potent antibodi purifi receptor rai rabbit capabl inhibit igfii bind dilution fulli precipit igfiiprelabel receptor type antibodi react igfii receptor rat adipo tissu brain heart kidnei lung spleen howev littl crossreact wa seen speci comparison abil receptor antibodi inhibit igfii bind somal plasma membran indic specif immunolog differ igfii receptor membran prepar 
87053607 anim carbohydr sequenc glycoproteinsm glycosyl hypothyroidismm kinet macromolecular mice pituitari glandm pituitari neoplasmsm protein process posttransl support govt ph thyrotropinm structur highmanno oligosaccharid mou thyrotropin differenti process alpha versu betasubunit heterodim determin structur high manno oligosaccharid unit alpha betasubunit mou tsh heterodim free alphasubunit mou thyrotrop tumor tissu pituitari euthyroid hypothyroid mice incub d23hman homogen incub presenc absenc ph buffer dissoci heterodim highli enrich tsh betasubunit tsh heterodim obtain antitsh beta serum free alphasubunit subsequ obtain antilh alphaserum high unit relea endoglycosida analyz paper chromatographi oligosaccharid residu predomin subunit tissu type unit tend accumul tsh betasubunit wherea mantrim man9glcnac man8glcnac proce rapidli tsh alphasubunit free alphasubunit rate tsh betasubunit process wa function tissu type rate euthyroid pituitari tissu equal tumor tissu wa greater hypothyroid pituitari tissu suggest process mai physiolog regul hypothyroid calf serum slow tsh alphasubunit process euthyroid pituitari thu previou report slower process man9glcnac man8glcnac heterodim compar free alphasubunit larg accumul man9glcnac tsh betasubunit 
87053608 adenyl cyclasem anim femal gonadotropin chorionicpd lhpd ovaryb progesteronem pregnancypp rat region blood flowd support nonu govt factor redistribu ovarian blood flow injec human chorion gonadotropin lutein hormon adult pregnant rat lh human cg hcg induc increa total ovarian blood flow effect lhhcg luteal blood flow howev unknown thi work studi effect hcg luteal ovarian blood flow differ stage pregnanc adult femal rat pregnanc wa induc mate steril male rat length pregnanc wa dai dure thi blood flow wa measur injec radioact sphere dure anesthesia autopsi corpora lutea identifi extirp stereomicroscop remain ovari count radioact blood flow wa calcul progesteron level determin plasma ovarian tissu furthermor respon adenyl cycla wa test ovarian tissu dai pregnanc arteri injec hcg iu vehicl salin wa min befor blood flow determin anesthet rat luteal blood flow wa chang hcg dai pregnanc wherea remain ovari blood flow increa 2fold therebi result redistribu blood flow gram nihlhb9 test dai pregnanc mimick effect hcg dai pregnanc hcg iu wa ip consciou rat min befor blood flow determin min hcg wa pronounc redistribu ovarian blood flow reduc luteal blood flow 4fold increa flow remain ovari lh hcg doubl progesteron content remain ovari corpora lutea increa progesteron content wa seen min hcg exposur hcg injec paramet return control level adenyl cycla wa nonrespon increa total ovarian blood flow coincid increa steroidogenesi effect ar relea metabolit andor vasoact substanc despit thi increa blood flow corpu luteum wa increa render vascular mechan unlik acut lhhcg effect corpu luteum pregnanc 
87053609 affin label amino acid sequenc amino acidsm anim cell differenti cell division cell cultur insulinlik growth factor iph insulinlik growth factor iiph musclesph receptor insulinph recombin proteinsm somatomedinsph structureact relationship support nonu govt support govt ph type ii insulinlik growth factor igf receptor ha low affin igfi analog pleiotyp action igf myoblast ar appar mediat type receptor charact bind sever action somatomedin insulinlik growth factor ii igfi igfii l6 myoblast igfi igfii ar potent stimul amino acid uptak cell prolif differenti thei suppress protein degrad cell measur rel potenc ar igfi greater igfii greater insulin recombin dnaproduc analog igfi thr59igfi nmetigfi activ nativ igfi assai howev 125ilabel hormon studi bind igf receptor wa strike differ nativ recombin igfi molecul bound significantli type receptor 350k molecul dissoci sulfhydryl reduc recombin analog exhibit littl crossreact type ii receptor 220k molecul dissoci reduc thu equal activ nativ igfi recombin dnaproduc analog coupl higher potenc igfi compar igfii suggest type ii receptor plai littl role action somatomedin studi l6 myoblast 
87053610 adenosin cyclic monophosphatem anim cell line cycloheximidepd cytoplasmph dibutyryl cyclic amppd lactatesm leydig cell tumorm leydig cellsm male mitochondriam pregnenolonebi progesteronebi protein kinasesm rat support govt nonph constitut steroidogenesi r2c leydig tumor cell line maintain adenosin 35cyclic monophosphateindepend produc cycloheximidesensit factor enhanc mitochondri pregnenolon biosynthesi studi design charact constitut steroidogenesi leydig tumor cell constitut steroidogenesi wa investig compar constitut activ r2c leydig tumor cell trophic hormonerespon ma10 leydig tumor cell unlik ma10 cell r2c cell appear synth steroid hormon independ campprotein kina pathwai adenyl cycla r2c cell stimul expect manner cholera toxin camp concentr cell low r2c cell steroidogenesi dissoci campdepend process campdepend process steroidogen cell protein kina activ lactat format low basal activ r2c cell stimul bu2camp dose depend similar detect ma10 cell steroid hormon biosynthesi parallel campdepend process ma10 cell r2c cell cycloheximid howev cau similar dosedepend inhibi steroidogenesi r2c ma10 cell cell compon bioassai wa shown r2c cell constitut synth extramitochondri cycloheximidesensit factor function ident factor produc respon hcg ma10 cell thi factor enhanc mitochondri pregnenolon biosynthesi thu constitut steroidogenesi r2c cell explain campindepend cycloheximidesensit constitut produc extramitochondri factor activ mitochondri pregnenolon biosynthesi 
87053614 anim biolog transportd cell line deoxyglucosem dexamethasonepd glucosem hydrogen peroxideai mice support govt ph dexamethason inhibi hydrogen peroxidestimul gluco transport action corticosteroid inhibit gluco transport mechan thi ha unclear evid ha suggest action insulin receptor postbind postreceptor effect ha report hydrogen peroxid act postbind site stimul gluco transport studi carri 3t3l1 fibroblast determin corticosteroid inhibit hydrogen peroxideinduc gluco transport thi cell type insulin hydrogen peroxid produc mark increa gluco transport 30min incub increa produc hydrogen peroxid insulin wa inhibit previou incub cell dexamethason support conclusion dexamethason ha effect gluco transport postbind site chang membran lipid influenc movem andor activ gluco transport dexamethason alter membran lipid dexamethasoneinduc chang lipid plasma membran mai import mediat steroid effect gluco transport 
87053619 ag factor anim biolog assai cell cycl cell cultur cultur media isoelectr male mice molecular weight rat receptor insulinm sertoli cellsm somatomedinsip support govt ph partial charact somatomedinlik peptid medium cultur rat sertoli cell peptid recogn antibodi human somatomedincinsulinlik growth factor smcigfi ha partial purifi cultur sertoli cell prepar sexual immatur rat mol wt thi peptid determin gel filtrat chromatographi immunoblot analysi sampl resolv polyacrylamid gel electrophoresi isoelectr focu indic isoelectr thi peptid wa neutral howev smaller peptid mol wt crossreact antibodi smcigfi wa relea gel filtrat acet acid similarli rever phase hplc c18 column acid condition relea smcigfi immunoreact peptid mol wt thi smaller speci appar result dissoci thi peptid bind protein unlik larger neutral form isoelectr smaller peptid wa thi pi similar ghdepend smcigfi peptid isol rat serum peptid unlik larger form react parallel manner human smcigfi smcigfi ria radioreceptor assai addition mol wt peptid behav progr factor balbc3t3 assai compet 125ismcigfi bind type smcigfi receptor cultur rat sertoli cell summari result thi studi demonstr rat sertoli cell cultur secret peptid rat equiv human smcigfi 
87053622 amino acid sequenc anim glycoproteinss mice placenta protein process posttransl proteinsim recombin proteinsim support govt ph secretion proliferin proliferin plf member prlgh famili mrna ha detect prolif mou cell cultur mou placenta suspen murin placent tissu shown produc plf detect immunoprecipit report plf secret heterogen glycoprotein grow mou cell line placent tissu amino acid preprotein serv signal peptid placent plf immunolog distinguish previou describ mou placent lactogen 
87053623 adren cortexcyen adrenocorticotrop hormonepd anim cholesterolbi dexamethasonepd guinea pig hydrocortisonebl hydroxymethylglutaryl coa reductasesm kinet male sodium fluoridepd differenti activ 3hydroxy3methylglutaryl coenzym reducta zone adren cortex cholesterol metabol steroidogenesi outer zona fasciculataglomerulosa inner zona reticulari zone adren cortex examin guinea pig previou studi content cholesterol inner zone consid lower outer zone basal low densiti lipoprotein ldl receptor activ similar zone explor cholesterol metabol guinea pig adren cortex activ 3hydroxy3methylglutaryl coenzym hmgcoa reducta ratelimit step cholesterol synthesi ha examin thi paper form initi report wa basal specif activ hmgcoa reducta wa similar outer inner adrenocort zone approxim pmol mevalon formedmin mg somal protein administr acth cau 5fold increa hmgcoa reducta activ outer inner zone respect increa hmgcoa reducta activ acth treatment wa alwai greater inner zone outer zone thi contrast ldl receptor activ doe increa inner zone doe outer zone acth treatment dexamethason wa administ hmgcoa reducta activ decrea outer zone wa chang reducta activ inner zone similar happen ldl receptor activ dure dexamethason administr suppr endogen acth effect hmgcoa reducta activ inner zone exogen acth administr cau mark increa enzym activ clear mai relat phosphorylationdephosphoryl mechan base sodium fluorid solution block hmgcoa reducta phosphata evid present indic pharmacolog dose acth alter phosphorylationdephosphoryl statu hmgcoa reducta inner adrenocort zone outer cortic zone 
87053625 anim compar studi enkephalinsm guinea pigsm macaca mulattam pituitari gland posteriorm protein precursorsm protein process posttransl speci specif support nonu govt support govt ph swinem speciesspecif process prodynorphin posterior pituitari mammal steadi state level prodynorphinderiv opioid peptid dynorphin dynorphin alphaneoendorphin exten studi magnocellularposterior pituitari rat determin rat serv gener model prodynorphin process mammalian posterior pituitari examin steadi state level prodynorphinderiv opioid peptid posterior pituitari repr diver order mammal guinea pig order rodentia pig order artiodactyla rhesu monkei order primat speci studi wa evid speciesspecif deviat rat model pronounc differ observ respect conver dynorphin a117 dynorphin a18 rodent rat guinea pig steadi state condition molar ratio form ar approxim respect howev pig rhesu monkei molar ratio form ar respect thu steadi state condition conver dynorphin a117 dynorphin a18 appear minor event porcin rhesu monkei posterior pituitari speciesspecif variat observ respect steadi state level alphaneoendorphin dynorphin b113 addition result studi suggest conver prodynorphinderiv opioid leuenkephalin probabl repr minor event speci studi 
87053627 ag factor anim anim newbornph estradiolpd femal male ovariectomi pituitari gland anteriorgd prolactin rat sex factor postnat develop pituitari lactotrop rat measur rever hemolyt plaqu assai develop chang sexual differ lactotrop popul studi rever hemolyt plaqu assai detec measur prl secretion individu cell conjunc prl immunocytochemistri icc pituitari gland sex differ ag monodisp trypsin freshli disper cell incub cunningham chamber measur fraction plaqueform cell size plaqu form attach glass slide measur fraction cell stain prl icc percentag plaqueform cell sex gradual increa ag total anterior pituitari cell popul dai ag adult level femal proestru male sexual differ percentag plaqueform cell consist seen dai ag thereaft mean size plaqu sex increa ag dai ag peak level femal proestru male dai ag adult level femal proestru male sexual differ appear dai ag estrogendepend result icc close match plaqu assai dai ag adult male dai fraction cell stain prl wa twice cell form plaqu adult male rat immunostain prl cell onli plaqueform cell thi differ howev disappear estrogen treatment result demonstr sexual differ lactotrop popul develop puberti rat appear estrogen depend 
87053629 anim antifibrinolyt agentsm calciumm catecholaminesm estradiolpd femal metalloproteinsm nucleotid cyclicm potassiumm pregnanc pregnanc animalm sodiumm support govt ph swine uterusm effect earli pregnanc acut betaestradiol administr porcin uterin secretion cyclic nucleotid catecholamin thi studi investig acut effect betaestradiol ion cyclic nucleotid catecholamin associ tempor chang uterin secretori product pregnant cyclic nonpregn gilt uterin flush utf endometrium endom uterin horn nonpregn pregnant gilt collect dai protein plasma inhibitor na increa linearli utf pregnant gilt ca2 chang bipha higher concentr pregnant gilt dai endometri camp cgmp increa dai pregnanc utf norepinephrin ne concentr increa cyclic gilt dai endometri ne increa dai decrea dai utf pregnant gilt higher concentr dopamin da peak dai decrea dai da utf nonpregn gilt decrea dai remain low dai catecholamin metabolit 34dihydroxyphenylglycol endom utf decrea linearli dai turnov rate endometri catecholamin wa 24fold higher dure earli pregnanc compar cyclic gilt effect acut administr exogen mg studi utf endom dai nonpregn gilt min post postsalineethanol injec potassium plasma inhibitor cgmp increa rapidli min injec level chang bipha increa concentr min plasmin inhibitor return level similar control min wherea cgmp remain elev min postinjec ca2 na increa endom ne utf da lower etreat gilt addition turnov rate wa significantli lower ne da utf etreat gilt increa ca2 utf prece increa protein secretion plasmin inhibitor mai plai role estimul endometri epith secretori vesicl exocytosisabstract truncat 
87053630 anim cell cycl cell line doserespon relationship drug estradiolpd estrogenspd gene expr regulationd prolactinbi rat receptor estrogenm rna messengerm structureact relationship support nonu govt support govt ph regul prolactin produc cell growth estradiol differ sensit estradiol occur level messeng ribonucl acid accumul betaestradiol increa growth rate gh4c1 cell halfmaxim effect concentr ec50 10fold ec50 stimul prl produc examin effect estrogen estriol estron alphaestradiol metabolismresist analog ethynyl estradiol moxestrol agonist effect potent stimul cell growth stimul prl produc order analog potenc biolog effect wa order potenc inhibit satur 3hestradiol bind intact cell therefor biolog effect appear mediat receptor metabol betaestradiol unlik account differ concentr requir elicit effect select estrogenrespon clone cdna librari gh4c1 cell clone chosen becau thei induc estrogen concentr stimul growth estradiol cau maxim stimul mrna correspond recombin clone concentr 10fold lower requir maxim stimul prl mrna data indic differ sensit estrogen occur level mrna accumul level biolog respon 
87053633 ag factor androgenbind proteinss anim cell compart cell cultur cultur media epitheliumci vitro male permeabl rat sertoli cellsseul support govt ph transferrin bipolar secretion androgenbind protein transferrin sertoli cell cultur twocompart cultur chamber influenc variou medium supplem sertoli cell sc monolai permeabl 3hinulin polar secretion transferrin trf androgenbind protein abp wa investig twocompart cultur chamber sc 18dayold rat maintain dai follow media modifi eagl mediumham f12 dfm dfm plu insulin epiderm growth factor progesteron hydrocortison vitamin 6f 6f plu testosteron 7f 7f plu fsh 8f 6f plu fetal bovin serum 6f2 6f plu fetal bovin serum 6f5 monolai permeabl 3hinulin decrea rapidli dure initi dai cultur sc isol 14dai old anim remain stabl media dfm morpholog examin reveal presenc tight junction neighbour sc ag group indic novo format secretion trf wa lowest dfm steadili declin media trf secretion peak dai remain rel constant dai medium 7f onli slightli inconsist increa secretion wherea 8f wa alwai highli stimulatori compar 6f supplem 6f serum result greatest trf secretion case abp differ secretion pattern depend medium composi secretion wa greatest presenc fetal bovin serum medium supplem differenti affect polar trf abp secretion ratio trf secret outer inner compart ocic wa approxim dfm wa influenc supplem 6f 7f 8f howev serumcontain media ocic ratio gradual increa dai averag ocic ratio abp wa dfm contrast trf declin serumfr media serum supplem rever increa abp ratio dai data indic sc grown permeabl support form confluent monolai limit diffusion macromolecul format tight junction monolai permeabl total polar secretion trf abp ar differenti regul hormon serum factor 
87053637 anim cattleph estradiolbl estrogenss estronebl femal pregnanc pregnanc animalph progesteron relaxinmepd secretori rate support govt nonph factor acut decrea progesteron increa estrogen secretion cau relaxin dure late pregnanc beef heifer purifi porcin relaxin umg wa administ im rlxim mg cervic os rlxo mg dai approxim dai befor parturi normal occur gestat determin profil immunoreact relaxin effect progesteron estron e1 betaestradiol betae2 secretion periph blood plasma beef heifer control receiv pb ml im gelpb gel ml os cervic os relaxintr im heifer calv min treatment thu data thi heifer includ subsequ analysi relaxintr heifer acut elev relaxin precipit decrea progesteron signif elev e1 betae2 plasma relaxin level ngml rlxim rlxo control anim respect periph plasma relaxin peak ngml befor return ngml treatment relaxin administr account progesteron e1 betae2 variabl treatment respect abrupt decrea progesteron prece rise e1 betae2 respect maximum progesteron deviat pretreat mean concentr ngml rlxim rlxo control progesteron rebound respect pretreat mean rlxim rlxo peak elev e1 wa pgml betae2 wa ngml rlxim rlxo control respect result provid strong evid pharmacolog dosag relaxin induc acut depr progesteron secretion begin min beef heifer dure late pregnanc suggest earli mark luteolyt effect relaxin progesteron secretion cattl direct indirect action mechan ar unknown 
87053638 anim bind competit braincym cell nucleusm neurogliam neuronsm rat receptor thyroid hormonem thyroxinem triiodothyroninem triiodothyronin reversem triiodothyronin bind adult rat brain compart receptor popul purifi neuron glial nuclei order investig local nuclear t3 receptor adult rat brain develop techniqu separ neuron glial nuclei compar nuclear t3 bind fraction glial neuron nuclear popul prepar homogen brain cerebellum follow discontinu densiti gradient centrifug sucro purpo comparison liver nuclei prepar centrifug sucro scopic examin nuclei confirm puriti nuclear fraction abov minim extranuclear contamin t3 bind studi perform wash nuclear fraction satur analysi techniqu maximum bind bmax dissoci constant kd obtain nonlinear leastsquar regr analysi min incub bmax neuron nuclei wa fmolmg dna mean se comparison fmolmg dna glial nuclei correct valu bmax glial nuclei assum neuron nuclear contamin wa fmolmg dna bmax liver nuclei wa contamin wa fmolmg dna bmax liver nuclei wa fmolmg dna kd valu nm nm nm neuron glial liver nuclei respect specif t3 bind nuclear receptor neuron glial nuclei wa studi competi studi reveal close similar rel bind affin t3 greater t4 greater rt3 conclud higher t3 bind capac neuron nuclei mai relat higher protein synthet abil suggest t3 mai import rapid structur turnov cell effect t3 myelin glial cell mai mediat nucleu 
87053640 anestrusph anim estradiolbl estrusph femal gonadotropin pituitaryblpd hamstersph mesocricetusph organ weightd ovaryph phenobarbitalpd pituitari glandph progesteronebl support govt ph uterusah dynam pituitari ovarian chang occur dure anestru estru transition golden hamster anestr hamster exhibit daili afternoon gonadotropin progesteron surg littl estrogen secretion experi dai anestr femal transfer dai detect hormon chang associ recoveri cyclic morn afternoon blood sampl increa durat dai femal autopsi vagin estru transfer dai differ dai estrou control onli lower uterin weight femal durat exhibit sign recoveri thei shown estru thei displai afternoon gonadotropin surg low circul progesteron high estradiol level stimul uteri enhanc follicular develop result experi provid evid daili gonadotropin surg ar cau se anestru chang estrogen secretion ar essenti transition anestru phenobarbit blockad daili surg anestr femal result increa follicular growth estrogen secretion furthermor daili afternoon injec gonadotropin appear daili surg anestr hamster simpli reflect low estradiol level signal promot rapid follicular matur dure recoveri anestru onc initi howev thi recoveri appear occur dai rapid cascad event follicular develop estrogen secretion resum daili lh surg cea progesteron level declin ovulatori surg gonadotropin trigger 
87053642 adenosin cyclic monophosphatem adenyl cyclasem anim cattl cell cycl enzym activationd glycoproteinsph hydrofluor acid receptor thyrotropinph structureact relationship support nonu govt support govt ph thyrotropinpdph carbohydr moieti bovin thyrotropin essenti bioactiv receptor recogni tsh glycoprotein hormon carbohydr content vari differ speci studi suggest variant tsh defici carbohydr occur natur signif carbohydr moieti tsh respect thyrotrop function unclear present studi undertaken therefor examin thi highli purifi prepar bovin tsh btsh wa deglycosyl treatment anhydr hydrogen fluorid amino acid carbohydr anali origin deglycosyl prepar indic approxim carbohydr origin present remov protein moieti wa unalt judg tsh radioreceptor assai btsh deglycosyl btsh dgbtsh bound human thyroid membran equal affin sinc cau halfmaxim inhibi 125ibtsh bind approxim equal concentr nonetheless dgbtsh optim concentr displai onli activ intact tsh stimul adenyl cycla activ human thyroid membran dgbtsh antagon adenyl cyclasestimul activ intact btsh thi onli weakli sinc aboli btsh effect requir approxim 40fold higher concentr dgbtsh cultur frtl5 cell clone line follicular cell deriv normal rat thyroid intact dgbtsh enhanc cell growth measur 3hthymidin incorpor stimul camp relea medium respon elicit dgbtsh wa cau equal concentr intact hormon accord vitro assai dgbtsh evok smaller respon btsh vivo mou assai conclud requir receptor recogni carbohydr moieti btsh essenti expr biolog activ 
87053645 anim cattl cellfr cytoplasm granulesm deoxychol acidpd exocytosi glutathionepd vitro osmolar concentr pituitari gland anteriorseul prolactin raffino somatotropin sucro support govt ph osmot pressur regul prolactin growth hormon relea bovin secretori granul prl gh ar store bovin pituitari secretori granul intermolecular disulfidelink multim mani monomersoligom vitro incub granul reduc glutathion gsh result produc monom hormon increa hormon relea test hypothesi increa granular osmol conver oligom lower mol wt form ar kei granul ruptur hormon relea wa measur granul incub medium hyperosmot addition raffino sucro prl relea ph raffino wa reduc control valu wherea gh relea rang control valu augment relea stimul mm gsh wa diminish raffino prl gh control valu ic50 raffino inhibi prl relea wa thi shift presenc mm gsh raffino blunt granul respon gsh gsh concentr test decrea stimul relea ph interf abil maintain osmot gradient maneuv accomplish partial disrup granul membran deoxychol treatment reduc abolish raffino inhibi molecular size granul fraction superose6 pharmacia indic prl monom remain pellet granul fraction increa raffino 2fold basal gshstimul condition data support concept thioldisulfid equilibria mai import prl gh storag secretion influenc granular osmol exocytosi vivo osmot mediat granul ruptur mai trigger thiol dure granuleplasma membran fusion 
87053648 anim bone bonesm calciumm chicken cholecalciferolsm duodenumm fracturesm kidneym support nonu govt wound heal metabol vitamin d3 dure fractur heal chick metabol vitamin d3 wa studi chick experi fractur perform tibia chick fed vitamin ddefici diet supplem radioact label vitamin d3 chick divid group group right tibia wa fractur wherea group serv nonfractur control group dure follow dai fractur heal metabolit 3hvitamin d3 measur callu epiphysi diaphysi plasma duodenum kidnei histolog examin callu bone measur intestin absorp calcium renal produc dihydroxyl metabolit vitamin d3 perform level dihydroxyl metabolit increa callu level 3h2425dihydroxyvitamin d3 coincid format cartilagin tissu renal produc thi steroid duodenum fractur chick level 3h125dihydroxyvitamin d3 drop significantli dure fractur coincid reduc intestin absorp calcium plasma dure heal process level 3h125dihydroxyvitamin d3 normal indic dure process fractur repair chang metabol expr vitamin ar order meet new requir bodi stress condition skelet fractur 
87053652 alkalin phosphatasem breast neoplasmsen calcitriolph cell line cycloheximidepd dexamethasonepd human hydrocortisonepd vitro isoenzymesm radioimmunoassai receptor glucocorticoidm receptor steroidm support govt ph 125dihydroxyvitamin d3 exert opposit effect regul human embryon nonembryon alkalin phosphata isoenzym regul alkalin phosphata activ steroid hormon wa studi human breast cancer cell line mdamb157 bt20 mdamb157 cell shown express alkalin phosphata isoenzym produc normal breast tissu activ thi isoenzym increa 3fold 72h treatment cell 125dihydroxyvitamin d3 125oh2d3 2fold treatment hydrocortison hc 5fold treatment hormon bt20 cell express isoenzym phenotyp breast ectop express isoenzym phenotyp term placenta embryon tissu treatment bt20 cell 125oh2d3 result decrea alkalin phosphata activ embryon isoenzym wa 2fold increa activ treatment hc enzym activ wa similar control valu treatment hormon cell line chang alkalin phosphata activ correl chang gram isoenzym mg cellular protein measur ria increa enzym activ inhibit cell incub simultan steroid cycloheximid studi receptor cell line cell line bound 125oh2d3 125oh2d3bind protein mol wt d3 receptor wa present bt20 cell express larger mol wt protein bind 125oh2d3 specif 125oh2d3 isom hc receptor similar quantiti bind affin cell line 
87053655 adipo tissueph anim dietari carbohydratesph gene expr regulationd isoelectr male molecular weight proteinsg rat rna messengerg support nonu govt support govt ph thyroid hormonespd effect thyroid hormon high carbohydr feed gene expr rat epididym adipo tissu determin messeng rna activ profil epididym fat euthyroid hypothyroid hyperthyroid rat anim fed high carbohydr fatfr lipogen diet radioautograph twodimen gel vitro translat product rna quantit computerassist videodensitometri analyz multivari statist spot observ presum repr translat product separ messeng rna respon chang hormon state eighteen increa decrea stage transition hypothyroid hyperthyroid state spot chang bipha manner product respond lipogen diet increa decrea spot respond similar fashion thyroid hormon administr previou shown liver appear substanti overlap genom respon carbohydr thyroid hormon administr wherea carbohydrategen chang ar larg includ thyroidhormon induc alter major thyroid hormon respon chang ar duplic diet multivari analysi clear separ state reveal wa necessari monitor onli spot achiev effect separ state analyz 
87053657 anim brown fatm cell nucleusm cytoplasmm male rat receptor thyroid hormonem support nonu govt support govt ph triiodothyroninem nuclear 353triiodothyronin t3 brown adipo tissu receptor occup sourc t3 determin vivo techniqu sourc t3 associ high affin low capac cellular nuclear receptor brown adipo tissu bat estim vivo pulselabel techniqu maxim bind capac wa measur vivo satur analysi nuclear receptor occup endogen level t3 t4 euthyroid rat wa estim equilibrium nuclear serum ratio tracer t3 local gener nuclear t3 serum t4 ratio inject tracer t3 t4 ratio multipli respect endogen concentr t3 t4 measur ria maxim bind capac wa ng t3mg dna satur wa fiftyf percent nuclear t3 wa gener local wa deriv circul t3 bat henc compar liver number receptor approxim 5000cell pituitari regard satur rel contribu local gener t3 plasma t3 nuclear t3 result suggest bat mai import target thyroid hormon data alter activ type ii 5deiodina thi tissu mai influenc satur nuclear t3 receptor 
87053659 anim gene expr regul hypothalamuscyph hypothalamu anteriorph male nucleic acid hybrid oxytoc paraventricular hypothalam nucleusph rat rna messengerg support nonu govt waterelectrolyt balanc oxytocin gene expr discret hypothalam magnocellular cell group stimul prolong salt load effect prolong osmot stimul oxytocin ot mrna level otproduc neuron wa investig separ hypothalam nuclei rat drink nacl 2fold increa ot mrna content wa northern blot analysi dissect supraopt nucleu son paraventricular nucleu pvn sampl similar chang vasopressin vp mrna level thi treatment result depletion ot vp neurointermedi lobe pituitari gland mark increa ot vp plasma level analysi ot mrna concentr quantit situ hybrid son pvn anterior commissur nucleu respond similarli 15fold increa ot mrna dai osmot stimul result demonstr ot gene expr magnocellular neuron son pvn anterior commissur nucleu sensit thi osmot stimulu vp gene magnocellular neuron son pvn respon otproduc neuron mai role ot regul water electrolyt balanc 
87053662 anim cytoplasmul doserespon relationship drug femal mice pinocytosisd rat secretori rate support nonu govt thyroid glandcyph thyrotropinpd progress recruit follicular cell grade secretori respon dure stimul thyroid gland thyrotropin earliest respon thyroid cell tsh macropinocytosi format cellular colloid droplet demonstr increa stimul tsh onli elicit highli individu macropinocytot respon differ follicular cell fraction tshrespon cell function tsh dose pretreat t4 mice rat inject ip bovin tsh kill macropinocytot respon tsh wa evalu period acidschiffstain 3micron thyroid term droplet number follicl addition assess recruit percentag dropletcontain cell variabl increa increa tsh stimul thei reach plateau mu tsh mice mu tsh rat percentag dropletcontain cell gradual increa mice tsh mu tsh rat tsh mu tsh over pinocytot respon thyrocyt recruit modifi extra thyroid factor exampl pretreat mice iodinedefici diet increa maxim percentag droplet contain cell nearli obviou separ compon macropinocytot respon thyroid gland tsh distinguish gradual increa fraction dropletcontain cell increa number colloid droplet tshrespon cell progress tsh stimul recruit thyrocyt gradual increa natur threshold hormon stimulu appear fundam mechan thyroid gland possibli organ 
87053718 anim brainm epilepsym norepinephrinem rat rat mutant strain tyrosin hydroxylasem indic noradrenerg function central nervou seizurena genet epilepsypron rat norepinephrin concentr tyrosin hydroxyla activ determin brain moderateseizur severeseizur genet epilepsypron rat gepr nonepilept control rat moderateseizur gepr3 severeseizur gepr9 anim widespread abnorm brain norepinephrin concentr abnorm tyrosin hydroxyla activ restrict midbrain state abnorm seizur suscept sever gepr mai determin noradrenerg deficit hypothalamusthalamu seizur sever suscept mai determin noradrenerg deficit telencephalon midbrain ponsmedulla seizur sever suscept mai determin noradrenerg abnorm cerebellum 
87053722 abnorm druginducedet anim epilepsydtg father femal fetusd genotyp male mice mice neurolog mutant phenytoinaebl support nonu govt congenit defect offspr epilept father role genotyp phenytoin therapi mou model progeni coisogen c57bl6j mice homozyg totter tgtg wildtyp allel examin determin role parent seizur disord patern anticonvul drug therapi incid congenit malform pregnanc outcom parent epilept genotyp compar variou matern fetal reproduct paramet addition progeni phenytointr male totter tgtg mice spontan seizur disord control untreat male mice similarli examin evid congenit defect result experi suggest parent genotyp respect seizur disord patern anticonvul treatment phenytoin respon increa incid congenit malform 
87053723 anticonvulsantsaetu case report child child preschool drug therapi combin electroencephalographi epilepsydt femal human male seizurescidt seizur induc aggrav anticonvul case epilept children ar report anticonvul therapi aggrav control seizur induc minor seizur thi wa cau excess polytherapi case inappropri drug type epilepsi case sixth case appropri anticonvul wa induc multipl astaticmyoclon seizur thi phenomenon druginduc seizur apt occur particularli certain type childhood epilepsi ar refractori therapi ar accompani slow spikewav discharg eeg lennoxgastaut syndrom 
87053726 adult ag anticonvulsantsm electroencephalographi electromyographi electrooculographi epilepsymepp femal human male membran potenti middl ag prolactinblph sleep stagesph effect interict epileptiform discharg nocturn plasma prolactin concentr epilept patient complex partial seizur investig effect interict epileptiform discharg plasma prolactin prl level studi epilept patient complex partial seizur cp experi clinic subclin ictal event dure allnight monitor polygraph record video imag densiti peak dure nonrem stage wa significantli reduc dure rem stage mean plasma prl concentr epilept patient sampl 30min interv moder signif elev dure nonrem awak stage dure rem stage compar nonepilept control subject studi similar fashion data obtain thi physiolog control environ indic cumul effect mai modifi prl regulatori mechan result modest elev plasma concentr independ ictal discharg 
87053727 adult epilepsycoep femal finland human longitudin studi male middl ag multipl sclerosisco prognosi preval prognosi epilepsi patient multipl sclerosi analysi clinic definit multipl sclerosi ms patient includ case southern provinc finland januari reveal epilept seizur patient date patient treatment ageadjust preval activ epilepsi wa significantli higher gener popul percentag partial seizur wa significantli increa propor seri adult epilepsi patient compar ag distribu patient includ patient symptomat epilepsi attack appear befor ms symptom mean followup seizur wa patient seizur disappear total dure surveil septemb result increa comorbid ms epilepsi case howev prognosi epilepsi wa ani clear correl sever ms epilepsi 
87053728 adolesc adult ag epilepsyclth femal human male middl ag netherland neurologi physician role physician famili questionnair role support nonu govt epilepsi gener practic dutch situat treatment supervi epilept patient specialist medicin possibl chang role specialist gener practition care patient wa explor questionnair mail dutch neurologist random sampl gener practition patient ask opinion real situat wa studi group patient retriev regist gener practition demograph psychosoci epilepsi characterist sampl specialist tend want chang role gener practition desir chang present patient want chang futur chang accept patient expect supervi gener practition onli demograph psychosoci characterist differ popul larg epilepsi characterist correspond studi 
87053729 adult attitud health epilepsypx femal health educationmt human male netherland questionnair support nonu govt previou experi epilepsi effect inform chang public percep epilepsi differ regard effect health inform attitud chang ar suggest peopl direct behavior experi health topic peopl indirect nonbehavior experi effect differ method health educ epilepsi frequent health educ practic ar assess pretest posttest design control group control experi epilepsi subject student teachertrain colleg treatment attitud knowledg epilepsi chang posit wai treatment equal effect befor treatment direct behavior experi relat knowledg posit attitud epilepsi treatment subject direct behavior experi epilepsi chang attitud knowledg compar subject indirect experi direct experi appear restrain process new inform attitud chang 
87053730 adolesc adult epilepsypp femal fertil human marriag middl ag minnesota reproduc retrospect studi sex factor fertil person epilepsi  data rochesterolmst counti medic record linkag project util assess fertil person epilepsi popul agespecif reproduc rate rochest resid  estim number live birth minnesota depart health statist vital statist comparison rate affect person over fertil rate significantli reduc expect affect male affect femal individu partial seizur simpl complex disadvantag wherea gener onset dure studi period male disadvantag femal malefem differ wa greatest dure low popul fertil male deficit mark diagnosi femal deficit mark befor diagnosi differ propor evermarri personyear sex onli partial explain observ differ 
87053731 achiev adolesc aptitud test child epilepsypx femal human intellig male mathemat read support nonu govt support govt ph vocabulari academ achiev children epilepsi academ achiev score children epilepsi examin relat demograph clinic seizur variabl group children academ progress expect ag iq level academ defici greatest arithmet follow spell read comprehen recogni result multipl regr anali indic modest combin predict signif demograph clinic seizur variabl academ perform addition magnitud relationship vari academ area individu variabl examin strongest correl academ perform ag child ag seizur onset lifetim total seizur frequenc presenc multipl seizur absenc tonicclon result ar discuss relat develop understand factor underli academ vulner children epilepsi 
87053732 adolesc adult ag factor ag compar studi epilepsypx femal human intellig male middl ag neuropsycholog test psychomotor perform reaction sex factor behavior characterist epilepsi patient compar normal control neuropsycholog test procedur measur behavior characterist patient epilepsi unaffect anticonvul drug compar result control subject match ag sex educ nationwid va cooper studi patient welldefin seizur type select batteri neuropsycholog test prior initi drug therapi seventyfour control subject administ test batteri standard condition va test center test control repeat patient epilepsi score significantli consist level control subject behavior measur differ reach statist signif test motor function finger tap pegboard color cognitiveatten digit symbol discrimin reaction fluenci subtest profil mood statu tension depr vigor confusion data provid profil behavior characterist unm patient epilepsi 
87053733 case report cerebr cortexpa electroencephalographi epilepsydtpp femal human middl ag phenytointu tinnitusdtpa tomographi xrai comput ictal tinnitu unilat high pitch tinnitu wa sole epilept ictal manifest 45yearold woman electrograph seizur origin contralat midtempor area consist correl tinnitu comput tomographi ct demonstr lesion involv superior tempor gyru inferior portion supramargin gyru case illustr cortic origin tinnitu 
87054667 abortifaci agent nonsteroidaltu femal human methotrexatetu pregnanc pregnanc ectopicdtth nonsurg treatment ectop pregnanc 
87054671 adolesc adult ascit fluidpa endometriosispa endometriumci femal human endometri tissu periton fluid periton fluid pf wa studi presenc endometri tissu consecut seri women docum tubal patenc undergo diagnost laparoscopi tubal lavag hysteroscopi pf wa complet aspir culdesac befor uterin irrig pf wa analyz presenc endometri tissu nativ pf signif differ incid endometri tissu patient endometriosi wa observ reflux pf obtain uterin irrig significantli higher incid endometri tissu women endometriosi compar control propo model explain develop endometriosi ar mutual exclu mai independ mai repr distinct pathophysiolog disea process 
87054672 adult endometriosisclmepa femal human prostaglandin fbi support govt ph classif endometriot implant morpholog appear capac synth prostaglandin sever symptom endometriosi ha alwai correl anatom sever disea thi correl mai variat metabol activ endometriot implant present differ stage disea becau prostaglandin pgf ha implic hormon mediat clinic symptom endometriosi pgf synthesi content wa measur implant patient mild moder sever exten disea assess pgf produc wa relat statu implant author classifi implant base gross histolog criteria petechi reddish intermedi brown powderburn black pgf produc implant patient mild moder disea wa greater implant patient sever exten disea pgf content wa similar stage endometriosi petechi implant produc twice pgf intermedi implant turn produc pgf powderburn implant powderburn implant vitro capac produc pgf pgf contain implant class wa similar therefor endometriot implant pgf produc possibli biochem activ ar depend physic statu implant classif implant morpholog appear mai afford addition assist determin prognosi disea examin subtl effect disea symptom 
87054673 adhesionscl adult fallopian tube diseasesclsu fallopian tubessu femal human laser surgeri pregnanc pregnanc ectop prognosi preoper classif predict uterin ectop pregnanc rate distal tubal surgeri simpl preoper classif describ predict uterin ectop pregnanc rate follow distal tubal surgeri laser co2 surgic salpingostomi perform patient januari januari patient underw preoper assess includ hysterosalpingogram laparoscopi formul preoper classif base patient divid group accord tubal damag subsequ uterin pregnanc rate grade grade ii grade iii grade iv patient divid group accord adhesion subsequ uterin pregnanc rate adhesion mild adhesion moder adhesion sever adhesion result preoper manag propo patient consid distal tubal surgeri vitro fertil 
87054679 adult case report estradiolm femal graafian folliclepp human infertil femaleetpp lhme ovarian diseasesco support nonu govt subtl abnorm follicular develop hormon profil women unexplain infertil prospect studi unselect coupl diagno unexplain infertil wa patient subtl abnorm follicular develop detect case poor follicular growth wa observ wa prematur rise lutein hormon lh subsequ low level estradiol e2 late follicular phase unusu wide lh peak thi wa follow low progesteron level luteal phase case follicular growth wa abrupt prematur lh surg thi surg wa trigger earli rise e2 level follicl wa size case lutein unruptur follicl syndrom wa diagno sound examin abnorm repetit 
87054683 adolesc adult antithrombin iiim blood glucosem cholesterolbl contracept oral hormonalpd contracept oral syntheticpd diabet mellitu insulindependentbl fatti acid nonesterifiedbl femal hemoglobin glycosylatedm human sex hormonebind globulinbl support nonu govt triglyceridesbl oral contracept diabet women metabol effect compound differ estrogenprogestogen profil metabol effect oral contracept differ estrogenprogestogen profil monopha nonalkyl estrogennorethindron lowdo monopha ethinyl estradiol ee2norethindron progestogen onli treatment norethindron tripha ee2levonorgestrel examin insulindepend diabet women dure 6month studi period differ fast plasma gluco 24hour insulin requir glycat hemoglobin free fatti acid lowden lipoprotein cholesterol concentr highden lipoprotein cholesteroltot cholesterol ratio patient treatment group compar nonalkyl estrogennorethindron tripha ee2levonorgestrel formul lowdo ee2norethindron combin result signif increa plasma triglycerid veri lowden lipoprotein cholesterol level unfavor clinic view norethindroneonli treatment appear appropri altern nonalkyl estrogennorethindron combin tripha ee2levonorgestrel formul 
87054685 adult cervix uteri compar studi femal human insemin artificialmt insemin artifici homologousmt male sperm count uteru cervic versu uterin insemin correl outcom antec postcoit test thirtyfour infertil women altern cycl cervic insemin ici ejacul homolog semen mean cyclespati versu uterin insemin iui wash sperm mean cyclespati twenti women prior postcoit test consist demonstr equal motil sperm highpow field hpf conceiv dure iui cycl conceiv dure ici cycl mantelhaenszel chisquar test pregnanc rate iui cycl wa compar ici cycl statist signif differ fisher exact chisquar test fourteen women prior postcoit test consist demonstr greater equal motil sperm hpf conceiv dure iui cycl conceiv dure ici cycl differ wa signif pregnanc rate iui cycl wa compar ici cycl signif iui mai help manag infertil associ rel poor postcoit test equal motil sperm hpf rel postcoit test greater equal motil sperm hpf 
87054686 adult emotion femal human steril tubalpx support nonu govt studi women request interv contracept steril return surgeri initi record women present interv tubal ligat characterist steril juxtapo characterist return surgeri followup telephon interview conduct explor regret steril steril women subsequ histori women return surgeri examin determin failur return screen select women greatest risk regret high level subsequ unwant concep pregnanc wastag nonreturn group institu factor implic failur return variabl avail initi present ar propo identifi women risk adver consequ postpon steril facilit return increa regret 
87054688 embryo transfermt femal fertil vitromt human ovul undetect ovul vitro fertilizationembryo transfer patient retrospect evalu wa consecut vitro fertilizationembryo transfer ivfet treatment cycl culmin surgic interven oocyt pickup patient dispar wa number matur follicl present dai human chorion gonadotropin administr compar dai surgeri thi suggest occurr undetect ovul endogen lutein hormon lh surg wa detect patient anoth cohort evid earli lutein detect endogen lh surg final group earli lutein wa defin possibl explan outcom implic success ivfet ar discuss 
87054689 compar studi embryo transfermt femal fertil vitromt fetal death gonadotropin chorion human peptid fragmentss period pregnanc support nonu govt doe cyclic human chorion gonadotropin secretion indic embryo loss vitro fertil human chorion gonadotropin hcg beta subunit curv normal singleton vitro fertil ivf pregnanc cyclic peak dure dai embryo transfer et thi phenomenon demonstr normal spontan concep hcg curv singleton ivf pregnanc achiev transfer embryo therefor compar statist hcg curv singleton ivf pregnanc achiev transfer onli embryo hcg level singleton ivf pregnanc achiev transfer embryo statist higher hcg level dai et separ evalu wa observ declin hcg level normal singleton ivf pregnanc prece firsttrimest abor incid peak singleton ivf pregnanc observ cyclic hcg secretion mai indic earli embryo death thi observ support conten multipl et result significantli multipl implant previou appreci thu embryo surviv utero mai repr anoth major contributori factor success failur ivf 
87054691 amniot fluid anim cultur media embryo embryo transfermt femal fertil vitromt human mice tissu cultur success human amniot fluid mou embryo cultur human vitro fertil embryo cultur transfer develop mou human embryo wa assess human amniot fluid determin suitabl cultur medium human vitro fertil ivf twocel mou embryo develop blastocyst rate similar whittingham t6 fetal calf serum significantli mou embryo hatch amniot fluid differ wa individu patient amniot fluid obtain gestat preliminari trial compar amniot fluid t6 matern serum human ivf signif differ fertil rate embryo develop dure vitro expand blastocyst obtain amniot fluid dai vitro pregnanc obtain patient transfer embryo grown amniot fluid patient transfer embryo grown t6 matern serum 
87054692 anim cultur media femal fertil vitromt glove surgic human mice protein qualiti control talca factor influenc murin embryo bioassai effect protein ag medium surgic glove coat 2cell murin embryo bioassai qualiti control human vitro fertil ivf wa evalu effect protein supplem medium ag surgic glove coat ham f10 medium gibco grand island ny protein supplem support growth 2cell embryo blastocyst addition bovin serum albumin bsa fetal cord serum fc matern serum ms enhanc reduc blastul rate medium alon bsa fc ms unsuppl ham f10 medium wa contain major peak approxim dalton sever minor peak analyz highperform liquid chromatographi hplc sodium sulfatepolyacrylamid gel electrophoresi sdspage suggest presenc protein medium store medium dai degr affect hplc profil abil support embryo growth blastul rate fresh store dai coat surgic glove affect embryo growth talccoat tc talcfr starchcoat sc surgic glove progress embryotox thei touch medium increa length compar uncoat latex ul glove untouch control medium qualiti control medium prepar handl murin embryo bioassai reempha requir protein supplem fresh medium possibl contamin talcfr sc surgic glove reevalu 
87054693 adenosin cyclic monophosphatebi corpu luteumm femal fertil vitro gonadotropin chorionicpd granulosa cellsm human lutein cellsm progesteronebi stimul chemic support nonu govt vitro recoveri human chorion gonadotropinstimul cyclic adenosin 35monophosph produc desensit human granulosalut cell human granulosalut cell produc cyclic adenosin 35monophosph camp progesteron studi respon purifi human chorion gonadotropin hcg cultur cell hyperstimul follicl vitro fertil patient hcg injec patient befor laparoscopi cau partial desensit adenyl cycla cell gonadotropin preincub cell hormon free medium dai significantli increa camp respon hcg produc wa stimul initi hcg desensit cell preincub hcg subsequ stimulu ngml hcg elicit maxim camp respon wherea ngml hcg wa suffici bring maxim secretion timecour studi indic maxim camp respon hcg wa obtain basal hcgstimul accumul continu rise preincub granulosalut cell hyperstimul follicl improv cell camp respon hcg wherea respon remain unalt 
87054694 adult constric pathologicco ejaculatori duct epididymissu human male surgerymt middl ag oligospermiaetsu va deferenssu surgic epididymovasostomi treatment occlu azoospermia principl azoospermia ha explan occlusion duct seriou dysfunc testicular parenchyma case duct occlusion ar suitabl reconstruct surgeri author describ reconstruct techniqu base mobil singl loop epididym duct caudal possibl twolai sidetoend anastomosi va deferen ensur followup evalu anastomosi unilat anastomosi wa primarili case crossov anastomosi wa necessari case reoper possibl thi wa perform epididym duct wa empti contralat epididymi wa explor patient postop oligozoospermia offer supplementari contralat oper patient underw epididymovasostomi followup evalu present sperm repeat test patient father children patient postop normospermia antisperm antibodi excel fertil prognosi singleloop dissec techniqu provid anatom specif high percentag patent anastomo doe interf possibl reoper 
87054696 alkalin phosphatasem human infertil maleen isoenzymesm male semenen support nonu govt placentaltyp alkalin phosphata human semin plasma fertil infertil solidpha enzym immunoassai base monoclon antibodi reactiv differ form human placentaltyp alkalin phosphata appli detec human semin plasma fertil infertil placentallik form alkalin phosphata plaplik ap occur testicular tissu wa normal semin plasma incid detec level thi isoenzym correl significantli design fertil statu donor semin plasma plaplik ap mai reflect germ cell function andor access testicular product ejacul 
87054697 calciumpd human vitro male phosphocreatinepd sperm motilityd stimul chemic verapamilpd enhanc human sperm motil veloc vitro effect calcium creatin phosphat becau role motil regul energi transport calcium creatin phosphat examin effect sperm motil veloc specimen normal donor semen migrat sperm fraction incub mmol calcium mmol magnesium mmol creatin phosphat presenc mumol verapamil calcium creatin phosphat sampl subject multipl exposur photographi pictur frame differ drop sperm motil veloc analyz calcium calciumcreatin phosphat condition sperm motil veloc significantli increa compar control valu sperm motil declin follow verapamil exposur motil valu remain level control presenc addition calcium creatin phosphat effect calcium creatin phosphat rapidli minut improv sperm veloc motil ar fulli achiev load effect calcium sperm transfer media addition calcium veloc decrea initi control valu magnesium alon effect motil veloc experi indic calcium creatin phosphat support sperm motil veloc significantli increa level thu addition calcium creatin phosphat insemin media mai enhanc fertil capac sperm dure vitro fertil gamet fallopian transfer procedur 
87054699 anim compar studi danazoltu diathermi endometriosisdtppsuth femal fertil indomethacintu surgeri rat rat inbr strain effect treatment experi produc endometri periton implant endometriosi wa induc surgic implant piec endometrium uterin mesenteri rat fertil wa assess variou treatment rat endometriosi treat surgic excision implant highfrequ diathermi danazol periton indomethacin rat implant left untreat result compar rat sham surgeri implant fat uterin mesenteri reproduct perform wa control anim sham surgeri anim endometri implant maximum restor fertil wa achiev indomethacin surgeri danazol therapi effect prevent residu endometriosi anim tend fertil treatment adhesion pronounc diathermi pronounc surgeri indomethacin therapi rat treat indomethacin persist endometriot cyst invari smaller site periton injec thi suggest local antiprostaglandin effect 
87054700 adult case report chlamydia trachomati chlamydia infectionstm femal human insemin artifici insemin artifici heterolog male transmi chlamydia trachomati artifici insemin 
87054701 adhesionspc adult case report dextransadtu fallopian tubessu femal human instil drug peritoneum postop complicationspc subfasci dextran collec periton instil hyskon patient develop subfasci collec dextran abdomin instil hyskon seroma wound dehisc rule nonleak periton closur mai decrea incid thi complic nonleak fascial closur decrea exten dextran collec prevent separ skin 
87054702 adult case report constric pathologicth dilatationi fallopian tube diseasesth femal human support nonu govt transcerv balloon tuboplasti tbt new techniqu balloon cathet techniqu fashion similar balloon angioplasti allow reestablish tubal patenc select case tubal occlusion case present describ transcerv dilat recan proxim occlud fallopian tube patient infertil 
87054704 chronic disea fallopian tube diseasesco femal human pregnanc pregnanc ectopicet salpingitisco tubal cau ectop pregnanc complet histolog studi gravid tube nearli chronic lesion cs wa frequent lesion encount follow sin frequent lesion exten ampulla isthmu involv therefor conserv approach treatment certain tp 
87054706 adult case report fallopian tubessu femal human surgerymt tubal reanastomosi contralat fallopian tube 
87054707 antibodi monoclonalimst antigensim femal human male spermatozoaim trophoblastim clinic relev world health organ workshop human sperm trophoblast antigen letter 
87054708 human male steril rever vasectomymt openend vasectomi letter 
87054709 anim fallopian tube diseasessu fallopian tubessu femal human infertil femalesu method mice pregnanc prognosi salpingitissu uterussu determin success surgeri proxim tubal disea editori 
87054710 adenomarar adolesc adosteroldu adren gland neoplasmsrar adren hyperplasia congenitaldiri adult ag androgenss compar studi diagnosi differenti femal hormon ectop human middl ag ovarian diseasesdiri ovarian neoplasmsrar sterolsdu support nonu govt support govt ph syndrom testosteronebldu tomographi xrai comput virilismdiet diagnost consid viril iodomethylnorcholesterol scan local androgen secret tumor accur local sourc androgen hypersecr critic appropri surgic medic manag women viril patient viril hyperandrogen variou cau evalu sequenti studi testosteron stimul suppr test tomographi ct select venou cathet 131iiodomethylnorcholesterol np59 scintigraphi comparison diagnost accuraci local studi ultim diagno thi group viril women endocrinolog suppressionstimul studi ar limit valu tumor local help onli patient steroidogen enzym defici select cathet ct scan mai provid spuriou local data np59 scintigraphi depict anatom local function androgen hypersecr mai provid signif local data evalu patient viril syndrom 
87054714 adult analysi varianc bromocriptineadtu clomipheneadtu compar studi drug therapi combin femal followup studi galactorrheadi human infertil femaledt lactat disordersdi pregnanc prognosi prolactinbl pyridoxinetu support govt ph bromocriptin therapi normoprolactinem women unexplain infertil galactorrhea fortythr women unexplain infertil women ovul clomiphen citrat therapi fail conceiv evalu becau presenc express galactorrhea normal random prolactin level over mean durat infertil women wa mean standard error mean ag wa fiftytwo women primari infertil treatment protocol evalu twentyf women unexplain infertil group receiv lowdo bromocriptin mg bedtim dai cycl women unexplain infertil group receiv mg pyridoxin continu women receiv clomiphen citrat group receiv bromocriptin manner similar group subject follow treatment cycl pregnanc occur estim cumul pregnanc rate treatment cycl wa group significantli higher rate group leedesu statist women treat bromocriptin conceiv women treat pyridoxin furthermor infertil galactorrh women random prolactin level wa greater equal ngml conceiv express galactorrhea women unexplain infertil high normal prolactin concentr mai serv clinic sign indic women mai benefit lowdo bromocriptin treatment administ bedtim 
87054719 administr oral adult ag factor compar studi doserespon relationship drug drug evalu dydrogesteronepd dnabi endometriumdeenm estradiol dehydrogenasesan femal glycogenm human isocitr dehydrogenasean medroxyprogesteroneaapd menopau menstrual cycl middl ag norethindronepd norgestrelpd progest hormon syntheticadpd progesteronepd refer valu assess potenc oral administ progestin women effect dose oral administ progestin estrogenprim postmenopau endometri biochemistri morpholog featur analyz progestin test norethindron medroxyprogesteron acet mpa norgestrel dydrogesteron progesteron dose requir elicit respon similar seen premenopau secretori endometria wa assess paramet measur rel potenc calcul potenc rel valu norethindron ar norgestrel dl norgestrel mpa dydrogesteron progesteron dose norethindron requir elicit secretori phase activ wa mgdai valu agr publish data obtain differ method delai menstruat premenopau women endometri histolog featur estrogenprim ovariectom women 
87054721 ascit fluidan compar studi estradiolan femal follicular phase human luteal phase ovul detectionmt plasminogenan pregnanc progesteroneanbl plasminogen periton fluid possibl nonsteroid indic ovul plasminogen level periton fluid evalu fertil women regular ovulatori cycl sampl obtain befor ovul sampl ovul plasminogen content concentr postovulatori periton fluid wa mg mgdl respect valu significantli higher preovulatori periton fluid mg mgdl respect estradiol progesteron concentr periton fluid significantli higher ovul respect concentr serum periton fluid linear correl periton fluid plasminogen significantli elev ovul mai nonsteroid marker follicular ruptur oocyt extrusion 
87054722 ascit fluidan autoantibodiesan blood proteinsan chromatographi gel compar studi endometriosisimm endometriumanim femal glycoproteinsanim human menstrual cycl pregnanc proteinsanim proteinsan radioimmunoassai support govt ph uterin neoplasmsimm serum periton fluid protein women endometriosi examin protein serum periton fluid women endometriosi healthi control evid autoimmun respon account impair fertil antibodi endometri glycoprotein progestin depend endometri protein pep ani serum periton fluid sampl level pep differ serum women moder sever endometriosi mild endometriosi diseasefr cycl control pep level periton fluid mild endometriosi control differ elev fluid obtain secretori phase women moder sever disea thi suggest pep level periton fluid reflect extent ectop endometri growth salient wa heretofor undescrib protein mol wt secretori phase periton fluid sampl absenc dure prolif phase 
87054724 fallopian tube diseasescopasu fallopian tubespasu femal human hysterosalpingographi infertil femaleet surgeri pregnanc pregnanc ectopicep prognosi uterussu prognost factor influenc pregnanc rate surgic cornual anastomosi eightytwo women symmetr cornual blockag select evalu result surgic anastomosi relat data preoper hysterosalpingographi histolog studi exci tubal specimen serial occlud tubal portion examin term pregnanc rate wa sever prognost factor influenc postop pregnanc rate reveal maxim tubal length preserv mural portion absenc chronic inflamm absenc tubal inclusion tubal wall absenc tubal endometriosi 
87054725 adolesc adult compar studi femal followup studi human infertil femaleep laparotomi method peritoneoscopi postop complic pregnanc pregnanc ectopicepsu recurr factor conserv laparoscop treatment ectop pregnanc tubal pregnanc treat conserv laparoscop techniqu case requir subsequ laparotomi laparoscop procedur becau retain trophoblast tissu patient desir subsequ pregnanc uterin pregnanc ectop pregnanc women attempt concep follow conserv laparoscop remov ectop gestat sole remain fallopian tube establish uterin pregnanc thi group patient ectop pregnanc fertil result analyz accord previou histori postop uterin pregnanc rate wa patient histori infertil group compar patient histori infertil previou ectop pregnanc group ii subsequ ectop pregnanc rate group wa versu group ii thi larg seri clearli demonstr rel safeti efficaci conserv laparoscop treatment tubal pregnanc 
87054730 compar studi embryo transfer femal fertil vitro human male menstrual cycl oocyt peritoneoscopi pregnanc prognosi prospect studi sperm count sperm motil spermatozoaul support nonu govt sperm morpholog featur prognost factor vitro fertil determin prognost valu percentag normal sperm morpholog featur human vitro fertil ivf program author conduct prospect studi women bilat tubal damag base percentag morpholog normal spermatozoa patient divid group group normal morpholog featur group ii group iii group iv hundr nineti success laparoscop cycl evalu group oocyt obtain fertil pregnanc result group ii oocyt fertil pregnanc rate embryo transfer et group iii oocyt fertil pregnanc rate group iv oocyt fertil pregnanc rate probabl model indic wa clear threshold normal sperm morpholog featur high fertil pregnanc rate group normal sperm morpholog featur greater 
87054731 ejacul femal human insemin artifici homolog lhblur male ovul detec pregnanc sex disord specimen handl sperm count sperm motil spermatozoa urin simpl effect techniqu increa pregnanc rate coupl retrograd ejacul patient retrograd ejacul occasion sampl reason sperm number motil underw protocol includ lutein hormonetim uterin insemin wash sperm recov urin pregnanc occur date patient patient earli protocol period describ techniqu collect sperm ovul sperm recoveri wash uterin insemin ar rel simpl costeffect appear effect contribut pregnanc mani coupl retrograd ejacul 
87054734 adult anim ascit fluid endometriosiscopp femal hamster human infertil femaleet mesocricetu mice mice inbr icr oviductsph ovum ovum transport pariti pregnanc uterin neoplasmscopp factor inhibit ovum captur oviduct fimbria present endometriosi periton fluid cumulusfimbria interac wa investig vitro endometriosi periton fluid pf oviduct fimbria golden hamster incub endometriosi nonendometriosi pf cultur medium contain bovin serum albumin control wa mou oocytecumulu complex 5minut interv minut incub period loss fimbrial capabl ovum captur ovum captur disappear ocdt standard error mean minut endometriosi nonendometriosi pf control respect ocdt wa significantli decrea cellfr filtrat endometriosi pf contain molecular size greater minut respect factor inhibit fimbrial capabl ovum captur present endometriosi pf 
87054735 catheterizationi fallopian tube femal gametogenesi human infertil femaleth male oocyt pregnanc spermatozoa new stirrabl cathet gamet fallopian tube transfer gift cannul fimbriat end fallopian tube dure gamet fallopian tube transfer gift mai extrem difficult requir minilaparotomi ideal laparoscop gift cathet flexibl stirrabl diamet sturdi enabl manipul cathet wa develop collabor cook obgyn division cook indiana primari emphasi easi laparoscop manipul attempt gift result pregnanc 
87054736 blastomeresph cell cultur cultur mediaan femal granulosa cellss human inhibinan oocyt prognosi inhibin concentr cultur media human oocytecumuluscorona cell complex relat subsequ embryo cleavag demonstr vitro secretion inhibin human occc relat subsequ egg cleavag signal relea occc modul inhibin secretion granulosa cell ha discov inhibin secretion occc ha predict valu concern fertil cleavag oocyt 
87054737 adult embryo transfer femal fertil vitro graafian follicl human infertil femaleet lhbl oocyt ovul induc pregnanc progesteronebl syndrom empti follicl syndrom patient oocyt retriev dure ivf cycl studi attempt identifi predictor occurr sugg cau follicl aspir cycl women yield oocyt patient cycl produc egg empti follicl syndrom mai repr new syndrom cau infertil 
87054739 adult compar studi endometriosisco femal human pariti prospect studi ureterabra urographi uterin neoplasmsco uret abnorm women endometriosi highvolum venou urographi wa perform women surgic proven endometriosi subtl abnorm women patient urolog symptom wa evid hydrouret uret obstruc ivp longterm followup studi requir determin lesion progress cau uret obstruc 
87054740 adrenerg alpha receptor blockadersadaetu adrenerg beta receptor agonistsadaetu ethanolaminesadaetu femal human infertil maledt male oligospermiadt pregnanc quinazolinesadaetu sperm count sperm motil factor success treatment oligosperm azoosperm alpha 1blocker betastimul new treatment idiopath male infertil studi effect oral administr alpha 1blocker betastimul idiopath infertil bunazosin alpha 1blocker mgdai procaterol betastimul gramsdai oral twice daili administr alpha 1blocker betastimul elicit increa sperm output semin volum patient increa sperm output associ relax myoid cell lead dilat stenot area seminif tubul occur discontinu subsequ mainten tubular fluid flow adver effect observ thi seri 
87054743 abor habitualetpc autoimmun diseasescoth blood transfusion femal human immunotherapi pregnanc blood transfusion habitu abor letter 
87054745 clomiphenepdtu femal human infant newborn infertil maledt male sex ratio sex ratio male clomiphen treatment letter 
87055083 anim bind site biopsi colonpa colon neoplasmscimepa dimethylhydrazin intestin mucosamepa lectinsm male mucinsm precanc conditionsmepa rat stain stain support govt nonph support govt ph serial observ colon carcinogenesi rat premalign mucosa bind ulex europeu agglutinin evalu certain histochem test abil detect premalign mucosa dimethylhydrazin model colon carcinogenesi biweekli colonoscop biopsi descend colon perform wk control dimethylhydrazinetr rat biopsi specimen splenic flexur rectum ani visual tumor specimen stain period acidschiff detect neutral mucin highiron diamin alcian blue detect sialyl sulfat mucin fluorescein peanut agglutinin fluorescein ulex europeu agglutinin test consist detect premalign mucosa howev ulex europeu agglutinin bound onli control biopsi specimen cour studi bound increa number biopsi specimen dimethylhydrazinetr anim reach maximum posit wk moreov ulex europeu agglutinin bound strongli biopsi specimen tissu adjac tumor tumor muco atrophi focal dysplasia present frequent specimen rectum splenic flexur dimethylhydrazinetr anim control anim wa correl histochem marker atrophi dysplasia conclud ulex europeu agglutinin bind consist featur premalign colon mucosa dimethylhydrazinetr rat 
87055084 alcohol ethylto anim calciumph calcium channel blockerstu gastritiscipc indomethacinto male preme rat rat inbr f344 calcium channel blocker protect ethanol indomethacininduc gastric lesion rat current studi design investig effect calcium channel blocker chemic induc gastric lesion rat result thi studi indic pretreat male f344 rat calcium channel blocker verapamil diltiazem mg2 significantli protect ethanol indomethacininduc gastric lesion demonstr gross histopatholog evalu treatment rat calcium channel blocker befor ethanol indomethacin administr result signif declin mean number lesion glandular stomach damag area glandular stomach sever lesion calcium channel blocker cau signif declin incid indomethacininduc gastric lesion effect incid ethanolinduc gastric lesion result offer evid calcium channel blocker mai plai import role protec chemic induc gastric lesion therebi offer insight mechan gastric ulcer format specul thi knowledg mai prove import develop new improv therapi treatment preven gastric ulcer human 
87055085 adolesc adult ag diarrheaet fecesmi gastrointestin diseaseset human middl ag yersinia enterocoliticaip yersinia infectionsdi gastrointestin featur cultureposit yersinia enterocolitica infec yersinia enterocolitica wa cultur fece symptomat adult singl facil select cultur media isol confirm independ refer laboratori isol multipl serotyp defin biochem typic yersinia enterocolitica agent seen patient yersinia fredriksenii clostridium difficil diarrhea abdomin pain common wherea featur fever bloodi stool unusu antibiot opiat befor cultur wa common termin ileum wa seen radiograph patient onli barium studi abnorm fiberopt endoscopi biopsi studi greater case minim chang patient howev patient membran coliti concomit clostridium difficil cytotoxin diffu sever coliti new cultur techniqu possibli geograph differ contribut high isol rate thi organ yersinia enterocolitica occur sporad involv varieti serotyp associ broader clinic spectrum wa formerli appreci 
87055086 barrett esophagusdiet endoscopi esophag diseaseset gastroesophag refluxco human manometri prospect studi support govt nonph barrett esophagu preval occult complic gastroesophag reflux disea prospect studi patient symptom gastroesophag reflux wa undertaken determin preval barrett esophagu reevalu diagnost approach necessari detect thi complic endoscopi muco biopsi wa perform subject twelv barrett esophagu sensit specif endoscop radiolog examin barrett esophagu prospect evalu endoscopi wa significantli sensit radiologi detect barrett esophagu frequenc sever reflux symptom patient determin barrett esophagu reflux esophag normal esophag biopsi quantit similar group significantli greater daytim heartburn reflux esophag data indic barrett esophagu complic gastroesophag reflux previou believ 
87055087 alcoholismco dietari fatsm gastric juiceen human intestin absorp intestin secretionsen lipasem lipolysi male middl ag pancreat insufficiencyetm support govt ph role nonpancreat lipolyt activ exocrin pancreat insuffici patient exocrin pancreat insuffici mai absorb greater dietari fat despit absenc measur pancreat lipa activ nonpancreat lipolyt activ wa measur gastric duoden aspir patient exocrin pancreat insuffici secondari alcohol aspir alcohol evid exocrin pancreat dysfunc control sampl collect fast postprandi condition patient exocrin pancreat insuffici nonpancreat lipolyt activ gastric duoden aspir lipolyt activ gastric aspir wa significantli differ patient exocrin pancreat insuffici control dure fast postprandi period pancreat insuffici wa associ significantli higher nonpancreat lipolyt activ duodenum fast condition signif differ group wa postprandi nonpancreat lipolyt activ nonpancreat lipolyt activ account approxim total lipolyt activ ligam treitz patient exocrin pancreat insuffici oppo control subject observ suggest signif role nonpancreat lipolyt activ lingual lipa gastric lipa fat dige patient pancreat insuffici secondari chronic alcohol abu 
87055088 alcohol ethylto anim capillariesul cysteaminepd femal gastric mucosabsd preme prostaglandin fpd rat rat inbr strain support govt ph ethanolinduc damag muco capillari rat stomach structur featur effect prostaglandin f2 beta cysteamin impair muco circul mai contribut ethanolinduc gastric muco damag thi report describ diffu sever structur damag capillari gastric glandular mucosa rat occur min gastric instil ethanol wa gradient damag endoth cell structur wa sever disrupt profil capillari locat close lumin surfac morpholog evid damag wa evid wall capillari profil mean depth capillari structur wa gener normal deeper region mucosa pretreat gastric cysteamin mg100 gastric prostaglandin f2 beta mg100 significantli reduc depth mucosa damag capillari extend pretreat gastric prostaglandin f2 beta mg100 afford signif protec conclud 1min exposur ethanol induc strike damag circul glandular mucosa rat stomach sever damag capillari profil lumen spare capillari profil musculari mucosa pretreat sulfhydryl agent cysteamin larg dose prostaglandin f2 beta reduc extent doe abolish ethanolinduc damag gastric muco capillari 
87055089 adult ag degluti esophagogastr junctionpp esophaguspp femal gastroesophag refluxpp hernia diaphragmaticpp hernia hiatalpp human hydrogenion concentr male middl ag peristalsi technetium tc 99m sulfur colloiddu identif mechan delai esophag acid clearanc subject hiatu hernia determin hiatu hernia hh contribut delai clearanc acid esophagu patient gastroesophag reflux ger perform simultan esophag ph record radionuclid studi studi popul ger patient hh ger patient hh subject hh ger symptom acid clearanc wa measur cm abov manometr locat lower esophag sphincter le inject 15ml bolu hcl cm abov le acid wa label mu ci 99mtcsulfur colloid acid clearanc wa measur cm abov le injec 15ml bolu hcl cm abov le acid clearanc cm abov le wa faster ger patient hh compar ger patient hh asymptomat hh subject acid clearanc wa faster cm cm abov le hh nonhh subject studi nonhh subject swallow result increa ph monopha ph respon cm abov le symptomat asymptomat hh subject swallow result initi fall follow rise ph cm abov le bipha ph respon radionuclid studi reflux isotopelabel acid esophagu follow clearanc bipha respon accompani swallow hh subject swallowinduc reflux wa detect radionuclid scan nonhh subject base observ conclud dure acid clearanc acid trap hh sac reflux esophagu dure subsequ swallow relax le repeat episod acid reflux hh account delai acid clearanc observ ger patient hh 
87055090 amino acidsm egg proteinsm human hydrolysi intestin absorp jejunumm nitrogenm oligopeptidesm ovalbuminm bowel syndromem effect peptid chain length absorp egg protein hydroli normal human jejunum influenc peptid chain length partial enzym hydroli protein nitrogen amino acid absorp wa studi subject jejun perfusion techniqu hydroli egg white equiv amino acid mixtur perfu mmoll mmoll separ experi hydroli oh1 oh2 contain mainli dipeptid tripeptid wherea oh3 compri tripeptid pentapeptid judg chromatograph nitrogen absorp wa significantli slower higher chain length mixtur oh3 chain mixtur oh1 oh2 concentr similarli sever amino acid residu absorb oh3 oh1 oh2 data demonstr chain length heterogen mixtur peptid affect absorp nitrogen individu amino acid residu suggest brush border hydrolysi tetrapeptid pentapeptid limit absorp enzym hydroli protein simul composi postprandi lumin content 
87055091 amino acid sequenc anim antibodi monoclonaldu antigen determin chromatographi affin electrophoresi polyacrylamid gel gastric mucosaan human mice pepsinogengeim polymorph genet support govt nonph support govt ph immunochem electrophoret genet heterogen pepsinogen charact monoclon antibodi immunolog subclass human pepsinogen alphapg betapg identifi base reactiv murin monoclon antibodi recogn epitop alphapg isozymogen antibodi wa purifi major alpha betaisozymogen gastric mucosa determin contribu previou describ genet polymorph pg alphaepitop wa local pepsin region molecul major alphapg isozymogen pg alpha pg alpha major betapg isozymogen pg beta demonstr contain net charg differ locat respect pepsin activ peptid region propo alpha betasubclass contain net charg amino acid substitu encod correspond pepsinogen gene pga3 pga4 pga5 
87055092 adult ag bile acid saltsm carbon radioisotopesdu cholestyraminetu chronic disea diarrheapcpp femal human ileumpp intestin absorp malabsorp syndromespp male middl ag schill test support nonu govt support govt ph studi preval signif radiolabel bile acid malabsorp group patient idiopath chronic diarrhea studi radiolabel fecal bile acid excretion normal subject patient idiopath chronic diarrhea major purpo establish normal valu thi test presenc increa stool volum induc normal subject ing poorli absorb solution test bile acid malabsorp patient correl thi independ test ileal function schill test compar result bile acid excretion test subsequ effect bile acid bind agent cholestyramin stool weight normal subject fecal excretion radiolabel wa increa increa stool volum group patient idiopath chronic diarrhea excret radiolabel bile acid rapidli normal subject induc diarrhea t12 vs respect wa statist signif posit correl t12 radiolabel bile acid schill test result patient patient absorb label taurochol acid ani normal subject compar volum induc diarrhea cholestyramin statist signif effect stool weight patient group patient wa stool weight reduc normal rang summari patient idiopath chronic diarrhea bile acid malabsorp measur fecal excretion label bile acid thei respond cholestyramin therapi signif reduc stool weight signif wa clearli establish interpret bile acid malabsorp manifest underli intestin motil absorpt defect primari cau diarrhea 
87055094 adult compar studi diabet mellituspp doubleblind method femal gastric emptyingd human male metoclopramidetu middl ag piperidinestu random alloc support nonu govt support govt nonph support govt ph effect cisaprid gastric empti indigest solid patient gastroparesi diabeticorum comparison metoclopramid placebo cisaprid prokinet agent believ facilit acetylcholin relea myenter plexu gut effect cisaprid gastric empti solid wa studi diabet patient delai gastric empti indigest solid gastroparesi patient chronic nausea vomit symptom cisaprid mg wa venou min befor ing 400kcal test meal indigest solid radiopaqu marker separ dai random order patient receiv venou metoclopramid mg placebo min befor ing meal marker mean gastric empti radiopaqu marker assess serial radiograph gastric region wa accel metoclopramid cisaprid differ reach signif onli cisaprid wa consid intersubject variabl gastric empti respon cisaprid metoclopramid effect occur drug thi studi indic acut venou administr cisaprid accel gastric empti indigest solid patient diabet gastroparesi 
87055095 anim gallbladderph gastric fundusph guinea pig ileumph male muscl contrac muscl smoothph neuronsph proglumidepd receptor cholecystokinindeph receptor cholinergicph sincalidepd support govt ph region cellular heterogen cholecystokinin receptor mediat muscl contrac gut publish erratum appear gastroenterologi jun9262055 contractil action cholecystokinin cck smooth muscl gut direct gallbladd gastric fundu direct neural mediat intestin region differ charact pharmacolog cck receptor smooth muscl cell neuron gastric fundu gallbladd ileum guinea pig circular longitudin ileal smooth muscl tetrodotoxin wa separ direct neural mediat contractil effect cholecystokinin receptor smooth muscl cell locat muscl cell displai decrea order sensit ctermin octapeptid cholecystokinin express median dose select cholecystokinin antagonist proglumid express inhibitori dissoci constant median dose octapeptid cholecystokinin rang nm gallbladd muscl nm circular ileal muscl correspond inhibitori dissoci constant proglumid rang correct cholecystokinin receptor cholinerg neuron confin circular longitudin ileal muscl neuron sensit octapeptid cholecystokinin d50 nm correspond muscl cell sensit proglumid inhibitori dissoci constant correct result provid clear evid cellular heterogen cholecystokinin receptor differ sensit muscl cell neuron locat region heterogen differ sensit muscl cell variou locat 
87055096 coliti ulcerativedi colonoscopi crohn diseasedi followup studi human prospect studi colonoscopi inflammatori bowel disea diagnost accuraci propo endoscop score colonoscopi differenti diagnosi inflammatori bowel disea accuraci weight variou endoscop sign assess prospect studi patient colonoscopi endoscop appear ulcer coliti crohn coliti indetermin coliti followedup averag period mo final definit endoscopyindepend diagnosi wa reach mean autopsi surgeri histologi biopsi patient accuraci colonoscopi wa error indetermin diagno error frequent sever inflammatori activ endoscop featur thi differenti diagnosi discontinu involv anal lesion cobbleston mucosa crohn disea erosion ulcer granular ulcer coliti select endoscop featur predict valu endoscop score wa calcul mean likelihood ratio 
87055098 adult ag ag biopsi chronic disea dna viralan femal hepat core antigensan hepat surfac antigensan hepat virusg human liverim liver diseasesim male middl ag support nonu govt correl hepat viru dna antigen liver studi chronic liver disea hepat viru deoxyribonucl acid dna antigen hbsag hbcag studi liver biopsi specimen hbsagposit patient chronic liver disea free integr viral dna wa detect patient wherea hbsag hbcag demonstr immunohistolog respect patient detect free viral dna posit hbcag wherea onli integr viral dna alon detect viral dna wa posit hbcag furthermor hbcag wa posit correl free viral dna liver tissu contrast hbsag wa express onli liver free viral dna liver integr dna data suggest synthesi hbcag primarili direct free viral dna wherea hbsag mai direct free integr viral dna 
87055100 adult human indocyanin greendu liverm liver cirrhosi alcoholicm male middl ag sex hormonebind globulinm sex hormonesm hepat uptak sex steroid alcohol cirrhosi attempt determin extent degr liver function impair affect hepat uptak consequ alter plasma level endogen sex steroid male patient alcohol cirrhosi plasma level hepat uptak steroid dehydroepiandrosteron androstenedion testosteron dihydrotestosteron estron estradiol progesteron 17hydroxyprogesteron assess plasma level testosteron dehydroepiandrosteron significantli reduc wherea androstenedion estron estradiol significantli elev alcohol cirrhosi compar control sex hormon bind globulin level significantli elev hepat uptak sex steroid depend degr liver function impair shown linear signif relationship hepat extrac indocyanin green dihydrotestosteron signif addition hepat uptak sex steroid depend bind affin sex hormon bind globulin higher affin sex hormon bind globulin lower hepat uptak influenc liver function impair wa estim hepat clearanc account onli metabol clearanc sex steroid signif relationship plasma level sex steroid hepat clearanc wa alcohol cirrhosi extent hepat uptak sex steroid depend partli degr liver function impair partli degr thei ar bound sex hormon bind globulin produc rate periph metabol hepat uptak alon mai account alter circul level sex steroid 
87055101 followup studi hepat alcoholicco human liverpa liver cirrhosi alcoholiccomopa prognosi prospect studi prognosi alcohol cirrhosi presenc absenc alcohol hepat liver biopsi specimen percutan transjugular assess consecut patient alcohol liver disea noncirrhot cirrhot case follow yr cirrhot patient categor group hepat criteria defin hepat includ onli degr inflamm necrosi mallori bodi prognost weight term mortal yr thi classif result sharp separ group patient cirrhosi hepat low mortal yr yr anoth group patient cirrhosi hepat high mortal yr yr importantli 1yr mortal patient cirrhosi hepat wa statist differ patient cirrhosi hepat onli fatti liver yr yr mark differ sever variabl cirrhosi hepat combin clinic laboratori index hepat hepat score collagen space diss hepat hepat hepatocyt crosssec surfac area hepat hepat sever transjugular group percutan group collagen space diss hepatocyt surfac area statist differ cirrhosi hepat wa compar similar hepat group patient noncirrhot alcohol liver disea thi patient sampl presenc parenchym nodul fibrou septa se result increa mortal respect alcohol patient cirrhosi hepat 
87055102 adolesc adult ag femal followup studi hepat surfac antigensan hepat chronic activedt human male middl ag prednisonetu prognosi recurr risk factor sustain remi corticosteroid therapi sever hepat surfac antigenneg chronic activ hepat determin frequenc sustain remi assess longterm prognosi relap retreat patient sever hepat surfac antigenneg chronic activ hepat prolong followup initi corticosteroid withdraw mean yr evalu selec patient wa case sever disea twentyfour patient sustain remi yr mean yr initi therapi relap retreat patient sustain remi shorter durat ill befor therapi vs mo thei greater laboratori improv dure treatment frequenc cirrhosi death significantli greater patient relap patient relap ultim enter sustain remi retreat remi yr wa possibl patient major drug complic develop commonli relap requir retreat vs conclud patient enter remi dure initi therapi mai ultim achiev sustain remi especi disea durat adequ suppress dure treatment relap doe affect longterm prognosi retreat associ effect 
87055104 aorta abdominalsu case report duodenitiset gastritiset human ischemiaco male mesent arteriessu mesent vascular occlusioncosu middl ag chronic ischem gastriti rever revascular oper patient sever chronic gastriti duoden clinic endoscop disappear intestin revascular procedur report chronic intestin ischemia appear cau gastriti seen thi patient 
87055105 adolesc case report combin modal therapi esophag neoplasmsthul esophaguspa human male support nonu govt support govt ph synoviomathul polypoid synovi sarcoma esophagu pure sarcoma esophagu ar exceedingli rare report case esophag synovi sarcoma occur adolesc tumor wa local resect spare patient esophagectomi postop radiat therapi patient remain aliv evid disea mo oper uniqu natur polypoid sarcoma esophagu potenti cure esophagectomi discuss 
87055106 anim autoradiographi femal gastrointestin systemm liverm male pancreasm papiom receptor androgenm receptor estrogenm stomachm support govt ph sex steroid receptor stomach liver pancrea gastrointestin tract baboon sex steroid shown mark effect physiolog activ liver gastrointestin tract perform autoradiograph studi 3hestradiol 3hdihydrotestosteron male femal baboon purpo identifi estrogen androgen receptor liver pancrea stomach larg intestin baboon evid presenc estrogen androgen receptor wa appar high concentr silver grain nuclei cell tissu androgen receptor larg confin nuclei smooth muscl cell tunica musculari gut wall connect tissu interst cell liver pancrea stomach intestin estrogen receptor promin nuclei vascular smooth muscl cell liver pancrea gut major endocrin islet cell observ suggest varieti differ cell type liver pancrea gastrointestin tract contain estrogen androgen receptor modul cellular activ influenc sever differ physiolog process 
87055108 adult case report glycoproteinsdf heterozygot human male mesent vascular occlusionet mesent vein pedigr protein deficiencyg thrombosiset mesent vein thrombosi present manifest hereditari protein defici protein defici inherit autosom domin trait heterozygot reduc plasma protein concentr ar risk develop venou thromboembol occur earli ag appar cau major patient thrombosi restrict superfici deep venou leg thi case report describ presenc mesent vein thrombosi 30yrold hereditari protein defici hi famili protein defici wa recogn hi mother brother niec hi mother brother histori thrombot disea 
87055110 clinic compet gastroenterologi evalu procedur skill gastroenterologist editori 
87055111 azathioprinetu chlorambuciltu colchicinetu human liver cirrhosi biliarydt anoth treatment primari biliari cirrhosi editori 
87055112 bile refluxdt biliari tract diseasesdt compar studi deoxychol acidaa gastritisdt human research design ursodeoxychol acidtu efficaci udca treat bile reflux gastriti letter 
87055113 evok potenti somatosensori hepat encephalopathypp human somatosensori evok potenti hepat encephalopathi letter 
87055114 femal human immunolog defici syndromesco liver cirrhosi biliaryco lung diseasesco sarcoidosisco immun defici primari biliari cirrhosi letter 
87055115 dysgammaglobulinemiaco femal human igadf liver cirrhosi biliaryco middl ag select iga defici primari biliari cirrhosi letter 
87055117 compar studi femal human male research designst import adequ control experi design letter 
87055118 gastric mucosapa hernia diaphragmaticpa human linear gastric erosion associ diaphragmat hernia letter 
87055119 amiodaronepd cellular inclusionsd human vitro liverd amiodaroneinduc lysosom inclusion primari cultur human hepatocyt letter 
87055120 eat gallbladderph human gallbladd empti respon sham feed letter 
87055121 femal human hydrothoraxri liver cirrhosisco middl ag technetium tc 99m sulfur colloiddu 99mtcsulfur colloid studi hepat hydrothorax letter 
87055122 adult case report drug therapi combin hepat bdt human liver diseasesci male prednisolonea vidarabinea sever hepat failur araaprednisolon chronic type hepat letter 
87055124 adult ag colonph compar studi dietari fiberad femal gastrointestin motil gastrointestin systemra human male middl ag support govt ph simplifi assess segment colon transit transit radiopaqu marker human gut measur publish techniqu compar simplifi method distinct marker ingest healthi person success dai studi daili abdomin xrai individu stool collect radiographi mouthtoanu transit assess fecal output marker mean colon segment colon transit calcul daili radiograph establish method compar estim total colon segment transit base singl abdomin film fourth dai singlefilm techniqu correl valu obtain previou inconveni method simpler approach colon transit wa assess addition healthi subject total group total colon transit wa mean se segment transit wa right colon left colon rectosigmoid significantli shorter transit colon women thi differ wa appar extent right left colon rectosigmoid ag influenc transit significantli dose supplem fiber techniqu simpl conveni clinic usag reduc exposur radiat accept level role thi approach evalu colon transit select patient 
87055126 anim cardiac output colitisetpp colonb dinitrochlorobenzeneto hydrazinespd imidazolespd immun complex diseasepp male prostaglandinsph rabbit receptor prostaglandind region blood flow support govt ph thromboxan synthetaseai prostaglandin regul colon blood flow rabbit coliti human experi coliti ar associ relea vasoconstrictor vasodil eicosanoid determin pattern colon blood flow vivo role prostaglandin thromboxan immun complexmedi coliti delai hypersensitivitymedi coliti induc rabbit organ blood flow wa determin consciou anim radiolabel sphere befor cyclooxygena thromboxan syntheta inhibi colon blood flow wa twofold higher coliti control anim thromboxan syntheta inhibi dazoxiben cau slight increa colon perfusion anim coliti thromboxan receptor blockad effect prostaglandin inhibi indomethacin ibuprofen affect blood flow control anim coliti drug markedli reduc colon blood flow level control anim data demonstr vasodilatori prostaglandin enhanc colon blood flow acut colon inflamm 
87055129 anim anim newborn endocytosi intestin diseasesetpa intestin mucosami mice peyer patchesmi reoviridaepi reoviru infectionsetpa support nonu govt support govt ph adher penetr intestin epithelium reoviru type neonat mice 10dayold suckl adult mice reoviru type adher select penetr membran epith cell determin cell appear thei transport reoviru reoviru adher endocyto epith cell postnat examin neonat mou intestin transmi electron scopi reoviru type exposur dai cell account dome epith cell dai cell increa reoviru type adher surfac villu dome epith cell mark variat 26dayold anim dai onli absorpt cell profil adher reoviru adher greater mcell profil occur anim adher major peyer patch absorpt cell profil wa present onli 5dayold anim adher major undifferenti cell profil occur anim ag membran epith cell endocyto reoviru ag onli dai rare villu dome absorpt cell endocyto reoviru apic cytoplasm thu adher reoviru apic surfac muco epith cell nonselect newborn mice becom select postnat adher dai mcell profil substanti variabl number undifferenti cell profil absorpt cell profil 
87055130 adult femal gastrointestin motil human male motion sicknessetpp rotat spectrum analysi support govt nonph spectral analysi tachygastria record dure motion sick purpo present experi wa studi frequenc chang gastric myoelectr activ healthi human subject develop symptom motion sick vection illusori selfmotion fast healthi human subject seat insid circular vection drum rotat produc visual signal selfmotion ar conflict vestibular signal mismatch sensori input electrogastrogram wa obtain 15min period baselin rotat drum rotat stop respir symptom volunt subject continu measur inten symptom record subject continu normal 3cyclesmin activ dure drum rotat report symptom motion sick subject shift domin gastric frequenc cyclesmin cyclesmin dure drum rotat report symptom motion sick run spectral analysi reveal close correspond tachygastria report symptom motion sick 
87055271 audiometri pureton hear loss partialdi human middl ag referr consult modern hear assist physician ar gatewai editori 
87055272 ag drugsm geriatr human therapeut equiv gener sustitu affect qualiti geriatr care 
87055273 accid fall accid ag arrhythmiaco arteri occlu diseasesco drugsa gait hear disordersco human hypoten orthostaticco nervou diseasesco seizuresco sensat syncopeco vision disordersco cau fall logic diagnost procedur ani fall elderli mai signal impend major ill fall mai cau ani acut chronic ill cau weak dizzi mi stroke gi bleed mai present fall fall sign urinari tract respiratori gallbladd infec avoid openend happen patient state thei slip trippedpossibli true reason fall direct symptom difficulti walk feel dizzi elicit specif inform 
87055275 ag backacheetrath estrogenstu femal human osteoarthritiscorath osteoporosiscorath paindt spinal neoplasmscorascth tomographi xrai comput pain elderli updat diagnosi manag ct compr fractur adjunct plain xrai exclud sign metastasi howev increa bone densiti ct mai distinguish osteoporot fractur neoplast disea case radioiodin scan bone marrow biopsi myelographi mai necessari surgeri pain osteoarthrit spinal disea controversi potenti advantag surgeri weight risk anesthesia length toler postop immobl effect laminectomi fusion biomechan spine furthermor elderli ar increa risk postop complic 
87055276 ag audiometri femal hear aid hear loss sensorineuralth human male middl ag presbycusiscldietppth speech perceptionph restor hear older patient physician role grow evid failur diagno manag hear problem earli cour result signif andto extentirrev sensori depriv primari care physician routin screen patient ag pureton sensit gener physic examin batteryop inoff limitedfrequ audiomet ar avail 
87055357 anorexia nervosadipppx femal human weedkil editori 
87055358 adolesc adult anorexia nervosadidtpp diagnosi differenti domperidonetu esophag diseasesdi femal gastric empti gastrointestin diseasesdi gastrointestin motil human oesophag gastric motil disord patient categori primari anorexia nervosa gastrointestin motor function patient primari anorexia nervosa ha rare investig studi oesophag motor activ consecut patient meet standard diagnost criteria primari anorexia nervosa feighner et al dsm iii suffer achalasia primari anorexia nervosa diffu oesophag spasm sever gastrooesophag reflux upper oesophag sphincter hyperton partli nonpropul repetit high amplitud durat contrac prevail lower oesophagu anoth patient oesophag dysmotil respond therapi patient normal oesophag manometri gastric empti semisolid meal wa studi empti wa normal onli markedli delai case half empti min median min compar min median min healthi control patient effect domperidon mg iv placebo compar random doubl blind condition half empti shorten significantli domperidon conclusion symptom disord upper gastrointestin motor activ mai mistaken indic primari anorexia nervosa clinic evalu patient presum primari anorexia nervosa rule possibl disord oesophag motor activ underli symptom delai gastric empti frequent featur primari anorexia nervosa return normal domperidon 
87055359 adult colon disea functionalcopapp endoscopi esophaguspapp femal gastroesophag refluxco human hydrogenion concentr male manometri middl ag gastrooesophag reflux irrit bowel syndrom symptomat assess oesophag investig consecut patient irrit bowel syndrom attend gastroenterolog clinic symptom gastrooesophag reflux dysphagia globu sensat significantli common control group fractur clinic patient ambulatori oesophag ph monitor clearli abnorm reflux patient patient macroscop endoscop chang biopsi chang alon oesophag wa thu present over lower oesophag sphincter pressur wa significantli irrit bowel patient ag sex match control upper oesophag sphincter pressur wa compar group disord peristalsi wa oesophag symptom irrit bowel syndrom ar mainli cau gastrooesophag reflux predispo subnorm lower oesophag sphincter pressur oesophag spasm 
87055360 campylobacterip duoden ulcermi duodenitismi duodenummipa endoscopi gastritismi human prospect studi pylor antrummipa retrospect studi support nonu govt campylobact organ duoden antral endoscop biopsi relationship inflamm endoscop duoden biopsi studi retrospect pair duoden antral biopsi assess prospect campylobact organ seen retrospect examin duoden biopsi examin prospect antral biopsi duodenum organ mostli confin surfac epithelium area gastric metaplasia antrum thei superfici gland strong associ wa shown presenc campylobact organ histolog activ duoden inflamm 
87055361 ag cerebrovascular disordersmo dieta duoden ulcermo femal human male middl ag risk sodium chloridea stomach ulcercimo support nonu govt unit state dietari salt gastric ulcer publish erratum appear gut dec27121523 statist signif linear correl geograph variat salt consump mortal gastric duoden ulcer ar report suggest dietari consump salt risk factor mortal gastric ulcer 
87055362 adren cortexdem adren cortex hormonesbi adrenocorticotrop hormonepd anim cattl cell cultur cimetidinepd corticosteronebi desoxycorticosteronebi doserespon relationship drug hydrocortisonebi ranitidinepd dose relat vitro effect ranitidin cimetidin basal acthstimul steroidogenesi isol bovin adrenocort cell incub ngml acth variou concentr gramsml cimetidin ranitidin cortisol corticosteron deoxycorticosteron output measur cimetidin ranitidin gramsml inhibit acthstimul corticosteron cortisol synthesi cimetidin decrea basal cortisol synthesi inhibitori effect cimetidin cortisol synthesi approxim greater ranitidin cimetidin gramsml ranitidin increa deoxycorticosteron synthesi acthstimul cell indic inhibi betahydroxyl adren steroidogen pathwai dose cimetidin ranitidin produc vitro effect ar greater plasma concentr normal clinic thei import acut ill patient venou bolu injec cimetidin antagonist accumul adren produc high cellular concentr 
87055363 adult chloridesm eat femal gastric acid human intestin absorp jejunumm male potassiumm sodiumm vagu nerveph waterm influenc sham feed salt water absorp human jejunum vagal stimul induc sham feed healthi subject wa examin possibl autonom nervou involv control human jejun absorp gastric acid secretion wa measur gastric aspir correct recoveri jejun absorp wa determin tripl lumen perfusion techniqu sham feed induc signif increa gastric acid secretion mmolh jejun absorp water decrea significantli ml30cmh sodium mmol30cmh chlorid mmol30cmh dure sham feed gastric acid secretion jejun absorp return basal valu result suggest vagal stimul mai influenc jejun absorp salt water support possibl autonom nervou ha physiolog role control intestin muco function 
87055364 adolesc adult ag celiac diseasedhim enzymelink immunosorb assai human igabi iga secretorybi iggbi igmbi immunoglobulinsbi intestin mucosaim jejunumim middl ag organ cultur support nonu govt immunoglobulin produc coeliac biopsi organ cultur produc immunoglobulin jejun mucosa dure organ cultur ha studi untreat coeliac patient iga secretori iga igm cultur medium higher normal control result treat coeliac patient differ control subject muco biopsi patient serum iga defici produc veri littl iga larg igg igm addition frazer gluten fraction iii alphagliadin cultur stimul ani addition increa secretion immunoglobulin untreat coeliac patient produc iga igm bowel mucosa continu dure organ cultur igg appear insignif 
87055365 adult breath test compar studi femal fructosem glucosem human hydrogenan intestin absorp male middl ag sucrosem absorp capac fructo healthi adult comparison sucro constitu monosaccharid capac absorb fructo healthi adult wa investig mean hydrogen breath analysi fructo absorp wa quantifi lactulo standard signif hydrogen produc greater equal ppm rise breath hydrogen wa challeng solution fructo subject respect subject malabsorp dose possibli fructo contrast malabsorp detect ani subject ing sucro mixtur gluco fructo ing mixtur fructo gluco fructo gluco malabsorp wa present subject respect symptom dure challeng mild absent conclud healthi state absorp capac fructo alon rang absorp capac fructo sucro higher gluco stimul fructo uptak dose depend fashion possibl exist intestin transport fructo consid elucid clinic relev import 
87055366 administr oral adult ag enterocol membranousdtm fecesan femal human injec venou male metronidazoleaaadantu middl ag faecal metronidazol concentr dure oral venou therapi antibiot associ coliti clostridium difficil faecal metronidazol hydroxymetronidazol concentr measur high pressur liquid chromatographi ar report dure episod clostridium difficil coliti patient bactericid faecal concentr present patient acut disea receiv oral venou metronidazol respond therapi metronidazol hydroxymetronidazol concentr diarrhoea improv substanc wa detect faec patient recoveri thi demonstr colon therapeut concentr metronidazol support clinic experi oral metronidazol effect treatment antibiot associ diarrhoea cau difficil suggest potenti role venou metronidazol thi disea 
87055367 aminesan anim cattl chromatographi layer compar studi fecesan femal gastroenterit human infant infant food male milk phenethylaminesan spectrum analysi mass support nonu govt tryptaminesan tyraminean studi free faecal amin infant gastroent healthi infant free primari amin present faec infant gastroent examin field desorp mass spectrometri lacton form fluorescamin deriv prior separ ptyramin 2phenylethylamin diamin putrescin cadaverin sever acyl deriv common constitu number amin characteri layer chromatographi field desorp mass spectrometri amin dansyl deriv compar studi wa faecal amin select infant gastroent diarrhoea healthi infant ptyramin abund amin wa significantli higher sick infant over presenc ptyramin wa significantli relat diet infant faecal tyramin wa low breast fed infant significantli higher infant fed cow milk 
87055368 adult ag ag cholecystectomya colon polypset femal human intestin polypset male middl ag rectal neoplasmset retrospect studi risk cholecystectomi adenomat polyp larg bowel seventi patient women colon adenoma compar adenoma free control women investig possibl associ previou cholecystectomi subsequ develop adenoma data gather retrospect medic record over wa signif associ colon adenoma previou cholecystectomi women ar consid separ howev case control undergon cholecystectomi odd ratio infin lower confid limit greater associ previou cholecystectomi larg bowel adenoma wa women right colon adenoma undergon previou cholecystectomi compar onli women left adenoma 
87055369 adult ag ag cholangiopancreatographi endoscop retrograd common bile duct neoplasmspasu femal human male middl ag vater ampullapasu tumour tumour region ampulla vater endoscop clinic patholog studi larg seri patient refer endoscop retrograd cholangiopancreatographi endoscopist patient duodenoscop appear periampullari tumour thirti lesion neoplast remain patient inflammatori nonneoplast lesion tumour distinguish neoplasm endoscop appear cholangiopancreatogram similar diamet pancreat duct tend higher tumour group gall stone present significantli patient tumour endoscop biopsi correctli diagno ampullari carcinoma tumour patient subject surgic excision biopsi becau suspici histolog featur endoscop biopsi neoplast group patient underw whippl procedur surgic bypass endoscop sphincterotomi onli di success biliari drainag over surviv wa contrast patient tumour clinic median follow rang endoscop sphincterotomi old patient di unrel cau 
87055370 adult ag ag cholangiopancreatographi endoscop retrogrademt common bile duct calculirasu common bile duct neoplasmssu femal gastrectomi human male middl ag endoscop retrograd cholangiographi endoscop papillotomi patient previou billrothii resec method endoscop retrograd cholangiographi erc endoscop papillotomi ept patient billrothii oper ar describ experi dure sinc present endoscop retrograd cholangiopancreatographi wa success patient endoscop papillotomi wa success patient describ method differ hospit differ endoscopist wa differ result conclud patient billrothii oper mai undergo endoscop diagnost therapeut procedur high rate success similar result ordinari patient greater risk complic 
87055371 alcoholismpa esophag gastric varicespa femal gastric mucosapa gastroscopi human hyperten portalpa liver cirrhosispa male middl ag portal hyperten gastric mucosa endoscop studi endoscop featur gastric mucosa patient cirrhosi systemat investig patient observ endoscop aspect consist multipl erythemat area outlin subtl yellowish network resembl mosaic mainli locat proxim stomach test valu thi sign compar group patient portal hyperten cirrhosi control patient sign liver disea portal hyperten thi endoscop pattern wa observ patient cirrhosi wherea oesophag varic seen onli contrast onli patient control group thi aspect moreov thi sign wa patient non cirrhot portal hyperten wa seen patient chronic alcohol liver disea cirrhot patient endtosid portacav shunt endoscop chang becau muco andor submuco oedema cong highlight normal area gastrica pattern relat rai portal pressur conclud mosaic pattern gastric mucosa sensibl specif sign diagnosi portal hyperten whatev cau 
87055372 femal hemodynamicsd human liver cirrhosisdtpp male middl ag propranololtu splanchnic circulationd support nonu govt influenc degr liver failur splanchnic haemodynam respon propranolol patient cirrhosi splanchnic haemodynam studi patient cirrhosi classifi group accord degr liver failur modifi pugh classif patient group cardiac index wa significantli lower group vascular resist wa higher significantli patient liver failur wedg hepat venou pressur wa significantli lower group patient group correspond valu group azygo blood flow averag lmin mean sd group wa significantli lower group lmin respect group acut administr propranolol induc statist signif chang splanchnic haemodynam patient group group mean valu azygo blood flow propranolol remain significantli higher group moreov fraction azygo blood flow cardiac output decrea group slightli increa group thi studi patient cirrhosi degr liver failur mai determin haemodynam respon drug act portal hyperten 
87055374 cimetidinetu compar studi doubleblind method duoden ulcerdtpa femal human male middl ag recurr stomach ulcerdtpa effect cimetidin heal recurr duoden ulcer gastric ulcer effect cimetidin heal recurr duoden ulcer gastric ulcer compar extent acid secret area wa examin endoscop congo red methylen blue test extent acid secret area gastric ulcer classifi ulcer exten acid secret area duoden ulcer associ exten acid secret area gastric acid output basal state maxim stimul gastrin highest duoden ulcer lowest gastric ulcer exten acid secret area cimetidin treatment significantli promot heal duoden ulcer gastric ulcer exten acid secret area compar placebo gastric ulcer exten acid secret area cimetidin significantli diminish recurr duoden ulcer gastric ulcer exten acid secret area indic japan cimetidin promot heal duoden gastric ulcer associ high gastric acid produc prevent recurr duoden ulcer ha littl influenc heal recurr gastric ulcer associ low acid secretion 
87055375 adolesc case report colitiscopa colonpa eosinophiliacopa gastroenteritiscopa human male eosinophil gastroent present adolesc isol colon involv eosinophil gastroent commonli involv stomach proxim intestin eosinophil inflamm mucosa submucosa serosa patient report isol eosinophil coliti initi present iron defici anaemia ow occult gastrointestin blood loss empha evalu entir gastrointestin tract patient eosinophil gastroent 
87055376 adult ag atrophi case report cholecystectomya cholestasisetth femal hepat duct common human liverpa male expect manag patient unilat hepat duct strictur liver atrophi patient postcholecystectomi unilat hepat duct strictur subsequ liver atrophi treat conserv success outcom follow understand pathophysiolog sequela segment hepat duct obstruc suggest circumst reconstruct surgeri attend risk mai invari necessari 
87055377 coliti ulcerativepa colonpa colonoscopi human relationship disea activ indic colonoscop patient colon inflammatori bowel disea letter 
87055378 case report cimetidinea femal human immunosuppr strongyloidiasiset anoth exampl strongyloid stercorali infec associ cimetidin immunosuppress patient letter 
87055758 fee medicalst hospit insur healthec prefer provid organizationsec unit state physician fee import success ppa oper 
87055759 health care coalitionsog health plan organizationsog insur liabilitylj malpracticelj missouri tenness vermont coalition plai kei role tort reform passag 
87055760 hospit insur liabilitylj malpracticelj unit state danzon leader malpract studi 
87055763 comput commun network comput manag inform systemstd multiinstitu systemsog unit state data undergo chang multi chang 
87055765 data collec health care coalitionsec health plan organizationsec unit state dollar fuel coalition 
87055766 financ manag financ manag hospit health facil health facil closur hospit restructuringec incom medic staff hospitalsd personnel selectionec physician referr consultationec statist unit state bankruptci happen 
87055767 financ managementtd financ manag hospitaltd health facil administr hospit administr role unit state new econom environ alter cfo role 
87055768 attitud health personnel financ managementtd financ manag hospitaltd health facil administr hospit administr role unit state cfo major shift hospit role complet transition 
87055769 financ manag financ manag hospit health facil administr hospit administr manag inform systemsog new york citi lutheran cfo valu player 
87055770 data collec hospit job descrip market health servicesog unit state hospit sale effort begin shape 
87055772 health facil health facil merger health mainten organizationsog minnesota unit state unit healthcar increa stake hmo ventur 
87055773 data collec medic staff hospitalsd statist unit state hospit physician survei 
87055774 ambulatori care facilitiesog data collec hospit administr hospit restructur ownershiptd physician primari health care unit state hospit becom drive forc acc market 
87055775 health facil health facil environ hospit administrationtd human patient advocaci professionalpati relat unit state cousin hospitalpati teamwork lower cost interview myk cherskov 
87055776 hospit bed capac materi manag hospitalmt michigan roboticsec work simplif robot suppli monei labor 
87055778 data collec job satisfac labor unionsog personnel hospit statist unit state union activ rise new aha report state 
87055779 certif data collec nur staff hospitaltd personnel staf schedul unit state rn twothird nur staff 
87055780 multiinstitu systemstd rehabilit centersog unit state multi flock increasingli attract rehab field 
87055781 catchment area health colorado hospit publicut human medic indig patient transfer public hospit dump patient 
87055782 data collec nur homesst public opinion unit state public hold low opinion nur home care 
87055783 data collec economicstd econom hospitaltd inflat economictd statist unit state sluggish gnp rise inflat mean troubl 
87055784 financ auditmt financ managementmt financ manag hospitalmt unit state ensur facil financ health 
87055785 altruism hospit nur carest termin carest unit state ar lose care dimen 
87055786 health policylj unit state 99th congress enact major health polici reform 
87055787 health policylj medic indig unit state legisl focu indig care continu 
87055788 legisl hospit unit state unit state dept health human servic hospit hand hh seriou defeat 
87055789 econom competitionlj legisl hospit unit state unit state feder trade commi antitrust issu focu 
87055790 hospit proprietarytd multiinstitu systemstd unit state multi retrench reshap strategi 
87055791 commerc data collec health care coalition health plan organ unit state busi aggress search data pai 
87055793 financ managementlj financ manag hospitallj taxeslj unit state tax reform financ crunch highlight 
87055794 hospit plan market health servicestd unit state longterm shape hospit market 
87055795 data collec hospit public opinion unit state public opinion sai hospit imag unchang 
87055797 data collec health mainten organizationstd unit state manag care hot hot 
87055798 deliveri health caretd physician unit state physician grappl chang health deliveri 
87055799 employ incent planslj medic staff hospitalec taxeslj unit state physicianincom guarant mai jeopard taxexempt statu 
87055800 data collec hospit administrationtd hospit restructuringtd unit state hospit busi smart diversifi 
87055802 equip suppli hospit industri purcha hospitaltd unit state supplier merg gui prosper 
87055804 antibioticstu biotechnologytd cross infectionpc human unit state new drug deflat resist bacteria hospit infec 
87055807 ag hospit human popul dynam right die unit state righttolif issu cloud ag popul 
87055808 administr personnel data collec nur administr unit state nur execut 
87055809 hospit ruraltd hospit specialtd unit state specialti provid feast famin 
87055810 capit expenditurestd data collec economicstd hospit inform systemsec statist unit state hospit info spend billion 
87055811 acquir immunodefici syndrom adolesc femal human nation health program pregnanc pregnanc adolesc social problem substanc abu aid drug teen health care social ill 
87055812 econom competitiontd health planningtd unit state competi health plan fade 
87055813 hospit radioact wasteec refu disposalec unit state dispo cost radioact wast steadili increa 
87056135 androgensbltu anemiabletth blood transfusion femal folic acidbltu hematocrit hemodialysisa histidinebltu human ironbltu male support govt ph uremiacoth minim anemia chronic hemodialysi patient 
87056136 diabet nephropathiesppth diabet neuropathiesppth diabet retinopathyppth hemodialysi human kidnei failur chronicth manag diabet renal insuffici 
87056137 hemodialysi human hypertensionetpp kidnei failur chroniccoth hyperten dialysi patient editori 
87056138 child child preschool hemodialysisa human infant kidnei failur chronicth chronic hemodialysi children editori 
87056139 blood human kidnei failur acuteetth liver diseasesco filtrationmt continu arterioven filtrat manag renal complic liver disea editori 
87056141 blood compar studi feveretmi hemodialysisa human kidnei failur acuteth kidnei failur chronicth retrospect studi septicemiaco filtrationa occurr fever dure hemodialysi hemofiltr compar studi occurr fever dure variou blood purif method wa evalu retrospect studi demonstr patient treat chronic conven hemodialysi experi febril episod patient chronic hemofiltr versu sinc mani increa temperatur explain conven mean ha assum treatment cau fever possibli activ monocyt hormon interleukin wa differ magnitud temperatur septicaemia obviou cau thi necessit opinion earli antibiot therapi case fever develop clear explan 
87056142 case report catheterizationa hemodialysisa human jugular veinsra male middl ag subclavian vein thrombosisetra tomographi xrai comput intern jugular vein thrombosi subclavian vein cannul detec comput tomographi 
87056143 ag ascitesetth blood case report human kidnei failur chronicetth liver cirrhosisco liver cirrhosi alcoholicetth male middl ag filtrat continu arterioven filtrat cirrhot patient ascit renal failur assess continu arterioven filtrat cavu constitut altern hemodialysi manag patient advanc liver failur carri cavu patient decompen laennec cirrhosi cavu wa util patient acut renal failur pulmonari edema stabil renal function facilit administr larg fluid case cavu wa successfulli util mobil fluid patient refractori conven diuret regimen conclud cavu mai constitut appropri altern tradition hemodialysi patient advanc liver disea renal function impair 
87056144 adolesc blood calciumbl child dihydroxycholecalciferolsbl femal human kidnei failur chronicblth male parathyroid hormonesbl phosphatesbl filtrat miner metabol dure hemofiltr session children studi effect session hemofiltr miner metabol group urem children observ increa calcemia accompani posit calcium balanc decrea plasma phosphat pthmm substanti loss plasma 25oh wa conclud hemofiltr ha posit effect calcemia veri effect remov phosphat act onli temporarili pth remov adequ calcium concentr provid substitu fluid 
87056148 blood hemodialysi human filtrationismt filtrat control dure continu arterioven hemodialysi pair volumetr diali pump letter 
87056149 bicarbon buffer infusion parent solution observ prepar bicarbon buffer parent solution letter 
87056150 formaldehydean kidnei artifici increa sensit residu formaldehyd test reu diali letter 
87056151 blood hemodialysi hemoperfu human kidnei diseasesth membran artifici periton dialysi continu ambulatori plasma exchang plasmapheresi filtrat blood detoxif therapeut altern nephrologi author summar number blood detoxif procedur emphasi hemoperfu hemodialysi chronic ambulatori periton dialysi 
87056152 aluminumm charcoal hemoperfu human immunosorbentsad ironm kidnei failur chronicth liver diseasesth membran artifici poisoningth support nonu govt uremiath hemoperfu base artifici cell aluminium iron remov immunosorp fulmin hepat failur uremia poison metabol assist author review artifici cell applic hemoperfu chronic renal failur poison fulmin hepat failur remov aluminium iron metabol assist area review includ artifici cell contain enzym multienzym immunosorb cell cultur area artifici cell form membran coat adsorb encapsul adsorb enzym cell larg surfac volum relationship membran artifici cell allow rapid equilibr metabolit artifici cell contain enzym ion exchang resin activ charcoal hemoperfu encapsul membran coat absorb enzym cell immunosorb materi ar prevent relea unwant materi circul prevent adver effect blood cell becau problem charcoal relea emboli deplet platelet develop coat activ charcoal hemoperfu clinic applic thi ha exten clinic studi artifici cell approach ha appli number hemoperfu approach space onli allow thi paper summar approach origin thi research centr 
87056153 adsorp carbon cellulo charcoal collagen hemoperfu human ion exchang resin polym technic aspect hemoperfu review differ type adsorb hemoperfu differ type polym coat charcoal ar review 
87056154 adsorp anim drug screen dnabi extracorpor circul hemoperfu hepatectomi liver circul rat preclin evalu haemosorb selec assess procedur preclin evalu haemosorb relationship procedur intend applic ar exemplifi examin design util procedur base rat procedur ar describ haemoperfu membran plasma separ follow onlin sorbent treatment plasma plasma perfusion procedur ar suitabl singl repeat anim unrestrain consciou state relev intend applic demonstr respect artifici liver support abil rat extracorpor circuit provid inform relationship sorbent properti liver regen determin prolif respon follow partial hepatectomi 
87056155 adult charcoal chronic disea femal hemodialysi hemoperfu human male middl ag support nonu govt factor uremiath hemoperfu reducedtim programm chronic uremia longterm result thi paper report author experi clinic charcoal hemoperfu mean reduc weekli treatment chronic urem patient differ programm appli programm patient involv substitut procedur standard dialysi durat procedur combin hemodialysi hemoperfu durat programm patient involv substitut procedur durat procedur combin hemodialysi hemoperfu conven dialysi net weekli reduc wa programm programm efficaci programm wa evalu clinic hematochem nutrition instrum paramet 
87056157 adult blood coagul case report charcoal femal hemodialysi hemoperfu human kidnei failur chroniccoth male middl ag pericarditisetth periph nerv diseasesetth routin clinic applic hemodialysishemoperfu chronic renal failur case report hemodialysi patient treat combin hemodialysishemoperfu conven hemodialyz plu 70gram collodion coat activ charcoal devic total indic thi therapi includ pericard periph neuropathi clot conven hemodialyz reduc dialysi frequenc outcom wa benefici case stabl biochem hematolog paramet maintain increa heparin requir wa therapi wa costeffect 
87056158 cathet charcoal femal femor vein hemodialysi hemoperfu human male middl ag uremiath combin hemoperfusionhemodialysi treatment urem patient vascular access problem case report 
87056159 adsorp charcoal compar studi diffusion hemoperfu kinet mathemat model biolog particl size kinet model powder charcoal haemoperfu aim thi studi wa achiev understand mass transfer characterist filmadsorb haemoperfu devic structur model mathemat descrip differ diffusion step wa develop exact quantif appear veri difficult result insuffici fit predict measur concentr curv moreov mathemat turn simpl sinc concentr cour describ exponenti power therefor formal model wa develop assum linear isotherm adsorp propor averag concentr column thi model predict invitro inlet outlet concentr fit measur data accur relat model condition high particl mass transfer allow case powder adsorb conclud structur model yield predict tool optim devic geometri formal model constant determin devic perform enabl devic optim help invitro experi 
87056160 acetylprocainamidepo digoxinpo glutethimidepo hemoperfu human ion exchang resin poisoningth polystyren polyvinyl procainamidepo theophyllinepo resin hemoperfu drug intoxicationan updat hemoperfu amberlit xad4 resin column ha shown effect remov sedativehypnot analg drug cau acut intox appreci clinic toxic dramat shorten coma possibl decrea mortal mai achiev thrombocytopenia clot mai diminish preperfu coat albumin albumin coat mai facilit repeat hemoperfu ani complic resin hemoperfu ha procainamid nacetylprocainamid theophyllin intox achiev excep high clearanc rate 
87056161 adsorp bilirubinm crosslink reagent hemoperfu vitro ion exchang resin polystyren polyvinyl remov unconjug bilirubin macroreticular resin hemoperfu macropor polystyren polyvinylpyridin bead quaternari ammonium tertiari group tailormad adsorp unconjug bilirubin vitro studi order obtain high adsorp capac synth macropor resin averag pore size surfac area larg possibl crosslink resin increa bilirubin adsorb increa mgg mgg resin contain strong basic group higher adsorp capac correspond weak base group adsorp mechan studi chemic physic adsorp adsorp bilirubin plasma wa lower buffer solution 
87056162 adsorp anim bilirubinm disea model anim dog femal hemoperfu ion exchang resin jaundiceth male resin synthet investig bilirubin remov nk110 resin hemoperfu jaundic dog jaundic dog model wa common bile ductinferior vena cava shunt silicon rubber tube blood bilirubin level increa sd mg sd mg dog model treat column contain gm macroreticular resin nk110 wa link femor arteri vein rate blood flow column wa mlmin wa shown total bilirubin reduc sd sd conjug bilirubin decrea sd unconjug bilirubin sd signif chang protein electrolyt blood gase acid base balanc result nk110 resin ha bloodcompat adsorp properti 
87056164 anim biocompat materi implant artifici liverci liver diseasesth membran artifici rat rat inbr strain support nonu govt bioartifici liver implant artifici cell encapsul live hepatocyt increa surviv liver failur rat suspen live hepatocyt encapsul insid mean diamet algin artifici cell galactosamin fulmin hepat failur rat model wa injec galactosamin grade ii coma hepat failur rat divid pair pair wa randomli chosen control group treat group rat control group receiv periton injec capsul contain hepatocyt rat treat group receiv periton injec capsul contain hepatocyt surviv treat group significantli higher control group 
87056165 adsorp adult ag arthriti rheumatoidth electrophoresi femal human iggm lupu erythematosu systemicth male membran artifici middl ag mix connect tissu diseaseth protein denatur reticuloendoth remov denatur protein artifici reticuloendoth ar basic research ha reveal hydrophob residu increa molecular surfac denatur igg denatur protein plasma remov sever sorbent differ amino acid bond polyvinylalcohol hydroxid residu coval bond thu artifici reticuloendoth wa develop supplem human reticuloendoth remov denatur protein patient plasma clinic angiiti raynaud phenomenon associ collagen disea lupu erythematosu remark reduc follow seri ar treatment protein adsorb ar analyz twodimen electrophoresi virtual albumin wa detect igg constant isoelectr igm iga iga dimer c3 c4 fibrinogen unidentifi spot elut ar column 
87056166 adsorp apolipoprotein bme blood chemic analysi blood compon remov cholesterolbl femal human hypercholesterolemiath lipidsbl lipoprotein ldlme lipoprotein vldlme male middl ag plasma exchang adsorp lipoprotein contain apolipoproteinb plasma separ treatment famili hypercholesterolemia treatment famili hypercholesterolemia liposorb la40 wa clinic appli liposorb commerci develop affin adsorb plasma perfusion select adsorb low densiti lipoprotein veri low densiti lipoprotein special design plasmapheret treatment hypercholesterolemia liposorb column contain activ cellulo bead affin lipoprotein contain apolipoproteinb ha excel adsorp capac excel select minimum albumin loss thi new apheresi wa appli clinic case trial perfusion everi patient condition wa level total cholesterol mgdl replac fluid dure treatment thi paper clinic result patient shown mechan adsorp thi specif adsorb wa discuss 
87056167 blood cold heat human membran artifici plasmapheresi pressur temperatur filtrat blood detoxif membran plasma filtrat recogni macromolecul abnorm variou metabol immunolog relat disea state ha plasma exchang therapeut limit plasma exchang howev exist membran plasma filtrat provid practic altern solut remov select choic oper condition temperatur selec membranemodul design optim temperatur rang function plasma type solut concentr membran oper physiolog temperatur cryofiltr particularli suit remov cold aggreg solut oper abov physiolog temperatur suit separ solut larg size differ normal physiolog temperatur membran filtrat simpl safe perform select plasma exchang doe requir plasma product infusion versatil select sorption applic 
87056168 blood human lupu erythematosu systemicth membran artifici plasmapheresi filtrat select remov pathogenet macromolecul directli blood doubl filtrat techniqu doubl filtrat plasmapheresi dfpp techniqu devi attempt select remov pathogenet macromolecul antibodi immun complex viscosityincrea substanc directli blood order realiz differenti filtrat principl filter separ plasma anoth fraction plasma compon ar instal extracorpor circul line select separ plasma compon depend filtrat properti filter clinic experi evid thi techniqu regard conserv human blood product supplem 
87056170 acut disea anim biolog transport blood ga analysi blood substitut drug combinationsmetu emul fluorocarbonsmetu hemorrhageth human macaca mulatta oxygenm particl size shock hemorrhagicth develop clinic applic perfluorochem artifici blood review author experi fluosol da thi includ studi anim clinic trial patient 
87056440 calcitonintu doubleblind method femal human injec muscular migrainepc migrain prophylaxi salmon calcitonin crossov doubleblind placebocontrol studi 
87056441 amnesiaet amnesia retrogradeet case report child electroencephalographi human male migrainedi basilar migrain manifest transient global amnesia 9yearold child 
87056442 adult brainra case report human male migrainera tomographi xrai comput unusu transient high low densiti ct lesion migrain case report 
87056443 cerebrovascular circul chronic disea human thermographymt vascular headachepp valid vascular cold patch diagnosi chronic headach 
87056445 cluster headachepp facial nervepp human parasympathet nervou systempp vascular headachepp cluster headach nervu intermediu 
87056446 adolesc case report child cyproheptadinetu electroencephalographi headachedtpp human male pariet lobepp tempor lobepp transient focal headach persist ipsilat eeg disturb 
87056447 adolesc adult ag child chronic disea electroencephalographi femal headacheclg human male middl ag hereditari dysrhythm headach 
87056448 adolesc adult femal headachepx human male middl ag mmpi psychopathologi psychopathologi volunt headach research initi versu respond 
87056449 adult electrocardiographi femal headacheco heart diseasesco human male middl ag migraineco headach heart disea posit associ 
87056451 human thermographymt vascular headachedi thermographi marker vascular headach editori 
87056452 adult case report dihydroergotaminetu headachedt human injec venou male iv dhe45 reliev exer cephalgia letter 
87056453 administr oral adult femal human levodopatu migrainedt prolactinbl prolactin migrain effect ldopa plasma prolactin level migraineur normal 
87056454 adult cardiovascular systempp femal human male middl ag migrainepp reflexph cardiovascular reflex respon dure migrain attack 
87056455 adolesc basilar arteri case report electroencephalographi femal human migrainecldtpp photic stimul propranololtu nonepileptiform basilar arteri migrain 
87056456 adult electroencephalographi evok potenti visual femal human migrainepapp support nonu govt patternshift visual evok respon eeg migrain 
87056457 absent child cost cost analysi emploi epidemiolog method femal headacheecep human male san marino support nonu govt econom burden headach epidemiolog studi republ san marino 
87056459 headacheetpp human lighta migrainepp pain pupilr stress psychologicalco support nonu govt quantit assess photophobia migrain tension headach 
87056460 chronic disea cluster headachedt human migrainedt vascular headachecldtpcth treatment vascular headach 
87056462 adult femal human menstrual cycl migrainedipp neurosecretori systemspp piperazinesdu piribedildu piribedil test migrain neuroendocrinolog aspect 
87056463 cerebr angiographi hemiplegiara human migrainera unusu angiograph appear dure attack hemipleg migrain letter 
87056464 cerebrovascular disordersci contracept orala femal human migraineco migrain pill stroke letter 
87056726 anim capillariesph dog perfusion pulmonari alveolib pulmonari circul region blood flow support govt ph vertic gradient pulmonari capillari transit kei determin alveolar capillari perfusion ar transit extent recruit capillari ar heavili recruit depend lung ar direct data bear capillari transit affect graviti directli determin mean capillari transit surfac upper middl lower lung measur passag fluoresc dye capillari vivo televi scopi anesthet dog mean capillari transit averag upper lung midlung lower lung thi order magnitud variat speed blood transit establish vertic gradient capillari transit lung expect depend capillari network nearli fulli recruit wherea rel capillari perfu upper lung lengthi transit spar perfu capillari bed upper lung combin provid substanti pulmonari ga exchang reserv 
87056728 adult electroencephalographi electromyographi electrooculographi femal human male middl ag pressur respir sleepph sleep remph snore support nonu govt support govt ph occlusion pressur ventil dure sleep normal human previou investig normal human ha demonstr reduc ventil ventilatori respon chemic stimuli dure sleep interpret thi product decrea central nervou sensit normal stimuli maintain ventil wherea factor increa airflow resist contribut thi reduc respir improv understand event measur ventil occlusion pressur p01 dure unstimul ventil rebreathinginduc hypercapnia dure wake nonrapideyemov nrem rapideyemov rem sleep eighteen subject male femal snorer male femal studi ventil wa reduc dure nrem rem sleep thi decrem minut ventil tend greater snorer nonsnor unstimul p01 hand wa maintain increa dure sleep group studi male snorer largest increa hypercapn ventilatori respon dure nrem rem sleep tend lower dure rem nrem sleep howev p01 respon hypercapnia dure nrem sleep wa maintain wake level rem respon wa statist reduc studi suggest mechan reduc ventil hypercapn ventilatori respon seen dure sleep particularli nrem sleep multifactori total product decrea central respiratori drive 
87056730 anim cat diaphragmph electroencephalographi electromyographi electrooculographi femal musclesph respir sleep remph support nonu govt support govt ph control activ diaphragm rapideyemov sleep respir rapideyemov sleep rem highli variabl purpo thi studi wa investig sourc thi variabl determin order principl remain oper rem sleep unrestrain natur sleep cat record electroencephalogram electrooculogram neck electromyogram diaphragmat electromyogram emg comput averag madi refer examin madi dure tonic rem sinc breath fairli regular thi state control rang peak amplitud pemg inspiratori ti durat postinspiratori inspiratori activ expiratori calcul inspiratori slope pemgti determin overlai individu breath trace cour madi dure tonic rem form composit trace cour emg dure individu breath slowwav sleep sw complet period consecut breath rem tonic phasic compar thi tonic rem composit number ey movem breath wa tabul index phasic activ inspiratori slope dure sw tonic rem similar howev dure phasic rem mani breath displai increa excit decrea inhibi slope compar typic breath seen tonic rem occurr alter slope increa frequenc phasic event ti wa inver relat slope emg tend minim chang pemgabstract truncat 
87056731 adenosin cyclic monophosphatem adipo tissuem anim compar studi dibutyryl cyclic amppd exer femal glycerinm hypertensionpp isoproterenolpd kinet lipolysi rat rat inbr strain rat inbr shr rat inbr wky speci specif support nonu govt support govt ph enhanc lipolysi evid adipocyt exercisetrain shr adipocyt spontan hyperten rat shr ar respon isoproterenol dibutyryl adenosin 35cyclic monophosph camp stimul compar spraguedawlei wistarkyoto rat lipolyt activ adipocyt train normoten rat wa enhanc respon isoproterenol mm dibutyryl camp adipocyt train shr decrea isoproterenolstimul camp accumul evid adipocyt train normoten rat adipocyt train shr basal agonistinduc lipolysi fat cell isol normoten rat shr immedi follow 60min run wa increa sedentari train rat adenyl cycla activ fat cell membran wa blunt sedentari train shr absenc presenc 5guanylyl imidophosph appar differ exist antagonist affin bind site antagonist dihydroalprenolol normal rat shr evid chang affin agonist isoproterenol indic base enhanc potenc isoproterenol stimul lipolysi train normal rat betaadrenerg receptor densiti antagonist affin differ normoten rat shr respon train howev displac 3hdihydroalprenolol adipocyt shr requir greater concentr isoproterenol compar adipocyt normoten rat suggest increa agonist affin bind site normal rat data suggest postreceptor lesion lipolyt pathwai adipocyt spontan hyperten rat possibli guanin nucleotid regulatori protein levelabstract truncat 
87056733 anim diaphragmph electromyographi musclesph pressur respir sheepph support nonu govt support govt ph factor withinbreath electromyograph chang dure load breath adult sheep investig chang diaphragm electromyogram emg dure cour sever load breath subject consciou adult sheep inspiratori flow resist breath resist greater cmh2o l1 studi total emg power breath iemg emg power unit divid durat emg activ breath equal iemg1 iemg2 iemg3 total breath iemg transdiaphragmat pressur pdi increa remain high level certain period fall chang pattern iemg breath wa observ dure load breath increa totalbreath iemg wa associ mostli increa iemg3 emg power inspir similarli decrea total breath iemg wa primarili decrea iemg3 conclud sheep subject sever ifr load prolong period mark increa totalbreath iemg begin load breath mark decrea thi iemg decrea pdi ar larg chang iemg occur dure breath specul dure load breath recruit pattern diaphragmat muscl fiber chang dure cour inspiratori effort 
87056734 bronchidepp human vitro indomethacinpd lungdepp lung neoplasmspp muscl smoothdepp peptid phipd propranololpd support nonu govt vasoact intestin peptidepd vip phm role nonadrenerg inhibitori respon isol human airwai increa evid mani speci vasoact intestin peptid vip mai neurotransmitt nonadrenerg inhibitori nerv studi effect electr field stimul ef exogen vip isoproterenol iso human airwai vitro studi relat peptid peptid histidin methionin phm coexist vip human airwai nerv separ experi studi fragment vip amino acid sequenc vip110 vip1628 agonist antagonist activ human airwai obtain thoracotomi studi organ bath bronchi ef inhibitori respon wa unalt propranolol wa block tetrodotoxin wherea bronchiol wa littl nonadrenerg inhibitori respon vip phm iso cau dosedepend relax bronchi vip phm approxim 50fold potent iso vip iso mimick cour nonadrenerg inhibitori nerv stimul contrast bronchiol relax iso vip phm propranolol indomethacin alter relax effect vip phm suggest direct effect peptid airwai smooth muscl vip fragment agonist antagonist activ conclud vip phm ar potent bronchodil human bronchi iso associ relax effect peptid nonadrenerg inhibitori respon suggest thei mai possibl neurotransmitt nonadrenerg inhibitori nerv human airwai 
87056735 acclimat ag anim anim newborn anoxiapp bodi weight lunggdpp organ weight oxygen consump rat rat inbr strain respir support nonu govt respiratori adapt chronic hypoxia newborn rat newborn rat maintain hypox chamber o2 n2 dai birth wk postnat life bodi weight bw nosetail length hypox expo rat control anim grow air hematocrit rose oxygen consump vo2 measur manometr method wa lower rat differ remain dai normal bw dai ventil measur airflow plethysmograph wa elev rat breath o2 air rat increa tidal volum frequenc thi indic bipha ventilatori respon charact initi rise fall ventil normox valu commonli observ newborn dure acut hypox challeng immedi onli transient respon dry lung weighttobw ratio alveolar size larger rat lung volum cmh2o similar despit smaller bw rat henc rat chronic hypoxia immedi postnat period increa o2carri capac decrea metabol demand increa alveolar o2 avail promot structur chang lung protect ga exchang area optim structurefunc relationship lung result mai suggest lung structur alter chronic hypoxia attribut chang vo2 eventu ventilatori action organ 
87056736 adrenocorticotrop hormonebl adult exer human hydrocortisonebl male refer valu support govt nonph factor plasma adrenocorticotropin cortisol respon brief highinten exerc human purpo thi studi examin plasma cortisol adrenocorticotropin acth level follow brief highinten bout exerc subject perform 1min bout exerc cycl ergomet hi maximum o2 uptak blood sampl collect rest immedi follow exerc bout min postexerc mean se plasma acth level increa significantli pmoll rest pmoll immedi follow exerc mean se plasma cortisol level increa significantli mumol rest mumol min postexerc data brief highinten exerc result signif increa plasma cortisol acth level furthermor tempor sequenc hormon suggest increa plasma cortisol level follow brief highinten exerc result acthinduc steroidogenesi adren cortex 
87056738 action potenti affer pathwaysph anim blood pressur dog electr stimul phrenic nerveph pulmonari circul reflex support nonu govt support govt ph vascular resist stimul group iii iv phrenic affer reflexli decrea total lung resist dog littl reflex effect airwai calib evok stimul phrenic affer therefor chloraloseanesthet paralyz dog record airflow airwai pressur arteri pressur heart rate electr stimul phrenic nerv total lung resist wa calcul breath breath phrenic nerv wa stimul motor threshold compound action potenti wa record stimul phrenic nerv threshold activ group ii group iii fiber effect ani variabl measur stimul threshold activ mani group iii fiber group ii fiber reflexli decrea resist stimul threshold activ group iiv fiber evok progress greater decrea lung resist reflex bronchodil evok phrenic nerv stimul wa unaffect propranolol phentolamin wa abolish atropin conclud activ group iii iv phrenic nerv affer reflexli decrea total lung resist withdraw cholinerg tone airwai smooth muscl 
87056739 adult argipressinbl blood blood pressur heart rate hematocrit hemoglobinsan human male osmolar concentr postur potassiumbl pressur sodiumbl support nonu govt influenc central venou pressur chang plasma vasopressin human overnight food fluid restric healthi male examin befor dure lower bodi posit pressur lbpp mmhg mean se min befor dure grade lower bodi neg pressur lbnp mmhg min lbpp lbnp perform subject supin position plastic box enca subject xiphoid process thu includ splanchnic area central venou pressur cvp dure supin rest wa mmhg increa mmhg dure lbpp decrea significantli step lbnp mmhg min mmhg lbnp plasma arginin vasopressin avp chang significantli thi larg variat cvp mmhg mean arteri pressur increa significantli dure lbpp torr onli dure lbnp mmhg mmhg heart rate chang dure lbpp increa slightli beatsmin onli min lbnp mmhg plasma osmol sodium potassium chang dure experi hemoglobin concentr increa dure lbpp lbnp wherea hematocrit onli increa dure lbnpabstract truncat 
87056740 anemiapp blood circul blood transfusion cardiac output exer hemodynam hemoglobinsan human male oxygen consump support nonu govt effect longterm anemia retransfu central circul dure exerc purpo thi studi wa evalu effect longterm anemia subsequ retransfu erythrocyt variou circulatori paramet anemia wa induc healthi male subject repeat venesec store blood wa retransfu wk rang wk exerc test perform befor venesec control state anem state retransfu hemoglobin concentr level gl gl gl maxim o2 uptak wa lmin respect decrea heart rate beatsmin cardiac output lmin maxim exerc occur anem state compar control valu decrea rever accentu retransfu adapt respon submaxim exerc cycl anemia wa mediat increa cardiac output mainli increa heart rate wa increa o2 extrac periph tissu conclusion longterm anemia wa decrea heart rate cardiac output maxim exerc furthermor close correl hemoglobin concentr maxim o2 uptak human confirm 
87056742 energi metabol human locomo mathemat model biolog oxygen consump metabol cost walk equat model twenti publish experi workmanarmstrong equat predict walk vo2 review equat reexpress current accept terminologi shown equat serv basic model normal walk emploi thi model analyz vo2step lead elabor threecompart model metabol cost walk thi threecompart model provid ration estim fraction walk metabol cost power actual walk movem doubt express comfort speed walk defin energi term suggest requir maintain balanc walk mai determin comfort speed walk curvilinear relationship groundsp freeli chosen step frequenc walk 
87056743 acetylcholinepd anim atropinepd carbacholpd cat kinet oxygen consumptiond phentolaminepd pilocarpinepd propranololpd quinuclidinyl benzilatem receptor muscarinicm scopolaminepd sebac glandsdem support govt ph tracheam charact muscarin cholinerg receptor cat tracheal gland cell studi airwai gland indic muscarin cholinerg regul secretion becau cellular complex airwai receptor charact tissu unfea therefor util homogen disaggreg gland cell isol cat trachea muscarin antagonist 13hquinuclidinyl benzil 3hqnb charact glandular muscarin receptor receptor isol cell function intact assess carbachol stimul o2 consump se stimul wa dose depend mean effect concentr inhibit atropin dissoci constant kd nm phentolamin propranolol specif bind 3hqnb cell homogen wa satur high affin kd pm singl popul receptor maximum bind wa fmol106 cell receptor cell estim affin muscarin agent molar rang agonist molar rang antagonist histamin alphaadrenerg betaadrenerg agonist antagonist inhibit specif bind result suggest muscarin receptor tracheal gland cell ar high affin densiti 
87056744 anim carbon radioisotop cell membran permeabl chromium radioisotop dog erythrocytesph hematocrit vitro iodin radioisotop lungph perfusion support nonu govt support govt ph surfac properti uream effect perfu hematocrit urea permeabilitysurfac area isol dog lung dog lower left lung lobe static inflat perfu constant rate lobe perfu hematocrit wa alter wide rang permeabilitysurfac area urea wa calcul multipl indic dilution curv separ inject hematocrit level inject contain onli 125ialbumin vascular refer tracer contain 51crerythrocyt 125ialbumin vascular refer tracer contain 14curea permeat tracer result strongli indic phenomenon erythrocyt trap urea doe affect calcul urea permeabilitysurfac area product provid appropri albuminerythrocyt composit refer tracer util calcul 
87056745 anim dog ethan vitro irrig lungph method respir tidal volum factor nonuniform canin lung washout highfrequ ventil ethan washout dure low tidal volum ml highfrequ hz ventil hfv wa studi exci dog lung lung initi equilibr ethan concentr ethan wa monitor mass spectrometri multipl anatom site tracheobronchi tree dure washout observ lung chang uniform distribu ethan concentr nonuniform distribu threepha process phase wa nearli complet probabl correspond concentr gradient establish central airwai dure phase washout sever minut concentr variou alveolar region diverg final phase region concentr remain fix ratio washout site lung wa constant fraction rate data ar consist model durat phase magnitud region concentr differ establish thi phase ar depend magnitud differ region transport path natur region coupl common transport path airwai open 
87056747 adult cathet femal human hypopharynxpp lung disea obstructivedipp male middl ag palatepp respir respiratori systempp sleep apnea syndromesdipp support govt ph variabl site airwai narrow obstruct sleep apnea patient purpo thi wa determin site physiolog narrow upper airwai wa uniform differ patient obstruct sleep apnea inspiratori pressur measur esophag balloon cathet cathet locat differ site upper airwai supralaryng airwai oropharynx nasopharynx peak inspiratori pressur differ cathet allow assess pressur gradient airwai segment lungslarynxretroepiglott airwai esophagealsupralaryng pressur hypopharynx supralaryngealoropharynx pressur transpalat airwai oropharynxnasopharynx pressur patient hypopharyng obstruc wa present patient hypopharyng obstruc exist patient site obstruc wa locat level palat subject site obstruc wa dure repeat measur presenc absenc hypopharyng narrow dure sleep wa predict gradient measur differ segment upper airwai dure wake conclud site physiolog upper airwai obstruc vari patient obstruct sleep apnea predict pressur measur dure wake specul uvulopalatopharyngoplasti mai reliev obstruct apnea patient hypopharyng obstruc 
87056748 adult aldosteronebl angiotensin ibl blood proteinsan dehydr electrolytesbl femal fluid therapi hematocrit human immersionpp male middl ag plasma volum vasopressinsbl effect hydrat plasma volum endocrin respon water immer determin effect hydrat earli osmot vascular volum endocrin respon water immer hematocrit hemoglobin plasma renin activ pra plasma electrolyt aldosteron pa vasopressin pvp concentr measur dure immer follow 24h dehydr compar correspond valu follow rapid rehydr woman ag yr underw min stand immer neck prece 45min stand immer dehydr min rehydr water immer cau isoton expan plasma volum occur independ hydrat statu suppr pra pa dure immer occur independ hydrat statu suppr plasma vasopressin wa observ dure dehydr immer dure rehydr immer conclud plasma tonic factor influenc pvp suppr dure water immer 
87056751 adult airwai resist anoxiapp electroencephalographi electromyographi electrooculographi human lung disea obstructiveetpp male oxygenbl respir sleepph sleep apnea syndromespp support govt nonph tidal volum induc period breath dure sleep cau upper airwai obstruc human test hypothesi occlu apnea result sleepinduc period breath associ degr upper airwai comprom period breath wa induc dure nonrapideyemov nrem sleep administ hypox ga mixtur appli extern inspiratori resist cmh2o l1 normal male volunt addition standard polysomnographi sleep stage respiratori pattern monitor esophag pressur tidal volum vt airflow measur esophag cathet pneumotachograph respect attach tightfit mask allow calcul total pulmonari resist rp dure stage iii nrem sleep minim period breath wa evid subject howev subject dure hypoxia andor relief hypoxia ad resist pronounc period breath develop wax wane vt sometim apneic phase resist load hypoxia cau period nadir period chang vt rp wa usual highest wa signif linear relationship rp 1vt indic develop obstruct hypopnea subject ad resist subject anoth dure resist load upper airwai obstruc nadir period fluctuat vt wa observ conclud period breath result period diminu upper airwai muscl activ associ increa upper airwai resist predispo upper airwai collap 
87056752 diaphragmpp electromyographi human pressur respir sleep apnea syndromespp sleep stagesph support govt nonph factor respiratori dure nrem sleep patient occlu sleep apnea studi respiratori mechan patient occlu apnea inspiratori expiratori ti te calcul diaphragmat electromyogram obtain patient dure nonrapideyemov nrem sleep peak diaphragmat activ emgdi curvilinear relationship ti dure ventilatori occlu phase ti shorten emgdi decrea dure ventilatori phase prolong emgdi increa dure occlu phase howev emgdi vs ti occlu phase wa shift right ventilatori phase reflect rel ti dure upper airwai occlusion ti linear relationship pleural pressur remain unchang dure ventilatori occlu phase prolong neg inspiratori pressur increa result indic respiratori continu modifi patient occlu apnea inspiratori neural drive fluctuat dure nrem sleep suggest thi modif net effect chang inspiratori neural drive affer input predominantli upper airwai mechanoreceptor 
87056753 aminopyridinespd anim antigensad atropinepd capsaicinpd epitheliumdeimul male scopi electron scan muscl contrac muscl smoothimul ovalbumin physostigminepd rat rat inbr strain support nonu govt tracheadeimul epith modul tracheal smooth muscl respon antigen stimul role epithelium ha studi contractil respon rat trachea differ modul observ ar discuss respect vagal compon epith layer respon rat trachea immunolog stimul ar shown depend presenc epithelium prolong relax stage affect contrac thi prolong abolish neonat capsaicin pretreat wherea substanc induc significantli greater relax serotoninprecontract intact deepith trachea serotonin concentrationrespon curv ar shift right intact prepar partli rever neonat capsaicin pretreat hyporeact tissu exist relax factor relea epithelium hypoth possibli depend substanc pergic innerv muscarin cholinerg innerv slightli modul contrac relax antigeninduc respon independ presenc epith layer 4aminopyridin induc epitheliumdepend potenti contrac antigen serotonin involv acetylcholin step reaction cascad epithelialdepend contract relax factor ar thu suggest rat trachea 
87056754 anim blood glucosem calor intak carbon radioisotop dietari carbohydratesm fructosem glucosem glycogenm kinet liver glycogenm male musclesm rat rat inbr strain support nonu govt tritium carbohydr metabol fructosef foodrestrict run rat chronic cathet rat hepat glycogen wa increa fructo approxim gkg gavag ff rat lower overnight food restric fr rat 33h u14cgluco infu befor dure treadmil run dure exerc increa gluco produc ra wa alwai directli relat work inten faster increa gluco disappear result increa plasma gluco level ident workload increa ra plasma gluco liver glycogen breakdown higher ff control rat fr rat breakdown muscl glycogen wa ff rat incorpor 14cgluco glycogen rest mobil label dure exerc partli explain 14c estim carbohydr metabol disagr chemic measur muscl glycogen depletion wa accompani loss 14c 3h indic futil cycl gluco fr rat postexerc increa liver glycogen wa seen 14c3h similar plasma gluco indic direct synthesi gluco conclusion exerci rat increa gluco produc subject feedforward regul depend liver glycogen concentr endogen gluco mai incorpor glycogen work muscl mai directli liver glycogen synthesi conver trio fructo ing mai diminish muscular glycogen breakdown 14cgluco infusion techniqu determin muscular glycogenolysi doubt valu rat 
87056755 anim antibodi format dog histaminepd histamin liber igean immun lungph pollenim respiratori function test skin test support nonu govt support govt ph immunolog nonimmunolog respon ragweedsensit dog relationship airwai respon inhal antigen histamin immunolog relea lung histamin immunolog respon skin specif immunoglobulin ig antibodi examin inbr allerg dog immun extract ragw grass nonimmun control dog coloni airwai respon antigen histamin wa charact dose increa airflow resist total respiratori twice control valu ed200 highli signif correl airwai respon cutan respon antigen immunolog characterist ig histamin relea lung inhal antigen dog ragweedsensit dog wa inver correl immunolog respon reflect cutan respon antigen histamin relea lung inhal antigen nonimmunolog respon airwai histamin ed200 respect antigen ed200 wa correl histamin relea lung antigen inhal conclud airwai reaction inhal antigen allerg dog ar depend onli immunolog factor degr nonimmunolog airwai respon histamin factor ar correl inver 
87056756 acclimat bodi temperatur dive energi metabol human japan male oxygen consump respir season skin temperatur support nonu govt energet wetsuit dive japan male breathhold diver present studi wa undertaken investig energi balanc profes male breathhold diver tsushima island japan diver rectal tre mean skin tsk temperatur rate o2 consump vo2 measur dure dive work summer degr water winter degr water thermal insul energi cost dive work estim summer comparison subject clad wet suit protect swim trunk unprotect winter thei wore wet suit averag tre unprotect diver decrea degr end 1h dive work protect diver decrea degr summer degr winter averag tsk unprotect diver decrea degr summer protect diver decrea degr summer degr winter averag vo2 increa mlmin befor dive mlmin unprotect diver summer protect diver rose mlmin summer mlmin winter over thermal insul tissu wet suit calcul protect diver wa degr kcal1 m2 h1 summer degr kcal1 m2 h1 winterabstract truncat 
87056757 anim exer mathemat model biolog physiologi statist support nonu govt support govt nonph support govt ph estim respon curv closedloop physiolog control sever report address problem estim respon slope repeat measur pair data stimulu respon variabl ar subject biolog variabl earlier approach suffer sever drawback inform relationship error compon closedloop fulli util respon intercept directli estim normal procedur requir method mai fail certain circumst thi paper propo new gener method simultan estim respon slope intercept corrupt stimulusrespon data error variabl ar specif relat structur direct exten leastsquar approach thi method direct squar dl reduc ordinari leastsquar method measur variabl error free reducedmajoraxi rma method kermack haldan biometr magnitud normal error ar equal dl estim ar scale invari statist unbia alwai assum minimum varianc simpl modif method applic pair data howev relat error compon uncertain rma method optim possibl asymptot bia varianc result ar illustr variou type closedloop respiratori respon data 
87056758 anim anim newborn antibodi format dog hypersensit igean immun vitro muscl contrac muscl smoothph support nonu govt tracheaph chang crossbridg properti sensit airwai smooth muscl report previou ovalbuminsensit canin tracheal smooth muscl tsm maximum abil shorten increa thi account increa airwai narrow seen vivo allerg bronchoconstr wa associ increa veloc shorten report electromagnet muscl lever quick relea appli control sensit tsm interv cour lightli preload isoton contrac record obtain possibl determin earli contrac shorten rel rapidli cycl optim muscl length unit se cross bridg report sensit tsm earli bridg increa veloc compar similar bridg muscl control anim sinc maximum shorten muscl occur earli bridg ar oper bridg ar respon major shorten thu probabl increa allerg bronchoconstr produc increa activ earli rapidli cycl bridg bridg ar activ late shorten differ control sensit airwai smooth muscl 
87056760 adult electr stimul electrod electromyographyismt human male middl ag motor neuronsph musclesirph support nonu govt effect electrod locat myoelectr conduc veloc median frequenc estim effect surfac electrod locat estim median frequenc conduc veloc myoelectr signal wa investig locat identifi respect innerv zone tendon portion tibiali anterior muscl consid modif median frequenc conduc veloc paramet highest valu median frequenc occur region innerv zone tendon inser muscl decrea propor distanc area rate chang median frequenc wa effect electrod locat estim conduc veloc stabl region distal tendon adjac innerv zone thi region provid linear fit compar conduc veloc median frequenc estim implic signal detec procedur ar discuss 
87056761 adult bathsmt bodi temperatur human hypothermiath immer male bath rewarm immer hypothermia publish erratum appear appl physiol dec616follow trunkonli bath rewarm ha recommend wholebodi bath rewarm method treatment immer hypothermia present report direct comparison rel merit techniqu ha author favor trunkonli bath rewarm base propo assump core temperatur afterdrop minim prevent periph vasodil subject limb ar immer rewarm bath present studi trunkonli wholebodi bath rewarm ar compar rewarm mildli hypotherm male subject twice onc techniqu wa conclud trunkonli rewarm superior wholebodi bath rewarm therapi mild immer hypothermia base signif differ exist techniqu size durat core temperatur afterdrop rate rewarm 
87056762 cleft palatecopp electromyographi human infant gnathismcopp motor activ postur respir respiratori systempp sleepph sleep apnea syndromesetpp support govt ph control respiratori activ genioglossu muscl gnathic infant genioglossu gg muscl activ infant gnathia obstruct sleep apnea wa record assess role thi tongu muscl upper airwai mainten respiratori air flow esophag pressur muscular gg electromyogram emg record dure wake sleep tonic phasic inspiratori ggemg activ wa record infant occasion phasic gg activ record silent period unassoci respiratori embarrass gg activ increa dure sigh breath gg activ increa infant spontan chang oral nasal breath infant neck flexion associ complet upper airwai obstruc suggest ggemg activ influenc sudden chang upper airwai resist dure sleep ggemg activ significantli increa co2 breath equal nasal airwai occlusion dure sleep ggemg activ increa occlud breath progress increa dure subsequ occlud breath indic mechanoreceptor suggest chemoreceptor modul dure nasal occlusion trial wa progress increa phasic inspiratori activ ggemg wa greater diaphragm activ reflect esophag pressur excur pharyng airwai closur occur dure nasal occlusion trial neg pressur pharyng airwai close upper airwai close pressur correl ggemg activ closur suggest gg muscl contribut maintain pharyng airwai patenc gnathic infant 
87056763 halflif human kinet knee jointph nitrogenan nitrogen radioisotopesdu respir support govt nonph nitrogen ga exchang human knee human decompr sick presum result excess inert ga bodi ambient pressur reduc common symptom pain skelet joint direct studi nitrogen exchang thi region ha undertaken thi studi nitrogen tag radioact 13n wa prepar linear accel human subject rebreath thi ga close circuit min complet 100min washout period breath room air isotop 13n wa monitor continu subject knee dure entir period positron detector correc isotop decai halflif min concentr knee continu rise min washout period variou cau thi unexpect result ar discuss exten redistribu ga avascular knee tissu 
87056764 adipo tissueenph anim bodi weight compar studi exer femal kinet rat rat inbr strain support govt ph 35cyclic amp phosphodiesterasem distribu cyclic amp phosphodiestera adipo tissu train rat fat cell isol sedentari exerc train femal spraguedawlei rat cyclic amp phosphodiestera cyclic amppd activ determin crude homogen fat cell homogen p5 p48 s48 fraction exerc train result signif increa mean specif activ cyclic amppd pmol min1 mg1 homogen s48 fraction cyclic amp concentr p48 fraction cyclic amp cyclic amppd kinet plot accord lineweaverburk calcul micha constant km maximum enzym veloc vmax nonlinear indic low high enzym form micha constant significantli lower train rat control high km form cyclic amppd solubl fraction low km form p5 particul fraction vmax high km form p48 particul fraction train anim wa significantli higher control phosphodiestera inhibi methylxanthin variou fraction wa similar train sedentari anim chang specif activ micha constant vmax cyclic amppd crude homogen isol fat cell exerc train anim mai account decrea cellular level cyclic amp follow catecholamin stimul isol fat cell train rat 
87056767 anim blood specimen collectionismt dive comput pinnipediabl reflex sealsbl softwar support govt nonph swim comput monitor blood sampler freediv weddel seal equip sampl arteri blood depth freediv weddel seal leptonychot weddelli describ blood wa withdrawn aortic cathet submer peristalt roller pump store singl multiplesampl collec devic multipl sampler allow individu blood sampl collect dure singl dive blood pump wa control dedic comput allow initi blood sampl flexibl combin depth andor dure descend ascend phase dive dedic comput record swim depth veloc heart rate bodi temperatur select interv data transmit laboratori comput blood sampl retriev seal surfac breath 
87056768 anim arteriesph bodi temperatur carotid bodyph denerv exer heat horsesph rectum respir rest stresspp support govt nonph support govt ph arteri vs rectal temperatur poni rest exerc co2 inhal thermal stress assess poni adequaci rectal tre arteri temperatur tar condition common ventilatori control experi co2 breath thermal stress particularli exerc extent tartr differ lead error arteri blood ga correc control environ temperatur ta degr winter degr summer tar tre degr differ greater elev winter summer ta degr 2dai lower summer ta degr 2dai chang tar tre greater furthermor elev inspir pco2 torr min alter tar tre control greater dure treadmil exerc mph grade tar tre chang significantli greater rest min work mph grade tar increa progress degr tre tend increa degr min dure moder exerc mph grade tar increa degr tre increa degr final min heavi exerc mph grade tar increa degr tre increa degr tartr differ dure work load statist signif 001abstract truncat 
87056770 atmosph pressur human model biolog respir thermodynam water loss insen comput respiratori heat exchang equat propo estim convect sensibl wcv evapor insen wev respiratori heat exchang thei ar applic sealevel barometr pressur air breath sla hypo hyperbaria air ha artifici haa atmosph onli environ paramet requir ar sla temperatur ti partial pressur water vapor inspir air pih2o ha ti pih2o actual barometr pressur pb haa pih2o pb volumetr mass rho mix specif heat cp mix breath ga mixtur physiolog data ar avail result ar express energi unit liter pulmonari ventil wcvv wevv dm3 btp ventil valu result ar obtain unit power 
87056771 anim cathet lungph lymphph lymphat systemph method sheepph support govt ph overestim sheep lung lymph contamin previou report lymph chronic sheep lung lymph prepar contain lymph nonpulmonari sourc subsequ studi lymph flow rate cannul lymph vessel depend resist position lymph cannula becau account factor estim nonpulmonari lymph sheep lung lymph prepar data accur probabl overestim nonpulmonari lymph howev presenc nonpulmonari lymph remain potenti seriou problem sheep lung lymph prepar 
87056772 anim mathemat model biolog muscl contractiond musclesdeph neuromuscular depolar agentsaipd support govt ph integr model interac muscl relax antagonist integr model describ interac nondepolar neuromuscular block agent rever anticholinestera agent deriv compar naiv model experi data obtain anesthet dog consecut separ steadyst dtubocurarin block approxim induc dog rever edrophonium infusion edrophonium arteri concentr twitch tension anterior tibiali muscl measur integr naiv model fit twitch tension data model hypothet effect compart integr model consist fit twitch tension data naiv model sum squar deviat wa lower respect integr model naiv model contrast naiv model integr model capabl describ interac anticholinestera agent neuromuscular block agent concentr vari 
87056773 acut disea altitud anoxiapp human lungpp lung volum measur lung volum chang dure acut hypobar hypoxia letter 
87056774 blood pressur blood vesselsph hemostasi human physiologytd pulmonari surfactantsph thrombosispp physiologi cross new frontier 
87056776 anestheticsadpd anim behavior animald bodi temperatur cold male mice nitrogenadpd nitrou oxideadpd partial pressur support nonu govt effect subanesthet dose inert gase behavior thermoregul mice mice expo subanesthet partial pressur n2o atm n2 atm allow choo warm cool environ mark prefer cooler environ thi behavior wa associ onset hypothermia deep bodi temperatur fall degr usual new steadi level length spent cooler environ degr hypothermia produc increa partial pressur n2o n2 effect n2o behavior thermoregul bodi temperatur rever wa correl anesthet potenc abil gase alter thermoregul suggest effect agent thermoregul wa cau molecular interac underli anesthesia sinc gase elicit chang behavior thermoregul promot oppo onset hypothermia conclud thei mai act lower level deep bodi temperatur wa regul 
87056777 anim heart atriumph lungpp lymphat systempp pulmonari edemaetpp sheep support govt ph vena cava superiorph venou pressur effect venou pressur elev lymph flow lung edema format pulmonari lymph drain thorac duct venou circul sinc venou pressur svp overcom befor pulmonari lymph flow variat svp mai affect lymph flow rate therefor rate fluid accumul lung import thi issu evid consid varieti clinic interven increa svp promot pulmonari edema format volum infusion positivepressur ventil variou vasoact drug therapi record pulmonari arteri pressur pap left atrial pressur lap svp chronic unanesthet sheep occlusion balloon left atrium superior vena cava control respect pressur superior vena caval occlud wa abov azygo vein bronchial venou pressur elev balloon wa inflat threehour experi carri variou lap level svp elev mmhg fluid present lung wa determin wettodri weight ratio method control lap level signif differ lung fluid accumul shown anim control elev svp level lap wa elev abov control significantli greater pulmonari fluid accumul anim elev svp level compar control svp level conclud signif excess pulmonari edema format occur svp elev pulmonari vascular pressur normal associ rapid fluid accumul 
87056779 anesthesia anim dog esophagu lungph pentobarbit pressur respir support nonu govt thorax trachea activ passiv respiratori mechan anesthet dog spontan breath anesthet dog pentobarbit sodium mgkg airflow volum tracheal esophag pressur measur activ passiv mechan properti total respiratori lung chest wall calcul averag passiv valu respiratori lung chest wall elast respect cmh2o l1 resist pressurevsflow relationship relax respiratori lung chest wall determin linear relationship wa total passiv intrin resist averag cmh2o l1 wherea power function describ pulmonari pressureflow relationship exhibit upward concav chest wall present upward convex averag activ elast resist respiratori respect cmh2o l1 cmh2o l1 greater activ imp reflect pressur loss forcelength forceveloc properti inspiratori muscl distor respiratori relax configur 
87056780 anim bodi weight cold eat energi metabol longev male neoplasm experimentalpc rat support govt ph longev coldexpo rat reevalu rateofliv theori ha postul increa energi expenditur result shorten surviv test thi rateofliv theori examin effect rai energi expenditur mean cold exposur longev rat male 6moold spf longevan rat gradual accustom immer cool water degr mo thei stand cool water hdai dayswk thei maintain thi program ag mo cold exposur result increa food intak despit greater food intak coldexpo rat bodi weight significantli lower control anim ag mo averag ag death coldexpo rat wa dai compar dai control cold exposur appear protect neoplasia particularli sarcoma onli necropsi coldexpo rat malign compar control result thi studi provid support concept increa energi expenditur decrea longev 
87056783 airwai resistanc anim atropinepd chlorpheniraminepd dog doserespon relationship drug hexamethonium compoundspd kinet nicotineadpd phenoxybenzaminepd propranololpd vagotomi doserespon curv central periph airwai nicotin injec dog doserespon curv central periph airwai venou inject nicotin studi anesthet dog intact vagi nicotin cau dosedepend increa central airwai resist rc similar increa periph airwai resist rp concentr rang gramskg howev respon rc rp progress sequenti dose nicotin greater gramskg administ intact vagi administr propranolol wa greater increa rp rc nicotin dose gramskg vagotomi respon central periph airwai nicotin decrea dose nicotin gramskg dose nicotin greater gramskg suppress effect nicotin rc rp wa seen intact vagi condition vagi cut atropin administ respon nicotin wa depress combin atropin chlorpheniramin atropin phenoxybenzamin complet block reaction nicotin addition reaction nicotin complet block hexamethonium result suggest nicotin increa rc rp mainli vagal reflex stimul parasympathet ganglia 
87056786 adult bodi temperatur bodi temperatur regul exer human kinet male oxygen consump propranololdu receptor adrenerg betaph skin temperatur support govt ph sweat influenc betaadrenerg blockad control sweat human evalu role betaadrenerg receptor control human sweat studi subject dure min cycleergomet exerc maxim o2 consump degr oral administr placebo nonselect betablockad bb mg propranolol intern temperatur esophag temperatur te mean skin temperatur tsk local chest temperatur tch local chest sweat rate msw continu record control sweat wa describ slope linear relationship msw te threshold te onset sweat slope mswte relationship decrea mg cm2 min1 degr c1 dure bb te threshold sweat degr wa alter result bb data suggest bb modifi control sweat periph interac sinc tsk wa significantli reduc dure bb exerc control valu degr evalu influenc reduc local skin temperatur tsk alter control sweat reduc tch account onli decrea slope mswte relationship dure bb sinc evapor heat loss requir dure exerc bb estim energi balanc equat wa reduc compar control exerc conclud dure bb reduc sweat ani te consequ decrea local tsk direct effect sweat gland 
87056788 anim arteriolespa blood flow veloc brainb capillariespa cerebrovascular circul hemorrhagepa hippocampusb hypothalamusb medulla oblongatab rat support nonu govt support govt ph effect hemorrhag region morphometr index cerebr capillar thi studi wa perform determin brain increa number perfu capillari arteriol suppli region dure hemorrhag thi wa techniqu simultan determin total perfu region arteriolar capillari morphologi consciou longevan rat serv unbl control bled mmhg mmhg stabil min region cerebr blood flow wa determin 14ciodoantipyrin half anim fluorescein isothiocyanatedextran wa inject half determin perfu cerebr vascular morphometr index total vasculatur wa label postmortem alkalin phosphata stain region cerebr blood flow wa significantli increa anim bled mmhg dure hemorrhag mmhg cerebr blood flow wa reduc ml min1 g1 mean sd region redistribu treatment total capillari densiti rang capillariesmm2 control perfu anim bled mmhg mobil unperfu vascular reserv thei slight tendenc dure hemorrhag mmhg thi percent increa significantli largest increa occur pon approxim arteriol perfu control thi wa differ compar percent perfu dure hemorrhag despit over mobil unperfu arteriol region brain significantli mobil reserv sever hemorrhag hippocampu hypothalamu medulla 73abstract truncat 
87056789 adolesc arteriesph carotid arteriesph elast exer femor arteryph heart rate human male physic fit pul arteri elast physic work capac young test hypothesi posit relat arteri elast physic work capac pwc ag subject young yr old arteri elast wa evalu measur carotid femor pulsewav veloc rest slope sc relat diastol blood pressur wa studi dure cold pressor test test vascular reactiv relationship heart rate hr work load wa determin cycl ergomet variabl measur slope thi relat spwc power output hr min1 pwc170 pwc170 rang wkg valu rang ms strong inver linear relat wa pwc170 wherea hr rest wa posit relat pwc170 wa relationship hr rest slope sc spwc variabl depend mainli sympathet respon result import intrin mechan properti cardiovascular particularli arteri elast human adapt muscular exerc 
87056790 airwai resist anim arteri blood volum capillari dog hematocrit lungb respir respir artifici support govt ph tidal volum ventilatori chang pulmonari capillari blood volum assess arteri densiti improv densiti measur gravimetr densiti arteri blood dog fluctuat frequenc spontan mechan ventil similar densiti fluctuat observ blood leav isol perfu lobe dog ventil cyclicli emploi analysi balanc erythrocyt plasma flow disten capillari contain blood tube hematocrit lower hematocrit larg blood vessel deriv relationship estim densiti fluctuat chang pulmonari capillari blood volum vc mechan ventil maximum chang densiti ventil cycl increa se gl frequenc decrea cyclesmin densiti chang estim result chang vc larger tidal volum mechan ventil larger densiti fluctuat maximum densiti chang spontan respir cyclesmin wa onesixth mechan case indic smaller chang vc dure spontan respir airwai flow resist wa increa spontan respir larger densiti fluctuat observ 
87056791 anim bodi weight femal hypertrophi musclespa neoplasm transplant organ weight pituitari neoplasmspa rat rat inbr wf somatotropin support nonu govt skelet muscl hypertrophi rat growth hormonesecret tumor plantari muscl hypertrophi result surgic ablat synergist gastrocnemiu muscl wa compar nontumor gh3 tumorbear rat group gh3 cell subcutan inject 150g femal wistarfurth rat initi tumor dai tumorbear rat gain bodi wtdai compar nontumorbear rat left gastrocnemiu muscl wa surgic remov nontumor tumor group gastrocnemiu wa remov tumor group increa growth rate wa achiev dai surgeri anim kill plantari muscl remov wet weight left plantari muscl increa unop contralat control right nontumor tumor group respect right control plantari muscl tumor group wa heavier right control plantari nontumor group howev propor bodi weight plantari wa similar group effect gastrocnemiu ablat tumor treatment plantari weight wa addit percent increa unop contralat control wa similar group data demonstr skelet muscl hypertrophi occur adult anim growth ha stimul growth hormonesecret tumor suggest muscl growth respon cau tumor oper mechan differ workinduc hypertrophi 
87056792 abdomen adult airwai resist expiratori reserv volum function residu capac human lungph male maxim expiratori flowvolum curv residu volum respir restraint physic support nonu govt thorax total lung capac vital capac effect rib cage abdomin restric total respiratori resist reactanc healthi male subject studi effect rib cage abdomin strap lung volum airwai resist raw total respiratori resist rr reactanc xr rib cage abdomin strap cau signif decrea vital capac respect total lung capac tlc function residu capac frc expiratori reserv volum increa specif airwai conduct maxim expiratori flow control tlc decrea residu volum rv wa signif rib cage strap onli abdomin strap result minor over increa rr wherea rib cage strap produc mark increa low frequenc thu frequenc depend rr wa induc similar pattern lower absolut valu rr wa obtain thorac strap subject wa breath control frc xr wa decrea especi low frequenc abdomin strap thorac strap thu reson frequenc respiratori wa shift higher frequenc partition rr xr resist reactanc lung chest wall demonstr differ effect chest wall abdomin strap rr xr reflect chang mainli chest wall mechan 
87056793 anim atelectasisetpp lungbspp phosphatidylcholinesm proteinsm pulmonari alveolipp pulmonari edemaetpp pulmonari surfactantspdph rabbit respiratori insufficiencyetpp support govt ph surfac tension vagotomi respiratori distress surfact inhibi follow vagotomi rabbit model bilat cervic vagotomi adult rabbit cau respiratori failur charact pulmonari edema decrea lung complianc atelectasi docum 18fold increa radiolabel albumin leak vascular space alveolar wash vagotomi vs shamop rabbit despit twofold increa percent prelabel satur phosphatidylcholin secret alveolar wash satur phosphatidylcholin pool size differ minimum surfac tension vs dyncm alveolar wash vagotomi control rabbit respect solubl protein alveolar wash inhibit surfac tension lower properti natur surfact wherea control rabbit vagotomi rabbit respiratori failur treat mg natur surfact lipid gram arteri blood ga valu complianc improv rel control rabbit vagotomi result alveolar pulmonari edema surfact dysfunc despit normal surfact pool size respiratori failur surfact treatment improv respiratori failur 
87056795 adult caucasoid race compar studi creatin kinasem hexokinasem human ketoglutar dehydrogena complexm lactat dehydrogenasem male musclesahen negroid race phosphofructokinasem physic fit support nonu govt skelet muscl characterist sedentari black caucasian male twentythr male black african male caucasian subject ascertain sedentari particip thi studi design determin differ skelet muscl histochem biochem characterist racial group muscl fiber type propor iia iib fiber area activ sever enzym marker differ energi metabol pathwai determin biopsi vastu laterali result indic caucasian higher percent type lower percent type iia fiber propor african signif differ observ racial group type iib fiber propor fiber type area enzym catalyz reaction phosphagen creatin kina ck glycolyt hexokina hk phosphofructokina pfk lactat dehydrogena ldh metabol pathwai significantli higher activ black african group caucasian group signif differ wa activ oxid enzym malat dehydrogena mdh oxoglutar dehydrogena ogdh 3hydroxyacylcoa dehydrogena hadh consequ pfkogdh ratio wa significantli elev african racial differ observ african caucasian fiber type propor enzym activ phosphagen glycolyt metabol pathwai mai result inherit variat data suggest sedentari male black individu ar term skelet muscl characterist endow sport event durat 
87056796 adenosineadpd adult anoxiapp blood pressur heart rate human hypercapniapp male middl ag oxygen consumptiond pulmonari ga exchang respirationd support nonu govt effect adenosin ventilatori respon hypoxia hypercapnia human adenosin infusion gram kg1 min1 human stimul ventil cau abdomin chest discomfort exclud effect symptom differenti central periph site action measur effect adenosin infu level gram kg1 min1 threshold symptom rest ventil ve progress ventilatori respon isocapn hypoxia hyperox hypercapnia measur normal compar control salin infusion singl blind dai adenosin stimul ve mean increa sd lmin lower rest endtid pco2 petco2 mean fall torr increa heart rate mean increa beatsmin chang blood pressur adenosin increa hypox ventilatori respon control min1 sao21 sao2 percent arteri o2 satur adenosin min1 sao21 measur mean petco2 torr alter hypercapn respon thi differenti effect suggest adenosin mai stimul ventil periph central action therefor mai involv mechan periph chemorecep 
87056797 anim compar studi diaphragmdeph digoxinblpd dog doserespon relationship drug electr stimul hindlimb kinet muscl contractiond musclesph effect digoxin diaphragmat strength gener contrari hindlimb muscl extracellular calcium plai import role diaphragmat strength gener appl physiol sinc inotrop effect digitali appear relat cell membran transport calcium studi effect digoxin diaphragmat contractil anesthet dog diaphragm wa electr stimul muscular electrod transdiaphragmat pressur pdi dure supramaxim 2s stimul appli frequenc rang hz wa measur balloon cathet function residu capac cardiac output wa measur swanganz cathet diaphragmat blood flow qdi volum collec left inferior venou effluent forc gener sartoriu muscl dure electr stimul wa studi concomitantli pdi dog group mgkg digoxin wa infu min dog group mgkg wa administ measur perform dure control min digoxin administr group digoxin plasmat level min reach therapeut rang dog ngml wherea group digoxin plasmat level wa higher ngml signif chang cardiac output qdi wa administr digoxin dog group group babstract truncat 
87056798 abdomensu adult cholecystectomi diaphragmirpp electr stimul forc expiratori volum function residu capac human middl ag muscl contrac muscular diseasesetpp phrenic nervepp postop complic pressur vital capac diaphragmat contractil upper abdomin surgeri postop dysfunc diaphragm ha report upper abdomin surgeri thi studi wa design determin impair diaphragmat contractil wa involv genesi diaphragmat dysfunc observ upper abdomin surgeri patient undergo upper abdomin surgeri studi follow measur perform befor surgeri vital capac vc function residu capac frc forc expiratori volum diaphragmat function wa assess ratio chang gastric pressur delta pga chang transdiaphragmat pressur delta pdi final contractil diaphragm wa determin measur chang delta pdi gener dure bilat electr stimul phrenic nerv pdi stim diaphragmat dysfunc occur patient upper abdomin surgeri assess mark decrea delta pgadelta pdi surgeri compar preoper valu vc markedli decrea upper abdomin surgeri ml surgeri contrast chang frc pdi stim wa observ surgeri contrast chang frc pdi stim wa observ upper abdomin surgeri compar preoper valu conclud contractil diaphragm alter upper abdomin surgeri diaphragmat dysfunc secondari mechan possibl reflex ari peripheri chest wall andor peritoneum inhibit phrenic nerv output 
87056801 adult blood glucosem compar studi estradiolbl exer femal human kinet male oxygen consump physic endur run sex characterist somatotropinbl support nonu govt sex train differ human growth hormon level dure prolong exerc human growth hormon hgh level measur dure rest prolong treadmil exerc maximum o2 uptak vo2max immedi recoveri group subject 7group ag yr classifi male runner mr femal runner fr male control mc femal control fc determin sex differ hgh respon ar relat rest betaestradiol e2 andor cardiorespiratori endur cre gluco glc e2 hgh level determin serial blood sampl venou cathet glc chang significantli dure exerc differ trend runner increa vs control decrea result higher postexerc level runner rest hgh wa higher fr fc mr mc respect continu higher fc vs mc dure min exerc mr achiev higher peak hgh level exhibit higher valu mc exerc recoveri statist signif train differ femal strongest predictor peak hgh absolut work load group runner vs control combin account variabl hgh respon signif sexrel variabl sex rest e2 account variabl peak percent chang hgh e2 posit effect rest neg effect dure exerciseabstract truncat 
87056802 anim arteriesph blood flow veloc blood pressur blood volum dog elast lungb support govt nonph support govt ph vascular resist vasoconstr veinsph venou pressur pulmonari vascular complianc viscoelast dog lung lobe perfu constant arteri inflow rate occlusion venou outflow vo produc rapid jump venou pressur pv follow slower rise arteri pressur pa pv dure slow rise pat pvt tend converg becom concav upward volum blood lung increa compar dynam vascular volum vs pressur curv obtain vo static volum vs pressur curv obtain dye dilution slope static curv static complianc cst wa alwai larger slope dynam curv dynam complianc cdyn addition cdyn decrea increa blood flow rate venou occlusion vo wa follow interv arteri occlusion ao lobe wa isovolum pa pv level wa pressur instant ao attempt explain observ compart model wa construct hemodynam resist vascular complianc volum depend vessel wall viscoelast featur model account converg upward concav pa pv curv vo pressur relax isovolum state ao respect accord model analysi differ cst cdyn flow depend cdyn ar wall visco volum depend complianc respect model analysi suggest wai evalu chang viscoelast lobar vascular bed hypox vasoconstr increa total vascular resist decrea cst cdyn appear increa vessel wall visco 
87056803 abdomenah anim compar studi diaphragmah dog phrenic nerveph plethysmographi pressur respir support nonu govt support govt ph tidal volum relationship diaphragm length abdomin dimen examin relationship chang abdomin crosssec area measur respiratori induct plethysmographi chang length costal crural diaphragm measur sonomicrometri supin anesthet dog dure passiv inflat diaphragm shorten abdomin crosssec area increa dure passiv deflat diaphragm lengthen abdomin crosssec area decrea subsequ relationship costal crural diaphragmat length respect abdomin crosssec area dure passiv inflationdefl predict length chang costal crural diaphragm dure quiet breath befor bilat phrenicotomi intact anim inspiratori shorten crural diaphragm wa invari greater predict relationship dure passiv inflat dure inspir phrenicotomi crural diaphragm invari lengthen wherea costal diaphragm shorten gener wa correl measur predict length chang crural diaphragm befor phrenicotomi poor costal diaphragm befor phrenicotomi 
87056805 anim blood pressur blood volum bodi waterm heart atriumph kinet lungahph lymphat systemph organ weight perfusion pressur pulmonari arteryph sheep lymph flow lung weight isol sheep lung studi relationship lung weight lymph flow situ isol sheep lung prepar allow variabl measur simultan lung perfu constant rate ml min1 kg1 control lung left atrial pressur pla wa kept atmosph pressur experi lung pla wa kept atmosph 50min elev mmhg midwai perfusion dure thi period left atrial hyperten pulmonari arteri pressur rose mmhg lymph flow rose mlh lymphtoplasma oncot pressur ratio pi lpi left atrial pressur wa return control pulmonari arteri pressur lymph flow pi lpi return control level rate weight gain return left atrial pressur control wa control group howev dure period left atrial hyperten ml fluid filter lung thi larg increa lung weight remain pressur wa lower presenc thi substanti excess lung water despit control valu vascular pressur lymph flow rate weight gain pi lpi suggest absolut lung water ha littl influenc dynam aspect lung fluid balanc result ar consist twocompart model interst space onli compart readili drain lymphat 
87056806 anim dog electr stimul femal male pulmonari ga exchang respir artifici support nonu govt support govt ph tidal volum tracheaph vagu nerveph co2 elimin highfrequ oscil effect vagosympathet stimul effect electr stimul vagi ga transport mediat highfrequ low tidal volum ventil hfv wa examin anesthet paralyz propranololtr dog ga transport effici wa estim measur rate co2 remov lung vco2 achiev dure burst hfv appli befor control dure control electr stimul transect vagi dure vagal stimul heart rate wa maintain electr pace dure phase vagal stimul pulmonari imp increa cmh2o l1 vco2 increa electr stimul vagi wa stop imp vco2 return prestimul valu vco2 wa alwai higher dure electr stimul vagi hfv fix volum wa appli rang frequenc fix oscil frequenc wa rang tidal volum effect vagal stimul hfvmediat ga transport quit similar effect locat bia flow inlet outlet lung tracheal volum wa decrea ml equiv estim chang control airwai volum occur dure vagal stimul simul effect vagal stimul decrea tracheal volum vco2 previou describ model hfvmediat ga transportabstract truncat 
87056807 adult atropinedu autonom nervou systemph bed resta cardiovascular systemph electrocardiographi fourier analysi heart rate human male middl ag postur retrospect studi atropin unmask bedrest effect spectral analysi cardiac interbeat interv bedrest decondi suspect reduc cardiac reserv possibli impair autonom function heart rate respon normal subject reveal consid variabl reflect rel broadband interbeat interv power spectrum reduc thi autonom modul variabl predict cau narrow spectrum retrospect analyz data aerob condition ag rang yr undergon orthostat toler test lower bodi neg pressur prebe rest dai bed rest placebo venou atropin spectra deriv fourier analysi interbeat interv data spectral power wa estim comput rootmeansquar rm valu mean sd band encompass 2nd 64th harmon subject suffici number beat placebo rm ms prebe rest ms bed rest ns atropin rm ms prebe rest ms bed rest data suggest atropin unmask decondi effect bed rest athlet evidenc reduc interbeat interv spectral power appar placebo spectral analysi offer mean quantit effect bedrest decondi autonom perturb cardiac dynam 
87056808 paminoazobenzeneaapd acetazolamidepd anim azo compoundspd carbon anhydra inhibitorspd compar studi dextranspd hydrogenion concentr lungen male molecular weight perfusion pulmonari ga exchang rat rat inbr strain support nonu govt support govt ph effect dextranbound inhibitor carbon anhydra activ isol rat lung effect macromolecular prontosildextran inhibitor pd carbon anhydra ca activ isol rat lung studi isol lung perfu krebsr bicarbon krb solution contain inhibitor pd mol wt pd mol wt lowmolecularweight inhibitor prontosil acetazolamid cour effluent perfu ph equilibr wa measur stopflow ph electrod apparatu pulmonari co2 excretion vco2 wa monitor continu record expir co2 concentr lung ventil room air perfu degr krb prebubbl co2 o2 n2 result obtain lowmolecularweight inhibitor pd cau postcapillari ph disequilibria delta ph effluent perfu howev onli acetazolamid prontosil cau reduc vco2 result suggest vascular ca presum associ endoth cell membran access inhibitor respon equilibr co2 hco3 reaction perfu condition doe affect co2 excretion extravascular possibli cellular ca inhibit lowmolecularweight inhibitor primarili respon enhanc co2 transfer alveolarcapillari barrier perhap facilit co2 diffusion respon ph equilibr 
87056809 action potenti anim lungir lung volum measur mechanoreceptorsph rabbit respir factor vagotomi vagu nerveph effect expiratori load expiratori durat pulmonari stretch receptor discharg slowli adapt pulmonari stretch receptor hypoth affer mediat vagal depend volumerel prolong expiratori te dure expiratori load ha suggest vagal compon thi prolong te tempor summat pulmonari stretch receptor psr activ dure expiratori load thi hypothesi wa test rabbit expo resist elast singlebreath expiratori load psr simultan record type load result decrea expir volum ve increa expiratori durat te te resist load significantli greater elast load equiv ve thu differ vete relationship resist elast load te wa plot area expir volum trajectori singl linear relationship wa observ psr activ record dure expiratori load increa ve decrea te increa singl linear relationship result number psr spike dure expir wa plot associ te type load demonstr volumerel prolong te singlebreath expiratori load associ increa psr discharg result support hypothesi vagal compon loaddepend prolong te function tempor spatial summat psr activ dure expiratori phase 
87056813 adolesc adult femal human lung volum measur male oxygen consump postur pulmonari ga exchang respir spirometri vital capac effect postur vital capac influenc extrem bodi postur vital capac vc wa examin young adult human postur requir support bodi weight arm arm hang bar arm hand grip parallel bar involv muscl flex extend trunk partial situp position supin nearli maxim spinal exten flexion stand chang inspiratori expiratori volum extrem recogn subject vc effort stand postur continu breath spiromet control observ vc pair wa perform unstress postur allow correc influenc rebreath chang correct vc greatest averag reduc approxim partial situp position dure support bodi weight arm vc wa slightli increa signif increa inspiratori extrem chang expiratori extrem spinal exten produc increa lung volum extrem signif chang vc wherea spinal flexion influenc upper extrem increa lung volum lower extrem chang ar discuss term trunk muscl action 
87056814 adult bodi temperatur cold forearm hematocrit human immer male distor calcul wholebodi hematocrit dure lowerbodi immer water differ venou hematocrit immer nonimm arm dure immer lower bodi cold water dure compar exposur warm water fourteen healthi expo differ experi condition arm immer bodi immer control alwai sat upright upper extrem hung vertic dure arm immer forearm wa complet immer min cold water degr warm water degr thi coldwarm water protocol wa repeat separ dai exposur remain condition bodi immer immer forearm tissu xiphoid process control immer blood sampl simultan drawn cannul vein antecubit fossa hematocrit differ hct diff wa measur subtract nonimm forearm hematocrit hct dry immer forearm hematocrit hct wet hct diff wa approxim zero expo control condition bodi immer warm water remain condition hct wet drop hct dry 3wai analysi varianc decrem hct diff differ venou hematocrit immer nonimm region bodi indic chang wholebodi hematocrit calcul largevessel hematocrit immer lower bodi cold water 
87056815 abdomin wallpp diaphragmpp electromyographi femal human male pleura pressur respir respiratori musclespp sleep sleep apnea syndromespp stomach support govt nonph respiratori muscl interac dure nrem sleep patient occlu apnea studi respiratori muscl interac patient occlu apnea diaphragmat electromyogram emgdi gastric pleural transdiaphragmat pressur pga ppl pdi respect studi patient dure nonrapideyemov nrem sleep diaphragmat forc output assess pdi follow period chang emgdi dure occlu phase increa pdi wa increa emgdi thi increa pdi wa essenti increa ppl sinc pga emgdi linear relationship chang dure occlu ventilatori phase abdomin muscl recruit evid pga abdomin motion trace dure occlu phase paradox rib cage motion wa observ suggest thi increa diaphragmat effici wa chang diaphragmat lengthten characterist result demonstr patient occlu apnea diaphragm predomin respiratori muscl dure nrem sleep function support abdomin muscl recruit 
87056818 adult airwai resist anesthesia local compar studi human middl ag mouthph nasal cavityph respiratori airflow support govt ph role nose resist load detec previou resist load detec rld studi ignor nose usual rout breath weber law predict delta r50 ad load detect present fix percent background resist r0 thu delta r50r0 ratio weber fraction constant nose sensit ad load wonder nose plai role rld determin thi wa true charact effect chang r0 rang normal nasal resist rn determin r0 delta r50 standard techniqu follow condition nose vs decongest nose nose vs nose ad extern r0 cmh2o l1 nose vs anesthet nose nose vs mouth mouth vs mouth ad load cmh2o l1 decongest decrea rn se cmh2o l1 delta r50 cmh2o l1 extern load cmh2o l1 wa ad nose delta r50 chang significantli cmh2o l1 weber fraction decrea 002abstract truncat 
87056820 anim anoxiam dog hindlimb isoproterenolpd methoxaminepd musclesbsm oxygen consumptiond receptor adrenerg alphaph receptor adrenerg betaph region blood flowd support nonu govt support govt ph vasoconstr adrenerg local control o2 uptak dure sever hypoxia distribu wholebodi o2 suppli dure sever hypoxia recoveri relat region distribu o2 deficit repai wa studi mongrel dog anesthet paralyz ventil maintain endtid pco2 torr group alpha betaadrenerg receptor block elimin neural humor adrenerg influenc group alphaadrenerg receptor stimul decrea o2 deliveri excess vasoconstr group betaadrenerg receptor stimul increa o2 deliveri wholebodi hindlimb muscl o2 uptak vascular respon measur dure normox control min sever hypoxia o2 n2 min normox recoveri respect wholebodi o2 deficit excess o2 uptak recoveri partition muscl nonmuscl area data neural humor influenc littl effect region distribu total o2 deficit o2 excess recoveri o2 deficit decrea somewhat increa deliveri excess o2 recoveri wa unaffect thi suggest excess o2 recoveri wa function energi deficit dure hypoxia o2 deficit 
87056821 albuminsm anim blood pressur capillari permeabl capillari resist cattl compar studi endotheliumm femal guinea pig lungbsdem male meclofenam acidpd support govt ph srsapd thromboxan b2me vascular resist 6ketoprostaglandin f1 alpham mechan peptidoleukotrieneinduc increa pulmonari transvascular fluid filtrat examin effect leukotrien c4 ltc4 d4 ltd4 gram pulmonari vascular filtrat coeffici measur vessel wall conduct water alter pulmonari vascular resist pvr isolatedperfu guinea pig lung assess ltc4 ltd4 increa permeabl albumin cultur monolai pulmonari arteri endoth cell ringerperfu bloodperfu lung ltc4 result increa pulmonari arteri pressur ppa pulmonari capillari pressur pcap measur equilibr pressur simultan pulmonari arteri venou occlusion pulmonari venou resist rv increa greater extent arteri resist ra ringerperfu bloodperu lung challeng ltc4 greater increa pvr bloodperfu lung correspond greater elev lung effluent thromboxan b2 txb2 concentr ltc4stimul increa pvr wa prevent pretreat meclofenam ltd4 induc rapid increa ppa pcap ringerperfu bloodperfu lung howev ppa decrea befor stabil pressur higher base line increa rv ltd4 greater ra ltd4stimul increa ra rv parallel elev txb2 concentr ltc4 increa ppa pcap pvr txb2 concentr greater bloodperfu ringerperfu lung pretreat meclofenam reduc magnitud initi increa ppa prevent responseabstract truncat 
87056822 adult altitud exer heart rate human male oxygen consump propranololdu receptor adrenerg betaph support govt nonph support govt ph sympathet nervou systemph propranolol doe impair exerc oxygen uptak normal high altitud decrea maxim o2 uptak vo2max stimul sympathet nervou previou shown occur high altitud hypoth tachycardia mediat betaadrenerg stimul act defend vo2max high altitud propranolol treatment begin befor highaltitud ascent reduc heart rate dure maxim submaxim exerc healthi treat propranolol mg daili compar healthi subject receiv placebo lacto compar sealevel valu vo2max dai high altitud magnitud fall wa similar placebo propranolol treatment group vs ns vo2max remain similar high altitud group onc treatment wa discontinu dure min submaxim vo2max exerc propranololtr subject maintain o2 uptak level larg placebo subject mainten maxim submaxim level o2 uptak propranololtr subject attribut increa minut ventil arteri o2 satur hemoglobin concentr appear propranololtr subject maintain o2 uptak transport greater propor o2 uptak heartbeat thu contrari hypothesi betaadrenerg blockad impair maxim submaxim o2 uptak high altitud perhap compensatori mechan act maintain stroke volum cardiac output 
87056823 acidba equilibrium adult blood pressur blood transfusion autolog cardiac output exer heart rate hemodynam human lactatesbl male oxygen consump physic endur polycythemiaetpp run stroke volum support nonu govt effect grade erythrocythemia cardiovascular metabol respon exerc effect grade induc erythrocythemia cardiovascular metabol respon inten treadmil run studi highli train endur runner autolog infusion unit blood mlu administ sequenti dai apart maxim o2 consump vo2max increa lmin control lmin r2 lmin r3 cardiac output dure treadmil run control vo2max wa lmin lmin r2 lmin r3 correspond heart rate unchang stroke volum wa increa r3 peak lactat concentr wa reduc arteri acidba statu improv r2 r3 standard bout inten exerc arteri blood pressur electrocardiogram dure exerc affect erythrocythemia conclud reinfusion autolog blood highli train endur runner normal hematologi doe adver affect cardiovascular respon maxim exerc addition increa vo2max follow reinfusion suggest aerob power work muscl wa surpass level erythrocythemia 
87056824 adenosin triphosphatem adult biopsi needl electr stimul femal glycolysi human hydrogenion concentr hydrolysi inosin monophosphatem male musclesm phosphocreatinem support nonu govt ph measur human skelet muscl sampl effect phosphagen hydrolysi measur muscl ph phm homogen techniqu ar routin exten phosphagen hydrolysi ha occur exposur homogen degr ph meter phosphocreatin atp rapidli degrad control concentr attempt chemic arrest thi hydrolysi unsuccess therefor examin signif phosphagen hydrolysi phm measur human biopsi rest follow inten electr stimul accomplish thi phm wa measur degr exten hydrolysi occur homogen phm wa measur degr phosphagen degr phosphagen hydrolysi effect phosphagen hydrolysi phm degr wa estim thi effect degr rest sampl phosphagen hydrolysi produc nonsignif acidif ph unit electr stimul sampl nonsignif alkalin unit measur homogen pco2 suggest co2 remain sampl dure phm measur degr present work substanti homogen techniqu accur practic method estim cellular ph rest exerc human muscl sampl 
87056826 anim dye kinet male model anatom nasopharynxahph papio respiratori airflow support govt nonph water airflow characterist baboon nasal passag cast airflow pattern nasal passag influenc distribu airpollutantinduc lesion airwai mucosa littl airflow characterist complex nasopharyng airwai human experi anim airflow characterist nasopharyng airwai adult male baboon kg bodi wt investig thermistor probe compar flow visual cinephotograph techniqu clear acryl hollow cast baboon nose wa thermistor probe insert record air veloc cast lumen wind tunnel propel air cast ident cast wa studi pass water cast pul dye reveal flow cinephotographi wa determin flow veloc flow pattern flow rate adjust basi reynold conver correl method wherea cinephotographi reveal area turbul vortexlik flow detect thermistor probe result suggest water flow mai provid inform complex airwai airflow determin method 
87056827 adult compar studi exer human male qualiti control regr analysi specimen handlingmt sweatan ureaan validityr sweat analysi wholebodi washdown vs region collec subject yr mean sd exerci min low moder vo2max high moder environ sweat collect upper ub lower lb midchest mc stomach thigh area wholebodi washdown wa analyz urea nitrogen excep region measur similar site overestim sever significantli regr analysi estim mgh region collec followsl 1366ub 1181t 0598mc 0649ub 0244lb 0560t 0223mc inten 0497mc 0483t 0112lb recoveri exogen urea appli subject bodi wa mean se interinvestig reliabl coeffici wa signif rel low investig urea recoveri vs wa significantli differ repeat determin investig differ greater investig reliabl coeffici differ wide vs togeth data indic solut recoveri high howev inter investig reliabl varyabstract truncat 
87056828 anim cardiac output compar studi energi metabol heart ventriclem human model biolog oxygen consump stroke volum support nonu govt energi cost minim left ventricular ejec optim control model new optim model explain observ left ventricular ejec pattern present model arteri load describ modifi windkessel load ejec pattern cardiac output fix stroke volum durat ejec predict minim criterion describ total ventricular o2 consump ejec pattern model close resembl observ ejec pattern model predic chang valu paramet ar qualit correct result strongli suggest control ejec pattern satisfi principl energi cost minim 
87056830 exer human musclesm thermodynam effici free energi muscular work letter 
87057496 femur headpp femur head necrosisdisu human pressur osteonecrosi editori 
87057497 adult ag biopsi compar studi femal femor fracturesep femur headppsu femur head necrosiscodisu followup studi human male method middl ag postop complicationsep pressur prognosi retrospect studi core decompr femor head osteonecrosi result forti coredecompr procedur perform ischem necrosi femor head thirtyon patient fouryear period retrospect review ascertain effect procedur data support publish rate success procedur stage1 stage2 lesion mean length followup eighteen hip decompr prior collap femor head demonstr progr lesion judg failur clinic radiograph criteria tomograph scan magnet reson imag prove sensit diagnosi preoper test isotop bonescan wa sensit function oper test method ficat provid ad sensit specif result preoper bone scan postop oper fractur occur hip incid exce ani previou publish report conclud core decompr consid rel ineffect procedur signif morbid 
87057498 adolesc adult compar studi dislocationsdisu femal finger injuri human joint instabilitydi ligam articularinsu male metacarpophalang jointinsu method middl ag retrospect studi ruptur ruptur displac ulnar collat ligam metacarpophalang joint thumb preoper diagnosi evalu treatment injuri ulnar collat ligam metacarpophalang joint thumb remain controversi retrospect studi wa assess abil determin displac ligam stener lesion wa present review accumul experi patient injuri thi ligam treat surgic sinc method evalu chang compar preoper oper diagno twenti patient treat surgic twenti patient treat consid forti patient treat oper sixteen typic stener lesion ulnar collat ligam wa roll ly beneath adductor aponeurosi stabil wa test metacarpophalang joint complet exten vari flexion twenti thumb evalu thi techniqu treat surgic stener lesion stabil wa test joint flexion becau anatom studi complet incid stener lesion twenti thumb treat repair reattach ligam dure thi wa centabstract truncat 
87057499 adolesc child compar studi femal followup studi human male orthop fixat devic postop complicationsepsu reoper retrospect studi scoliosiscosu spinal fusionaei adolesc idiopath scoliosi treat harringtonrod distrac fusion hundr thirtythr patient adolesc idiopath scoliosi treat inser singl harrington distrac rod spinal fusion postop immobil consist belowtheshould cast mean preoper curv wa degr rang degr mean final curv wa degr rang degr neurolog injuri deep wound infec twelv patient requir surgeri complic treat successfulli durat followup rang twentyfour seventytwo final followup patient resum normal preoper activ limit 
87057501 adolesc adult anterior compart syndromecodisu chronic disea compar studi compart syndromessu exer fasciasu femal followup studi human male middl ag musclespp postop complicationsep pressur recurr reoper rest support nonu govt chronic anteriorcompart syndrom leg result treatment fasciotomi thirti leg nineteen patient bilat unilat chronic anteriorcompart syndrom treat fasciotomi addition patient leg compr superfici peron nerv befor fasciotomi patient compart syndrom leg patient compr superfici peron nerv reliev partial fasciectomi fasciotomi compart patient bilat nerv compr superfici peron nerv anom patient compart syndrom wa reliev fasciotomi thi compart patient requir fasciotomi recurr chronic compart syndrom averag length followup twentyf fasciotomi anterior compart syndrom function capac wa unlimit increa eighteen patient twentyeight leg wa unchang patient leg compr superfici peron nerv muscular pressur anterior compart normal rest dure exerc origin fasciotomi twentyeight leg fasciotomi leg 
87057502 accid traffic adolesc adult anterior compart syndromedietsu compart syndromeset fasciasu femal fractur opencosu human male middl ag retrospect studi tibial fracturescosu compart syndrom open tibial fractur retrospect review case patient acut open fractur tibial shaft admit multipletrauma referr center threeyear period reveal incid accompani compart syndrom eighteen fractur sixteen patient eighteen compart syndrom wa docum measur compart pressur obtain salineinjec techniqu treat fourcompart fasciotomi incid compart syndrom wa directli propor degr injuri soft tissu bone thi complic occur associ comminut gradeiii open injuri pedestrian physician maintain high index suspicion detect compart syndrom patient ha multipl trauma clinic sign symptom mai mask close injuri head ventilatori support prolong anesthesia surgic procedur 
87057503 adolesc adult athlet injuriescodi cervic vertebraeabra footbal human male neural conduc paralysisdiet quadriplegiadiet registri spinal cord injuriescodi spinal stenosiscoetra syndrom factor unit state neurapraxia cervic spinal cord transient quadriplegia purpo thi studi wa defin distinct clinic entiti syndrom neurapraxia cervic spinal cord transient quadriplegia sensori chang includ burn pain numb tingl loss sensat motor chang rang weak complet paralysi episod ar transient complet recoveri usual occur minut patient gradual resolu occur period thirtysix fortyeight burn paresthesia pain neck present injuri complet return motor function painfr motion cervic spine seri routin roentgenogram cervic spine neg fractur disloc patient howev roentgenograph includ develop spinal stenosi seventeen patient congenit fusion patient cervic instabl patient intervertebr disc disea patient spinal stenosi wa determin differ roentgenograph method wa standard method wa ratio method devi measur level sixth vertebr bodi routin roentgenogram cervic spine wa avail twentyfour thirtytwo patient control group fortynin male subject similar ag ani neurolog complaint ratio method measur indic signif spinal stenosi group twentyfour patient roentgenogram avail compar ratio approxim control group wa statist signif spinal stenosi patient compar control subject method determin spinal stenosi survei school particip nation collegi athlet associ ncaa footbal season athlet histori wa suggest neurapraxia cervic spinal cord phenomenon neurapraxia cervic spinal cord occur individu develop stenosi cervic spine congenit fusion cervic instabl protrusion intervertebr disc associ decrea anteroposterior diamet spinal canal postul athlet diminu anteroposterior diamet spinal canal spinal cord forc hyperexten hyperflexion compress cau transitori motor sensori manifestationsabstract truncat 
87057504 adult athlet injuriescora case report cervic vertebraeabra cineradiographi footbal human male myelographi quadriplegiaetra spinal stenosiscncora tomographi xrai comput congenit cervic stenosi present transient quadriplegia athlet report case case patient complet transient quadriplegia develop injuri wa incur plai footbal ar present patient congenit narrow cervic vertebr canal critic stenosi result transient quadriplegia occur presum injuri cervic disc opinion myelogram patient histori transient quadriplegia numb burn sensat lower extrem radiograph studi ar interpret neg patient stenosi cervic spine advi discontinu particip contact sport 
87057505 acut disea adolesc arm injuriescoth bone nailsa burnscoth child child preschool equip design femal human infant leg injuriescoth male retrospect studi splintsa skelet suspen manag sever burn children sixteenyear experi skelet suspen wa shriner burn institut galveston texa treatment burn pediatr patient affect extrem skelet suspen wa acut burn extrem facilit skingraft extrem function position surgic correc burnacquir deform retrospect examin patient fifti complic relat skelet suspen fortyf infec infec resolv remov pin administr antibiot thi establish low rate complic skelet suspen continu adjunct care sever burn pediatr patient 
87057506 acut disea adolesc adult case report compar studi diagnosi differenti femal gaucher diseasecodipa human method osteomyelitisdietpa support nonu govt osteomyel gaucher disea rel common complic gaucher disea socal crisi frequent difficult differenti acut osteomyel review case fortynin patient gaucher disea treat massachusett gener hospit patient requir admi hospit acut symptom complex repr crisi infec patient prove acut hematogen osteomyel delai diagnosi infec patient osteomyel unsatisfactori outcom 
87057507 anim biomechan bone nail calluspp compar studi dietari proteinstu disea model anim femor fracturesdhpp femurpp fractur fixat medullari fractur closeddhpp male rat rat inbr strain support nonu govt trace elementstu vitamin dtu wound healingd contribu dietari protein miner heal experi fractur biomechan studi examin contribu dietari protein miner fractureh assess mechan properti fractur callu rat fed diet wa defici enrich nutrient order isol effect diet fractureh develop method produc standard close femor fractur minimumsofttissu injuri group anim studi group wa control group rat undergo oper rat group ii underw medullari pin right femur fractur wa creat rat group iii underw pin ident group ii close transver femor fractur wa produc immedi surgeri anim group subdivid diettreat subgroup subgroup receiv regular diet subgroup receiv proteinfr diet subgroup receiv mineralfr diet wa calcium phosphoru vitamin subgroup receiv proteinsuppl diet wa compo calcul requir protein subgroup receiv mineralsuppl diet wa compo calcul requir calcium phosphoru therapeut dose vitamin equiv treatment osteomalacia end anim kill right femur wa subject torsiontest failureabstract truncat 
87057508 anim bone developmentd bone resorptiond compar studi dog femurahdera hip prosthesi materi test metallurgi prosthesi design support nonu govt support govt ph factor titaniumpd compar studi porou coat weightbear total hiparthroplasti model purpo thi studi compar ingrowth bone type porou coat determin effect type porou coat degr coverag stem remodel bone femor cementless hip arthroplasti left total hip arthroplasti wa perform forti dog thirti dog titaniumalloi femor prosthesi type commerci pure titanium porou materi appli length anterior posterior surfac stem sinter fibermet sinter bead plasma flamesprai coat remain dog femor compon wa circumferenti coat commerci pure titanium wa plasma flamesprai length stem group anim kill kill ingrowth bone type porou coat wa observ indic secur fixat compon wa ingrowth bone new medullari bone adjac proxim distal aspect stem compar middl level stem group signif differ ingrowth bone wa observ bead surfac fibermet surfac wa significantli ingrowth bead surfac fibermet surfac group proximaltodist gradient loss cortic bone wa observ group dog stem circumferenti coat experienc sever loss bone group stem partial coat magnitud loss bone wa depend extent type porou coat 
87057509 ag bone plate bone wire femal followup studi human humer fracturescoppsu male method middl ag movem postop care postop complicationsep retrospect studi shoulder dislocationcoppsu shoulder jointpp threepart fractur proxim humeru oper treatment retrospect review case patient threepart fractur proxim humeru present fourteen fractur treat tensionband wire ao buttress plate patient evalu pain rang motion strength function involv shoulder radiograph result averag fiftyfour injuri followup shoulder averag degr activ elev degr activ extern rotat degr activ abduc intern rotat lumbar vertebra onli earli complic wa failur fixat patient treat buttress plate patient radiograph evid avascular necrosi humer head develop requir revision hemiarthroplasti conclusion recommend oper treatment healthi activ individu ha threepart fractur proxim humeru result difficult fractur ar obtain tensionband wire 
87057512 actuari analysi femal followup studi hip jointra hip prosthesi human male middl ag prognosi prosthesi failur retrospect studi factor survivorship analysi total hip replac result seri activ patient fiftyf old senior csr perform primari total hip replac eightyf consecut patient fiftyf old patient degen joint disea survivorship analysi wa calcul predict cumul rate success thi seri total hip replac followup thi method analysi data wa chosen becau provid predic expect durabl total hip arthroplasti ani individu patient revision becau loosen infec el radiograph evid migrat compon wa criterion failur revision perform asept loosen acetabular compon infec necessit revision radiograph evid loss fixat wa seen addition acetabular compon femor stem lifet calcul predict survivorship total hip replac thi seri followup base result applic thi method analysi current seri conclud primari cement total hip replac perform coxarthrosi expect function durabl activ middleag patient 
87057513 adult anuriadietth flowmet hip prosthesi human male middl ag postop complicationsdietth preoper care prospect studi prostat risk factor urinari cathet urodynam urinari reten total hip arthroplasti prospect studi sixtyfour wa conduct befor thei underw total hip arthroplasti try identifi factor ar predict postop urinari reten urolog histori physic examin provid inform wa help accur identifi patient risk peak urinari flow rate wa seventeen liter statist signif likelihood develop urinari reten manag hope reduc incid thi complic propo 
87057514 accid traffic acut disea adult case report compart syndromesetpasu fasciasu femor fracturescopasu fractur closedcopasu human male middl ag motorcycl thigh acut compart syndrom thigh complic fractur femur report case 
87057515 adult anterior compart syndromeetpa case report compart syndromeset fasciasu herniacosu human male muscular diseasescosu postop complicationsetpa compart syndrom complic repair hernia tibiali anterior case report 
87057516 adult bladder neoplasmssu case report compart syndromesetpa human male neoplasm multipl primarysu postop complicationsetpapc protect devic shoesa thrombophlebitispc factor acut compart syndrom cau malfunc pneumaticcompr boot case report 
87057517 anesthesia epidurala bupivacain case report compart syndromesetpa fibulatr fractur ununitedsu human male middl ag pain postoperativeth postop complicationsetpa staphylococc infectionspasu tibial fracturessu compart syndrom mask epidur anesthesia postop pain report case 
87057519 accid fall acut disea case report compart syndromesetpasu fasciasu forearm injuriescopasu human male middl ag radiu fracturescopasu acut compart syndrom forearm associ fractur distal end radiu report case 
87057520 adult backacheetra case report fracturescora fractur spontaneouscora fractur ununitedcora human lumbar vertebraeinra male spondylolisthesiset spondylolysisetra fractur pedicl fourth lumbar vertebra associ contralat spondylolysi report case 
87057523 compar studi hip prosthesi human prospect studi prosthesi design prosthesi failur conven versu resurfac total hip arthroplasti longterm prospect studi concomit bilat implant prosth letter 
87057524 bone neoplasmssu giant cell tumorssu human giantcel tumor bone letter 
87057525 anesthesiamt hip jointsu human knee jointsu postop complicationspc thrombophlebitispc prophylaxi venou thromboembol disea follow hip knee surgeri letter 
87057526 clinic trialsmt human orthop random alloc random clinic trial orthopa oblig option letter 
87057527 arthriti infectiouspa case report chlamydia infectionspa human macrophagesul mast cellsul scopi electron reiter diseasepa arthriti presum cau chlamydia reiter syndrom case report electron scopic studi letter 
87057529 atlantoaxi jointinra case report cervic vertebraera child diagnosi differenti human male movem factor traction earli diagnosi atlantoaxi rotatori fixat atlantoaxi rotatori fixat spectrum rotatori abnorm atlantoaxi joint rotatori fixat anterior displac atla type ha report onli case ha prolong interv injuri diagnosi major case eventu requir cervic fusion persist deform instabl case ar present thi diagnosi wa earli aid rotat odontoid radiograph tomographi computeri axial tomographi treatment period halter traction achiev reduc earli return function author conclud earli recogni treatment thi rare condition mai prevent subsequ deform instabl cervic fusion ha requir 
87057530 axisinra case report cast surgic fracturesparath human infant hangman fractur infant case report fractur pedicl axi vertebra infant nonop manag minerva cast result union recoveri complic 
87057532 adult case report fibrosi human male sciatic nervepa sciaticaet sciatica cau perifibrosi sciatic nerv 
87057533 ag arthroscopi evalu studi femal human knee jointsu male middl ag arthroscop partial meniscectomi patient ag 
87057534 accid traffic adult athlet injuriesdi cervic vertebraera femal human male neurolog examin prognosi spinal cord injuriescodipp syndrom reapprai acut traumat central cord syndrom review patient traumat central cord syndrom reveal atyp variat ar common exist literatur suggest mai seen wide varieti acut injuri cervic spine gener outcom favour prognosi admi suggest hand function hyperpathia lhermitt sign normal perian sensat studi ha highlight valu regular muscl chart ha cast doubt previou neuroanatom assump syndrom 
87057535 adolesc compar studi femal human lateralityph neurolog examinationmt scoliosisdietpp sensori thresholdsph spinal cordpp vibrationdu vibratori respon idiopath scoliosi clinic studi suggest neurolog lesion mai cau adolesc idiopath scoliosi anim experi implic posterior column pathwai tri determin differ neurolog respon detect measur clinic compar threshold detec vibratori sensat girl adolesc idiopath scoliosi clinic normal agematch control highli signif reduc threshold detec vibrat wa seen scoliot group compar control curv magnitud correl thi threshold upper lower extrem signif asymmetri right leftsid threshold vibrat wa demonstr scoliot group studi support concept aberr function posterior column pathwai cord mai primari import aetiologi idiopath scoliosi clinic practic test measur thi function present 
87057536 acut disea adolesc adult chymopapaintu femal human intervertebr diskpa intervertebr disk chemolysi intervertebr disk displacementcodidt male nuclear magnet resonancedu prospect studi sciaticaet support nonu govt factor chang intervertebr disc chemonucleolysi demonstr magnet reson imag magnet reson imag mri spine produc imag reflect chemic composi intervertebr disc conduct prospect studi serial chang mri appear intervertebr disc chemonucleolysi enzym chymopapain fourteen patient studi singlelevel chemonucleolysi result compar control group disc patient diagnost discographi enzym inser consist pattern gradual loss signal nucleu pulposu culmin complet loss nuclear signal wa seen case chemonucleolysi chymopapain therefor produc mri chang analog prematur gross disc degen rate thi occur vari complet loss signal transitori minor endplat chang present patient probabl repr mild chemic disciti similar chang seen discographi group 
87057537 adolesc bodi height compar studi femal human male refer valu scoliosisppra sex characterist spinegdra observ growth adolesc spine measur increa height width vertebr bodi express percentag total growth children ag group boi girl singl thorac adolesc idiopath scoliosi group girl singl lumbar adolesc idiopath scoliosi signif differ growth increm spinal dimen vertebr bodi involv scoliot curv vertebra outsid curv patient vertebra slender girl boi 
87057538 adult evalu studi human intervertebr disk displacementra lumbar vertebraera middl ag tomographi xrai computedmt role computeri tomographi intervertebr disc prolap computeri tomographi lumbar spine wa perform patient clinic evid prolap intervertebr disc normal equivoc radiculogram patient posit scan oper presenc pathologi wa confirm ct scan alwai help diagno disc disord facil ar scarc great britain emploi patient neg noncontributori radiculographi 
87057539 acut disea adolesc adult brachial plexusinrasu compar studi human iopamidoldu male metrizamidedu myelographi factor tomographi xrai comput computeri axial tomographi traction injuri brachial plexu sever traction injuri mai damag brachial plexu ani level spinal cord axillari outlet investig aim determin level injuri nerv trunk cord particular refer obtain firm evid ani dural preganglion damag report result computeri axial tomographi cervic spine comparison conven myelographi surgic explor plexu ct scan contrast enhanc greatli improv diagnost accuraci particularli c5 c6 root level 
87057540 adolesc adult athlet injuriessu bone wire cast surgic chronic disea femal followup studi human knee injuriessu ligam articularinsu male method middl ag tendonstr reconstruc anterior cruciat ligam allogen tendon graft oper chronic ligam insuffici describ allogen human tendon articular replac anterior cruciat ligam depend type degr function instabl recommend addition case supplementari extraarticular procedur review patient oper abl return sport activ indic oper techniqu ar discuss allogen tendon recommend 
87057541 adolesc arthroscopi case report human knee injuriesrasu ligam articularinrasu male isol avul tibial attach posterior cruciat ligam childhood 
87057543 adolesc child child preschool femal followup studi fractur ununitedra human male radiusra radiu fracturesra angul radiu children fractur studi children malunion forearm fractur present ag injuri site fractur degr direc angul union correl loss forearm rotat review guidelin ar propo accept angular deform union import avoid radial deviat radiu mainten inteross gap shaft radiu ulna 
87057544 adolesc child child preschool dislocationsetrath elbow jointinra femal human humer fracturescorath male traction supracondylar fractur humeru assess cubitu varu baumann angl simpl method radiolog assess ha measur angl axi humer shaft growth plate capitellum baumann angl normal arm signif relationship wa baumann angl carri angl baumann angl wa measur reduc supracondylar fractur humeru wa correl final carri angl measur followup wa signif differ baumann angl reduc measur followup suggest thi angl reduc reliabl predict accur final carri angl 
87057545 acut disea adolesc adult carpal tunnel syndromeetpasu case report femal human male middl ag prognosi radiu fracturescopath factor wrist injuriescopath acut carpal tunnel syndrom complic delai decompr patient suffer injuri wrist complic acut tunnel syndrom pain associ median nerv paraesthesia hypoaesthesia ar indic urgent treatment patient oper wa delai outcom wa poor 
87057546 accid traffic adolesc adult automobil biomechan compar studi england femal femor fracturesepetpp human male middl ag seat belt support nonu govt factor wound heal biomechan aspect femor fractur automobil accid medic engin studi wa car accid involv vehicl occup injuri thei sustain correl crash contact insid car possibl forc gener crash estim relat injuri car occup suffer femor shaft fractur incid rear seat occup respect associ injuri region bodi cau death thi group associ injuri sever car occup wear seat belt incid femor fractur wa significantli differ mean veloc chang deltav cau femor fractur wa mph kmh wa higher incid femor shaft fractur deltav wa mph estim forc cau fractur higher cadav studi union femor fractur correl sever crash wa mean averag femor fractur 
87057547 calcaneu child clubfootetsu followup studi human meningomyeloceleco method paralysisetsu recurr tendon paraarticulartr hemitranspl tendo calcaneu children spinal neurolog disord paralyt lesion tricep sura onli activ muscl leg elong division tendo calcaneu alon mai prevent recurr equinu deform patient limb thi pattern muscl activ equinu deform wa treat hemitranspl tendo calcaneu followup wa end growth limb wa recurr deform failur technic fault mai cau loss activ transplant tendon twostag oper describ recommend manag thi pattern paralyt deform 
87057548 followup studi hip jointra hip prosthesi human osteoarthritisrasu photogrammetri prosthesi failur factor mechan loosen total hip prosth radiograph roentgen stereophotogrammetr studi twenti patient examin standard radiographi roentgen stereophotogrammetr analysi rsa dure twoyear period total hip arthroplasti acetabular compon migrat cranial femor compon migrat distal thi migrat wa rapid dure oper support possibl mechan loosen initi thermal injuri dure polym cement frequent migrat metal femor compon compar polyethylen acetabular compon mai becau metal act heat sink standard radiograph inadequ assess earli mechan loosen wherea rsa reveal migrat arthroplasti 
87057549 adult ag arthrodesismt bone wire femal human male metatarsophalang jointrasu middl ag toe jointsu simpl techniqu arthrodesi metatarsophalang joint 
87057550 bandag evalu studi human knee joint knee prosthesi orthop postop care pressur factor robert jone bandag bulki compr dress robert jone bandag orthopa surgeon review histori monitor muscular compart pressur total knee replac increa compart pressur help reduc bleed tissu oedema size effusion haemarthro 
87057551 adolesc buttock case report chronic disea femal fibromapa human neoplasm inva neoplasm regr spontan pelvic neoplasmspa factor spontan regr desmoid tumour 15yearold girl present veri larg desmoid tumour buttock extend pelvi thigh requir hindquart amput remov thi wa perform tumour underw spontan regr fourteen patient aliv sugg case expect approach treatment justifi essenti nonmalign condition 
87057552 followup studi human knee jointra osteoarthritisrasu osteotomymt tibiarasu dome osteotomi tibia osteoarthr knee proxim tibial osteotomi commonli perform osteoarthr knee deform result dome osteotomi review minimum followup averag befor oper knee pain sever disturb sleep review knee free pain onli slight pain restrict activ preoper rang movem wa maintain wa onli slight tendenc radiolog chang progress actual improv case correl wa correc deform physiolog valgu result explain tibial osteotomi produc sustain pain relief 
87057553 ag ag arthriti rheumatoidrasu femal followup studi human knee jointra knee prosthesisa male middl ag osteoarthritisrasu postop complicationsep prosthesi design st georg modular knee prosthesi twoandahalf sixyear followup st georg modular knee replac ha studi case observ period rang knee compart replac poor result thi group revi hing arthroplasti case arthrodesi complic insignif infec conclud unicompart knee arthroplasti recommend joint involv locali compart onli generali joint disea prefer semiconstrain total condylar prosthesi 
87057554 aluminum hydroxidetu calcium carbonatetu case report child drug evalu drug therapi combin femal human hydroxycholecalciferolstu infant kidnei failur chronicco male renal osteodystrophydtra factor manag rachit deform children chronic renal failur children chronic renal failur sever rachit deform lower limb treat alphahydroxyvitamin alphaohd3 wa symptomat biochem radiolog improv children oper correc deform wa recommend trial treatment alphaohd3 thi condition befor surgic procedur 
87057555 arthriti rheumatoidsu followup studi human knee prosthesisa osteoarthritissu postop complicationsep prosthesi failur reoper sweden factor surviv knee arthroplasti nationwid multicentr investig case prospect nationwid studi knee arthroplasti ha wai sweden sinc octob end arthroplasti osteoarthr rheumatoid arthriti record review oper actuari method probabl prosthesi remain situ wa calcul osteoarthr thi probabl rang hing prosth medial compart prosth twoand threecompart prosth produc intermedi result surviv rheumatoid arthriti probabl vari medial compart prosth threecompart prosth main reason failur wa loosen compon common wa infec probabl revision infec wa osteoarthr rheumatoid arthriti revision threecompart prosthesi knee fusion primari revision wa requir case 
87057556 accid traffic adult arteri bone neoplasmssu case report fibulabstr human male method sarcoma ewingssu surgic flap tibiainsu osteocutan free fibular graft free osteocutan fibular graft revasculari vascular anastomo onestag reconstruc exten bone skin loss lower leg patient addition integr skin flap vasculari fibular graft reconstruc bone defect signif skin loss possibl techniqu design rai flap present advantag thi transfer vascular osteocutan flap ar avail length straight cortic bone larg skin flap diamet vascular pedicl dissec carri tourniquet 
87057557 acut disea child femur head necrosiset followup studi hip jointpp human leggperth diseasediet pressur prospect studi risk support nonu govt synovitiscodi transient synov perth disea aetiolog connec prospect studi wa children transient synov ani cau synovi effusion elev articular pressur dure followup case perth disea wa diagno late clinic radiograph chang minim moder overgrowth femor head widen joint space result support wide accept concept perth disea develop result period elev articular pressur transient synov research thi perth disea follow premi thei ar differ disea ani aetiolog connec 
87057558 biomechan cadav compar studi earli ambul evalu studi human knee jointphsu knee prosthesi method wound heal anterior midlin medial parapatellar incision arthroplasti knee compar studi earli mobil arthroplasti knee sometim result wound breakdown commonli incision anterior midlin medial parapatellar incision compar order determin potenti wound heal studi cleavag line knee demonstr medial parapatellar incision li parallel line whilst anterior midlin incision li perpendicular addition medial parapatellar wound wa subject significantli tension dure flexion arthroplasti expect heal faster liabl disrup dure earli mobil 
87057559 adult anterior compart syndromepasu case report chronic disea compart syndromessu exer fasciapasu human male method pressur reoper repeat compart decompr partial fasciectomi standard decompr anterior compart syndrom patient present persist symptom pressur valu abov normal repeat procedur combin fasciectomi reliev pain postop pressur valu normal 
87057560 adolesc adult anterior compart syndromedith cathet child chronic disea compart syndromesdi diagnosi differenti exer femal human leg male pressur support nonu govt transduc pressur exerc pain lower leg chronic compart syndrom medial tibial syndrom aetiologi pain lower leg dure exerc ha studi athlet monitor compart pressur dure exerc technetium bone scan patient assign diagnost group chronic compart syndrom medial tibial syndrom nonspecif result indic subcutan fasciotomi affect compart treatment choic chronic compart syndrom treatment patient medial tibial syndrom oper conserv ha unsuccess nonspecif symptom treat conserv success 
87057561 ag biopsi case report femal femor neoplasmsetpa femurb histiocytomaetpa human infarctioncopa knee prosthesi sarcomaetpa vitallium epithelioid sarcoma associ total knee replac case report case report epithelioid sarcoma develop appar benign enchondroma bone infarct site chromecobalt total knee replac 
87057562 adolesc adult arthroscopi child femal human joint instabilitydi knee jointra leg length inequalitydi ligam articularabra male congenit aplasia cruciat ligam report case instabl knee frequent associ congenit leglength discrep studi patient clinic radiolog arthroscop clinic sign knee instabl signif radiolog chang present arthroscopi anterior cruciat ligam wa complet absent patient functionless thi defici appear congenit condition mai predispo meniscu injuri retropatellar pain mai lead sublux disloc knee dure leglengthen procedur 
87057563 anim axonsphul basem membranephul compar studi electr stimul musclesphtrul nerv regen neural conduc rat rat inbr strain sciatic nerveinphul support nonu govt factor regen sciatic nerv rat effect muscl basem membran orient substratum ha implic develop regen axon synap prepar basem membran matrix autogen striat muscl repair sciatic nerv rat investig result histologi electrophysiologi treat graft coaxial align nerv fascicl function recoveri appear dai growth axon distal nerv graft myotub right angl nerv fascicl support nerv regen slower rate graft coaxial align untreat muscl allow axon penetr onli natur degen muscl fibr minim axon penetr distal nerv conclud rat treat graft correctli orient empti myotub facilit guid regen periph nerv injuri lead recolon distal stump function recoveri 
87057564 abnorm multipleetpara ankl jointabpara case report child preschool femal followup studi human infant infant newborn leg length inequalityetpara male genesi ballandsocket ankl ballandsocket ankl rare deform associ preexist condition congenit shorten lower limb coalition tarsal bone absent digit rai aplasia hypoplasia fibula observ patient thi deform averag initi examin dai arthrographi configur ankl wa appar normal patient ag ballandsocket joint develop ag possibli compen loss inver cau tarsal coalition ballandsocket joint therefor probabl congenit acquir deform secondari variou preexist congenit condition 
87057565 human orthop proce report univ colleg council associ societi abstract 
87057594 adolesc adult ag cardiopulmonari bypass child cineangiographi echocardiographi femal followup studi heart atrium heart neoplasmspasu human japan leiomyomasu male middl ag myxomasu myxosarcomasu neoplasm recurr localsu surgic manag cavitari cardiac tumor review patient current statu japan patient cavitari cardiac tumor oper kobe univ hospit septemb januari patient twelv women thei rang ag symptom chest pain dyspnea cough palpit syncop definit diagnosi wa confirm echo cineangiocardiographi benign tumor consist myxoma leiomyoma malign myxosarcoma left atrium wa common chamber involv instanc follow right atrium surgeri wa perform case cardiopulmonari bypass moder hypothermia cold crystalloid cardioplegia tumor remov en bloc base attach atrial septum free wall case patient underw concomit mitral annuloplasti mitral commissurotomi case left atrial myxoma di postop case associ mitral annuloplasti di congest heart failur newli develop chordal ruptur surgeri di congest heart failur oper reexcision recurr myxosarcoma left atrium wa perform case surgic procedur remain case benign tumor ar ar recurr favor result surgic interven recommend prior occurr heart failur sever complic coronari periph embol whenev cardiac tumor ar detect noninva echocardiographi cineangiocardiographi 
87057596 adult ag blood transfusionut blood volum coronari diseasesu evalu studi femal hemoglobinsan human male middl ag prospect studi reduc blood surgeri coronari arteri disea nineti consecut patient underw surgeri coronari arteri disea eightyon requir blood transfusion immedi postop period patient receiv unit blood bled excess reexplor twelv postop haemoglobin gdl dure stai thei transfu total unit blood befor discharg postop blood loss transfu earli averag ml sem loss transfu patient averag ml patient transfu mean loss ml ns sixtynin patient transfu haemoglobin postop dai wa gdl sd thi declin gdl fifth dai discharg haemoglobin wa gdl patient di myocardi infarc dai pancreat fourth earli blood transfusion haemoglobin abov gdl untransfu patient supraventricular arrhythmia percent serou wound discharg infect sternal dehisc conclud bank blood transfusion attend hazard expen easili avoid patient thi save resourc increa avail blood rare group surgeri 
87057599 antigen helminthan case report echinococcosi hepaticcodi echinococcusim femal heart atrium heart diseasescop human middl ag pulmonari embolismet thrombosisp pulmonari embol parasit cardiac clot secondari hepat alveolar echinococcosi excep form hepat alveolar echinococcosi metastasi right atrium report thi cardiac locat parasitosi wa reveal attack pulmonari embol produc secondari pulmonari lesion thi case suggest pulmonari metasta alveolar echinococcosi liver migrat parasit clot hepat vein 
87057601 aortic valv aortic valv stenosisdi case report diagnosi differenti heart neoplasmsdisu human infant male myxomadisu myxoma aortic valv child myxoma ar predominantli locat right left atrium report unusu case myxoma adher aortic valv child present symptom subaort stenosi inva method tumor wa diagno locat aortic valv surgic remov child recov accord knowledg thi report myxoma aortic valv 
87057603 aortic valvesu aortic valv insufficiencyet bioprosthesi case report equip failur femal heart valv prosthesi human male middl ag prolap reoper suturesa bjorkshilei valv malfunc prolap sutur sever aortic regurgit develop patient aortic valv replac sutur prolap annulu bjorkshilei prosthesi reoper offend sutur trim tuck aortic wall elimin aortic regurgit prolap unravel knot mai cau evert sew skirt dure replac mai prevent thi complic 
87057605 adolesc adult ag ag arteriesinsu case report child dislocationscosu femal fracturescosu human male method middl ag retrospect studi veinsinsu wound nonpenetr wound penetr traumat vascular lesion associ fractur disloc mai januari patient traumat vascular lesion treat servic present associ fractur andor disloc high index suspicion earli recogni presenc vascular injuri thorough clinic evalu routin doppler flowmet broad indic preoper angiographi result prompt repair lesion major case earli explor wide fasciotomi temporari lumin shunt dure bone fixat procedur usual intern plate definit venou arteri repair limb stabil wa achiev frequent oper angiographi predomin factor treatment outcom complex injuri limb close fractur andor disloc preserv limb open expo skelet injuri result limb salvag rate 
87057606 ag blood vessel prosthesi case report emerg femal human iliac vein male method middl ag polytetrafluoroethylen thrombophlebitissu reconstruc inser expand polytetrafluoroethylen eptf iliac venou obstruc surgic therapi dvt leg includ reconstruc blood circul thrombectomi fogarti cathet alwai satisfactori indic varieti opinion howev postphlebit syndrom result incomplet treatment therefor surgic approach prioriti acut stage disea patient complet obstruc insuffici remov thrombi proxim region leg dvt perform crossov femorofemor bypass eptf includ wire reinforc graft abl obtain longterm patenc period 
87057607 ag ag amput aneurysmsu angiographi arteri occlu diseasesco human legb middl ag poplit arterysu retrospect studi thrombosisco signif tibial arteri disea manag poplit aneurysm clinic radiograph histolog featur sixtyon poplit aneurysm patient ar review twentyseven aneurysm thrombo present acut ischaem limb sudden onset sever claudic thirtyfour patent aneurysm present ischaem ulcer claudic tibial arteri disea asymptomat normal distal pul thrombosi reconstruc difficult requir femorotibi graft reconstruc wa possibl lead amput primari treatment follow fail revascular patent aneurysm tibial arteri frequent occlud postul oblit atheromat disea tibial vessel slow flow aneurysm vessel respon high incid thrombosi poor graft patenc high amput rate 
87057608 ag ag femal femor arterysu followup studi human ischemiasu legb male method middl ag poplit arterysu reoper retrospect studi umbil veinstr eightyear experi human umbil vein graft arteri reconstruc glutaraldehydetan human umbil vein huv graft carri femoropoplit composit aortopoplit dacron graft wa insert proxim femorotibi axillofemor femorofemor iliofemor bypass autogen saphen vein wa absent inadequ patient limb salvag wa primari indic surgeri cumul patenc rate respect huv bypass respect femoropoplit bypass femorotibi bypass fail dure follow surgeri axillofemor composit aortopoplit bypass thrombo surgeri respect periop mortal wa over mortal wa follow conclusion drawn result huv graft achiev cumul patenc rate superior report autogen saphen vein limb salvag situat saphen vein avail huv graft offer accept salvag rate result 8year followup period demonstr durabl longterm patenc huv graft 
87057609 adult ag ag aorta abdominalsu aortic aneurysmsu aortic rupturesu creatinineur femal human kidneypp male middl ag postop complic retrospect studi renal function follow aneurysmectomi abdomin aorta postop renal function wa evalu patient oper abdomin aortic aneurysm fortyfour patient oper acut becau impend actual ruptur aneurysm fortysix patient oper elect over mortal rate wa postop mortal postop renal function wa evalu measur screatinin impair renal function wa postop surviv patient forti percent patient oper elect postop renal impair compar patient oper acut postop mortal rate patient impair renal function wa compar patient unchang renal function signif relat postop renal impair administr aminoglycosid durat oper clamp aorta wa signif relationship postop renal impair episod hypoten volum blood transfusion 
87057610 acut disea ag aorta abdominalra aortic aneurysmrasu aortic rupturerasu case report diagnosi differenti emerg hematomara human male middl ag tomographi xrai comput differenti ruptur aortic aneurysm acut expan computeri tomographi ct scan obtain patient present abdomin pain abdomin aortic aneurysm evid hypovolaemia periaort haematoma evid ruptur wa scan patient confirm immedi oper retrospect diagnosi rapidli expand acut aneurysm wa patient pathologi wa earli elect oper ct scan differenti wellcontrol ruptur rapidli expand aneurysm 
87057611 ag aorta abdominalsu aortic rupturerasu case report chronic disea diagnosi differenti human male middl ag tomographi xrai comput tuberculosi spinaldi chroniccontain ruptur abdomin aortic aneurysm real ruptur abdomin aortic aneurysm readili diagno triad abdomin pain shock pulsatil abdomin mass ar present clinic diagnosi difficult howev patient present chronic pain aneurysm readili palpabl patient confu abdomin symptom ct scan provid rapid noninva diagnosi acut leak aaa ha docum onli rare thi report identifi patient ruptur aortic aneurysm sever prior operationa contain chronic ruptur 
87057612 aorta abdominalrasu aortic aneurysmrasu aortographi diagnost test routin evalu studi human prospect studi routin angiographi abdomin aortic aneurysm case inform oper selec ongo prospect protocol routin abdomin aortic angiographi evalu patient present elect abdomin aortic aneurysmorrhaphi wa assess efficaci direct periop manag eighteen angiogram provid deci inform addition potenti help oper manag therefor feel routin angiographi valuabl preoper workup patient abdomin aortic aneurysm 
87057613 arteri occlu diseasesetrasu athlet injuriesco bicycl blood vessel prosthesi case report child human iliac arteryra male sport wound nonpenetratingco extern iliac arteri occlusion bicycl handl injuri blunt injuri youth extern iliac arteri secondari thrombosi associ clinic seemingli minor blunt injuri right lower quadrant abdomen present symptom delai eventu becam dramat method diagnosi evalu ar discuss selec oper procedur outlin potenti signif vascular injuri suspect follow close blunt injuri proxim major vascular conduit earli aggress treatment young mandatori prevent onli usual complic limb ischemia discrep limb length seen grow youth depriv normal circul extrem 
87057614 aneurysm dissectingsu aorta thoracicri aortic aneurysmsu case report dissemin vascular coagulationetri human male method middl ag postop complic technetium tc 99m aggreg albumindu dissemin vascular coagulopathi associ thromboexclu dissect aortic aneurysm dissemin vascular coagulopathi dic wa demonstr patient underw surgic thromboexclu blood flow rever dissect aortic aneurysm larg clot descend thorac aorta extraanatom bypass graft cau factor consump coagulopathi lowdo heparin togeth freshfrozen plasma wa effect howev extrem caution adopt patient minim develop dic becau factor respon coagul abnorm ar remov patient undergo surgic treatment thromboexclu 
87057615 adult aneurysmet arterioarteri fistuladisu case report femal human ligat mammari arteriessu pulmonari arterysu thorac arteriessu intern mammari arteri pulmonari arteri fistula rare case arterioven fistula intern mammari arteri pulmonari arteri present clinic histori recurr bronchiti dyspnoea dure exerc presenc right parastern murmur normal heart size normal blood gase justifi execu arterioven thorac angiographi reveal presenc cirsoid aneurysm suppli intern extern mammari arteri diagnost investig surgic indic patient rare fistul commun intern mammari arteri pulmonari circul ar anali 
87057616 ag anesthesiamt cardiopulmonari bypass case report femal goiter substernalcosu human intub tracheal laryng diseasesco spasmco imposs intubationwhat patient present endotrach intub wa imposs secondari obstruct substern goiter laryng spasm cardiopulmonari bypass wa util provid safe induc anesthesia intub substern goiter remov altern method anesthet manag ar discuss 
87057932 adenosin cyclic monophosphateur adult ag ag agingm bone bonesm bone disea metabolicetm calciumbl human kidnei function test male middl ag mineralsm parathyroid hormonesblph support nonu govt support govt nonph support govt ph vitamin dbl alter calcium vitamin parathyroid hormon physiologi normal ag relationship develop senil osteopenia effect ag calcium bone metabol systemat examin identifi agerel alter vitamin pth physiologi assess impact skelet health studi normal ag yr excel health ani evid metabol bone disea andor risk factor osteopenia serum 25hydroxyvitamin 25ohd concentr declin steadili advanc ag wa correspond declin serum 2425dihydroxyvitamin 2425oh2d level serum 125oh2d concentr howev vari thi ag rang ns plasma pth level increa ag wa concomit increa urinari camp excretion renal function creatinin clearanc clearli declin increa ag conjunc chang calcium metabol radial vertebr bone miner content declin wherea fall radial bone miner content singl photon absorptiometri proxim distal site wa slight wa mark decrea vertebr bone miner content measur quantit comput tomographi fall vertebr bone miner content correl declin serum 25ohd 2425oh2d concentr respect declin renal function multipl regr analysi reveal effect ag bone miner content account larg concomit chang miner metabol declin renal function fall serum 2425oh2d level close associ fall bone miner content result indic declin renal function alter vitamin metabol occur ag normal chang contribut cau associ declin skelet miner content ag 
87057937 adult birth weight carrier proteinsbl diabet mellitu insulindependentbl femal fetal bloodm human infant newborn insulinlik growth factor ibl pregnanc pregnanc diabetesbl somatomedinsbl support nonu govt factor serum level somatomedin somatomedinbind protein pregnant women type gestat diabet infant serum level low mol wt form somatomedinbind protein smbp 5fold higher diabet nondiabet pregnant women nonpregn women differ wa women type diabet gestat diabet wa neg correl matern level smbp dure trimest birth weight percentil infant wa 3fold elev matern insulinlik growth factor igfi level dure pregnanc diabet nondiabet women posit correl wa matern igfi level birth weight percentil infant correl ratio igfi smbp mai reflect igfi avail placenta birth weight percentil wa higher se estim weight percentil wa ratio igfi smbp cord blood wa correl birth weight cord blood igfi smbp valu igfii level cord serum higher infant diabet nondiabet mother rai matern smbp level influenc igfi avail fetalplac unit igfii particip gluco homeostasi fetu 
87057939 androgensbl case report human infant infant newborn male mass fragmentographi hermaphroditismen support govt ph testosteron 5alphareductasedf tetrahydrocortisolaaur diagnosi alphareducta defici infanc diagnosi alphareducta defici infanc report male hermaphrodit dominican republ basal plasma testosteron dihydrotestosteron ratio significantli elev affect infant increa markedli infant administr hcg sinc urinari etiocholanolon androsteron ratio determin accur thi ag group diagnosi alphareducta defici wa confirm elev urinari tetrahydrocortisol thf alphatetrahydrocortisol alphathf ratio determin ga chromatographymass spectrometri affect male infant compar agematch normal infant thf5 alphathf ratio howev lower normal children affect infant suggest increa alphareducta activ infanc affect infant thf5 alphathf ratio compar ratio adult carrier male significantli lower ratio adult homozygot affect infant ar relat larg dominican kindr studi previou initi rai femal parent counsel chang male sex rear 
87057940 adult amino acidsim anim antibodi monoclonalbi antibodi specif femal genit neoplasm femalebl gonadotropin chorionicblim human immunoassaymt male mice mice inbr balb middl ag peptid fragmentsim support nonu govt support govt ph testicular neoplasmsbl sensit specif assai human chorion gonadotropin hcg base antipeptid antihcg monoclon antibodi construc clinic implic develop highli sensit specif assai hcg monoclon antibodi mab direct 37amino acid synthet polypeptid analog carboxylterminu ctp beta hcg antibodi vari affin beta hcg specif epitop ctp investig measur hormon level radiolabel indic alphasubunitreact mab monoclonalimmunoradiometr assai lower limit sensit ngml serum level hcg hcglike materi ctp structur measur healthi blood donor healthi nonpregn women younger yr serum valu vari ngml moreov healthi women older yr detect level ngml rang studi disappear rate normal women follow serum hcg serum level women previou receiv singl im injec hormon individu fail develop pregnanc vitro fertil hcg declin ngml result contrast patient hcgproduc tumor patient ani evid recurr disea hcg level becam undetect howev level consist abov ngml patient subsequ increa hcg level associ tumor recurr conclud thi hcg assai base antipeptid antihcg mab mai tumor monitor 
87057941 adren cortex hormonesbl adult androgensbl case report dexamethasonetu diagnosi differenti drug resist femal human hydrocortisonebl male menstruat disordersbldtg pedigr virilismbldtg famili cortisol resist differenti diagnost therapeut aspect 26yrold woman present hirsut male pattern scalp bald geheimratsecken menstrual irregular hyperten sign symptom cush syndrom plasma cortisol level greatli elev suppress normal respon dexamethason cortisol bind transcortin wa normal plasma androstenedion testosteron level increa 17hydroxyprogesteron aldosteron level normal studi reveal increa cortisol produc rate increa 24h urinari cortisol excretion increa plasma acth level normal diurnal rhythm cortisol elev level normal increm plasma acth cortisol gh prl respon insulininduc hypoglycemia father brother increa plasma cortisol level suppress normal respon dexamethason chronic therapi dexamethason mg daili result decrea hirsut normal scalp hair menstrual cyclic normal plasma testosteron androstenedion level sign symptom cush syndrom develop central regul secretion acth cortisol gh prl insulin test diurnal rhythm remain qualit normal lower setpoint conclud thi patient autosom dominantli inherit hereditari partial cortisol insensit result increa adrenocort cortisol androgen secretion result clinic symptom afflict male member famili propositu result indic potenti insulin test distinguish thi disord cush disea 
87057943 ag ag bromocriptinepd cell cultur compar studi dopamineph estradiolph femal human male middl ag pituitari gland pituitari neoplasmss prolactin support nonu govt tamoxifenpd differ interac dopamin estradiol prolactin relea cultur normal tumor human pituitari cell studi interac dopamin estradiol prl relea cultur normal tumor prlsecret cell prepar human pituitari pituitari gland obtain sudden death previou normal individu viabil isol pituitari cell prepar disper dispa wa dai cultur dopamin nm inhibit prl relea cell prepar normal pituitari sem pretreat cell nm estradiol alter dopaminemedi inhibi prl relea estradiol alon increa basal prl relea cell prl content cultur prlsecret pituitari tumor cell obtain transsphenoid oper patient similarli sensit dopamin estradiol stimul tumor cell prl relea content significantli diminish inhibitori effect dopamin estrogen receptor blocker tamoxifen alter prl relea rever estradiolinduc insensit prolactinoma cell dopamin agonist bromocriptin conclusion vitro result indic estrogen antagon effect dopamin normal human prlsecret pituitari cell human pituitari tumor cell howev estradiol decrea sensit prl relea dopamin agonist estrogen action acut rever tamoxifen 
87057946 adult deuterium human kinet male mass fragmentographymt testosteronebl pharmacokinet properti testosteron propion normal pharmacokinet characterist testosteron propion studi normal singl im dose mg testosteron propionate191919d3 plasma level testosteron propionate191919d3 activ metabolit testosterone191919d3 endogen testosteron measur ga chromatographymass spectrometri testosteron propionate191919d3 wa gradual transfer im injec site circul plasma level testosteron propionate191919d3 maintain ngml administr plasma testosterone191919d3 level maintain abov physiolog testosteron level plasma level endogen testosteron chang littl 
87057947 adolesc adrenocorticotrop hormonebl adult cush syndromebldtur dehydroepiandrosteroneaabl dexamethasonedu femal human hydrocortisoneblur ketoconazoletu male middl ag factor 17hydroxycorticosteroidsur 17ketosteroidsur ketoconazol treatment cush syndrom therapeut valu ketoconazol term treatment patient cush syndrom wa studi patient cush disea adren adenoma receiv mgdai ketoconazol plasma acth cortisol dehydroepiandrosteron sulfat level urinari cortisol 17ketosteroid tetrahydro11deoxycortisol excretion determin period dure treatment period plasma acth cortisol respon crh stimul determin befor dure treatment rapid subsequ persist clinic improv occur patient plasma dehydroepiandrosteron sulfat urinari 17ketosteroid cortisol excretion decrea initi treatment subsequ remain normal nearli treatment period urinari tetrahydro11deoxycortisol excretion increa significantli plasma cortisol level decrea plasma acth level chang individu plasma acth cortisol increm respon crh compar befor dure treatment cortisol respon insulininduc hypoglycemia improv patient wa restor normal anoth patient test recov normal adren suppress respon low dose dexamethason dure ketoconazol treatment ketoconazol effect term control hypercortisol pituitari adren origin effect appear mediat inhibi adren betahydroxyla 1720lya unknown wai prevent expect rise acth secretion patient cush disea 
87057948 adren gland neoplasmsan adren glandsan adult ag anim chromatographi gel chromatographi high pressur liquid histocytochemistri human immunochemistri middl ag peptidesan pheochromocytomaan radioimmunoassai swine local molecular form galanin human adren elev level pheochromocytoma galanin immunoreact wa measur ria antibodi direct nonc ctermin position porcin galanin tissu extract normal adren pheochromocytoma plasma normal subject patient pheochromocytoma ctermin galaninlik immunoreact wa detect plasma tissu suggest differ amino acid sequenc human compar porcin galanin nonctermin direct antibodi wa therefor charact human galanin immunoreact gel permeat chromatographi rever phase high pressur liquid chromatographi local immunocytochemistri galanin content adren gland wa sem pmolg contrast howev pheochromocytoma greater concentr pmolg gel chromatographi rever phase high pressur liquid chromatographi reveal molecular form galanin immunoreact ident elution position normal adren tumor concentr galanin plasma normal subject pheochromocytoma patient wa detec limit assai pmollit immunocytochemistri galanin wa local scatter cell cluster tumor cell pheochromocytoma onli chromaffin cell cortic nerv fiber normal adren 
87057951 adolesc adult ag ag femal histocytochemistri human hyperparathyroidismmepa immunochemistri male middl ag parathyroid glandsanpa parathyroid hormonesan stain stain parathyroid local twentynin consecut patient suspect primari hyperparathyroid examin preoper sound sonograph guid fine needl aspir aspir immunostain pth patient local enlarg parathyroid gland wa success patient tumor locat retrostern thu detect sound patient multinodular goiter imp local patient renal osteodystrophi enlarg parathyroid gland neck visual preoper cytologi wa diagnost cytolog featur suggest parathyroid cell immunostain aspir smear pth howev correctli diagno preoper local lesion sound routin procedur choic preoper local abnorm parathyroid gland primari hyperparathyroid fine needl aspir immunocytochemistri suppli confirm necessari 
87057952 fatti acid nonesterifiedbl human oleic acidsbl protein bind serum albuminm support nonu govt support govt nonph support govt ph thyroxinebl effect free fatti acid concentr free thyroxin human serum role albumin concentr ffa normal human plasma vivo gener rang meqlit slightli higher concentr occasion report patient ar ill determin ffa concentr mai increa concentr free t4 serum ad increa oleic acid pool normal human serum ffa content measur free t4 equilibrium dialysi total ffa meqlit normal serum repr ffa albumin molar ratio littl effect free t4 concentr higher ffa concentr progress increa free t4 thi molar ratio ffa albumin exce cau signif increa free t4 concentr dilut serum serum patient nonthyroid ill serum albumin remov chromatographi affigel blue wa sensit effect ffa free t4 thi enhanc sensit wa rever readdition albumin serum addition albumin normal serum result diminish effect ffa free t4 result indic follow physiolog concentr ffa significantli increa free t4 concentr normal human serum ffa reach supraphysiolog concentr serum vitro higher affin ffabind site albumin becom satur appar ffa albumin molar ratio approxim excess ffa interact serum protein includ thyroid hormonebind globulin therebi increa free t4 concentr concentr albumin ffa binder consid evalu observ effect ffa explor relev hypothesi ffa mai inhibit bind t4 plasma protein patient nonthyroid ill measur plasma ffa concentr sever ill patient hospit inten care unit mean plasma ffa concentr sem meqlit mean serum albumin concentr gdl patient mean plasma ffa albumin molar ratio wa sinc ffa albumin molar ratio exc approxim befor signif increa serum free t4 concentr occur result suggest ffa commonli influenc circul free t4 concentr vivo sever ill patient 
87057957 adult ag ag agingbl human impotencebl lhbl male protein bind sex hormonebind globulinm support nonu govt support govt nonph testosteronebl decrea bioavail testosteron ag normal impot tissu avail bioavail testosteron includ circul free ft albuminbound reason assess bioavail ammonium sulfat precipit sex hormonebind globulin shbgbound supernat nonshbgbound nonshbgt correl physiolog androgen activ assess bioavail normal ag analyz serum sampl healthi ag yr old compar result sampl young yr old mean serum ft lh concentr significantli differ group howev mean absolut nonshbgt level wa significantli lower older group separ popul impot otherw healthi yr old yr old yr old mean absolut nonshbgt concentr wa lower middleag elderli young absolut ft wa lower onli elderli group mean lh level similar ag group data suggest serum concentr tissu avail ar decrea ag nonshbgt measur sensit indic thi decrea ar serum serum ft measur chang appear begin middl ag 
87057961 adult anim bind competit calcifediolm calciumm cell cultur chicken chromatographi high pressur liquid doserespon relationship drug human intestin absorp lipopolysaccharidespd macrophagesdem monocytesm pulmonari alveolim support nonu govt support govt ph 25hydroxyvitamin d3 metabol lipopolysaccharidestimul normal human macrophag cultur normal human pulmonari alveolar macrophag periph blood monocytederiv macrophag studi capac metabol 3h25hydroxyvitamin d3 25ohd3 incub macrophag bacteri lipopolysaccharid lp result conver 3h25ohd3 polar vitamin d3 metabolit pmol106 cell untreat macrophag synth thi metabolit sever suggest metabolit wa biolog activ form vitamin d3 125dihydroxyvitamin d3 125oh2d3 metabolit comigr chemic synth 125oh2d3 differ high perform liquid chromatograph metabolit affin chick intestin 125oh2d3 receptor authent 125oh2d3 biolog activ macrophag metabolit vivo stimul intestin calcium absorp bone calcium mobil rachit chick wa ident activ chemic synth 125oh2d3 lpsstimul synthesi 125oh2d3lik compound macrophag wa dose depend linear fashion halfmaxim respon wa typic ng lps106 cell polymyxin abolish effect lp 25ohd3 metabol macrophag data suggest lpsstimul macrophag modul local level function 125oh2d3respon cell relea 125oh2d3lik metabolit 
87057965 antibodiesan case report femal grave diseaseco human hyperthyroidismbldtet infant newborn ipodatetu support govt ph thyroid glandim thyrotropinbl thyroxinebl triiodothyroninebl triiodothyronin reversebl treatment neonat hyperthyroid grave disea sodium ipod describ effect administr repeat dose sodium ipod newborn infant hyperthyroid transient grave disea pretreat dai serum t4 t3 concentr gramsdl ngdl respect dose ipod serum t3 subsequ rang ngdl 39dai ipod treatment period serum t4 decrea ipod administr pretreat valu dai treatment respect valu thereaft dure treatment rang gramsdl plateau valu ar upper rang normal neonat period rapid clinic improv occur hyperiodothyroninemia abat serum rt3 concentr increa ngdl greater ngdl ipod dose thyroidstimul immunoglobulin wa present matern cord sera halflif serum thyroidstimul immunoglobulin infant wa approxim dai antithyroglobulin antimicrosom antibodi present infant dai ag titer decrea progress thereaft halflif antimicrosom antibodi titer wa data suggest sodium ipod treatment neonat hyperthyroid grave disea 
87057966 adenosin cyclic monophosphatebi adolesc adult ag anim cell line child dname femal human iggpd male middl ag myxedemaim rat receptor thyrotropinm support nonu govt thymidinem thyroid glandgdm thyroid autoimmuneim thyrotropinaimepd inhibi thyrotropininduc growth rat thyroid cell frtl5 immunoglobulin patient primari myxedema studi thyroid growthblock activ immunoglobulin igg fraction serum patient primari myxedema patient goitrou hashimoto thyroid normal subject measur abil igg inhibit tshinduc 3hthymidin incorpor dna rat thyroid cell line frtl5 group patient receiv t4 studi 3hthymidin incorpor induc muml bovin tsh wa significantli inhibit addition mgml igg patient primari myxedema wa affect igg normal subject patient goitrou hashimoto thyroid igg patient primari myxedema inhibit 3hthymidin incorpor induc grave igg induc forskolin cholera toxin bu2camp phorbol12myristate13acet inhibi tshinduc 3hthymidin incorpor igg patient primari myxedema wa significantli correl inhibitori activ tshinduc camp gener tsh bind data indic growthblock antibodi ar direct tsh receptor cau thyroid atrophi patient primari myxedema 
87057968 acetatesm adren glandsemenm adrenocorticotrop hormonepd androstenedioneaabi cell cultur cholesterolbi cultur media dehydroepiandrosteronebi human hydrocortisonebi hydroxymethylglutaryl coa reductasesm lipoproteinspd naphthalenespd support govt ph steroidogenesi human fetal adren role cholesterol synth novo primari monolai cultur human fetal adren cell maintain lipoproteindeplet lipoproteinsuppl media respond chronic acth treatment similarli increa steroid secretion princip steroid secret medium wa dehydroepiandrosteron sulfat presenc human low densiti lipoprotein hldl medium enhanc secretion nonsulfoconjug steroid especi dehydroepiandrosteron secretion rate betahydroxyandrostenedion wa similar cortisol absenc hldl acth increa cholesterologenesi maintain high rate steroid secretion acth treatment increa accumul 3hydroxy3methylglutaryl coenzym reducta ratedetermin enzym cholesterol biosynthesi wa immunoblot analysi demonstr thi enzym wa 97k protein human fetal adren cell interestingli content thi enzym cell treat acth lipoproteindeplet medium wa similar adren fetal zone tissu thi suggest cholesterologenesi novo addition plasma ldl import sourc steroid precursor vivo human fetal adren gland 
87057969 adult clomiphenepd doubleblind method endorphinsbl estradiolbl estrogen antagonistspd femal human luteal phase lhse progesteronebl random alloc receptor estrogenm support nonu govt effect luteal phase estrogen antagon lutein hormon pulsatil luteal function women pulsatil lh secretion wa studi determin frequenc lh pul wa alter administr clomiphen citrat cc mg dai dure midlut phase menstrual cycl normal women receiv cc placebo altern cycl random doubl blind fashion dai drug administr blood sampl obtain 15min interv serum lh determin daili blood sampl obtain luteal phase determin serum lh estradiol e2 progesteron lh pul frequenc increa sem8 placebo cc treatment pul amplitud chang transver mean serum lh wa higher cc miuml placebo miuml luteal phase length wa increa dai administr cc luteal phase level e2 progesteron measur daili significantli elev cctreat cycl suggest cc increa frequenc hypothalam gnrh secretori episod perhap action involv decrea endogen opioid peptid activ sinc periph progesteron level elev cctreat cycl e2 mai plai permiss role abil progesteron increa endogen opioid peptid activ acut furthermor sinc luteal phase wa significantli prolong increa endogen lh pul frequenc slow frequenc lh pul normal late luteal phase mai contribut onset luteolysi human 
87057970 adult alcoholismbl estradiolbl estriolbl estrogensbl femal fetal alcohol syndromeet gonadotropin chorionicbl human pregnancybl progesteronebl prolactinbl support nonu govt estradiol estriol progesteron prolactin human chorion gonadotropin pregnant women alcohol abu serum estradiol estriol progesteron prl hcg concentr measur 4week interv pregnant women chronic abu alcohol abstin pregnant women sixteen alcohol user birth infant fetal alcohol syndrom fa wherea remain infant alcohol user infant abstin women healthi women infant fa decrea estradiol estriol level pregnanc progesteron level tend low contrast alcohol user increa prl level dure 1624th pregnanc compar abstin women thi rise wa relat fa concentr hcg fluctuat wide ani consist differ alcohol user abstin women thu heavi matern abu alcohol result fa accompani primarili secondarili reduc estrogen concentr pregnanc increa prl level dure 1624th pregnanc 
87057971 adult circadian rhythm human male sleep depriv support govt nonph thyrotropinbl factor effect 64hour sleep depriv circadian waveform thyrotropin tsh evid sleeprel inhibi tsh relea halfhourli sampl plasma tsh wa dai normal young sleep wa deni awaken accommod sleep polygraph sleep wa resum dai d3 consecut usual sleep miss thi protocol allow examin ani modulatori effect daili pattern tsh concentr dure sleep depriv d12  dure resump usual nightli sleep d3 compar previou studi group normal young circadian natur daili tsh waveform wa evidenc daili repeti subject basal dure d12 sleep depriv synchron basal depriv resum sleep dai peak subject daili tsh pattern d12 consist daili maxima cosin acropha d12 consist d3 basal sleep wa resum half daili tsh concentr maxima daili cosinor amplitud d12 greater respect sleepresum tsh pattern d3 group mean tsh pattern cosinor confid ellip indic daili peak tsh waveform significantli larger dure d12 sleep depriv dure basal d3 period result indic signif alter daili tsh waveform occur respon absenc sleep ar compat exist inhibitori effect earli nightli sleep tsh relea tsh pattern dure interv rise tsh level congruent basal depriv resum sleep period prompt rever basal tsh pattern occur sleep wa resum d3 observ suggest alter tsh waveform dure sleep depriv arisen inhibitori effect sleep chang period phase gener oscil 
87057973 ag blood glucosem diabet mellitu noninsulindependentbl fatti acid nonesterifiedbl femal gluco toler test human insulin infusion insulin resist male middl ag obesitybl support nonu govt support govt nonph support govt ph resist insulin suppr plasma free fatti acid concentr insulin stimul gluco uptak noninsulindepend diabet mellitu abil insulin stimul tissu gluco uptak lower plasma ffa concentr wa quantifi individu normal gluco toler patient noninsulindepend diabet mellitu niddm subdivid ob nonob subject measur dure 5h gluco clamp studi carri plasma insulin concentr uml min uml min differ patient group compar twowai analysi varianc abil insulin suppress plasma ffa concentr stimul gluco uptak wa significantli reduc patient niddm thi wa true ob nonob group defect abil insulin suppress plasma ffa concentr patient niddm wa appar lower insulin concentr wherea resist insulinstimul gluco uptak niddm wa dramat high insulin concentr final signif correl insulinstimul gluco uptak plasma ffa concentr wa entir group data empha patient niddm ar resist multipl action insulin magnitud defect insulin suppr plasma ffa level stimul tissu gluco uptak ar roughli compar 
87057974 adenomaco adren gland hyperfunctionco adrenocorticotrop hormon case report desoxycorticosteronebl edemaet femal human hydrocortisoneblur hypokalemiaet middl ag pituitari neoplasmsco support nonu govt cyclic edema hypokalemia occult episod hypercort yearli episod edema hypokalemia anxieti depr cortisol deoxycorticosteron surg secondari pituitari adenoma woman ani usual clinic featur cush syndrom dure clinic remi recogniz laboratori abnorm episod follow incomplet transphenoid pituitari tumor resec ha yr sinc receiv radiotherapi episod cau mineralocorticoid action larg acthinduc increa cortisol deoxycorticosteron secretion histori episod edema hypokalemia attribut women surrept diuret abu requir care search hypercort absenc clinic cush syndrom 
87057975 adult bone neoplasmssc calcitriolbl carcinoma renal cellblco femal human hypercalcemiablet kidnei neoplasmsblco male middl ag phosphorusbl circul 125dihydroxyvitamin concentr patient renal cell carcinomaassoci hypercalcemia ar rare suppress measur serum 125dihydroxyvitamin concentr patient renal cell carcinomaassoci hypercalcemia onli patient low serum 125dihydroxyvitamin pgml level mean 125dihydroxyvitamin level patient wa sd pgml differ valu pgml agematch normocalcem patient variou malign eightyseven percent hypercalcem patient exten skelet metasta malign hematolog malign suppress serum 125dihydroxyvitamin level pgml hypercalcem patient malign skelet metasta onli low serum 125dihydroxyvitamin level mean serum 125dihydroxyvitamin level group wa pgml significantli lower normocalcem patient renal cell carcinomaassoci hypercalcemia suppr circul 125dihydroxyvitamin concentr uncommon 
87057976 acanthosi nigricansblco adult androgensbl dehydroepiandrosteroneaabl femal human hydrocortisonebl hyperinsulinismblco insulin infusion insulin resist lhbl progesteronebl support govt ph testosteronebl effect hyperinsulinemia serum testosteron progesteron dehydroepiandrosteron sulfat cortisol level normal women woman hyperandrogen insulin resist acanthosi nigrican insulin mai mediat hyperandrogen frequent occur patient insulinresist state test thi hypothesi studi normal women woman hyperandrogen insulin resist acanthosi nigrican hyperinsulinemiceuglycem clamp techniqu woman receiv ukg insulin bolu dose follow mukg min insulin infusion normal women averag insulin level sem uml wa achiev serum gluco wa clamp mgdl thi level insulin mai bind insulinlik growth factor receptor receptor contrari work hypothesi rise serum testosteron occur ani women dure insulin infusion women serum testosteron level decrea analyz percentag basal valu serum progesteron level normal women insulin infusion chang thereaft dehydroepiandrosteron sulfat dhea level howev uniformli progress decrea insulin infusion normal women woman hyperandrogen insulin resist acanthosi nigrican fall serum dhea level wa diurnal rhythmic chang serum dhea level correl serum cortisol suppr prl relea wa exclud cau fall dhea level result indic acut hyperinsulinemia 16h durat doe increa serum testosteron dhea concentr ind cau declin serum dhea level normal women singl woman studi hyperandrogen insulin resist acanthosi nigrican 
87057977 adolesc adult desmopressintu doserespon relationship drug drug therapi combin human hypernatremiadtm kidneyd male osmolar concentr support nonu govt vasopressinsadblur waterelectrolyt balanc increa renal sensit vasopressin patient essenti hypernatremia patient essenti hypernatremia maintain urinari concentr abil despit plasma hyperosmol low plasma vasopressin concentr investig renal sensit low dose vasopressin infusion patient syndrom hypodipsia hypernatremia select osmoreceptor dysfunc earli puberti aggress behavior patient water load hypoton diuresi wa establish vasopressin wa infu stepwi increm fmolkg min patient increa renal sensit vasopressin achiev neg free water clearanc infusion rate fmolkg min normal greater equal treatment 1desamino8darginin vasopressin ddavp improv behavior report sensat thirst ddavp therapi patient reduc renal sensit infu vasopressin conclud untreat patient essenti hypernatremia increa renal sensit vasopressin reduc ddavp administr 
87057980 adult ejacul electromyographi femal human male muscl contrac muscl smoothph orgasm oxytocinbl pelvisbsph pul radioimmunoassai region blood flow support govt ph plasma oxytocin increa human sexual respon purpo thi studi wa determin plasma oxytocin ot level chang dure human sexual respon demonstr tempor pattern chang plasma ot level measur ria befor dure privat selfstimul orgasm normal women blood sampl collect continu indwel venou cathet subject press signal indic finish orgasmejacul object assess sexual arou orgasm wa obtain measur bloodpul amplitud electromyograph activ record continu test anal devic contain photoplethysmograph electromyograph electrod connect polygraph locat adjac room measur allow collec data women chang blood flow muscl activ lower pelvicpub area plasma ot level increa dure sexual arou women significantli higher dure orgasmejacul dure prior baselin test suggest tempor pattern secretion relat smooth muscl contrac reproduct dure orgasm 
87057983 adenomaimm antibodi monoclonalm antigen surfacem bind site antibodi calciummeph cytosolm human immunochemistri parathyroid glandsm parathyroid hormonesbl parathyroid neoplasmsimm support nonu govt support govt ph bind monoclon antibodi 4f2 cell surfac antigen disper adenomat parathyroid cell rai cytosol calcium inhibit parathyroid hormon secretion cour charact monoclon antibodi mab recogn cell surfac antigen disper human parathyroid cell dptc identifi mab 4f2 bound avidli parathyroid cell mark effect parathyroid function bind mab 4f2 human adenomat dptc result mark sem reduc low calcium castimul pth secretion level equiv cell suppress high extracellular ca mm typic function effect optim antibodi dilution cell viabil wa confirm conclusion experi trypan blue exclusion greater cell surfac immunofluoresc parallel studi casensit dye quin2 inhibi pth secretion 4f2treat cell wa associ concomit increa cytosol ca cai mm ca valu approach cai level control cell incub high ca mab control p3 bind dptc mab lc72 recogn differ epitop antigen 4f2 dptc alter pth secretion cai immunoprecipit 125ilabel parathyroid cell extract mab 4f2 demonstr protein mol wt approxim nonreduc condition dalton reduc mercaptoethanol studi suggest mab4f2 bind cell surfac antigen inhibit pth secretion human adenomat parathyroid cell vitro alter secretori function relat attend increa cai 4f2 antigen dptc heterodim protein approxim 85k 45k 4f2 antigen mai import compon casen andor signaltransduc mechan thi cell 
87057984 adolesc adult ag ag circadian rhythm compar studi estradiolblph human insulinlik growth factor ibl male middl ag pul sex factor somatotropin support nonu govt support govt ph testosteronebl effect sex ag 24hour profil growth hormon secretion import endogen estradiol concentr undertook studi separ combin effect ag sex pulsatil pattern gh secretion 24h secretori profil gh wa gener 20min sampl young women ag yr young ag yr postmenopau women ag greater yr older ag greater yr computerassist pul analysi program wa assess total gh secretion reflect 24h integr gh concentr ighc pulsatil secretion denot pul frequenc durat amplitud fraction gh secret pul dure 24h period fghp ighc wa significantli greater women greater young old mean pul amplitud durat fghp greater young respect significantli differ sex mean pul frequenc wa affect sex ag serum concentr free estradiol free testosteron correl ighc pul amplitud fghp correct effect estradiol sex ag influenc ighc mean pul amplitud effect ag fghp wa reduc indic gh secretion fghp strongest correl somatomedinc somatomedinc declin significantli ag sex result indic sex ag independ interrel effect gh secretion effect larg account correspond variat endogen estradiol level observ suggest amplifi action estradiol neuroendocrin regul pulsatil gh relea 
87058096 angiotensin iipd anim argipressinpd calciumph chloridesm glomerular mesangiumdeph male membran potentialsd potassiumm rat rat inbr strain support nonu govt tetraethylammonium compoundspd angiotensin ii vasopressin stimul calciumactiv chlorid conduct rat mesangi cell attempt clarifi mechan angiotensin ii aii arginin vasopressin avp regul mesangi cell function examin membran potenti chang mesangi cell cell contract membran potenti depolar respon aii avp depolar wa associ decrea input resist ca ionophor a23187 cau similar mesangi cell contrac depolar rever potenti vr depolar respon aii avp wa mv mean sd respect onli vr aiiinduc depolar vr ca ionophoreinduc respon wa depend extracellular cl concentr aii avp cau cell contrac membran depolar cafr medium contain mm egta data suggest presenc ca activ cl channel mesangi cell aii avp increa cl permeabl elev cai relea cellular organella 
87058097 adolesc adult ag child child preschool chromosom deletion femal fibroblastsm human linkag genet male middl ag mutat osteogenesi imperfectagem procollagenanbig protein conform support nonu govt support govt ph osteogenesi imperfecta type iv biochem confirm genet linkag pro alpha 2i gene type collagen fibroblast affect member larg pedigr osteogenesi imperfecta oi type iv genet link pro alpha 2i gene type collagen synth popul pro alpha 2i chain popul normal popul appear deletion amino acid residu middl tripl helic domain mutat pro alpha 2i cau increa posttransl modif aminotermin half pro alpha 1i chain lower melt temperatur type collagen molecul incorpor mutant pro alpha 2i chain prevent delai secretion molecul fibroblast cell cultur basi thi studi linkag studi addition famili appear oi type iv phenotyp result heterozygo mutat pro alpha 2i alter tripl helic structur type collagen 
87058099 adult ag factor aortapp arteriespp electr conduct exer femal hemodynamicsd human hypertensionpp male middl ag nitroprussidepd propranololpd arteri hemodynam human hyperten differ aortic imp normoten hyperten ar charact examin imp normoten hyperten mean vs mmhg agematch chine patient undergo cardiac cathet rest dure nitroprussid handgrip exerc befor beta blockad propranolol hyperten higher resist vs dynscm5 characterist imp vs dynscm5 total extern power vs mw periph reflec ratio backward forward wave compon vs zero cross imp phase angl vs hz abnorm elimin vasodilat differ group exacerb pressur wa increa dure handgrip exerc beta blockad increa resist reflec thu hemodynam abnorm essenti hyperten increa resist reflec pul wave veloc decrea complianc ar compat increa vasomotor tone unmask dure gener beta blockad 
87058100 anim bicarbonatesmepd biolog transportd femal hydrogenion concentr vitro kidnei cortexm kinet rabbit sodiummepd support nonu govt support govt nonph support govt ph sitsaapd valinomycinpd electrogen sodiumbicarbon cotransport rabbit renal cortic basolat membran vesicl present studi examin mechan bicarbon transport basolat membran vesicl prepar rabbit renal cortex isotop sodium uptak wa stimul bicarbon compar glucon nmolmg protein versu nmolmg protein thi process wa inhibit disulfon stilben imposi interiorposit potassium diffusion potenti stimul isotop sodium uptak nmolmg protein effect occur onli presenc bicarbon wa block disulfon stilben kinet analysi rate bicarbonatedepend sodium uptak function sodium concentr reveal satur stimul vmax nmolmg protein km mm effect bicarbon concentr bicarbonatedepend sodium uptak wa complex present result demonstr electrogen neg charg sodiumbicarbon cotransport basolat membran vesicl rabbit renal cortex electrogen impli stoichiometri bicarbon ion sodium ion 
87058102 anemia hemolyt congenitalbl anemia sickl cellbl biolog transport calciumph dehydrationbl erythrocytesm hemoglobinsan human ion channelsph ouabainpd potassiumm sodiumm support govt ph sitsaapd cation depletion sodium pump red cell patholog cation leak sickl cell xerocyt mechan sickl cell xerocyt red cell becom deplet cation vivo ha identifi previou type cell exhibit elev permeabl sodium potassium case sickl cell deoxygen ouabaininsensit flux sodium potassium equiv howev cell type condition incub vitro sickl cell lost cation onli deoxygen thi cation depletion wa block ouabain remov extern potassium pretreat 44diisothiocyanostilbene22disulfon block increa cation permeabl induc deoxygen loss cation exhibit oxygen xerocyt similarli incub wa block ouabain data support hypothesi elev passiv cation flux xerocyt deoxygen sickl cell ar directli respon cation depletion cell patholog leak interact sodium pump produc net loss cellular cation 
87058103 anim bone marrowm cell cultur fetal hemoglobinbi hematopoiet stem cellsm hemoglobin abi macaca mulatta probabl support nonu govt support govt ph investig simian ontogen switch fetal adult hemoglobin progenitor cell level ontogen switch fetal adult hemoglobin result discontinu event replac fetal erythroid progenitor cell adult gradual modul hemoglobin program singl progenitor cell pool result progenitor midswitch skew fraction betaglobin synthesi program gaussian distribu studi obtain bone marrow rhesu monkei fetu midswitch mononuclear cell cultur methyl cellulo erythropoietin singl bfuederiv coloni remov incub 3hleucin globin synthesi wa examin gel electrophoresi fluorographi betaglobin synthesi pattern singl fetal coloni wa skew fit normal distribu fetal pattern resembl pattern artifici mixtur fetal adult progenitor suggest fetal progenitor pool contain popul differ betaglobin program thi nongaussian distribu progenitor midswitch fetu consist discontinu model hemoglobin switch dure ontogeni 
87058104 adolesc adult ag factor ag amniot fluidan blood proteinsanim carrier proteinsanblim cross reaction femal human hydrogenion concentr kidnei diseasesbl male middl ag pregnanc radioimmunoassai somatomedinsm somatotropinpd support nonu govt radioimmunoassai growth hormonedepend insulinlik growth factor bind protein human plasma specif radioimmunoassai ha establish growth hormonedepend insulinlik growth factor igf bind protein bp human plasma assai wa direct 53kd acidst bp subunit main immunoreact bp circul appar molecular mass approxim kd onli higher primat speci crossreact igfi igfii peptid effect circul bp level healthi subject rose threefold earli childhood puberti adult ag mean level sd wa gramsml declin ag strong growth hormonedepend bp wa seen wa 22fold increa activ acromegali reduc growth hormon defici poorli control diabet subject bp level normal wherea renal failur thirdterm pregnanc mild elev wa seen measur bp mai provid adjunct igf assai growth disord 
87058106 adult chromatographi affin chromatographi gel heparinpd human hyperlipoproteinemiabl lipasebl lipoprotein lipasebl lipoproteinsbl liveren support nonu govt support govt ph centrifug associ plasma lipoprotein postheparin lipa activ studi design explor associ lipoprotein lipa lpl hepat triglycerid lipa htgl activ lipoprotein human postheparin plasma php major peak lpl activ gel filtrat php elut triglyceriderich lipoprotein just befor peak low densiti lipoprotein ldl cholesterol php contain chylomicron addition peak lpl activ elut void volum column htgl activ elut ldl prece elution high densiti lipoprotein cholesterol lpl activ preheparin plasma elut position rel lipoprotein lpl php gel filtrat purifi human milk lpl mix plasma isol ldl produc peak activ elut befor ldl dure gel filtrat php high salt buffer nacl isol lipoprotein centrifug high salt densiti solution lipa activ wa associ lipoprotein lpl activ wa remov php elution immunoaffin column contain antibodi apolipoprotein apo apo sinc lipoprotein php undergon prior vivo lipolysi lpl activ php mai bound remnant chylomicron veri low densiti lipoprotein 
87058107 anim calcitriolpd calciumpd carbon radioisotopesdu cholecalciferolsm femal vitro liverm rat rat inbr strain steroid hydroxylasesan support nonu govt vitamin deficiencym influenc calcium 125dihydroxyvitamin d3 supplem hepat somal vivo metabol vitamin d3 vitamin ddeplet rat hypocalcem vitamin ddeplet rat supplem calcium 125oh2d3 metabol d3 25ohd3 wa studi infusion pmol 125oh2d3 h1 normal slight hypercalcemia associ physiolog supraphysiolog plasma concentr hormon calcium supplem normal plasma calcium despit 125oh2d3 concentr low observ hypocalcem control constant administr 14cd3 dure supplem regimen uncov stimul vivo 25ohd3 produc calcium supplem thi wa confirm vitro increa hepat somal d325 hydroxyla group supplem pharmacolog dose hormon displai lower circul concentr d3 25ohd3 vitro 25ohd3 produc remain unaffect 125oh2d3 investig kinet venou 25oh3hd3 reveal similar elimin constant group data indic calcium supplem hypocalcem ddeplet rat result increa transform d3 25ohd3 supplem 125oh2d3 doe affect vitro d325 hydroxyla influenc vivo handl vitamin accel metabol 
87058109 absorp alkalos anim bicarbonatesm biolog transport bodi waterm chloridesm glomerular filtrat rate kidnei tubul proximalm rat rat inbr strain support nonu govt support govt ph axial heterogen bicarbon chlorid water transport rat proxim convolut tubul effect chang lumin flow rate alkalemia studi examin regul superfici proxim convolut tubul pct transport function length singl nephron glomerular filtrat rate sngfr increa nlmin hydropenia nlmin euvolemia bicarbon chlorid water reabsorp earli 1st mm pct increa propor peqmm min peqmm min nlmm min peqmm min peqmm min nlmm min respect high transport rate increa howev sngfr nlmin atrial natriuret factor glucagon administr anion water transport rate late pct lower exhibit flow depend dure chronic metabol alkalosi acidif wa inhibit late earli pct conclusion earli pct distinguish late pct highcapac flowrespon satur anion waterreabsorpt process rel unaffect alkalemia 
87058111 activ daili live basal metabol bodi weight calorimetri energi metabol environ control food human obesitym oxygen consump regr analysi sleepph factor determin 24hour energi expenditur method result respiratori chamber daili human energi requir calcul separ compon energi expenditur ar inaccur usual poor agreem measur energi intak measur energi expenditur period determin accur rate daili energi expenditur human provid descrip human respiratori chamber method determin rate energi expenditur 24h period subject result fatfr mass ffm estim densitometri avail determin 24h energi expenditur 24ee explain varianc observ individu 24ee kcald ffm 24ee individu veri reproduc coeffici variat adjust differ ffm consid interperson variabl daili energi expenditur larg portion variabl 24ee individu independ differ bodi size wa variabl degr spontan physic activ fidget account kcald subject 
87058112 anim byssinosispa cottonanto dusta endotoxinsto epitheliumpa flavonesto lungdemepa plant extractsto povidonepd proteinsbi rat rat inbr strain support govt ph tanninsanto tracheapa cotton dustmedi lung epith injuri determin constitu cotton plant plai role byssinosi injur pulmonari epithelium ad extract cotton dust green bract fielddri bract human a549 rat type ii pneumocyt injuri wa measur pneumocyt lysi detach inhibi protein synthesi extract cotton dust fielddri bract produc signif dose timedepend lysi detach target cell green bract extract wa damag extract treat polyvinylpolypyrrolidon remov tannin produc significantli injuri contrast purifi 5734tetrahydroxyflavan 34diol thf tannin cotton dust bract cau substanti cell damag fielddri bract extract thf produc dosedepend inhibi pneumocyt protein synthesi endotoxin level correl observ injuri thf ad rat tracheal explant cau epith disrup desquam wherea endotoxin instil cotton dust fielddri bract extract rat lung produc disrup bronchial epithelium smooth muscl constric polyvinylpolypyrrolidonetr cotton dust extract produc injuri suggest extract cotton plant ar toxic alveolar tracheal bronchial epithelium thf tannin mai respon agent 
87058113 anaphylatoxin bloodph blood proteinsmepd chemotact factorspd chemotaxisd chromatographi gel complem 5aamepd electrophoresi polyacrylamid gel human iodin radioisotopesdu molecular weight peptid sialic acidspd attach human c5a arg cochemotaxin requir maximum expr chemotact activ chemotact activ human c5a arg enhanc significantli anion polypeptid cochemotaxin normal human serum plasma cochemotaxin attach oligosaccharid chain nativ c5a arg form complex potent chemotact activ human polymorphonuclear leukocyt capabl enhanc chemotact activ nativ c5a arg cochemotaxin effect chemotact activ deglycosyl c5a arg nativ c5a nformylmethionylleucylphenylalanin compon oligosaccharid chain onli sialic acid prevent enhanc cochemotaxin chemotact activ exhibit nativ c5a arg sialic acid prevent format c5a argcochemotaxin complex detect acid polyacrylamid gel electrophoresi molecular siev chromatographi polyacrylamid gel sucro densiti gradient centrifug 
87058115 amylasess anim bile acid saltspd calciumm deoxychol acidpd diglyceridesbi doserespon relationship drug vitro male pancreasdem pancreatitiset phosphoinositidesm polyethylen glycolspd rat rat inbr strain scopolamin derivativesm sincalidepd support nonu govt tetradecanoylphorbol acetatepd enhanc secretagogueinduc phosphoinositid turnov amyla secretion bile acid isol rat pancreat acini mm deoxychol enhanc amyla secretion induc submaxim dose carbachol cholecystokinin octapeptid affect maxim level reaction isol rat pancreat acini deoxychol alon induc reaction bile acid cholat chenodeoxychol ursodeoxychol taurochol activ similar condition deoxychol enhanc secretagogueinduc diacylglycerol format wa deriv mainli phospholipa cmediat hydrolysi phosphatidylinositol phosphatidylinositol4monophosph deoxychol enhanc secretagogueinduc hydrolysi phosphatidylinositol45bisphosph ca2 mobil deoxychol affect amyla secretion wa induc simultan addition protein kina cactiv 12otetradecanoylphorbol13acet ca2 ionophor ionomycin sinc diacylglycerol ca2 mai respon secretagogueinduc amyla secretion result indic bile acid increa sensit secretagogu diacylglycerol format subsequ activ protein kina therebi enhanc amyla secretion pancreat acini 
87058117 absorp adenosin cyclic monophosphatepd anim bicarbonatesm biolog transportd chloridesm kidnei cortexm kidnei tubulesm kidnei tubul collectingdem kinet permeabl rabbit support nonu govt support govt nonph support govt ph cyclic adenosin monophosphatestimul anion transport rabbit cortic collect duct kinet stoichiometri conduct pathwai cyclic amp stimul hco3 secretion cl selfexchang rabbit cortic collect tubul vari peritubular cl chang cl selfexchang rate satur kinet km mm hco3 secretion satur kinet function mean lumin cl km mm cl selfexchang clhco3 exchang thu appear carriermedi additionremov basolat hco3 qualit chang cl hco3 transport expect clhco3 exchang quantit chang cl absorp hco3 secretion diffu cl permeabl transepith conduct presenc hco3co2 camp higher absenc suggest hco3co2 camp togeth increa conduct cl pathwai parallel clhco3 exchang thu camp onli stimul over process anion exchang probabl increa electroneutr exchang andor seri cl conduct stimul cl conduct parallel exchang process 
87058119 adenosin triphosphatean anim carbonyl cyanid mchlorophenyl hydrazonepd electron transport histoplasmaphpi mice mice inbr akr oxygen consump support nonu govt support govt ph temperatur virul correl pathogen temperatur sensit differ strain histoplasma capsulatum compar myce yeast transition strain histoplasma capsulatum low level virul g184a g222b virul strain differ level pathogen mice morpholog transition ar initi temperatur shift degr degr strain undergo similar physiolog chang ar sever g184a g222b strain transition myce yeast morphologi virul strain ar onethird rapid differ temperatur sensit strain correl temperatur requir complet uncoupl oxid phosphoryl differ sensit elev temperatur extend growth yeast cell strain consid togeth result suggest sensit elev temperatur mai kei factor account differ virul uncoupl oxid phosphoryl mai primari event morpholog transition strain 
87058124 actinsm adenosin triphosphatean blood bank blood preserv blood proteinsm electrophoresi polyacrylamid gel erythrocyt ag erythrocyt membranean human membran proteinsan oxidationreduc phospholipidsan spectrinm support govt ph molecular defect membran skeleton blood bankstor red cell abnorm spectrinprotein 41actin complex format dure liquid preserv blood bank condition red cell membran inexor undergo damag decrea erythrocyt surviv transfusion accordingli survei membran skelet protein interac dure storag uncov decrea vitro format spectrinactin complex absenc presenc protein actual format spectrinactinprotein complex linear fashion dure storag period thi fall spectrinactin interac tightli correl declin total red cell phospholipid measur simultan thi decrem spectrinactin associ restor greater normal valu preincub store spectrin mm dithiothreitol thi storag injuri spectrinactin interac weaken membran skeleton lead decrea red cell surviv vitro rever damag reduc agent suggest possibl new direc prolong shelf life store blood 
87058127 cell movementd chemotact factorspd chemotact factor eosinophilpd eosinophilsd human vitro leukotrien bpd platelet activ factor support nonu govt plateletactiv factor potent chemotact chemokinet factor human eosinophil plateletactiv factor pafaceth inflammatori mediat wide rang biolog activ includ neutrophil aggreg chemotaxi wa studi effect human eosinophil locomo chemotaxi chemokinesi human eosinophil puriti obtain donor varieti disea associ hypereosinophilia pafaceth elicit direc locomo eosinophil dosedepend fashion concentr lysopaf minim activ dose rang compar pafaceth eosinophil locomotori respon leukotrien b4 ltb4 histamin valyl alanyleosinophil chemotact factor anaphylaxi ecfa tetrapeptid wa neglig conver neutrophil respon pafaceth optimum wa compar effect ltb4 optimum dose wa shown pafaceth elicit chemotaxi chemokinesi eosinophil comparison normal densiti light densiti eosinophil reveal qualit differ respon pafaceth chemoattract light densiti cell demonstr greater degr locomo pafaceth ltb4 thu pafaceth appear potent eosinophilotact agent mai plai role inflammatori reaction charact eosinophil infiltr 
87058128 abetalipoproteinemiag apolipoprotein bbigeim human liveran protein process posttransl rna messengeran analysi apolipoprotein gene messeng ribonucl acid abetalipoproteinemia apolipoprotein b100 apob100 gene leukocyt apob100 messeng rna mrna translat apolipoprotein liver normal abetalipoproteinem individu evalu complementari dna probe apob100 cover middl region apob100 mrna util southern blot analysi indic apob100 gene present abetalipoproteinemia major inser deletion polyadenyl hepat apob100 mrna abetalipoproteinem patient wa normal size concentr apob100 mrna wa increa sixfold compar control hepat apob100 mrna level apob100 wa detect hepatocyt abetalipoproteinem patient immunohistochem techniqu result indic biochem defect abetalipoproteinem patient studi consist posttransl defect apob100 process secretion upregul apob100 mrna 
87058129 antibodi monoclonalim bind site blood plateletsm fibrinogenpd glycoproteinsimm human vitro platelet membran glycoproteinsph support govt ph identif new class induc receptor platelet thrombospondin interact platelet gpiibiiiaindepend mechan thrombospondin fibrinogen fibronectin von willebrand factor bind platelet stimul agonist support platelet adh function receptor protein ar associ membran glycoprotein gpiibiiia thrombasthen platelet defici gpiibiiia util examin role thi membran protein interac thrombospondin platelet radioiodin thrombospondin bound thrombinstimul platelet normal thrombasthen donor similar affin capac monitor monoclon antibodi thrombospondin dival iondepend independ pathwai expr endogen pool thrombospondin surfac thrombinstimul platelet normal thrombasthen donor qualit quantit similar gpiibiiia ligand associ gpiibiiia thu ar essenti bind thrombospondin platelet therefor thrombospondin interact uniqu receptor platelet 
87058170 bronchial neoplasmsenpa case report creatin kina isoenzymesbl diagnosi differenti femal human lactat dehydrogenasebl middl ag myocardi infarctiondien plasma enzym chang carcinoma bronchu mimick myocardi infarc letter 
87058174 adult ag ag colon neoplasmss femal human intestin mucosa male middl ag mucinss period acidschiff reaction rectal neoplasmss colorect goblet cell sialomucin heterogen relat malign disea mucu secret colorect cancer differ respect produc normal over reduc loss oacetyl substitu sialic acid increa neutral mucin similar chang report appar normal mucosa border colorect cancer normal left colorect mucosa patient rectal cancer wa studi case wa match ag sex patient diverticular disea patient irrit bowel syndrom twenti patient right cancer match patient crohn disea stain mild period acid schiff mpa select stain nacetyl sialic acid oacetyl group close relat techniqu reaction grade neg weak inten inten reaction wa case wa differ variou match group phenylhydrazin interposi fail block mpa effect indic posit result wa defici sialic acid oacetyl substitu neutral mucin differ stain pattern left right colon probabl differ ratio total sialic acidfuco indic hitherto unsuspect colorect goblet cell sialomucin heterogen gener popul associ neoplast disea appar 

